Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AC091057.5 ENSG00000284906 "Rho GTPase-activating protein 11B " Q3KRB8 15 30624548-30685606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles NA Yes Vesicles "HPA064479: AB_2685272" 0.2 0.1 0.8 10.3 1.8 7.1 0.5 0.7 0.9 0.1 5.1 0.6 0.0 1.1 0.8 0.2 1.8 0.2 0.3 0.2 1.0 0.0 0.1 0.9 2.8 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.6 0.0 1.2 0.3 0.1 0.1 0.4 0.9 1.5 0.8 1.9 1.4 1.0 5.8 2.1 14.4 0.0 1.4 5.7 0.5 0.0 1.0 1.0 1.6 0.3 0.0 0.8 0.0 4.4 2.9 5.0 2.5 0.1 0.6 2.8 4.6 1.9 3.2 3.7 3.0 3.7 2.8 1.8 1.9 3.6 4.0 2.6 1.6 2.8 6.1 3.1 7.4 10.0 1.3 0.0 4.7 5.3 0.2 0.2 2.1 1.6 1.1 2.2 6.6 4.4 8.7 2.2 2.1 3.6 4.0 1.5 2.2 1.5 5.1 5.1 1.3 0.9 2.8 2.4 2.2 5.4 2.0 1.0 1.4 2.5 2.4 2.5 5.0 4.2 2.4 3.9 3.0 3.2 6.1 1.7 5.4 4.0 1.6 0.3 0.2 0.4 0.0 0.0 0.6 0.8 0.6 0.1 1.0 0.1 0.1 0.1 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS6 ADAM-TS6 ENSG00000049192 "ADAM metallopeptidase with thrombospondin type 1 motif 6" Q9UKP5 5 65148736-65481920 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 32.4" "Cell type enhanced" "Detected in many" 7 "B-cells: 16.4;Cytotrophoblasts: 28.3;Muller glia cells: 28.3;Peritubular cells: 17.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 4.8;naive B-cell: 3.6" "Group enriched" "Detected in many" 13 "B-cells: 4.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ: 10.0;HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;hTERT-HME1: 12.2;TIME: 11.5;U-2197: 13.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043441 Enhanced "Secreted to extracellular matrix" NA Yes "HPA043441: AB_2678484" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.70e-3)" "unprognostic (4.33e-2)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (8.24e-2)" "unprognostic (1.65e-2)" "unprognostic (4.77e-2)" "unprognostic (8.04e-2)" "unprognostic (1.56e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-6)" "unprognostic (3.23e-5)" "unprognostic (2.09e-1)" "unprognostic (3.02e-4)" "unprognostic (4.18e-3)" 2.2 0.7 0.9 2.0 0.8 0.3 1.8 0.2 1.8 2.9 1.4 0.8 1.6 0.6 5.1 3.0 1.0 2.7 6.3 2.3 0.8 0.9 1.5 0.5 2.3 1.7 0.8 1.4 1.8 0.5 0.4 2.0 32.4 2.9 2.3 0.9 1.4 0.6 0.9 0.4 0.8 2.4 5.4 3.2 3.4 1.8 1.9 0.7 3.3 0.9 1.2 1.9 3.6 1.7 4.8 0.2 0.0 0.0 0.0 1.4 0.1 2.1 0.0 0.5 0.5 0.0 1.7 0.0 10.0 5.9 6.2 7.4 0.0 0.2 0.0 0.0 3.8 4.4 0.4 0.1 1.9 11.0 1.5 0.0 0.1 3.7 0.2 0.3 0.0 0.5 0.7 0.0 10.2 12.2 3.0 5.5 1.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 2.1 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 1.4 0.0 0.0 11.5 2.4 3.7 13.1 8.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 1.3 0.0 1.0 4.8 0.3 0.5 0.0 3.6 1.3 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.8 0.2 1.4 0.8 0.9 0.8 1.4 2.9 0.7 0.0 0.0 16.4 0.0 0.2 7.8 2.2 0.0 0.0 0.0 3.5 0.0 28.3 0.0 0.7 12.3 9.9 0.0 0.0 0.0 3.5 4.0 0.1 1.1 0.0 2.2 0.0 0.0 5.5 0.0 6.4 11.2 2.9 0.0 0.0 0.6 28.3 1.7 0.0 17.0 0.8 0.7 6.5 4.1 4.9 1.3 0.0 11.9 0.0 0.2 0.0 ADGRE5 "CD97, TM7LN1" ENSG00000123146 "Adhesion G protein-coupled receptor E5" P48960 19 14380501-14408725 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA013707 Enhanced Approved Cytosol "Secreted to blood" NA Yes 10000000 930000 Cytosol "HPA013707: AB_1846345" "unprognostic (3.16e-1)" "unprognostic (1.80e-1)" "unprognostic (5.10e-2)" "unprognostic (2.30e-1)" "unprognostic (2.85e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.51e-2)" "unprognostic (6.06e-3)" "unprognostic (3.14e-2)" "unprognostic (1.08e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (2.08e-2)" "unprognostic (4.14e-2)" "unprognostic (2.44e-2)" "unprognostic (6.41e-2)" 17.7 8.9 2.5 23.0 4.0 55.3 14.3 1.1 5.2 21.7 15.9 12.9 0.5 12.9 56.9 18.5 11.6 19.1 27.1 16.4 3.0 2.4 10.7 15.5 30.3 41.1 6.3 3.2 10.7 16.2 2.4 3.3 18.2 5.9 11.3 9.0 6.9 17.0 3.6 12.5 6.0 22.2 36.2 4.2 56.9 15.0 6.9 4.9 24.3 8.6 3.7 22.5 34.7 12.4 3.9 13.3 95.3 43.2 22.8 25.8 23.3 30.8 21.9 0.2 21.0 9.3 15.3 3.3 21.4 34.5 15.4 16.9 6.2 31.3 3.5 21.7 27.5 22.0 7.3 5.7 10.4 6.9 19.2 6.4 6.9 32.5 2.7 11.5 14.9 32.3 6.7 0.3 15.7 5.4 5.0 1.5 6.1 9.0 27.7 16.8 6.9 0.9 20.0 0.6 24.5 27.3 2.0 9.2 16.1 5.2 2.7 0.2 0.7 12.2 17.5 15.2 0.5 4.5 13.8 3.7 5.2 8.7 21.7 35.2 0.0 0.1 0.2 18.7 26.7 19.5 42.0 18.6 95.3 25.8 36.7 17.3 3.9 13.1 17.8 13.3 2.6 9.4 12.8 82.7 22.8 43.2 6.4 9.0 23.3 2.5 4.0 1.1 5.2 3.0 2.4 6.3 3.2 5.9 4.9 32.8 102.4 15.9 7.4 0.0 0.2 3.1 12.7 50.9 31.8 0.0 0.0 2.7 0.0 15.1 0.0 4.5 10.2 23.3 19.1 36.8 4.8 9.8 70.9 1.5 47.0 0.0 4.7 26.4 83.8 1.0 6.1 50.6 0.0 2.8 34.7 2.3 17.9 21.0 4.6 0.7 1.2 25.8 17.2 0.5 5.7 0.0 6.6 152.3 31.8 14.1 AKIRIN2 "C6orf166, dJ486L4.2, FLJ10342" ENSG00000135334 "Akirin 2" Q53H80 6 87675072-87702209 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064239 Supported Nucleoplasm No Yes Nucleoplasm "HPA064239: AB_2685222" "unprognostic (9.65e-2)" "unprognostic (2.56e-1)" "unprognostic (8.25e-2)" "unprognostic (8.09e-2)" "unprognostic (3.58e-1)" "unprognostic (1.87e-2)" "unprognostic (1.07e-1)" "unprognostic (5.38e-2)" "unprognostic (6.17e-2)" "unprognostic (6.60e-3)" "unprognostic (1.62e-2)" "unprognostic (2.56e-1)" "unprognostic (1.48e-2)" "unprognostic (9.62e-2)" "unprognostic (9.55e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" 27.9 24.1 23.7 19.9 27.0 53.4 22.0 19.3 27.8 13.7 14.1 17.5 10.3 11.4 16.3 22.5 20.5 16.2 14.4 20.1 22.1 21.1 14.8 27.8 21.9 34.5 19.3 18.6 20.7 8.5 12.0 15.5 16.7 17.3 13.4 11.9 21.3 15.5 11.6 54.2 12.9 13.6 15.9 20.2 35.7 12.1 20.7 14.7 45.0 14.1 14.8 26.1 21.4 14.9 15.4 27.0 51.9 25.6 12.5 13.6 11.1 10.4 11.4 32.7 18.5 20.8 14.4 19.2 18.7 12.0 15.7 15.5 18.0 8.2 27.8 20.3 19.3 25.8 16.2 18.2 13.6 18.1 35.3 22.6 16.1 10.3 40.2 22.7 13.7 13.9 16.6 14.1 19.2 19.2 15.2 17.1 11.2 31.2 19.4 20.2 13.8 4.3 28.3 23.2 9.1 17.8 17.2 23.3 11.3 19.4 9.4 24.6 23.4 11.4 6.7 18.2 19.6 8.2 32.8 21.7 12.9 8.7 10.8 24.2 18.8 20.9 17.6 14.1 18.1 20.5 23.1 20.6 21.7 10.7 25.6 11.0 15.4 10.5 10.3 19.5 12.6 8.3 8.7 51.9 12.5 24.6 27.0 13.6 11.1 23.7 27.0 19.3 24.5 22.1 21.1 19.3 18.6 17.3 14.7 23.8 16.6 44.6 173.9 85.7 12.9 18.5 28.1 4.0 19.4 17.4 7.9 40.7 38.1 26.5 41.2 28.6 13.7 23.3 12.9 57.9 48.3 99.6 32.4 25.8 69.7 11.1 11.6 38.6 81.5 82.9 33.1 86.1 70.9 25.2 8.3 53.7 23.7 10.5 26.5 40.8 14.2 6.5 48.6 61.8 46.9 81.2 114.2 55.8 10.9 178.8 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 58.0;Ito cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.0 22.5 1.4 0.0 0.5 0.0 3.7 3.1 8.5 1.0 0.8 0.0 40.9 0.0 10.3 39.3 25.8 13.6 0.0 25.1 1.2 1.7 0.1 0.0 2.2 0.0 0.8 0.2 0.3 0.2 4.4 26.9 13.3 69.7 3.2 0.2 1.7 0.0 39.3 0.4 0.7 0.0 0.9 4.5 5.7 0.0 10.1 0.0 11.6 53.8 4.1 0.0 16.2 1.9 0.1 0.8 2.4 0.2 0.8 0.5 32.6 0.3 25.1 0.3 0.0 0.0 2.1 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 8.9 1.9 5.9 10.4 2.2 21.1 0.8 0.0 2.7 6.8 1.8 0.0 0.7 1.7 4.3 1.2 4.5 0.0 0.0 17.0 23.1 6.7 5.2 6.9 0.8 4.4 0.0 58.0 30.7 3.8 0.9 2.3 2.3 1.7 8.2 2.5 14.9 26.7 0.8 0.7 0.0 4.1 0.0 25.5 0.3 0.7 0.4 7.1 4.4 0.2 13.4 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921276 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 81 "heart muscle: 398.9;skeletal muscle: 333.3" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 12578.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA038736: AB_2676184" "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 1.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 2.1 1.5 0.1 0.1 398.9 0.0 0.0 0.1 0.1 4.5 0.2 0.0 0.0 0.1 0.4 0.1 0.1 0.7 0.1 0.9 0.1 0.0 0.8 0.1 333.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 2.9 1.6 0.5 0.3 0.0 0.4 0.5 1.9 0.6 0.9 0.4 0.2 2.9 0.8 0.5 0.0 0.4 0.5 0.0 1.7 0.1 0.5 0.9 38.0 1.4 0.0 104.9 0.1 4.0 1.0 0.1 0.2 1.3 0.1 0.1 0.0 0.2 11.7 2.3 0.0 0.0 3.7 0.0 0.7 1.8 57.1 35.8 0.0 0.0 0.0 128.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 41.0 0.0 0.1 179.4 0.3 13.8 0.2 14.1 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.2 0.4 0.4 0.3 0.7 0.9 0.6 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 848.6 37.7 0.0 1.3 0.0 0.0 12578.5 10.2 1.4 9.1 0.0 0.0 0.1 0.0 19.0 2.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 3.5 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 68.4 14.4 12.0 9.1 1.6 4.2 12.9 43.2 25.3 52.2 39.2 9.8 21.2 3.4 12.5 21.8 27.8 35.3 9.4 25.2 100.3 2.3 6.8 4.7 16.2 8.1 0.2 6.7 5.5 0.9 1.1 34.0 22.4 6.2 16.2 4.6 9.8 7.3 42.5 10.3 5.7 7.8 13.3 10.5 15.2 4.2 36.0 2.3 11.5 11.2 5.1 6.0 22.7 26.4 3.9 17.4 17.8 7.7 15.3 32.7 36.8 19.2 50.4 3.0 4.8 6.4 11.1 10.9 68.6 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 0.0 0.6 0.0 1.0 12.6 0.0 0.6 0.0 2.7 1.2 0.0 0.0 2.5 0.0 0.5 106.8 0.1 0.9 0.0 0.2 20.2 3.5 1.3 0.0 0.0 8.0 0.0 0.0 1.8 1.5 41.2 1.1 2.6 0.0 0.0 2.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 20.9 14.9 8.2 2.4 1.5 1.6 1.4 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 sigma 1 subunit" P61966 7 101154400-101161596 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 291.8;Proximal tubular cells: 208.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" NA Yes "Golgi apparatus, Vesicles" "HPA060945: AB_2684393" "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 7.6 9.7 30.6 7.9 41.1 3.0 10.8 7.9 45.8 6.8 16.5 6.4 4.6 23.3 6.6 10.6 10.9 8.9 9.3 4.2 22.9 14.6 16.6 15.5 6.7 6.9 12.3 25.3 7.9 8.0 6.3 10.5 10.2 10.1 10.9 14.2 4.6 10.4 6.1 3.5 12.3 18.0 7.9 8.7 7.7 13.2 6.9 9.3 4.7 9.3 7.4 8.5 8.7 6.1 4.4 8.2 2.1 5.5 1.9 5.9 4.2 26.4 21.5 14.5 27.4 10.7 17.6 31.4 17.8 12.1 12.1 12.9 11.5 33.8 5.9 31.1 19.4 23.5 13.2 8.3 27.3 10.8 13.4 13.4 4.0 13.5 14.3 13.2 10.8 20.1 19.7 20.9 11.9 5.2 18.1 17.9 13.4 12.9 24.0 29.9 66.0 9.0 23.4 23.1 39.2 43.4 5.7 6.6 12.4 29.1 22.6 11.4 37.3 10.1 26.8 32.4 24.9 11.8 10.1 18.5 17.5 30.5 6.6 12.2 5.4 11.3 11.4 44.4 12.0 35.1 0.8 5.5 0.5 4.2 4.9 3.7 4.4 5.9 4.7 7.4 3.8 3.5 3.2 2.1 1.9 2.8 8.2 5.5 4.2 30.6 41.1 7.9 35.1 22.9 14.6 12.3 25.3 10.1 9.3 6.0 0.0 18.5 25.1 34.5 26.2 1.1 50.9 0.0 2.3 52.4 7.9 145.9 291.8 115.8 1.0 22.5 124.9 0.0 97.6 75.8 26.7 26.8 5.7 37.6 83.8 28.6 86.6 25.2 24.7 2.0 32.5 23.2 50.6 83.0 83.1 23.6 132.7 74.8 20.5 208.8 16.4 19.4 13.3 10.1 80.0 39.6 50.6 15.2 96.8 26.8 APEX2 "APE2, APEXL2, XTH2, ZGRF2" ENSG00000169188 "Apurinic/apyrimidinic endodeoxyribonuclease 2" Q9UBZ4 X 55000357-55009057 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" "DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048577 Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Vesicles "HPA048577: AB_2680448" "unprognostic (2.90e-2)" "prognostic favorable (6.17e-4)" "unprognostic (4.32e-2)" "unprognostic (2.39e-1)" "unprognostic (1.62e-1)" "unprognostic (5.62e-2)" "prognostic unfavorable (6.13e-7)" "unprognostic (5.89e-2)" "unprognostic (4.87e-2)" "prognostic favorable (5.21e-4)" "unprognostic (7.46e-2)" "unprognostic (3.16e-1)" "unprognostic (6.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.17e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.63e-4)" 11.1 12.8 8.6 12.0 12.3 11.9 10.2 8.7 11.8 10.0 12.3 13.7 8.2 12.3 11.5 12.6 20.8 10.7 13.9 10.6 8.7 7.2 15.4 18.5 10.3 14.2 9.7 6.0 14.4 10.7 10.7 12.7 17.8 8.8 11.0 15.1 9.1 10.4 10.0 10.3 16.7 18.7 10.0 9.9 18.0 10.8 7.7 8.9 21.9 10.6 10.2 27.4 11.6 12.7 6.7 9.4 9.2 9.9 26.6 7.5 6.3 22.0 19.9 7.9 11.4 11.5 7.7 13.4 9.1 12.3 17.7 17.3 10.8 18.6 14.6 14.3 8.6 20.9 16.6 18.0 17.3 13.4 11.8 13.7 17.8 19.8 11.0 7.4 10.9 16.8 7.6 14.2 24.9 9.0 8.4 14.0 15.6 9.1 9.9 13.1 21.5 14.7 14.3 15.6 10.5 24.0 13.1 13.1 15.9 9.5 11.1 7.3 8.0 17.2 20.9 8.8 18.8 16.5 8.5 8.1 10.5 15.3 21.1 11.8 10.4 13.3 12.1 11.2 18.7 12.4 9.2 7.8 8.5 7.5 9.9 6.2 6.1 7.1 7.4 9.4 6.7 6.4 6.2 2.9 26.6 8.3 5.1 7.5 6.3 8.6 12.3 8.7 11.8 8.7 7.2 9.7 6.0 8.8 8.9 3.0 16.9 15.2 10.8 11.4 3.2 4.7 10.2 12.0 9.1 10.4 0.0 43.2 13.3 21.7 0.2 7.7 13.7 70.0 13.2 28.4 7.0 7.8 8.1 10.2 21.2 6.4 5.8 8.6 8.6 0.8 5.5 13.5 0.0 29.7 11.1 5.8 15.0 14.8 8.1 15.8 2.1 19.4 4.4 1.0 10.8 11.0 39.8 15.8 11.3 10.0 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639949 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.9 1.5 2.0 17.2 2.9 16.4 3.3 1.1 3.9 1.6 5.4 1.6 0.5 4.3 2.3 0.5 7.5 0.5 4.1 1.4 2.2 1.9 0.8 1.2 2.0 9.4 4.4 0.8 0.8 3.1 0.9 1.0 4.7 2.0 1.2 6.7 0.8 2.0 0.5 1.7 3.2 9.6 3.3 8.9 5.0 2.6 6.4 1.9 35.0 1.0 5.3 10.3 2.6 2.7 0.9 1.7 2.6 1.8 0.5 3.8 1.1 23.5 25.4 20.3 13.4 1.4 3.8 12.2 23.9 13.8 22.8 17.6 17.5 12.0 13.7 7.6 14.0 26.1 17.5 14.3 12.5 30.8 26.9 8.3 43.4 22.9 8.9 0.5 32.3 17.4 1.2 1.5 18.3 14.5 4.3 16.8 27.0 30.0 32.6 26.4 9.6 16.9 10.8 12.7 19.7 14.9 20.1 45.5 10.7 8.1 12.5 19.6 13.5 25.1 13.0 5.4 11.0 18.5 31.0 12.9 30.8 22.8 12.9 25.4 11.9 18.8 37.8 13.2 38.4 26.9 0.1 1.1 2.6 2.3 1.8 0.9 0.9 3.8 3.3 1.7 0.7 1.5 2.0 0.0 0.5 0.3 0.6 2.8 1.1 2.0 2.9 1.1 3.9 2.2 1.9 4.4 0.8 2.0 1.9 0.0 2.9 1.5 0.9 4.2 0.0 0.8 5.1 1.4 2.3 1.8 0.0 2.5 0.0 0.8 2.9 1.1 0.5 0.0 0.7 20.0 1.1 1.0 0.0 1.0 8.0 0.0 0.0 2.5 4.1 3.4 0.6 3.2 0.0 3.6 3.7 0.0 0.5 1.1 0.4 0.2 0.9 6.5 0.9 24.4 18.6 1.9 2.6 3.2 5.1 1.4 ARHGEF39 "C9orf100, FLJ14642" ENSG00000137135 "Rho guanine nucleotide exchange factor 39" Q8N4T4 9 35658875-35675866 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.0" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 86.7;Erythroid cells: 46.7;Late spermatids: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 2.4" "Low region specificity" "Detected in all" HPA061299 Uncertain NA Yes "HPA061299: AB_2684473" "unprognostic (2.93e-1)" "unprognostic (3.90e-1)" "unprognostic (3.31e-2)" "unprognostic (3.40e-2)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (3.60e-2)" "unprognostic (8.55e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.14e-1)" "unprognostic (9.75e-2)" "unprognostic (6.04e-9)" "unprognostic (3.31e-3)" "unprognostic (3.38e-1)" "unprognostic (5.14e-2)" "unprognostic (1.46e-1)" 1.6 1.4 0.6 10.0 0.6 3.3 1.3 1.7 0.6 1.4 3.7 0.3 0.7 4.1 2.1 1.6 5.6 0.5 3.6 0.9 1.0 0.6 0.9 1.0 1.4 3.7 0.6 0.0 0.8 1.6 0.0 0.6 2.8 0.6 0.8 2.1 0.4 1.4 0.7 0.6 2.0 5.5 1.4 0.6 2.0 2.7 2.9 0.1 18.0 0.5 1.7 7.1 0.9 1.7 1.8 0.9 1.4 1.2 1.7 3.6 0.7 5.3 8.3 7.9 3.9 0.1 0.3 5.3 4.0 1.5 3.5 3.1 9.2 4.3 3.3 2.4 0.6 4.8 4.2 3.9 2.3 1.4 9.8 6.2 5.4 10.7 3.3 0.0 4.5 8.1 0.3 0.2 1.7 1.0 1.2 1.3 4.9 3.7 3.1 1.5 2.7 1.1 2.5 5.0 3.8 2.7 4.5 6.1 2.0 1.3 2.3 5.6 2.2 2.0 4.4 1.2 3.3 6.5 2.6 0.8 2.6 8.3 2.9 2.8 3.1 3.7 1.5 1.5 2.4 5.5 1.2 1.0 0.8 2.4 0.7 3.6 0.9 1.7 2.4 0.9 1.8 0.6 1.6 1.4 1.7 1.2 0.8 1.9 0.7 0.6 0.6 1.7 0.6 1.0 0.6 0.6 0.0 0.6 0.1 0.0 0.0 2.7 1.4 2.4 1.7 1.0 2.5 1.4 1.2 1.8 0.0 1.4 0.0 0.8 86.7 1.1 1.0 46.7 0.7 16.7 1.9 0.9 0.0 0.6 4.4 0.0 3.4 1.8 3.1 30.7 0.9 2.5 5.0 0.0 2.4 1.9 0.6 0.0 0.4 0.3 1.8 0.0 1.7 2.6 3.3 1.8 1.6 1.9 3.6 0.7 ARID1A "B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1" ENSG00000117713 "AT-rich interaction domain 1A" O14497 1 26693236-26782110 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005456, CAB016334" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016334: AB_673396, HPA005456: AB_1078205" "unprognostic (2.83e-1)" "unprognostic (1.81e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" "unprognostic (7.76e-2)" "unprognostic (1.01e-2)" "unprognostic (1.62e-2)" "unprognostic (6.05e-2)" "unprognostic (2.66e-1)" "unprognostic (6.54e-2)" 18.6 18.4 17.4 24.9 17.0 33.8 27.8 23.6 19.1 20.3 23.7 21.7 23.9 15.8 24.1 17.3 23.2 20.6 21.9 15.5 14.8 12.8 13.7 15.9 18.8 35.6 20.3 19.2 24.1 23.9 27.5 15.8 19.3 17.2 16.5 16.4 18.9 21.4 23.1 22.6 20.6 20.7 18.4 15.4 25.9 19.5 16.5 19.8 57.3 24.8 14.2 24.5 24.4 20.4 4.3 5.3 7.4 3.3 4.7 5.1 3.5 19.2 18.3 25.9 27.0 7.5 7.2 12.2 9.0 7.9 12.4 8.8 13.3 13.0 27.2 7.9 11.7 7.8 11.7 22.5 10.0 14.5 33.6 8.8 23.1 11.9 8.9 6.2 34.2 7.4 8.3 7.1 14.6 10.5 6.9 10.6 19.7 27.6 30.5 8.0 9.1 28.8 13.3 27.4 12.5 8.5 30.1 17.1 15.4 7.7 13.0 24.3 20.0 15.8 13.4 10.9 15.0 3.9 19.4 18.7 13.3 12.9 12.4 14.6 14.5 19.1 12.5 8.1 21.9 11.7 0.4 3.3 2.9 4.0 2.9 5.1 4.3 3.2 4.9 3.1 4.3 4.0 4.4 7.4 4.7 2.8 5.3 1.5 3.5 17.4 17.0 23.6 19.1 14.8 12.8 20.3 19.2 17.2 19.8 56.6 36.8 33.6 18.1 65.3 60.2 31.1 28.1 25.4 28.4 36.6 49.1 31.8 1.7 31.8 14.2 37.2 28.4 0.0 32.5 32.1 42.6 39.3 56.9 53.9 43.0 69.9 45.7 51.0 93.5 7.5 35.6 45.4 38.8 34.3 56.1 31.2 40.3 31.6 39.3 14.5 37.1 51.8 27.2 46.0 55.3 82.4 30.7 41.2 46.0 27.7 ARL4A ARL4 ENSG00000122644 "ADP ribosylation factor like GTPase 4A" P40617 7 12686856-12690934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Group enriched" "Detected in all" 6 "Early spermatids: 1213.7;Late spermatids: 2876.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;K-562: 73.5" "Low region specificity" "Detected in all" HPA064513 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064513: AB_2685276" "unprognostic (8.29e-2)" "unprognostic (1.34e-1)" "unprognostic (3.94e-1)" "unprognostic (4.97e-2)" "unprognostic (3.88e-2)" "unprognostic (7.43e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-2)" "unprognostic (7.27e-3)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (9.42e-3)" "unprognostic (9.49e-3)" 22.6 3.6 12.3 6.7 6.7 30.8 21.5 3.0 15.8 16.9 19.4 3.2 7.4 11.3 13.6 9.9 23.5 11.0 7.5 7.0 6.0 4.6 5.2 6.6 8.6 9.5 10.3 11.0 5.2 3.5 1.8 5.6 19.2 8.5 12.0 13.7 4.0 39.0 6.8 4.2 34.9 44.6 12.8 6.5 9.5 10.3 71.2 6.7 3.7 8.8 9.2 6.5 10.5 25.0 22.8 7.4 3.3 15.4 6.5 17.6 7.3 10.1 10.9 29.0 61.8 4.7 7.8 0.0 4.1 3.8 6.8 4.1 9.6 7.7 0.0 1.8 5.8 17.5 2.9 6.4 5.3 6.9 2.2 4.8 2.1 14.2 8.9 9.7 8.9 3.8 3.5 21.1 4.0 17.9 4.3 16.3 4.1 73.5 10.0 6.9 4.4 0.4 12.6 10.5 29.7 12.5 0.0 10.1 4.7 9.0 4.9 5.3 5.0 6.9 7.3 1.4 7.8 3.6 7.3 5.6 2.7 9.7 10.3 16.7 4.6 6.0 2.3 7.1 3.7 10.9 3.3 7.8 0.3 6.3 13.0 17.6 21.4 15.0 9.7 7.4 22.8 7.4 6.1 1.1 6.5 15.4 6.6 8.9 7.3 12.3 6.7 3.0 15.8 6.0 4.6 10.3 11.0 8.5 6.7 20.8 20.7 36.3 179.9 301.7 21.4 12.9 40.8 100.4 60.3 19.2 80.5 129.5 23.2 34.7 1213.7 160.4 353.7 23.3 25.7 18.5 63.5 47.1 78.5 18.7 55.4 3.2 60.0 103.2 124.4 2876.1 63.9 134.7 114.7 54.1 63.0 9.4 39.9 112.2 25.1 13.0 114.7 12.9 42.2 236.6 53.4 205.1 371.3 38.3 56.5 52.6 ARL6IP1 "AIP1, ARL6IP, ARMER, KIAA0069, SPG61" ENSG00000170540 "ADP ribosylation factor like GTPase 6 interacting protein 1" Q15041 16 18791667-18801678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA045307 Uncertain Approved "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (2.42e-1)" "unprognostic (3.47e-2)" "unprognostic (4.07e-3)" "unprognostic (1.12e-1)" "unprognostic (1.54e-1)" "unprognostic (2.60e-3)" "unprognostic (2.58e-2)" "unprognostic (1.76e-2)" "unprognostic (3.88e-2)" "unprognostic (6.83e-2)" "unprognostic (1.91e-3)" "unprognostic (3.33e-2)" "unprognostic (1.13e-2)" "unprognostic (7.09e-2)" "unprognostic (4.60e-2)" "unprognostic (6.32e-3)" "unprognostic (5.36e-3)" 29.6 40.9 75.9 16.5 62.0 40.2 26.2 76.5 93.0 19.5 31.5 28.6 13.8 31.4 16.7 29.7 19.8 20.5 30.2 8.8 65.7 70.1 35.1 80.7 18.0 27.0 65.2 44.6 24.7 18.6 45.1 13.4 20.3 68.6 18.1 29.0 40.9 18.6 17.4 8.3 14.8 27.5 16.0 43.0 20.4 27.8 28.1 20.4 33.1 26.2 11.3 24.9 27.8 14.2 41.2 57.2 40.1 32.4 44.1 67.7 63.0 48.3 44.2 58.8 45.9 21.1 13.6 52.6 28.3 27.3 44.0 35.2 27.1 117.2 42.3 51.9 27.1 29.6 53.1 42.1 19.9 51.2 54.1 19.0 30.0 27.3 73.7 16.8 42.4 32.1 11.3 19.4 30.4 31.9 32.6 43.9 25.0 32.7 44.1 84.6 43.8 29.8 32.1 72.2 42.4 15.1 50.8 73.8 35.9 47.2 27.3 35.8 40.7 62.2 39.0 27.9 41.4 80.0 42.9 24.2 28.9 27.2 20.5 50.5 15.0 26.6 51.0 25.8 29.0 55.8 40.1 32.4 20.9 48.7 30.0 44.7 41.2 43.2 52.4 32.0 38.3 38.5 45.8 27.7 44.1 30.9 57.2 67.7 63.0 75.9 62.0 76.5 93.0 65.7 70.1 65.2 44.6 68.6 20.4 62.5 47.7 99.8 227.5 331.0 171.8 27.4 341.4 91.0 61.4 272.2 123.7 218.9 147.6 292.3 62.1 144.0 214.0 677.5 180.9 329.7 163.0 191.1 134.8 383.9 223.1 84.2 140.0 177.4 230.1 29.6 78.6 248.9 190.6 385.9 155.5 189.5 210.1 217.5 104.3 161.1 161.3 90.5 101.1 73.5 56.8 285.4 273.1 186.2 246.9 307.2 ASF1B FLJ10604 ENSG00000105011 "Anti-silencing function 1B histone chaperone" Q9NVP2 19 14119509-14136956 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 39.2;lymphoid tissue: 45.1;testis: 45.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 35.5;Extravillous trophoblasts: 30.7;Spermatocytes: 54.1;Spermatogonia: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 7 "neutrophil: 39.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 39.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054036, HPA069385" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA054036: AB_2682350, HPA069385: " "unprognostic (3.14e-1)" "prognostic favorable (4.45e-5)" "unprognostic (2.41e-3)" "unprognostic (2.40e-1)" "unprognostic (2.15e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.87e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.48e-3)" "prognostic unfavorable (2.22e-16)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (3.92e-2)" "unprognostic (4.31e-2)" 1.3 1.6 0.7 15.1 1.3 10.0 0.9 0.3 0.8 2.0 7.2 0.8 1.1 4.9 0.9 1.9 9.3 0.7 3.0 1.2 0.6 0.4 1.5 1.4 3.1 11.5 0.9 0.3 1.0 0.8 0.0 0.9 3.8 0.9 0.9 7.6 0.7 2.0 0.3 0.7 2.9 5.2 1.5 1.0 6.4 3.1 45.2 0.6 45.1 0.7 6.4 14.0 1.9 2.9 0.8 0.8 39.2 5.2 1.0 3.3 2.0 28.6 11.1 17.5 13.3 1.7 1.6 7.6 15.2 12.5 28.6 36.2 11.5 14.1 27.4 14.0 7.7 12.1 17.6 18.6 10.6 22.5 24.3 13.4 25.9 23.5 8.0 0.1 17.4 16.2 0.3 0.7 16.0 5.5 3.2 11.1 20.0 22.3 38.4 14.0 32.6 35.3 14.8 8.0 30.2 27.1 34.1 25.9 22.6 8.9 12.4 21.4 7.8 18.0 13.3 7.6 4.9 10.0 18.0 5.4 16.6 10.3 41.9 25.1 20.6 20.8 35.0 13.2 32.0 16.1 0.4 4.0 1.0 1.4 5.2 0.8 0.8 1.2 1.5 0.8 0.8 0.7 1.3 39.2 1.0 5.1 0.3 3.3 2.0 0.7 1.3 0.3 0.8 0.6 0.4 0.9 0.3 0.9 0.6 0.0 1.1 4.5 2.3 2.3 0.0 0.4 2.5 0.0 1.2 0.0 0.0 9.2 0.0 1.3 35.5 0.1 2.9 23.3 1.1 30.7 0.4 0.8 4.6 0.0 17.8 0.0 1.2 0.6 7.1 22.9 0.0 4.2 1.7 1.8 3.4 0.4 0.8 2.9 0.7 0.0 0.7 0.0 0.2 54.1 88.8 1.0 8.7 4.4 7.1 0.9 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Cell type enhanced" "Detected in many" 16 "Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 20.1 11.3 18.3 11.2 1.1 2.5 6.9 16.1 11.3 16.0 12.7 7.8 15.7 20.5 5.7 12.6 7.0 20.3 15.7 6.4 20.0 18.5 11.9 14.4 26.5 7.5 0.2 21.5 10.3 0.2 0.6 12.8 9.0 4.1 16.8 16.6 18.0 24.4 16.4 7.9 17.2 10.0 8.3 16.2 3.1 13.2 25.2 15.1 5.8 5.5 9.6 13.7 22.9 11.8 5.1 11.8 13.2 8.9 12.8 9.9 9.7 17.0 29.2 7.0 9.5 11.9 7.8 5.9 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 0.0 0.6 3.7 0.6 5.5 0.0 1.0 0.0 0.0 1.2 1.8 0.0 6.4 0.0 0.3 2.9 0.3 0.3 70.0 0.0 13.2 1.3 0.7 1.1 1.0 9.3 0.0 0.0 1.8 4.0 3.3 0.6 3.1 0.0 1.0 1.5 0.5 0.4 0.0 1.4 0.0 0.3 0.0 0.0 32.6 30.2 3.0 3.1 4.9 4.9 1.7 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 74.6;Spermatogonia: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 75.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.5 9.9 14.2 4.8 2.5 3.2 6.2 20.0 6.9 17.3 19.3 7.5 11.1 16.7 6.1 6.3 6.8 12.2 18.9 6.4 27.8 23.2 10.1 30.0 10.7 15.2 1.0 10.9 14.9 1.0 1.0 16.4 5.4 3.7 5.2 9.8 14.0 17.0 12.8 26.4 31.4 8.2 2.5 19.3 9.9 16.4 16.9 9.0 6.1 11.7 18.2 7.9 29.0 75.6 5.1 6.0 15.4 10.4 3.2 13.1 18.1 10.3 24.0 5.5 9.8 15.5 8.6 18.4 10.2 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 6.0 8.3 14.2 19.9 14.1 2.5 22.9 2.5 5.3 11.4 3.5 3.9 8.2 1.7 2.4 46.2 6.7 2.2 23.3 1.9 21.2 7.3 19.9 13.9 14.0 9.7 1.6 1.2 9.2 11.1 17.9 6.9 6.6 1.7 5.4 4.4 5.2 2.7 3.5 13.1 0.9 2.1 0.0 8.6 74.6 90.7 10.7 11.3 15.3 12.8 24.8 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Group enriched" "Detected in many" 6 "Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.6 28.6 42.7 20.5 0.9 1.4 16.4 20.0 10.8 41.5 38.3 37.0 12.6 41.6 10.4 7.9 17.3 30.7 30.9 13.7 34.3 18.2 50.8 24.8 16.4 31.2 0.1 13.0 24.4 0.7 0.6 24.3 15.2 4.1 19.0 27.4 15.4 16.1 18.1 19.8 47.5 18.6 26.5 13.7 12.7 32.2 39.3 17.2 9.0 8.2 9.3 13.2 17.8 8.0 13.6 13.3 14.0 8.8 7.4 16.6 17.1 14.9 52.0 11.8 7.8 31.3 8.0 19.9 33.6 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 0.0 0.3 2.2 0.3 3.9 0.0 1.1 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.4 46.7 0.0 76.2 4.7 0.4 4.6 0.6 23.9 0.0 0.0 4.9 6.3 0.0 0.6 4.4 1.7 0.0 4.2 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.3 0.7 2.0 2.0 7.6 2.5 6.3 1.4 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219203-41261766 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Kupffer cells: 104.4;Sertoli cells: 207.0;Smooth muscle cells: 341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 8.8;plasmacytoid DC: 18.3" "Group enriched" "Detected in many" 14 "dendritic cells: 18.3;NK-cells: 8.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 67.0;U-251 MG: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" NA Yes 12100000 61000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 38.0 15.4 10.6 11.7 12.7 1.3 27.1 6.3 12.1 26.2 26.8 13.4 8.1 9.1 28.0 19.4 21.8 17.4 17.8 18.5 11.5 6.1 7.8 13.0 20.0 7.6 10.6 9.3 20.9 5.1 9.6 5.6 26.6 10.1 19.5 10.2 16.8 7.8 20.4 14.1 13.8 12.8 29.4 10.7 27.3 16.2 22.4 10.4 3.4 12.0 8.4 5.8 35.6 18.3 0.1 18.3 0.9 0.2 8.8 0.3 0.2 53.3 21.4 1.3 0.1 4.8 4.9 0.0 42.3 38.1 62.2 38.6 1.1 25.1 0.0 17.2 67.0 32.5 4.5 0.0 28.5 53.6 0.0 0.0 0.0 14.2 0.8 17.6 0.0 0.0 3.7 0.5 36.6 56.9 35.3 23.0 0.0 2.0 0.0 38.5 0.0 0.0 0.0 0.5 0.1 10.3 0.0 22.7 0.0 27.8 0.0 0.0 0.0 10.9 0.0 0.2 8.2 0.1 0.9 47.2 44.1 30.1 42.1 71.7 0.0 0.1 0.1 29.4 0.0 32.8 0.9 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 4.2 0.1 0.2 0.2 0.3 8.8 0.1 18.3 0.2 0.2 10.6 12.7 6.3 12.1 11.5 6.1 10.6 9.3 10.1 10.4 8.9 2.2 0.5 72.4 37.1 0.0 4.2 0.0 4.0 5.7 5.2 0.0 2.3 0.0 4.0 8.6 2.9 0.0 0.0 0.2 1.7 91.1 28.0 0.0 0.0 26.7 1.6 0.0 13.5 104.4 2.7 57.0 49.8 25.3 4.6 0.0 28.7 8.9 0.0 75.0 0.0 1.1 207.0 341.9 0.5 2.1 25.5 9.6 2.5 0.0 26.4 BIRC5 "API4, EPR-1, survivin" ENSG00000089685 "Baculoviral IAP repeat containing 5" O15392 17 78214186-78225636 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Protease inhibitor, Repressor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.6;testis: 51.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.9;Erythroid cells: 116.8;Extravillous trophoblasts: 134.7;Spermatocytes: 133.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 14.0" "Lineage enriched" "Detected in many" 6 "T-cells: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA002830, CAB004270" Enhanced Supported "Cytokinetic bridge" Yes Yes "Cytokinetic bridge" "CAB004270: AB_628302, HPA002830: AB_1857672" "unprognostic (8.04e-2)" "unprognostic (3.51e-2)" "unprognostic (4.48e-3)" "unprognostic (2.72e-3)" "unprognostic (3.37e-1)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.28e-6)" "prognostic unfavorable (4.49e-4)" "unprognostic (3.56e-3)" "unprognostic (4.53e-3)" "unprognostic (2.87e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" 2.3 1.5 0.4 14.1 0.7 20.8 5.3 0.7 0.6 1.9 4.8 0.3 0.2 4.6 0.9 1.4 13.4 0.4 2.2 2.4 0.5 0.4 1.3 2.2 2.4 9.7 0.6 0.2 0.9 0.8 0.0 0.4 6.1 0.5 0.9 5.2 0.2 2.1 0.2 0.6 3.5 4.7 2.4 0.7 6.3 3.2 51.4 0.3 61.6 0.5 14.4 11.7 2.0 3.2 2.5 0.8 0.5 0.0 2.2 14.0 3.0 32.0 30.0 27.1 29.3 1.7 2.8 10.0 24.7 13.9 35.3 23.2 24.5 12.7 33.1 10.1 14.3 26.7 17.1 27.4 15.8 30.9 11.1 38.0 21.8 17.7 28.8 0.2 20.9 16.4 0.9 1.1 19.5 14.5 5.1 24.9 25.0 27.3 28.0 27.1 18.6 44.6 20.0 20.1 22.7 52.8 23.3 44.0 25.5 8.3 11.9 33.5 23.1 18.9 21.5 16.8 13.8 28.4 19.9 9.3 42.7 37.9 18.4 35.1 20.3 16.3 38.2 15.6 8.8 37.1 0.0 0.0 0.0 0.7 0.0 0.2 2.5 4.3 2.8 0.8 0.3 0.0 0.4 0.5 2.2 0.0 0.3 14.0 3.0 0.4 0.7 0.7 0.6 0.5 0.4 0.6 0.2 0.5 0.3 0.0 30.7 18.5 1.0 7.2 0.5 2.0 5.1 4.0 17.0 0.0 0.0 17.0 0.0 1.2 73.9 0.6 1.8 116.8 0.0 134.7 7.2 0.9 9.2 1.6 43.1 0.0 2.9 11.1 11.1 29.8 2.8 11.5 1.7 0.0 3.4 0.4 0.4 3.4 0.7 0.0 0.5 6.5 1.0 133.1 40.7 5.6 16.0 7.5 15.2 4.0 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.3 3.9 12.7 8.6 1.6 1.6 9.0 7.5 6.7 11.8 12.9 10.3 12.9 14.6 4.3 4.3 6.9 9.6 11.4 7.3 15.7 13.5 6.3 18.0 6.3 8.4 1.5 33.9 11.7 1.3 1.9 5.3 11.6 2.6 9.8 15.5 8.2 6.3 8.5 5.2 15.2 9.8 5.6 23.3 4.6 11.1 7.5 6.5 4.0 5.8 3.4 4.0 7.5 7.3 5.4 10.1 4.9 12.4 3.5 3.3 7.5 5.7 9.5 5.4 4.9 10.5 9.2 16.1 8.2 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 3.0 3.2 2.4 1.3 0.6 1.9 0.2 0.0 2.7 2.3 1.8 2.0 3.9 0.0 1.5 1.0 0.2 2.3 0.0 2.2 9.8 0.7 1.4 1.1 0.0 3.8 7.9 0.0 3.1 5.1 0.8 0.9 2.9 0.0 1.8 1.9 1.0 1.4 2.6 1.1 0.5 2.1 12.9 1.9 1.2 4.7 1.0 2.4 2.5 4.0 1.3 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1, DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 64.7;Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611" "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 4.8 4.3 6.0 9.6 11.3 15.3 5.1 12.9 10.6 5.4 9.2 3.4 6.8 4.3 5.4 5.5 9.1 5.5 3.3 6.5 6.6 5.3 4.2 7.7 4.9 13.0 7.5 5.9 5.1 4.7 4.2 11.0 5.3 10.5 4.1 10.4 3.7 5.4 7.4 7.3 8.3 6.7 5.5 9.2 5.9 5.1 17.6 7.0 10.9 15.6 7.3 14.6 5.5 5.6 2.0 9.1 9.7 12.7 1.4 1.3 10.7 15.7 25.6 14.1 11.2 2.3 5.2 13.8 18.6 8.0 15.6 14.9 15.5 12.3 36.4 3.4 7.1 18.5 18.3 19.1 10.4 26.2 16.6 14.0 17.1 20.1 13.4 0.5 30.5 14.9 1.4 1.7 23.5 7.5 4.0 8.1 17.0 25.8 15.6 14.7 10.5 25.5 10.1 7.7 10.6 6.8 17.6 29.7 14.9 5.8 15.3 9.7 10.4 14.3 4.7 7.0 10.0 12.6 14.1 5.2 14.0 11.4 18.1 19.3 7.3 17.8 28.0 11.3 18.1 14.6 4.6 12.7 1.8 1.3 4.0 1.3 1.1 1.3 1.0 9.1 2.0 1.2 1.3 9.7 1.4 1.5 1.4 0.4 10.7 6.0 11.3 12.9 10.6 6.6 5.3 7.5 5.9 10.5 7.0 0.0 3.2 5.2 3.8 2.6 8.3 10.4 7.6 13.4 5.7 1.8 21.6 7.0 0.0 2.6 11.1 2.9 1.0 0.0 1.0 17.5 2.9 2.4 8.1 16.1 8.6 11.1 0.0 5.5 4.0 5.2 2.3 5.3 0.0 3.6 3.7 2.8 1.6 3.1 1.4 0.8 21.1 6.5 1.4 64.7 61.1 1.9 3.3 2.5 3.5 2.5 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139766-138178986 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 11.9 14.1 21.0 10.4 22.1 14.0 18.2 28.9 24.8 17.1 15.7 21.1 14.4 11.1 20.0 31.2 13.8 18.9 12.0 11.6 16.5 16.6 15.5 14.2 14.0 13.5 18.5 16.8 24.9 17.8 19.8 37.0 17.7 22.1 17.2 18.4 15.4 14.7 18.5 15.3 16.8 12.8 18.7 16.6 16.4 14.3 54.6 20.7 25.5 20.5 7.7 15.3 14.3 14.0 9.7 10.6 17.8 9.6 20.7 15.3 8.3 11.4 15.0 26.5 42.4 19.3 18.2 24.0 17.8 19.8 25.9 27.3 22.5 25.8 11.5 17.9 16.5 26.6 13.5 27.9 17.2 28.0 20.1 20.7 15.6 35.7 15.2 10.8 9.4 16.5 13.5 11.4 20.5 18.7 20.9 16.4 21.6 13.9 14.9 17.2 12.8 19.1 15.1 11.9 13.3 7.8 18.7 21.9 14.0 17.4 16.9 23.5 11.8 21.3 9.3 16.2 37.5 16.0 17.5 10.2 12.8 14.9 8.8 15.4 13.3 14.7 15.9 9.8 14.0 11.8 12.7 9.6 11.9 14.1 6.9 14.8 9.7 12.0 12.4 10.6 9.6 15.3 15.1 17.8 20.7 7.1 7.4 11.0 8.3 21.0 22.1 28.9 24.8 16.5 16.6 18.5 16.8 22.1 20.7 23.8 28.1 13.4 8.4 6.2 29.9 31.6 12.7 40.2 37.5 26.2 35.3 22.4 16.6 14.7 69.4 21.5 13.6 23.3 10.8 10.9 16.2 15.0 22.1 15.1 10.3 28.6 30.0 11.6 14.2 29.1 29.1 15.4 23.6 36.1 19.4 28.9 14.4 14.4 22.6 9.2 33.8 25.8 10.3 193.0 44.5 6.0 21.2 15.2 18.3 6.7 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993700-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 38.1;U-698: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.8 3.2 10.8 12.6 13.7 4.7 6.8 13.4 16.0 3.8 16.8 8.8 2.4 22.5 2.9 3.0 10.7 5.0 9.8 3.0 11.0 10.8 8.3 7.5 3.4 14.2 10.9 10.3 2.2 11.2 9.8 4.0 2.6 10.5 3.8 17.8 4.7 4.1 3.1 2.0 8.0 21.8 3.3 12.6 7.3 9.0 2.6 7.7 11.1 5.4 4.5 17.8 3.6 4.3 2.4 5.7 9.5 2.5 1.5 1.2 0.7 9.4 12.5 4.6 4.3 4.0 2.1 5.0 6.7 1.5 4.0 1.9 7.9 6.5 38.1 7.9 1.7 2.8 11.7 10.8 6.0 3.9 7.0 5.9 17.5 5.6 7.1 0.7 25.4 22.0 0.9 3.5 4.7 2.6 1.9 1.7 13.9 6.0 2.2 4.2 10.1 13.0 11.4 2.5 10.3 4.9 8.3 7.7 8.3 6.2 14.5 6.2 4.0 8.2 9.0 3.0 1.6 16.0 21.0 2.0 3.6 3.8 3.8 6.7 7.4 13.3 46.8 3.8 9.5 9.8 4.5 2.5 9.5 1.2 1.7 1.1 1.8 0.9 0.9 2.4 2.4 0.8 1.2 3.8 1.5 1.6 5.7 0.8 0.7 10.8 13.7 13.4 16.0 11.0 10.8 10.9 10.3 10.5 7.7 8.9 7.2 26.7 7.9 10.9 35.5 6.3 45.9 8.1 5.7 8.7 13.7 8.8 3.3 9.0 23.9 3.0 55.2 0.0 9.2 18.3 5.5 8.0 18.4 25.2 17.3 23.8 7.5 3.7 28.3 128.6 1.1 15.5 10.1 3.6 39.6 13.2 14.1 35.1 3.9 10.9 25.6 0.0 5.9 0.9 8.1 15.9 4.3 8.7 67.9 7.8 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61681266-61863521 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.1" "Group enriched" "Detected in many" 11 "Early spermatids: 136.2;Late spermatids: 148.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "MCF7: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 1.0 0.9 0.7 6.3 3.5 9.1 1.1 0.6 1.4 1.4 2.6 0.2 0.6 2.8 1.5 1.2 3.7 0.8 1.8 0.4 0.5 0.5 0.6 2.3 1.3 4.0 0.5 0.9 2.1 1.3 0.1 0.4 1.7 0.7 1.0 2.8 0.4 1.4 0.0 0.4 2.7 5.5 1.0 0.5 2.3 1.3 10.8 0.4 30.1 0.4 2.0 6.6 1.3 1.7 2.2 0.5 2.1 0.3 0.6 3.7 0.5 12.5 4.3 12.4 7.1 0.4 1.1 2.7 11.6 6.8 12.4 16.1 4.4 4.0 7.5 2.7 2.4 3.6 4.5 6.4 2.4 16.8 1.9 7.8 7.6 6.8 5.4 0.1 9.8 4.5 0.2 0.1 9.9 2.6 1.7 2.7 7.4 5.3 5.1 7.8 42.2 15.5 3.4 2.7 3.0 3.7 9.7 23.9 3.6 1.7 5.7 5.0 12.9 4.5 1.6 1.8 4.9 4.2 3.8 2.3 18.3 13.4 6.7 13.3 3.2 6.1 8.0 3.7 4.7 4.5 2.1 0.3 1.5 0.5 0.2 0.6 2.2 1.2 0.6 0.4 1.8 1.8 0.9 1.0 0.6 0.2 0.5 3.7 0.5 0.7 3.5 0.6 1.4 0.5 0.5 0.5 0.9 0.7 0.4 0.0 0.3 1.5 1.3 2.1 0.1 0.5 0.0 1.4 6.8 0.0 0.0 0.7 0.0 0.3 136.2 0.3 0.9 0.0 0.2 2.5 0.6 0.1 0.0 3.0 1.4 0.0 0.0 0.6 0.3 148.4 1.1 0.4 3.3 1.0 1.5 0.3 0.5 0.0 1.1 0.0 0.2 0.0 0.9 13.3 4.5 0.4 0.2 0.8 2.5 0.3 BTF3 "BTF3a, BTF3b, NACB" ENSG00000145741 "Basic transcription factor 3" P20290 5 73498408-73505635 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013007, HPA056420" Approved Supported Cytosol NA Yes 100000 Cytosol "CAB013007: , HPA056420: AB_2683125" "unprognostic (3.48e-3)" "unprognostic (2.11e-1)" "unprognostic (2.87e-3)" "unprognostic (1.86e-1)" "unprognostic (6.25e-2)" "unprognostic (1.41e-1)" "unprognostic (1.90e-3)" "unprognostic (1.78e-2)" "unprognostic (8.20e-3)" "unprognostic (5.18e-2)" "unprognostic (8.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (1.06e-1)" "unprognostic (2.87e-1)" "unprognostic (1.26e-2)" "unprognostic (2.16e-1)" 98.4 64.4 44.7 67.6 40.8 98.2 105.6 38.2 49.0 111.8 87.3 45.8 69.7 62.2 107.5 67.3 141.3 75.1 68.7 69.1 40.7 41.3 74.4 107.7 66.6 100.6 46.7 41.6 172.4 111.0 44.3 44.5 90.8 44.8 110.9 75.1 53.0 102.7 76.0 157.9 107.7 87.7 95.7 53.2 84.4 76.9 56.5 41.0 132.6 123.5 131.7 113.4 135.1 88.0 89.0 104.4 19.3 77.0 75.6 102.1 159.0 96.6 64.9 70.5 100.6 70.8 119.4 110.6 67.6 95.2 118.3 114.0 83.4 110.7 146.6 106.9 70.4 85.8 68.4 102.5 174.9 136.0 60.6 131.5 82.9 62.4 108.8 103.2 78.4 67.0 103.4 139.7 76.1 141.3 135.5 107.4 84.4 77.1 95.4 99.5 87.9 117.5 147.2 89.6 36.1 65.3 89.9 83.8 181.8 124.4 97.7 82.8 110.5 66.4 75.8 135.9 69.3 97.6 161.8 77.1 51.3 69.8 61.1 182.4 89.9 91.5 136.5 67.9 120.2 75.4 19.3 77.0 19.3 52.5 60.9 88.6 89.0 89.8 73.3 104.4 71.3 99.5 87.1 10.8 75.6 47.8 58.7 102.1 159.0 44.7 40.8 38.2 49.0 40.7 41.3 46.7 41.6 44.8 41.0 229.3 278.1 715.0 1745.8 1743.2 127.7 303.1 473.9 325.2 444.7 307.1 41.2 1161.2 771.0 802.1 569.6 816.5 667.0 303.7 1060.8 1748.3 874.0 889.8 408.6 437.5 930.1 81.0 569.4 571.5 843.2 380.0 1155.8 1046.3 750.8 1202.0 941.3 218.3 1129.2 785.5 795.5 944.8 96.9 633.8 1145.4 210.5 145.7 1707.3 1431.9 885.4 1216.6 1923.9 BTG3 "ANA, ANA/BTG3, APRO4, tob55" ENSG00000154640 "BTG anti-proliferation factor 3" Q14201 21 17593653-17612947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Syncytiotrophoblasts: 1415.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 21.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA018400 Approved NA Yes "HPA018400: AB_1845487" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.98e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (4.50e-3)" "unprognostic (1.75e-1)" "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.42e-2)" "unprognostic (3.08e-1)" "unprognostic (9.92e-2)" "unprognostic (2.40e-1)" 15.0 15.7 10.9 9.6 19.0 24.8 24.1 2.0 8.5 26.5 14.3 12.1 20.2 9.0 26.6 62.4 19.9 28.7 12.7 16.6 11.9 13.7 12.9 7.3 32.9 7.0 10.1 6.9 21.6 11.6 13.0 26.5 33.9 18.6 20.4 15.2 9.8 16.1 22.4 6.4 22.8 8.8 16.3 18.5 12.3 11.8 38.8 11.5 18.3 25.7 16.0 10.0 25.5 26.7 4.8 5.9 2.4 1.6 3.9 21.4 3.8 19.8 4.1 24.7 1.9 8.5 15.2 18.7 28.0 31.5 24.4 25.0 9.3 8.4 9.0 13.6 9.8 32.1 4.9 12.1 18.0 27.1 28.5 18.7 6.7 9.5 8.7 17.8 7.3 13.1 13.2 25.8 20.6 20.0 14.0 12.1 8.8 6.4 32.9 22.6 0.0 13.9 1.1 13.0 2.7 1.1 4.7 32.5 6.5 15.9 8.8 12.8 10.2 20.8 10.6 23.3 29.5 0.3 8.0 8.0 24.8 26.2 19.1 27.3 22.9 18.2 8.2 24.9 0.0 29.4 0.7 1.6 2.4 5.9 1.2 6.8 4.8 10.0 9.3 1.3 4.6 5.1 6.7 0.1 3.9 1.2 5.9 21.4 3.8 10.9 19.0 2.0 8.5 11.9 13.7 10.1 6.9 18.6 11.5 190.6 142.4 31.2 437.5 319.9 0.6 6.7 35.7 60.2 130.8 55.8 0.0 331.3 33.2 53.2 5.9 36.4 9.5 93.5 34.3 65.4 107.4 290.7 64.6 5.1 50.6 22.3 103.9 35.6 14.3 18.3 65.0 44.4 81.0 55.1 35.6 17.9 46.7 11.5 43.9 1.6 0.3 90.5 98.0 172.0 275.5 257.2 1415.6 38.8 49.1 379.7 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637698-110678114 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 56.5;testis: 30.9" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 68.1" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 1.1 0.9 0.5 15.8 1.0 8.9 0.6 0.3 1.0 1.2 2.8 0.4 0.0 2.4 0.7 2.3 5.8 0.5 1.0 1.1 0.5 0.5 0.9 0.8 2.1 11.6 0.6 0.2 1.0 0.7 0.0 0.4 2.4 0.5 0.7 4.3 0.4 1.4 0.0 0.5 1.8 3.1 1.4 1.3 7.9 1.8 30.9 0.1 56.5 0.6 5.7 12.1 2.5 2.0 1.8 2.4 3.0 0.2 1.4 6.1 1.1 30.3 8.9 23.4 14.7 1.0 1.7 12.4 15.8 10.4 27.5 20.8 18.7 17.5 20.6 9.8 9.1 25.8 13.3 29.9 11.5 34.2 16.3 14.6 68.1 9.5 14.9 0.2 19.6 19.3 0.4 0.7 21.2 10.5 3.9 16.1 23.1 29.8 43.0 22.5 10.0 32.8 16.4 22.6 10.8 16.9 21.8 20.0 31.4 5.6 9.6 15.7 6.8 11.2 9.6 8.5 14.9 7.5 16.6 6.6 12.5 20.5 9.4 21.9 22.5 21.1 25.3 8.5 15.2 22.0 3.0 0.0 0.7 0.6 0.2 0.9 1.8 2.5 1.0 0.8 1.4 1.6 1.5 0.0 1.4 0.1 2.4 6.1 1.1 0.5 1.0 0.3 1.0 0.5 0.5 0.6 0.2 0.5 0.1 0.0 1.0 7.8 0.2 0.5 0.0 0.8 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.2 8.3 0.0 0.0 0.0 0.0 8.1 0.3 0.2 0.0 0.2 6.6 0.0 0.0 1.3 1.3 4.7 0.3 1.7 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 68.0 14.1 0.4 0.6 2.5 2.0 0.9 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221136 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.5;testis: 25.6" "Group enriched" "Detected in many" 7 "Spermatocytes: 66.9;Spermatogonia: 28.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.8;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA008419 Supported Cytosol Yes Yes Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 1.0 0.9 0.3 18.4 0.6 11.4 1.5 0.4 0.5 1.3 4.0 0.4 0.1 3.3 1.1 0.8 6.5 0.5 1.1 0.6 0.4 0.4 0.8 0.7 1.8 8.7 0.4 0.3 0.6 0.5 0.0 0.4 3.4 0.5 0.6 4.4 0.3 1.6 0.1 0.7 2.3 2.9 1.2 0.6 5.4 1.7 25.6 0.1 49.5 0.5 3.1 10.6 1.1 2.0 2.8 2.8 0.0 0.2 0.7 0.7 0.5 21.8 11.1 35.5 14.1 0.9 2.5 11.5 20.8 11.7 22.3 19.4 16.2 8.4 19.8 11.7 7.5 20.5 24.7 33.5 11.3 24.3 17.0 18.0 28.9 28.7 15.0 0.0 26.1 15.9 0.5 0.6 13.6 12.8 4.4 16.1 22.9 24.9 21.1 22.2 7.4 20.4 15.9 24.0 18.4 12.7 21.9 29.2 15.0 6.8 11.1 23.2 14.3 12.8 12.3 4.5 16.2 14.3 13.5 9.3 17.1 18.1 17.0 18.4 11.1 18.8 32.4 9.1 29.3 22.2 0.0 0.0 0.0 0.2 0.2 0.3 2.4 0.7 0.6 0.7 2.8 0.1 0.4 0.0 0.7 0.1 2.8 0.0 0.5 0.3 0.6 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.1 3.0 1.4 0.8 0.3 0.7 0.4 0.4 0.0 0.0 3.4 0.0 0.0 1.3 0.0 0.3 2.5 0.0 0.3 0.0 0.0 5.1 0.4 0.2 0.0 0.2 4.3 0.0 0.0 1.3 0.6 2.4 1.4 1.5 0.0 0.0 1.4 0.0 0.8 0.8 0.4 0.0 0.1 6.5 0.0 66.9 28.8 0.3 0.7 0.8 1.7 0.4 BUB3 BUB3L ENSG00000154473 "BUB3, mitotic checkpoint protein" O43684 10 123154277-123170467 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003601, CAB037075" Supported Supported Nucleoplasm NA Yes 100000000 Nucleoplasm "CAB037075: AB_1078310, HPA003601: AB_1078309" "unprognostic (7.82e-2)" "prognostic favorable (2.04e-4)" "unprognostic (9.07e-2)" "unprognostic (1.83e-1)" "unprognostic (7.93e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (4.45e-5)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (6.30e-3)" "unprognostic (2.69e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.81e-7)" "unprognostic (8.80e-2)" "unprognostic (7.64e-2)" "unprognostic (1.51e-1)" "unprognostic (7.71e-2)" 23.8 35.1 21.1 35.3 26.6 51.0 27.9 30.4 28.3 20.2 27.7 31.3 22.3 24.5 24.5 22.7 38.2 22.1 20.7 19.6 19.8 28.3 24.1 25.1 22.4 51.8 33.3 23.6 27.4 20.5 20.7 37.3 22.6 31.3 21.8 29.6 16.8 26.5 21.4 23.4 28.9 30.3 22.2 29.1 38.8 24.4 35.4 28.2 67.8 28.1 22.8 49.0 30.3 26.5 43.0 25.8 32.7 24.3 45.6 71.6 52.4 51.7 52.2 33.7 37.3 19.2 18.2 29.1 54.2 58.0 60.4 48.1 45.3 35.8 46.6 20.3 24.7 28.8 33.6 49.8 58.7 63.5 37.8 49.7 29.3 63.3 49.6 20.0 57.1 36.4 15.1 23.1 53.6 69.0 32.6 40.5 39.8 35.5 46.9 54.1 44.6 46.9 35.4 20.7 26.9 49.3 64.4 16.8 29.9 27.5 57.5 25.2 25.5 30.6 20.7 25.9 14.6 23.5 29.6 31.7 47.5 29.1 29.8 79.8 25.1 35.4 72.5 25.9 56.8 20.0 32.7 23.6 32.4 53.5 24.3 48.1 43.0 49.1 54.2 24.2 37.5 52.9 55.7 11.7 45.6 21.2 25.8 71.6 52.4 21.1 26.6 30.4 28.3 19.8 28.3 33.3 23.6 31.3 28.2 23.8 35.1 84.1 58.3 116.0 25.8 36.7 38.2 37.5 25.0 36.6 9.8 71.6 59.7 62.8 111.8 69.4 34.1 23.3 51.2 112.6 68.6 51.7 49.7 36.7 69.7 9.5 39.1 44.8 49.9 110.6 41.7 56.4 91.1 199.2 46.1 52.8 54.3 35.1 43.5 60.0 21.6 103.5 63.6 136.5 153.0 116.6 54.3 139.0 54.0 50.5 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.2 19.6 4.9 16.4 25.2 21.0 12.9 3.4 23.3 4.2 11.5 24.6 33.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.1 3.9 6.7 18.1 15.2 15.2 16.9 21.9 15.6 7.2 6.6 10.6 38.1 9.3 5.2 9.6 5.7 4.5 46.3 7.7 6.5 11.8 11.1 3.9 3.9 6.1 6.3 8.4 15.8 6.2 10.8 3.8 16.8 33.6 16.4 45.6 8.3 7.1 3.1 3.5 19.9 3.0 26.1 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 14.9 6.1 6.7 24.0 13.6 10.2 13.7 15.3 0.0 1.2 15.7 9.8 13.0 6.6 11.6 6.3 10.5 10.0 0.0 10.0 13.3 15.8 19.5 3.5 9.6 12.3 15.9 4.6 16.0 11.5 19.9 19.8 6.6 10.1 14.4 11.6 22.3 13.9 0.0 33.2 5.1 7.2 19.4 12.5 13.9 14.3 11.2 18.3 8.7 8.4 22.4 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C17orf53 MGC3130 ENSG00000125319 "Chromosome 17 open reading frame 53" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA synthesis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1" "Cell type enhanced" "Detected in some" 12 "Extravillous trophoblasts: 7.0;Late spermatids: 5.5;Spermatocytes: 8.9;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 2.0 0.7 0.5 3.5 0.4 13.4 2.0 2.8 1.4 1.2 1.5 0.6 0.5 1.4 1.3 1.1 4.0 0.9 1.4 1.9 0.8 0.7 0.8 0.8 1.3 2.4 0.5 0.2 1.3 1.2 0.7 0.7 2.3 1.0 1.0 1.7 0.6 1.1 1.1 1.8 2.4 2.2 1.1 0.5 1.9 1.0 32.1 0.4 8.2 0.5 1.5 4.8 0.8 1.7 1.4 3.7 0.9 1.1 0.3 2.0 0.6 7.5 9.5 7.5 6.7 0.6 2.1 8.9 5.9 5.2 11.5 12.6 9.7 4.7 8.1 5.3 5.2 12.0 6.6 9.7 9.4 10.2 9.1 12.2 5.2 8.7 6.5 0.3 5.7 6.5 1.7 1.4 14.2 7.1 1.5 4.8 8.9 11.7 10.6 5.6 5.6 13.5 8.5 5.1 3.5 9.3 8.5 12.0 10.0 2.7 6.1 4.7 2.7 3.6 3.6 2.9 8.9 7.2 6.6 2.2 11.1 8.7 7.5 8.6 6.1 10.2 7.0 5.2 4.4 6.3 0.0 1.1 0.9 1.1 0.8 0.4 0.8 0.8 0.2 0.4 1.4 0.6 0.4 0.0 0.3 0.4 3.7 2.0 0.6 0.5 0.4 2.8 1.4 0.8 0.7 0.5 0.2 1.0 0.4 0.0 0.0 0.5 0.6 1.6 0.2 0.8 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.5 2.5 0.1 0.0 0.0 0.2 7.0 0.7 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.2 0.5 0.7 0.0 1.1 0.2 0.0 0.0 0.3 8.9 13.0 1.0 1.5 0.0 0.6 0.3 C19orf48 "BC006151, MGC13170" ENSG00000167747 "Chromosome 19 open reading frame 48" Q6RUI8 19 50797704-50804929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042000 Uncertain Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA042000: AB_10797377" "unprognostic (2.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.39e-2)" "unprognostic (7.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.80e-5)" "unprognostic (6.59e-3)" "unprognostic (1.84e-3)" "unprognostic (2.84e-1)" "unprognostic (1.14e-2)" "unprognostic (2.97e-1)" "unprognostic (6.84e-3)" "unprognostic (1.29e-1)" "unprognostic (3.67e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" 5.0 9.7 6.5 11.0 6.2 20.7 9.6 7.0 8.9 7.2 9.3 7.0 4.1 6.8 7.8 6.9 13.2 13.5 9.5 4.1 4.0 3.4 7.4 12.0 8.0 22.2 6.8 8.7 13.0 40.7 3.2 4.0 7.5 5.2 32.1 5.8 6.9 8.3 5.6 6.4 15.9 6.4 6.7 5.1 8.8 7.0 19.8 5.0 23.6 17.9 9.1 12.5 5.1 7.3 29.0 20.8 2.8 8.7 12.4 21.6 9.9 21.4 34.1 16.1 10.1 3.1 9.6 14.9 19.4 13.3 28.7 28.7 41.1 20.0 36.8 9.0 7.5 11.1 15.3 26.8 27.3 9.9 11.5 64.7 24.5 14.5 23.9 8.7 25.6 12.4 15.6 28.4 29.9 32.6 7.0 15.3 36.3 26.8 18.4 13.3 18.5 34.3 31.0 12.9 26.4 43.7 25.8 26.3 34.8 9.3 35.9 26.6 12.8 19.4 25.3 26.4 6.1 14.9 25.2 7.2 13.3 24.6 8.1 26.3 10.8 12.2 30.3 8.1 23.3 17.8 1.0 6.0 2.8 9.9 8.7 14.0 29.0 14.1 11.2 11.8 27.3 21.6 16.1 0.4 12.4 6.3 20.8 14.5 9.9 6.5 6.2 7.0 8.9 4.0 3.4 6.8 8.7 5.2 5.0 3.0 6.9 49.4 35.3 51.9 8.7 4.7 12.7 1.4 6.8 17.4 5.9 84.7 28.2 25.6 6.7 15.8 10.0 23.3 94.0 106.2 23.6 54.8 8.1 11.5 36.1 0.0 23.0 6.7 8.8 12.6 16.4 21.5 16.9 39.7 66.4 9.7 47.0 14.0 7.1 15.2 7.0 6.5 21.7 27.2 39.4 60.1 51.8 15.0 100.4 27.5 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 29.3" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.3 1.8 2.2 4.3 5.0 11.1 5.2 3.6 3.1 3.2 3.5 4.6 3.3 4.7 2.2 9.7 3.1 27.2 3.2 2.6 2.9 2.9 1.3 1.3 9.1 5.9 2.9 1.8 8.0 3.2 1.4 25.1 2.1 5.8 2.3 2.7 1.9 2.5 1.7 1.6 5.3 4.3 1.5 1.8 2.8 3.7 5.7 2.2 22.7 1.8 2.1 4.6 1.7 2.1 2.1 1.8 8.2 0.5 0.7 1.8 0.9 12.1 5.6 14.8 9.2 1.5 2.0 8.2 7.5 2.8 5.3 5.2 2.5 9.0 8.8 1.9 2.1 6.2 9.8 3.9 3.2 1.6 9.2 8.6 14.1 14.6 1.4 0.3 4.0 8.1 0.9 0.7 3.7 0.9 1.9 3.3 22.0 8.0 23.5 4.3 5.0 19.8 5.4 6.3 3.4 2.8 29.3 6.7 7.8 1.6 2.3 12.2 7.6 5.6 4.0 1.8 3.3 9.9 8.0 2.2 3.2 9.3 3.2 4.5 9.5 4.2 4.2 5.7 17.5 8.4 8.2 0.5 1.1 0.9 0.3 0.5 0.2 1.1 1.2 0.1 2.1 1.8 1.4 0.7 0.7 0.2 1.8 1.3 0.9 2.2 5.0 3.6 3.1 2.9 2.9 2.9 1.8 5.8 2.2 3.0 1.6 3.0 1.2 0.8 17.1 3.6 0.0 203.4 22.7 1.8 25.5 3.5 0.0 1.9 13.4 1.1 2.3 140.2 0.9 5.4 3.6 1.8 2.3 1.6 3.4 4.8 66.7 3.7 1.8 25.4 4.9 2.7 0.0 1.0 3.5 4.3 1.1 3.5 2.5 0.6 28.6 0.0 2.1 52.4 42.1 1.3 1.1 2.6 5.9 0.7 C2orf69 FLJ38973 ENSG00000178074 "Chromosome 2 open reading frame 69" Q8N8R5 2 199911256-199955935 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 96.7;Spermatocytes: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045225 Approved "Secreted - unknown location" NA Yes "HPA045225: AB_10960841" "unprognostic (6.94e-3)" "unprognostic (1.09e-1)" "unprognostic (7.17e-2)" "unprognostic (3.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (4.39e-3)" "unprognostic (1.92e-2)" "unprognostic (5.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.33e-3)" "unprognostic (1.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.41e-3)" "unprognostic (8.87e-2)" "unprognostic (1.03e-2)" "unprognostic (5.86e-2)" 11.6 18.4 17.7 8.9 18.5 23.6 12.1 14.3 20.0 7.9 9.9 7.3 5.1 10.4 8.3 8.7 8.8 6.0 8.0 8.2 16.2 16.3 11.3 12.3 7.6 8.4 15.9 13.4 8.8 10.2 11.4 8.5 6.7 13.3 8.5 10.4 6.4 9.0 6.6 13.5 8.2 9.0 9.7 15.8 8.3 8.8 18.6 12.7 10.2 8.6 8.9 9.0 7.4 8.5 5.2 3.6 10.8 5.4 2.9 8.6 4.3 11.5 5.3 9.9 13.4 14.0 17.7 16.7 16.6 10.0 11.3 13.5 11.8 8.4 9.6 9.8 11.7 12.0 9.4 10.4 8.8 19.1 14.2 9.5 14.7 9.2 15.0 8.2 14.7 18.3 9.1 8.0 12.9 11.3 6.1 12.6 6.5 10.5 19.0 19.0 10.0 8.1 12.9 14.5 5.1 14.2 7.9 12.9 8.6 11.1 12.0 16.2 7.1 8.0 6.1 12.3 13.3 8.9 12.8 10.9 17.7 14.5 19.7 13.2 12.6 20.3 9.5 14.1 9.5 8.8 7.1 4.2 10.8 6.0 5.4 8.6 5.2 6.7 5.6 3.6 4.8 7.1 7.4 3.5 2.9 4.0 2.1 6.1 4.3 17.7 18.5 14.3 20.0 16.2 16.3 15.9 13.4 13.3 12.7 3.0 3.2 25.1 23.0 33.8 19.4 9.8 2.5 13.4 5.7 15.7 27.5 9.4 23.2 10.8 96.7 15.0 11.7 0.0 16.1 15.1 16.4 16.8 8.1 16.3 10.6 12.7 17.9 23.9 16.4 55.3 12.4 16.2 15.1 10.0 15.8 55.2 12.3 10.5 20.5 15.7 24.7 19.4 21.7 107.2 44.6 39.3 8.2 18.5 15.3 13.9 CA2 "CA-II, CAII, Car2" ENSG00000104267 "Carbonic anhydrase 2" P00918 8 85463852-85481493 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Lyase "Disease mutation, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 108.1;stomach 1: 171.5" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 870.3;Erythroid cells: 2055.8;Muller glia cells: 1176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 33.8;HEK 293: 142.4;THP-1: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001550, CAB010102" Enhanced NA Yes 790000000 "CAB010102: AB_626796, HPA001550: AB_1078393" "unprognostic (6.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.63e-1)" "unprognostic (2.59e-1)" "unprognostic (9.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.72e-2)" "unprognostic (1.07e-1)" "unprognostic (5.23e-2)" "unprognostic (1.57e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.57e-6)" "unprognostic (2.45e-1)" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (6.49e-3)" 1.6 2.2 24.4 21.5 32.6 32.4 6.9 4.3 23.2 1.3 108.1 28.9 42.0 46.9 0.9 2.2 5.6 0.9 33.0 4.3 29.1 14.5 53.5 43.0 10.2 1.3 49.0 14.2 0.5 9.1 3.1 2.0 3.5 65.0 0.8 105.6 7.0 14.0 54.2 9.2 13.3 7.6 6.0 27.5 2.5 171.5 5.1 58.3 0.0 3.8 2.4 1.1 1.0 1.4 1.9 8.0 20.3 8.2 0.0 4.4 17.5 0.5 0.3 1.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 1.2 0.0 0.0 33.8 4.9 1.7 0.0 0.0 142.4 4.4 2.5 0.0 0.0 3.1 0.6 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.4 11.2 0.0 2.7 0.1 0.0 0.5 1.1 0.0 0.0 0.7 0.0 0.0 1.3 0.0 59.7 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 20.3 3.1 4.4 0.1 8.2 4.4 0.6 0.0 0.4 8.0 1.9 0.0 0.0 6.8 0.0 7.1 0.8 0.0 17.5 24.4 32.6 4.3 23.2 29.1 14.5 49.0 14.2 65.0 58.3 14.9 56.8 27.3 1.0 80.5 23.5 18.5 400.0 0.0 1.2 153.5 60.9 10.7 295.1 50.5 65.5 14.6 870.3 2055.8 9.9 311.4 6.4 1.1 16.1 101.2 34.8 12.7 29.2 1.8 8.2 179.8 3.1 46.0 70.9 1.0 94.2 1176.2 10.3 374.2 2.1 304.9 61.5 0.0 7.3 1.7 2.3 97.6 14.3 5.7 229.3 0.3 CALM2 "CAMII, PHKD" ENSG00000143933 "Calmodulin 2" P0DP24 2 47160082-47176601 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB007790, HPA044999" Approved NA Yes "CAB007790: AB_562257, HPA044999: AB_2679177" "prognostic unfavorable (5.05e-4)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.84e-4)" "unprognostic (9.21e-2)" "unprognostic (2.04e-3)" "prognostic unfavorable (8.35e-5)" "unprognostic (1.63e-2)" "unprognostic (4.67e-3)" "unprognostic (1.79e-2)" "unprognostic (1.97e-2)" "unprognostic (1.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.18e-2)" "unprognostic (2.29e-2)" "prognostic favorable (1.94e-5)" "unprognostic (1.24e-1)" 65.6 87.3 153.0 41.3 162.1 25.3 89.8 132.9 169.5 58.4 88.7 62.8 38.8 68.4 60.1 73.8 50.8 71.6 51.3 55.0 160.4 133.1 57.9 62.0 63.9 48.4 135.8 147.6 57.5 28.1 37.7 51.2 59.3 119.6 60.4 92.3 29.3 60.4 77.7 30.2 31.0 77.7 81.7 139.9 77.3 50.0 79.1 114.9 43.8 60.0 31.0 57.1 56.5 37.1 53.2 82.3 190.9 141.0 38.4 40.3 130.5 165.2 63.6 73.6 32.6 42.0 47.6 47.2 163.8 101.5 97.6 84.2 62.5 62.2 70.4 74.4 119.1 72.0 43.0 62.4 57.7 128.7 53.9 29.5 60.0 38.3 90.9 54.1 72.8 47.5 27.2 56.2 87.0 98.6 85.5 65.4 23.1 56.2 58.0 232.8 43.3 84.9 62.8 57.1 201.5 32.5 21.2 86.9 66.5 109.4 30.3 54.0 137.6 52.9 52.5 71.2 82.5 39.0 38.9 75.4 72.8 80.7 43.6 114.7 46.1 40.3 74.9 49.5 50.4 93.3 140.3 98.3 190.9 29.8 141.0 32.3 53.2 37.2 35.8 82.3 36.9 33.2 36.4 102.4 38.4 122.1 78.5 40.3 130.5 153.0 162.1 132.9 169.5 160.4 133.1 135.8 147.6 119.6 114.9 1289.3 525.2 388.5 961.5 1581.7 610.3 547.0 499.4 2395.7 1222.7 720.6 92.3 798.8 1953.0 1859.0 214.5 598.0 903.4 654.1 600.7 481.0 1210.0 791.7 634.5 511.4 1131.6 322.6 573.5 257.8 884.6 184.8 977.2 1240.6 1680.3 1146.1 906.5 1779.4 1759.7 1027.7 811.8 737.6 257.4 892.6 1822.0 1588.7 733.3 1453.8 213.5 621.1 614.7 973.8 CARHSP1 "CRHSP-24, CSDC1" ENSG00000153048 "Calcium regulated heat stable protein 1" Q9Y2V2 16 8852942-8869012 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 1687.9;Late spermatids: 5640.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051911 Enhanced NA Yes 150000 "HPA051911: AB_2681660" "unprognostic (4.08e-1)" "unprognostic (4.99e-2)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (2.08e-3)" "unprognostic (8.57e-2)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.61e-1)" "unprognostic (7.19e-3)" "unprognostic (1.76e-3)" "unprognostic (5.94e-2)" "unprognostic (1.10e-1)" "unprognostic (2.61e-1)" "prognostic favorable (7.24e-4)" 21.2 34.5 14.9 13.9 41.1 25.2 34.3 3.6 12.2 19.5 14.8 18.2 5.2 14.6 13.7 9.8 44.0 18.0 14.4 14.6 13.5 8.6 41.2 50.6 26.2 18.4 14.3 11.4 20.8 22.7 5.2 8.4 69.4 13.0 11.0 11.6 13.8 29.5 7.6 6.5 8.2 15.0 11.3 10.2 15.4 13.0 90.2 18.3 30.4 15.0 27.0 25.8 12.0 23.6 10.9 19.2 37.4 12.4 15.6 24.9 7.8 15.8 30.0 43.5 7.7 10.6 18.6 20.5 22.6 18.8 19.7 24.8 23.1 41.5 23.2 14.6 16.4 15.6 16.1 15.8 18.3 13.2 19.0 24.5 7.6 22.9 86.4 38.5 12.2 16.6 39.4 8.3 19.2 12.6 18.1 19.3 55.3 19.6 26.3 24.0 35.2 57.8 29.5 25.0 18.6 18.3 69.9 56.8 34.3 15.5 12.2 24.3 33.7 23.2 20.5 20.1 23.8 25.2 11.8 21.2 15.3 29.7 19.3 11.5 13.8 14.3 27.2 34.2 14.7 25.8 27.8 12.4 13.8 11.1 5.9 7.0 7.0 11.1 10.9 10.5 10.9 7.5 10.4 37.4 15.6 7.2 19.2 24.9 7.8 14.9 41.1 3.6 12.2 13.5 8.6 14.3 11.4 13.0 18.3 23.8 10.8 69.3 56.7 37.9 7.7 5.6 158.0 16.0 4.5 78.5 5.9 101.6 46.4 441.1 1687.9 120.3 99.7 93.5 208.0 260.9 56.4 97.9 39.2 278.9 61.2 11.1 139.1 135.1 73.7 5640.4 89.2 48.0 55.6 47.7 89.4 6.8 376.8 136.8 68.6 329.5 10.1 109.9 60.4 51.5 48.7 36.8 128.4 104.6 112.2 126.1 CBX3 HP1Hs-gamma ENSG00000122565 "Chromobox 3" Q13185 7 26201162-26213356 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001973, HPA004902" Supported Supported "Nucleoplasm,Nuclear bodies" NA Yes 40000 Nucleoplasm "Nuclear bodies" "CAB001973: , HPA004902: AB_1850635" "prognostic unfavorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (4.84e-2)" "unprognostic (1.12e-2)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "prognostic unfavorable (2.20e-8)" "unprognostic (2.13e-2)" "unprognostic (3.95e-2)" "unprognostic (3.71e-3)" "prognostic unfavorable (4.00e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.56e-7)" "unprognostic (7.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.17e-1)" "unprognostic (5.78e-2)" 40.7 49.4 41.2 54.3 38.8 65.8 69.4 37.4 45.9 33.9 38.4 20.3 39.0 49.8 39.5 42.1 36.4 33.9 28.6 43.3 39.0 40.8 51.1 45.8 37.0 68.6 44.9 37.2 45.3 31.8 22.4 27.5 45.4 51.1 30.7 43.7 23.7 35.0 45.6 60.4 27.1 56.4 46.7 66.9 54.0 29.3 45.1 33.7 92.3 32.1 38.2 65.0 39.8 38.1 38.8 37.4 55.2 48.4 39.5 60.7 35.1 50.3 22.3 47.7 47.1 17.2 31.3 37.6 39.6 30.2 30.2 30.7 26.3 42.6 76.6 32.0 26.1 64.7 40.3 39.8 33.0 49.4 21.1 29.7 43.7 29.4 29.3 18.9 69.0 42.5 22.9 29.0 23.8 34.2 37.5 40.7 48.9 69.9 37.9 51.1 28.8 66.5 83.3 60.7 43.8 32.3 43.6 44.3 63.2 44.0 28.3 58.4 64.8 32.8 69.8 36.3 52.9 59.3 62.7 30.2 27.5 49.9 32.0 52.5 56.3 81.1 130.3 23.9 59.5 123.9 47.8 38.4 55.2 34.6 47.6 42.8 38.8 51.7 42.7 37.4 35.8 55.0 54.0 39.3 39.5 48.4 30.5 60.7 35.1 41.2 38.8 37.4 45.9 39.0 40.8 44.9 37.2 51.1 33.7 101.3 77.8 131.1 75.5 127.6 104.6 114.5 129.9 139.2 130.8 61.1 72.6 154.4 119.3 152.3 115.5 136.8 88.3 303.7 123.2 293.9 107.2 64.5 211.9 239.9 127.2 47.7 105.7 149.1 266.0 31.0 126.2 175.5 99.5 110.0 127.3 132.2 139.2 87.7 92.3 112.3 126.4 77.6 91.0 234.4 415.8 94.4 226.4 163.9 186.9 86.2 CBX6 ENSG00000183741 "Chromobox 6" O95503 22 38861450-38872314 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048653 Uncertain Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA048653: AB_2680479" "unprognostic (1.65e-2)" "unprognostic (8.66e-2)" "unprognostic (6.20e-3)" "unprognostic (3.14e-3)" "unprognostic (1.56e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.90e-2)" "unprognostic (3.72e-3)" "unprognostic (5.97e-2)" "prognostic favorable (2.46e-6)" "unprognostic (2.75e-1)" "unprognostic (1.27e-3)" "unprognostic (7.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (2.26e-2)" 15.0 15.0 44.7 14.5 35.1 21.7 7.4 27.8 53.8 14.0 19.5 15.3 9.8 6.5 19.3 14.2 12.9 18.8 10.9 14.0 40.6 18.3 12.1 5.9 13.0 12.0 15.8 21.8 23.4 13.1 62.2 15.5 4.7 19.3 16.1 7.4 17.0 12.5 25.4 5.5 7.7 9.2 23.8 12.1 11.2 12.0 5.0 12.0 11.3 13.4 4.5 13.8 16.6 9.5 4.7 26.9 2.6 7.4 5.2 11.7 9.2 16.6 17.7 3.9 13.4 30.4 17.1 1.2 18.2 10.5 9.5 8.9 8.8 15.6 27.3 13.7 12.4 6.6 19.9 7.3 7.7 5.2 26.2 22.9 2.7 7.6 3.0 16.6 13.4 13.6 25.4 3.9 21.6 10.3 13.1 10.7 7.9 6.1 13.9 6.4 18.8 8.2 3.9 3.5 9.6 13.7 12.5 13.2 10.7 13.4 15.8 19.3 4.3 11.7 15.6 9.8 1.4 10.7 8.0 13.8 8.3 25.5 14.3 12.4 14.3 13.7 10.0 16.2 14.1 17.1 1.1 5.5 2.6 11.7 7.4 9.7 4.2 8.1 8.2 5.4 4.7 6.7 8.2 2.3 5.2 6.8 26.9 4.6 9.2 44.7 35.1 27.8 53.8 40.6 18.3 15.8 21.8 19.3 12.0 14.9 14.3 23.1 30.9 30.1 95.1 23.3 38.2 5.3 13.6 69.8 37.3 9.4 29.9 79.7 0.5 30.3 1.3 0.0 43.0 1.9 41.4 21.2 5.8 29.7 17.5 117.6 117.7 33.7 40.3 0.9 68.7 20.0 77.6 119.0 0.7 80.1 41.4 7.0 76.0 41.9 56.5 71.1 86.3 2.1 6.0 29.6 3.9 35.8 0.5 68.7 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 70.0;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.7 10.1 27.7 11.8 1.5 3.8 22.7 27.1 11.9 36.0 26.8 22.0 24.1 35.7 7.3 14.2 12.7 13.1 34.8 15.9 29.7 17.1 16.1 28.6 13.4 21.3 0.3 43.1 20.3 1.0 1.2 14.9 8.9 5.7 21.5 19.0 40.7 35.9 28.5 13.9 54.9 25.0 21.8 24.3 11.3 25.2 53.7 17.4 10.2 7.7 11.8 12.5 14.2 17.4 7.5 21.7 14.5 18.3 12.7 16.9 25.7 17.8 25.8 22.8 24.1 40.9 9.7 43.9 18.7 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 0.0 0.6 0.0 0.7 2.5 1.1 0.7 0.0 2.7 1.2 0.0 11.8 5.7 0.0 0.3 4.8 0.7 1.5 70.0 0.2 72.3 3.3 1.1 0.0 1.5 21.0 0.0 1.2 2.5 7.5 1.5 0.9 2.9 1.7 0.0 3.1 1.3 0.4 1.5 1.1 0.0 14.2 0.0 0.9 6.1 7.9 1.1 7.1 3.2 6.4 1.3 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167010-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.4" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 610.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Yes Yes Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522" "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.54e-7)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 3.2 4.6 2.7 23.9 4.8 20.5 4.6 6.5 5.6 4.4 9.9 1.6 1.6 9.3 3.5 2.8 28.8 3.3 3.5 1.9 3.5 4.2 4.6 2.9 3.4 23.6 4.0 4.2 3.7 4.0 1.6 2.6 12.1 11.5 2.6 14.2 1.7 5.3 1.7 2.0 6.4 8.7 6.4 2.5 9.1 7.1 21.7 1.3 71.4 6.3 23.3 30.1 5.3 7.5 13.2 5.1 2.4 4.1 6.5 14.7 5.5 58.6 40.6 55.8 49.6 2.9 5.0 131.7 26.0 19.5 68.6 58.1 60.0 55.4 36.1 31.7 23.9 78.7 37.0 56.1 56.8 77.0 35.4 27.7 22.9 33.9 41.4 0.9 19.9 26.2 2.2 3.6 39.3 27.4 6.3 36.6 35.4 27.6 28.7 55.8 55.9 27.2 23.7 31.0 19.5 25.8 28.7 40.2 37.0 25.1 21.7 28.4 17.9 44.7 21.1 19.2 32.8 40.3 20.9 15.3 15.3 49.7 27.6 64.9 14.4 26.6 50.4 21.2 34.9 47.0 2.4 1.8 1.2 2.8 4.1 4.0 13.2 7.6 6.7 5.1 8.6 2.5 2.4 1.0 6.5 1.9 4.2 14.7 5.5 2.7 4.8 6.5 5.6 3.5 4.2 4.0 4.2 11.5 1.3 0.0 0.3 5.2 4.8 10.2 4.2 1.5 2.5 13.4 4.5 5.2 2.0 53.5 1.7 5.3 63.8 1.8 2.9 46.7 1.2 610.8 11.3 3.6 2.3 3.0 50.4 0.0 1.2 6.2 6.0 9.4 2.8 4.4 3.3 3.6 4.6 2.8 2.5 0.0 2.5 4.3 2.9 6.5 3.1 28.8 70.2 6.4 34.7 4.4 11.5 2.7 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105078-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.2;testis: 73.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "T-reg: 17.8" "Lineage enriched" "Detected in many" 6 "T-cells: 17.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 2.0 1.1 0.4 21.0 0.4 24.7 2.5 0.3 0.6 1.8 5.5 0.5 0.2 5.2 1.0 1.5 11.3 0.5 1.6 1.2 0.4 0.4 1.0 1.0 1.9 12.0 0.4 0.3 0.8 0.7 0.0 0.4 6.7 0.4 1.1 6.3 0.4 2.1 0.6 0.4 3.6 5.1 2.0 1.3 5.2 3.0 73.9 0.2 70.2 0.8 10.3 16.0 1.8 3.4 1.8 2.3 0.7 0.1 3.0 17.8 1.8 28.7 25.3 41.6 10.3 1.9 3.8 22.1 23.8 15.3 36.9 30.4 40.9 17.7 26.7 17.3 15.4 21.6 35.5 39.3 20.2 34.9 27.7 21.1 34.6 29.6 23.2 0.5 25.7 22.3 1.4 2.7 15.9 20.3 7.2 25.0 33.0 34.9 42.9 27.8 20.9 29.3 37.5 30.7 12.4 15.0 34.3 58.9 27.1 11.6 20.3 25.9 17.5 32.6 17.7 21.5 34.0 30.7 25.7 13.0 18.4 31.2 20.2 45.3 19.1 28.7 47.5 12.0 58.9 25.9 0.0 0.1 0.6 0.1 0.0 0.2 1.8 3.9 4.1 2.3 0.9 0.0 0.1 0.7 3.0 0.0 0.1 17.8 1.8 0.4 0.4 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.2 0.0 1.1 7.8 1.0 4.2 0.0 0.3 0.0 1.4 2.3 0.0 0.0 26.7 0.0 0.4 102.4 0.4 1.7 163.5 0.2 106.5 1.1 1.7 0.0 0.8 25.3 0.0 2.9 3.1 10.7 30.4 4.0 4.2 0.0 3.6 5.5 0.0 0.5 1.7 1.8 0.0 0.2 0.0 0.0 88.2 36.6 5.4 13.6 3.2 12.4 2.0 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4273772-4305350 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 13.7 39.3 20.8 12.0 15.9 23.6 10.4 6.1 22.3 14.4 28.3 8.1 24.3 18.5 21.9 41.9 12.2 16.5 9.1 36.9 17.5 7.3 6.0 5.7 12.8 24.5 7.9 17.0 11.6 18.4 8.3 19.2 23.5 9.3 16.4 24.2 14.1 8.3 22.4 2.0 9.2 19.6 45.5 14.0 16.5 11.1 5.2 8.6 6.2 18.5 6.9 13.6 22.3 16.3 3.9 2.1 4.6 1.0 9.1 14.8 5.4 0.0 0.0 32.3 0.0 5.6 0.8 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.2 0.0 0.0 4.1 0.9 29.5 0.0 49.7 0.8 0.3 0.0 0.2 0.1 12.6 2.7 10.8 4.9 0.0 22.3 0.2 0.0 0.9 3.4 71.8 6.3 0.0 0.0 16.6 13.3 0.2 0.0 0.0 47.0 23.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.1 2.3 0.0 9.4 0.0 0.0 1.2 12.2 0.0 0.1 9.1 0.0 4.1 1.0 4.6 9.1 0.2 13.7 3.9 13.0 11.0 2.1 1.5 8.2 9.8 1.5 9.1 0.1 1.0 14.8 5.4 20.8 15.9 6.1 22.3 17.5 7.3 7.9 17.0 9.3 8.6 56.6 49.3 25.1 24.4 94.8 6.8 305.9 0.0 9.4 43.3 12.2 0.0 2.6 0.0 2.5 0.7 38.4 26.9 46.7 59.7 1.7 135.6 5.7 54.3 0.8 12.0 3.2 62.3 17.8 13.3 0.9 48.6 38.9 37.1 6.4 146.6 155.3 32.6 35.1 116.7 1.0 3.7 25.8 50.5 0.7 3.6 34.6 5.3 61.2 109.0 7.0 CCND3 ENSG00000112576 "Cyclin D3" P30281 6 41934933-42050357 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 129.2;lymphoid tissue: 142.5" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 197.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 94.2;REH: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000116, HPA042871" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB000116: , HPA042871: " "unprognostic (4.53e-2)" "unprognostic (4.45e-2)" "unprognostic (2.45e-1)" "unprognostic (4.40e-3)" "unprognostic (1.01e-1)" "unprognostic (9.80e-2)" "unprognostic (3.40e-2)" "unprognostic (5.25e-2)" "unprognostic (7.76e-2)" "unprognostic (3.45e-1)" "unprognostic (9.17e-2)" "unprognostic (6.39e-2)" "unprognostic (2.45e-3)" "unprognostic (9.12e-2)" "unprognostic (1.71e-1)" "prognostic favorable (8.08e-6)" "unprognostic (2.11e-1)" 20.2 39.8 16.1 28.9 17.5 74.7 36.0 13.3 19.8 13.3 17.3 11.3 14.1 16.0 10.8 10.4 13.5 13.4 19.0 16.3 15.4 14.5 13.7 8.0 32.1 83.8 14.1 15.5 11.1 10.9 5.0 10.1 21.9 9.3 14.2 11.4 10.2 18.1 14.4 6.5 14.6 22.0 11.7 11.5 51.2 18.0 7.4 10.0 142.5 26.8 9.3 32.8 13.0 16.6 24.1 42.4 129.2 45.8 39.0 52.8 66.2 9.2 33.7 3.5 7.8 6.4 13.2 40.9 10.8 6.2 11.2 8.2 6.3 4.2 39.7 18.4 7.2 10.0 5.7 9.4 13.2 5.8 6.7 6.1 62.9 15.0 5.1 14.1 10.2 55.6 12.5 8.7 10.8 4.1 3.4 13.7 26.7 31.7 3.9 16.0 12.5 94.2 49.4 1.5 28.4 7.2 89.5 13.7 4.4 25.9 6.2 12.0 3.1 9.2 11.8 5.3 4.7 7.3 40.2 22.9 12.5 6.9 10.7 12.1 2.5 2.0 62.1 7.3 21.7 7.5 129.2 30.5 87.7 52.8 35.1 37.0 16.4 36.4 42.5 42.4 24.1 42.8 45.0 42.8 39.0 45.8 27.8 23.2 66.2 16.1 17.5 13.3 19.8 15.4 14.5 14.1 15.5 9.3 10.0 56.6 64.8 78.2 82.2 24.0 9.3 21.8 56.0 16.0 18.2 19.2 5.9 150.0 24.9 17.1 12.1 47.0 34.6 93.5 21.5 66.5 22.6 44.0 25.5 3.9 39.8 11.1 9.2 55.9 111.4 7.4 38.3 68.6 35.4 7.2 16.9 35.9 21.6 28.8 48.8 13.2 14.6 45.3 26.8 1.7 5.7 19.7 197.8 130.7 19.5 56.2 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCNE2 CYCE2 ENSG00000175305 "Cyclin E2" O96020 8 94879770-94896678 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.2;brain: 22.2;testis: 18.9" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 50.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 8.8" "Group enriched" "Detected in many" 4 "NK-cells: 2.2;T-cells: 8.8" "Cell line enhanced" "Detected in many" "Karpas-707: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007825, CAB019374" Enhanced NA Yes "CAB007825: AB_598148, CAB019374: " "unprognostic (1.80e-2)" "unprognostic (4.81e-2)" "unprognostic (7.49e-2)" "unprognostic (2.08e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.87e-4)" "unprognostic (8.37e-4)" "prognostic unfavorable (8.77e-4)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.64e-2)" "unprognostic (1.04e-2)" "unprognostic (7.01e-12)" "unprognostic (1.81e-2)" "unprognostic (1.50e-1)" "unprognostic (1.06e-2)" "unprognostic (3.03e-1)" 1.3 0.9 3.1 4.9 11.3 24.2 1.5 3.3 6.3 1.7 4.0 10.4 0.0 2.6 1.3 0.1 3.6 1.0 1.7 0.9 5.7 3.5 0.9 1.6 1.7 7.9 8.0 6.5 1.4 2.3 0.5 1.1 3.1 11.8 1.3 4.3 0.6 1.5 0.0 0.8 4.4 3.1 1.4 22.2 1.9 2.9 18.9 4.9 12.7 1.1 2.4 7.0 1.9 1.9 1.1 1.3 1.1 0.3 2.2 8.8 1.1 17.9 2.4 9.6 5.9 1.2 2.2 6.6 18.5 6.4 11.6 11.5 4.3 8.1 9.4 12.6 7.8 3.6 9.5 7.4 6.7 15.8 6.6 6.8 19.0 10.1 1.6 0.1 7.6 11.6 0.6 0.4 8.4 0.8 2.5 5.9 11.7 8.1 39.7 16.5 5.2 29.0 3.5 3.2 14.4 5.5 20.7 16.5 4.5 3.2 10.1 13.9 5.8 12.4 3.3 2.3 1.2 16.7 8.0 5.0 12.4 8.1 9.1 16.5 7.6 7.9 22.9 10.0 13.9 9.0 0.0 0.3 0.2 1.6 0.3 0.5 0.7 2.0 2.3 1.3 1.1 0.6 1.3 1.1 2.2 0.3 0.1 8.8 1.1 3.1 11.3 3.3 5.7 5.7 3.5 8.0 6.5 11.8 4.9 6.0 1.7 0.0 0.8 3.8 2.0 1.7 0.0 1.4 2.3 1.8 5.9 2.6 0.0 0.2 5.6 2.1 8.2 0.0 0.2 7.0 1.1 1.0 0.0 0.9 3.8 7.9 0.0 3.1 2.7 6.1 1.1 1.7 0.0 0.0 2.4 1.0 0.1 0.6 0.4 0.0 4.2 6.5 2.1 50.4 5.0 3.3 1.6 6.9 1.7 0.4 CCNF "FBX1, FBXO1" ENSG00000162063 "Cyclin F" P41002 16 2429394-2458854 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Cell type enriched" "Detected in many" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060596, HPA070495, HPA071600" Enhanced Supported Centrosome NA Yes Centrosome "HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424" "unprognostic (3.87e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-3)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.46e-7)" "unprognostic (2.45e-2)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-1)" 2.1 1.8 4.1 6.0 3.2 9.2 5.1 11.6 4.9 2.1 3.0 1.9 3.6 4.4 1.5 3.4 8.1 1.5 1.5 1.8 4.3 3.9 1.7 1.6 2.2 10.5 1.9 3.1 1.8 1.7 0.8 1.8 3.8 2.4 3.0 3.2 0.7 3.2 3.4 2.5 7.2 3.2 1.8 1.7 4.7 2.6 5.1 2.3 35.7 1.6 3.4 14.2 5.0 2.9 2.7 1.4 0.1 1.1 4.1 3.1 1.7 8.4 13.4 12.9 11.8 0.8 1.2 10.1 10.2 5.0 14.3 11.0 26.6 10.4 17.9 3.5 5.7 4.2 14.4 21.3 7.9 6.8 12.7 10.1 19.6 13.9 8.1 1.0 12.8 12.9 0.8 1.0 10.1 4.8 1.8 10.6 15.1 20.8 11.7 7.2 18.4 18.7 8.5 12.7 9.1 6.1 31.4 15.1 16.0 3.9 3.7 12.5 7.0 15.2 13.3 2.8 6.7 14.2 6.6 7.3 7.9 20.5 5.6 10.6 7.2 8.6 30.9 2.3 12.8 10.7 0.0 1.1 0.0 2.8 0.6 1.7 2.7 1.5 3.1 0.5 2.6 1.2 1.7 0.1 4.1 0.9 1.4 2.2 1.7 4.1 3.2 11.6 4.9 4.3 3.9 1.9 3.1 2.4 2.3 0.0 4.6 0.8 2.1 2.5 4.6 1.7 0.0 0.0 2.3 1.8 11.8 0.8 0.0 1.0 0.8 1.3 0.7 70.0 0.5 10.5 0.9 1.2 1.1 0.8 5.0 7.9 1.2 1.8 1.6 0.0 1.7 1.0 5.0 1.0 1.9 0.6 0.9 0.0 2.5 0.2 1.3 0.0 2.7 2.1 5.1 1.0 1.6 1.5 1.8 1.4 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 52.6 25.7 35.9 23.4 1.2 3.2 34.4 24.4 21.9 71.2 38.0 40.3 43.8 30.5 14.3 22.4 25.1 37.1 39.2 46.6 59.5 23.9 29.0 44.6 25.4 24.9 0.3 31.1 16.3 1.0 2.2 49.4 44.8 6.2 30.1 29.3 20.1 21.0 32.2 20.4 29.9 19.1 45.4 25.1 34.6 43.5 49.3 19.3 17.3 14.0 21.2 10.4 43.1 29.2 13.5 28.8 20.5 39.4 15.6 21.3 50.0 23.6 75.6 16.1 14.3 31.6 15.3 38.8 31.7 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 0.0 0.6 16.2 2.0 9.3 0.0 0.7 0.0 2.7 1.2 0.0 0.0 13.4 0.0 2.1 97.6 0.7 3.2 70.0 0.3 127.9 4.1 2.0 0.0 1.0 30.9 0.0 0.0 8.0 5.0 7.0 2.6 5.2 0.0 2.8 2.9 0.2 0.7 0.0 1.8 2.1 2.6 0.0 1.4 74.9 48.1 7.3 8.9 1.3 15.5 2.6 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Uncertain "Vesicles,Mitotic spindle" Yes Yes Vesicles "Mitotic spindle" "HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 12.1 8.7 15.1 27.7 23.3 26.0 28.8 49.6 21.1 13.0 14.7 12.8 4.6 14.9 17.0 10.3 11.7 13.0 18.6 7.5 15.7 12.5 13.3 11.0 33.0 42.8 21.9 12.5 17.3 5.7 7.5 21.0 30.3 13.8 11.0 12.0 7.7 7.4 10.2 6.2 19.8 16.8 14.8 14.7 24.5 14.1 6.3 22.3 33.3 18.7 20.8 31.6 15.3 16.3 4.5 1.3 1.5 1.8 9.3 15.5 5.9 29.0 62.7 8.4 13.9 10.3 10.1 4.2 14.4 21.6 24.1 18.0 10.9 42.1 20.3 6.2 14.7 59.6 42.5 11.3 23.9 11.4 7.8 12.2 10.9 20.1 13.1 41.2 8.4 5.6 9.9 19.2 22.3 26.4 8.2 13.3 10.2 7.0 53.5 14.2 23.3 26.3 12.3 6.2 19.9 26.8 13.8 23.8 14.5 16.4 2.7 6.0 13.1 34.1 32.6 16.7 7.5 11.0 4.4 11.0 12.9 15.7 23.4 19.0 13.1 20.6 8.2 6.6 8.3 12.4 1.5 1.4 0.0 13.6 1.8 12.7 3.5 13.6 13.7 1.3 4.5 11.4 13.2 0.1 9.3 0.9 0.7 15.5 5.9 15.1 23.3 49.6 21.1 15.7 12.5 21.9 12.5 13.8 22.3 8.9 23.7 9.0 5.5 10.0 13.9 6.8 7.6 0.0 3.4 7.0 2.0 5.3 0.0 7.8 0.5 24.0 3.8 23.3 4.2 14.2 13.6 4.7 1.1 11.6 24.4 3.2 7.5 12.9 11.6 1.0 6.6 10.6 16.9 5.4 7.9 8.3 10.4 2.9 8.5 9.4 2.4 0.0 11.3 1.0 11.5 9.8 3.0 25.4 3.5 3.4 CDC25C "CDC25, PPP1R60" ENSG00000158402 "Cell division cycle 25C" P30307 5 138285265-138338355 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 23.3;testis: 22.3" "Group enriched" "Detected in some" 4 "Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB003800, HPA066991" Approved Enhanced "Nuclear speckles" No Yes "Nuclear speckles" "CAB003800: AB_562081, HPA066991: AB_2685760" "unprognostic (2.45e-3)" "unprognostic (5.89e-3)" "prognostic favorable (2.49e-4)" "unprognostic (9.72e-3)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.03e-6)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.56e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-3)" "unprognostic (1.00e-1)" "unprognostic (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.43e-1)" "unprognostic (2.59e-1)" "unprognostic (3.06e-1)" 1.1 0.6 0.3 6.7 0.4 5.2 1.1 0.4 0.6 0.6 3.3 0.1 0.7 3.0 0.3 0.6 2.5 0.2 0.4 0.7 0.4 0.4 0.4 0.6 0.7 2.6 0.4 0.3 0.3 0.3 0.0 0.4 1.9 0.3 0.4 4.0 0.0 1.2 0.7 0.2 1.1 3.7 0.5 0.3 1.7 1.2 22.3 0.2 23.3 0.3 1.8 5.0 0.6 0.9 1.0 0.1 0.7 0.0 2.1 2.7 0.5 13.3 5.6 18.8 14.5 0.4 1.9 4.7 8.1 8.7 18.4 25.4 13.5 26.0 6.2 6.8 4.9 20.2 7.3 15.5 12.4 17.8 5.1 10.6 4.7 7.6 10.0 0.1 3.2 4.9 0.4 0.5 10.9 9.0 1.9 11.8 13.5 6.9 12.3 11.2 7.4 8.7 8.1 4.8 10.6 6.1 5.7 17.2 7.3 3.2 4.1 9.5 5.9 18.1 5.5 8.6 17.3 9.2 6.7 3.5 10.2 8.6 7.0 12.9 7.5 6.1 6.1 4.0 6.8 7.7 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.5 0.3 0.0 0.2 0.0 0.0 0.7 2.1 0.0 0.1 2.7 0.5 0.3 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 32.9 0.0 0.3 0.0 0.0 5.7 0.2 0.3 0.0 0.2 2.2 0.0 0.0 0.0 0.3 35.1 1.7 1.2 0.0 1.0 0.6 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 36.3 8.3 0.4 1.1 0.0 1.6 0.1 CDC27 "ANAPC3, APC3, D0S1430E, D17S978E, NUC2" ENSG00000004897 "Cell division cycle 27" P30260 17 47117703-47189422 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016315, HPA028129, HPA052399, HPA065835" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: " "unprognostic (2.34e-2)" "unprognostic (8.83e-3)" "prognostic favorable (1.77e-4)" "unprognostic (4.26e-2)" "unprognostic (7.99e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.38e-4)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (7.95e-2)" "unprognostic (3.66e-2)" 29.2 18.9 19.4 18.7 25.2 23.0 23.3 26.0 33.0 23.7 17.2 14.8 13.8 14.4 23.2 19.6 17.6 17.6 18.6 22.8 18.3 22.6 16.8 23.8 20.4 21.3 19.4 23.9 19.5 14.3 27.8 26.8 25.0 31.5 17.6 18.2 14.6 15.7 16.5 31.6 15.5 15.3 24.4 17.7 24.2 16.1 23.5 17.4 25.2 42.8 15.5 22.9 23.6 17.3 9.0 7.7 9.6 10.3 12.8 11.6 5.4 23.6 25.4 21.3 17.1 14.4 22.9 12.7 33.5 30.2 32.0 32.8 16.2 12.5 31.9 22.6 28.0 20.5 11.4 22.9 18.9 44.2 45.8 23.5 37.1 26.8 14.4 15.6 21.7 16.9 16.6 9.3 28.8 22.8 15.5 33.0 18.7 29.5 17.8 26.0 20.1 26.7 9.9 10.1 13.4 20.7 14.4 54.7 14.1 19.3 15.0 14.2 17.3 16.8 5.9 18.6 19.0 17.9 15.4 35.1 33.5 29.1 21.1 24.7 18.2 31.5 28.9 18.5 13.0 23.1 9.6 4.4 6.2 8.1 10.3 7.8 6.0 6.8 8.5 6.0 9.0 6.7 7.6 5.7 12.8 7.4 7.7 11.6 5.4 19.4 25.2 26.0 33.0 18.3 22.6 19.4 23.9 31.5 17.4 8.9 22.9 28.9 16.0 23.1 20.2 34.3 22.9 10.7 28.4 19.2 15.7 24.5 13.3 23.9 23.6 38.7 10.6 163.5 23.1 29.3 36.3 14.9 25.5 25.2 24.1 33.4 13.3 37.4 24.8 22.5 26.2 19.8 6.8 31.5 13.5 19.5 24.1 10.5 28.0 17.4 13.9 19.4 33.0 88.5 35.1 23.5 9.6 21.0 14.3 13.1 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.2 11.1 13.9 10.9 0.6 1.3 5.9 16.4 7.7 18.9 18.8 8.5 7.4 14.8 5.8 4.9 7.5 12.8 14.8 10.8 17.0 18.0 25.0 19.8 12.6 9.3 0.7 28.7 10.9 0.4 0.5 14.5 6.5 1.8 9.5 15.3 87.8 18.7 11.0 17.7 23.3 13.6 4.2 25.7 8.4 19.4 23.1 6.5 4.4 12.7 18.0 9.5 8.9 9.8 2.8 6.5 6.4 12.8 3.6 14.8 23.7 11.2 14.9 6.4 11.8 17.2 7.8 14.4 19.7 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.8 0.4 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.9 88.0 0.3 0.4 46.7 0.0 16.8 1.0 0.2 0.0 0.0 6.2 0.0 0.0 3.7 0.6 6.1 0.6 0.9 0.0 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 6.5 0.9 23.9 49.8 1.6 4.1 1.3 2.5 0.4 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 86.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.4 17.6 21.3 15.1 1.1 2.3 19.5 27.8 8.3 24.4 29.5 20.0 11.4 20.6 17.4 5.9 14.1 37.1 18.4 12.6 24.3 10.9 14.5 16.7 21.0 17.9 0.7 22.8 10.3 0.6 0.9 28.2 16.9 2.6 7.3 14.2 30.5 19.3 11.8 13.3 33.1 5.5 17.5 15.1 6.5 24.4 51.9 19.4 4.0 28.7 14.6 13.1 25.3 86.7 8.6 17.4 17.6 19.8 6.1 17.6 25.2 28.8 32.9 8.1 17.5 39.7 15.2 15.1 19.2 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 0.0 1.3 2.2 1.1 3.8 0.0 0.6 0.0 0.0 1.2 0.0 0.0 12.0 0.0 1.2 1.4 0.5 1.1 23.3 0.6 27.7 2.4 1.1 0.0 0.9 6.8 0.0 0.0 1.8 1.3 0.2 2.6 1.3 0.0 0.0 1.7 0.3 1.2 2.9 0.7 0.2 0.3 12.9 1.0 11.4 23.0 1.4 14.0 2.5 4.6 2.0 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25458997-25507920 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 38.8;testis: 17.7" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 22.0;Early spermatids: 29.6;Extravillous trophoblasts: 12.3;Late spermatids: 14.4;Sertoli cells: 12.9;Spermatocytes: 45.9;Spermatogonia: 28.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.6;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.8 0.5 0.3 11.3 0.5 5.5 0.6 0.3 0.3 0.7 3.3 0.2 0.0 1.3 0.5 0.2 2.8 0.3 0.1 0.6 0.3 0.3 0.5 0.5 0.6 4.4 0.4 0.2 0.4 0.3 0.0 0.4 3.3 0.3 0.5 2.0 0.1 0.7 0.0 0.4 1.0 3.3 0.6 1.0 3.9 0.8 17.7 0.4 38.8 0.4 3.5 5.9 0.6 1.0 0.7 0.0 0.0 0.0 2.6 1.9 0.8 14.8 14.1 13.1 10.9 1.1 2.0 8.7 16.7 9.9 14.6 14.6 12.0 6.8 17.6 7.2 6.9 15.8 13.6 18.2 8.5 21.6 6.6 5.2 18.0 10.2 6.4 0.3 8.0 8.8 1.1 0.5 10.2 6.9 1.4 10.5 10.6 14.2 20.4 13.3 5.8 22.4 3.8 13.4 10.3 6.2 11.6 14.5 6.4 4.1 8.1 5.5 5.9 14.1 6.8 6.6 6.6 7.5 3.9 7.2 10.9 17.5 20.5 15.4 3.4 6.9 18.7 7.8 10.5 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 1.9 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.0 0.6 0.8 0.5 1.0 0.4 22.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.2 29.6 0.0 0.0 0.0 0.0 12.3 0.4 0.4 0.0 0.0 3.3 0.0 0.0 1.3 1.9 14.4 1.1 1.2 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.5 0.3 12.9 0.7 45.9 28.1 0.6 1.4 1.9 1.2 0.4 CDCA3 "GRCC8, TOME-1" ENSG00000111665 "Cell division cycle associated 3" Q99618 12 6844793-6852066 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.6;lymphoid tissue: 51.0" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 53.0;Erythroid cells: 46.7;Extravillous trophoblasts: 60.9;Spermatocytes: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.8" "Cell type enhanced" "Detected in many" "T-reg: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026587 Approved Cytosol NA Yes Cytosol "HPA026587: AB_1846386" "unprognostic (3.05e-1)" "unprognostic (1.32e-1)" "unprognostic (9.85e-2)" "unprognostic (1.63e-2)" "unprognostic (2.42e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.51e-5)" "prognostic unfavorable (9.77e-5)" "unprognostic (3.88e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-3)" "unprognostic (8.81e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.11e-1)" "unprognostic (4.94e-2)" 1.6 1.9 1.0 19.2 1.8 9.9 1.9 8.8 2.2 2.0 17.3 1.2 1.2 15.5 2.3 2.0 6.9 1.0 2.9 2.2 1.1 1.6 1.3 0.9 1.9 10.8 1.3 0.7 3.7 0.6 0.3 6.9 4.7 1.2 2.2 5.3 0.7 2.4 0.4 0.7 4.3 34.6 2.0 1.4 5.2 2.4 18.2 1.1 51.0 1.3 8.5 15.1 1.6 2.8 1.6 2.3 0.5 0.6 0.8 7.7 0.9 30.1 21.8 22.3 13.5 1.3 2.0 25.9 19.9 12.2 32.8 22.9 32.3 26.0 16.7 2.5 15.0 23.8 20.8 14.3 13.7 32.6 25.1 15.9 15.0 14.6 21.0 0.2 11.1 14.3 0.9 1.1 17.6 9.6 8.0 13.9 11.8 12.4 10.9 31.2 23.6 16.2 12.9 26.1 20.3 16.9 16.4 19.4 9.4 10.9 8.5 3.4 6.7 18.0 16.8 6.2 24.9 6.6 10.8 6.1 16.0 20.7 10.4 33.4 5.6 5.6 26.1 7.5 13.9 28.1 0.0 0.6 0.0 0.5 0.3 0.8 1.6 1.3 1.9 0.7 0.8 0.6 1.2 0.5 0.8 0.5 2.3 7.7 0.9 1.0 1.8 8.8 2.2 1.1 1.6 1.3 0.7 1.2 1.1 0.0 0.3 0.8 1.2 2.6 10.5 1.0 0.0 0.0 0.0 0.0 53.0 3.3 0.0 0.9 5.9 0.4 9.5 46.7 0.3 60.9 2.6 1.0 4.6 0.8 15.7 6.4 1.2 3.1 3.5 5.4 1.7 2.7 0.0 1.8 5.7 1.4 0.3 0.8 0.4 0.7 18.0 6.5 0.4 57.5 14.9 1.6 7.1 0.8 10.9 0.6 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 133.3;Spermatogonia: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.2 15.9 18.4 13.9 3.1 5.2 24.1 22.8 7.0 17.9 15.7 19.4 19.5 20.0 12.5 8.0 13.7 24.5 12.8 26.3 10.5 21.9 10.1 12.7 13.6 16.2 3.9 22.4 10.7 3.7 8.2 13.8 13.0 6.0 12.1 17.5 13.9 20.8 12.4 37.4 20.8 15.1 13.6 13.3 36.4 20.2 26.8 7.4 6.0 17.7 10.8 13.3 21.8 8.8 17.5 8.5 17.2 15.1 18.7 15.9 20.2 21.7 30.2 7.7 9.5 20.5 13.3 11.4 26.2 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 0.0 2.1 10.4 19.9 57.1 3.0 0.6 0.0 8.1 3.4 1.8 0.0 53.6 3.3 12.9 6.4 9.0 1.1 23.3 6.2 133.3 12.5 7.7 28.8 2.1 21.5 12.7 2.9 7.4 6.2 4.3 7.8 10.6 16.9 10.8 4.4 3.4 9.1 3.5 5.6 1.4 2.7 6.5 10.3 31.0 64.2 58.6 21.6 17.5 6.0 48.5 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9" "Group enriched" "Detected in many" 5 "Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "NK-cell: 5.8;T-reg: 4.2" "Group enriched" "Detected in many" 4 "NK-cells: 5.8;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.3 1.3 1.1 12.3 1.1 27.4 4.3 1.0 2.8 1.6 3.8 0.6 0.0 3.3 0.9 1.4 7.9 0.7 1.4 1.3 1.1 0.9 1.3 1.3 1.9 9.5 1.1 0.5 0.8 0.7 0.2 0.7 5.5 1.3 0.9 4.7 0.1 1.5 0.1 0.7 2.4 3.6 1.7 0.7 5.7 2.1 27.9 0.2 39.9 0.7 6.6 9.9 1.5 2.3 1.2 0.8 0.3 0.5 5.8 4.2 1.4 30.7 17.6 16.9 14.3 1.1 1.8 14.1 22.0 9.2 25.8 20.6 18.0 18.7 28.0 12.7 7.1 30.4 21.3 27.3 12.1 25.2 28.0 11.9 25.2 12.8 15.1 0.1 26.8 20.4 0.6 1.1 24.1 11.2 2.7 7.8 33.6 28.5 51.8 15.7 25.5 37.8 27.7 26.6 15.2 21.4 33.2 18.7 26.7 5.3 11.8 22.0 16.5 14.1 20.2 14.9 11.0 26.0 13.2 4.9 23.4 24.2 24.6 24.4 26.2 41.5 45.6 9.4 16.6 24.1 0.0 0.2 0.3 0.8 0.0 0.1 0.7 1.1 0.6 0.8 1.2 0.1 0.8 0.1 5.8 0.5 0.7 4.2 1.4 1.1 1.1 1.0 2.8 1.1 0.9 1.1 0.5 1.3 0.2 0.0 0.3 0.8 0.8 3.4 0.8 0.8 0.0 0.0 1.2 0.0 2.0 3.7 1.7 0.9 41.6 0.9 0.9 0.0 0.7 30.6 1.8 0.4 3.5 0.0 9.5 1.6 0.0 1.3 2.8 84.2 2.6 1.9 0.0 3.6 2.3 0.8 0.5 0.0 1.4 0.3 0.2 0.0 0.3 40.4 22.0 0.9 3.1 1.9 2.8 1.0 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 40.4;Leydig cells: 49.8;Peritubular cells: 32.5;Undifferentiated cells: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol No Yes "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 6.0 2.1 14.2 16.0 11.7 12.6 27.6 7.6 3.6 5.5 10.3 28.4 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.4 5.9 2.7 0.9 7.7 6.5 1.8 6.4 36.5 14.9 6.3 4.1 7.9 61.8 40.7 21.1 23.4 5.3 43.7 13.6 17.5 6.9 8.7 5.2 9.2 9.4 3.1 5.0 16.7 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.8 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 0.0 1.1 1.4 12.6 18.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.4 1.1 6.7 0.0 0.2 21.5 2.6 2.4 0.0 0.0 8.9 0.0 11.7 0.0 0.8 1.8 49.8 1.6 3.3 0.0 19.1 0.6 0.7 7.0 32.5 0.0 0.0 0.0 4.3 9.4 30.1 13.9 8.5 6.9 66.1 1.7 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.9 18.6 49.6 19.6 3.2 5.0 20.4 37.0 27.0 45.2 43.6 43.6 43.3 44.9 14.4 10.1 16.6 30.5 33.7 21.5 47.1 31.9 24.6 23.5 18.4 25.3 0.6 36.0 24.3 0.9 2.1 29.2 28.5 10.3 27.1 29.6 35.9 55.3 50.2 13.0 45.3 25.9 21.8 29.6 39.3 39.4 46.2 22.0 17.2 16.3 23.3 20.4 24.9 37.8 19.2 28.1 40.8 22.1 11.1 19.3 41.2 20.3 50.6 21.7 34.8 40.5 16.6 40.4 23.9 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 0.0 2.7 2.2 3.6 35.3 1.0 0.5 0.0 14.7 7.9 17.4 0.0 11.0 3.3 0.7 8.8 4.5 1.7 280.4 0.0 116.8 5.1 1.0 0.0 0.8 46.3 0.0 2.9 9.8 15.3 6.3 2.0 8.8 1.7 1.8 4.0 1.0 0.3 0.0 0.7 2.1 0.5 0.0 1.4 104.2 29.6 16.3 18.4 7.0 5.6 6.0 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.7 9.6 7.7 3.1 3.2 6.1 8.1 12.2 6.9 8.7 2.9 7.4 11.2 13.1 6.2 10.5 5.4 10.3 3.3 17.0 5.5 2.9 8.1 5.1 10.8 0.8 13.4 8.3 9.4 7.5 5.7 5.5 8.3 5.8 15.1 8.7 13.4 1.8 9.9 19.2 10.0 23.8 15.8 16.0 7.3 14.6 10.5 18.4 15.6 11.7 7.6 16.5 15.3 7.1 3.6 9.1 16.7 13.2 13.4 5.9 15.3 6.1 8.3 6.6 3.6 4.0 9.0 14.3 8.4 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 11.9 28.2 16.7 22.2 13.7 17.3 4.8 45.9 18.7 9.1 26.2 23.6 25.3 36.5 23.6 5.0 17.5 42.9 0.0 11.0 16.4 18.6 26.1 9.2 37.6 16.3 17.5 65.1 19.6 16.7 5.4 22.2 13.0 18.6 14.4 38.5 10.3 14.2 35.1 11.7 45.1 33.8 6.5 11.3 23.1 29.8 13.6 23.3 17.5 50.1 18.6 CDKN2D "INK4D, p19" ENSG00000129355 "Cyclin dependent kinase inhibitor 2D" P55273 19 10566462-10569059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;bone marrow: 119.4" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 111.8;Spermatogonia: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 32.8;MOLT-4: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011201, HPA043546" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB011201: AB_261049, HPA043546: AB_2678545" "unprognostic (3.08e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.57e-2)" "unprognostic (1.49e-2)" "unprognostic (3.29e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.08e-1)" "unprognostic (1.08e-2)" "unprognostic (6.55e-2)" "unprognostic (3.28e-1)" "unprognostic (1.50e-1)" "unprognostic (3.27e-3)" "unprognostic (9.90e-2)" "unprognostic (4.52e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" 5.5 4.7 27.9 6.8 24.2 119.4 4.1 14.3 28.7 2.6 3.9 4.2 0.5 3.9 2.4 2.5 3.8 3.0 4.0 8.4 22.9 17.9 2.7 2.1 6.6 11.1 14.3 14.3 2.8 2.8 2.6 3.4 4.8 11.8 2.5 3.6 2.4 3.2 3.0 6.3 6.0 3.5 4.6 5.7 9.7 2.8 10.9 3.6 18.6 1.8 2.8 8.4 4.2 2.4 17.3 16.0 44.1 10.7 11.9 11.3 9.5 11.0 1.7 5.7 3.7 3.0 4.7 1.4 7.3 8.6 8.1 7.1 2.2 2.7 3.1 2.4 7.7 8.2 2.3 1.9 1.8 2.9 12.3 4.6 32.8 2.0 3.6 3.5 3.3 26.6 1.9 6.1 4.1 3.1 6.7 2.2 19.5 1.3 27.0 8.0 1.5 40.4 17.3 1.1 8.5 8.5 6.6 5.5 1.8 3.6 0.9 8.0 4.2 5.1 3.9 5.6 1.1 3.5 8.7 1.7 9.6 4.9 15.8 10.8 16.9 5.7 5.7 10.1 5.6 6.8 35.9 5.6 23.5 10.0 6.8 8.0 17.3 8.3 11.3 5.4 15.9 7.9 9.4 44.1 11.9 10.7 16.0 6.7 9.5 27.9 24.2 14.3 28.7 22.9 17.9 14.3 14.3 11.8 3.6 6.0 9.5 48.4 13.8 20.6 28.1 8.5 2.5 5.3 3.4 5.2 11.8 2.4 8.3 6.0 15.3 15.3 5.8 46.7 4.3 7.1 11.0 10.0 20.7 3.0 8.7 44.5 6.9 20.3 36.0 8.5 6.6 24.1 28.7 10.8 5.8 17.7 9.9 10.5 5.6 3.4 29.5 19.4 30.3 111.8 87.1 29.0 4.1 44.9 3.6 23.8 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 80.3" "Cell type enriched" "Detected in many" 4 "Early spermatids: 2056.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 16.1" "Group enriched" "Detected in all" 5 "NK-cells: 5.8;T-cells: 16.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 2.4 1.0 1.6 6.5 1.7 12.8 1.5 1.5 2.5 1.0 4.5 0.2 0.2 3.8 0.9 1.1 4.4 0.7 0.9 3.0 1.4 1.9 1.0 1.1 1.1 8.8 1.7 1.9 0.9 0.7 0.0 1.0 2.3 2.8 0.9 5.8 0.9 1.7 0.1 3.9 1.8 4.0 2.2 1.0 2.3 1.8 80.3 0.3 18.3 1.1 6.4 9.5 2.1 1.8 2.0 1.6 1.1 1.4 5.8 16.1 2.9 55.2 21.2 16.3 16.3 2.7 3.3 9.4 13.2 19.5 28.2 31.2 16.0 27.6 27.2 9.7 20.6 29.7 40.7 24.7 16.0 52.7 32.6 11.9 13.8 15.3 26.4 2.0 17.2 9.8 1.2 1.0 17.6 30.7 9.9 17.9 26.4 6.9 34.8 33.8 39.3 23.8 14.0 5.7 54.1 46.0 14.8 14.4 5.9 14.9 12.1 6.7 8.5 24.2 14.3 10.5 12.8 29.6 14.7 6.5 12.5 42.9 19.7 31.2 8.4 9.7 18.7 20.9 24.9 22.8 0.0 1.3 1.1 1.2 1.4 0.6 2.0 5.2 4.3 1.6 0.9 2.7 2.2 0.9 5.8 0.9 1.2 16.1 2.9 1.6 1.7 1.5 2.5 1.4 1.9 1.7 1.9 2.8 0.3 0.0 0.0 0.8 3.1 8.2 1.4 9.3 0.0 0.0 1.2 1.8 2.0 9.8 0.0 2.8 2056.4 2.0 2.9 256.9 2.1 27.0 6.6 2.2 6.9 1.8 31.5 4.8 7.5 4.9 7.5 483.1 19.8 5.7 1.7 3.6 6.2 1.2 2.0 6.2 9.9 1.7 2.3 0.0 2.1 159.2 36.4 5.6 3.4 7.0 12.8 1.4 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803213-88809258 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.2;esophagus: 7.1" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 46.7;Extravillous trophoblasts: 78.3;Spermatogonia: 28.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 39.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.4 0.4 0.7 2.7 0.9 25.2 0.4 0.0 1.2 1.2 2.5 2.9 0.3 0.0 7.1 0.3 0.0 0.1 0.6 2.2 0.5 0.6 0.9 3.2 1.7 0.0 0.4 0.9 2.1 2.0 0.3 1.0 0.8 0.1 0.0 3.3 3.2 0.3 0.8 3.1 1.7 3.3 0.1 2.1 0.2 1.9 3.7 2.1 3.5 0.9 1.7 4.0 0.7 9.7 10.2 4.4 7.5 0.2 0.9 17.9 6.6 1.8 5.2 3.3 20.8 10.0 14.4 7.4 1.4 3.5 12.6 5.6 4.5 1.7 5.1 23.9 13.5 9.0 17.4 0.0 7.6 5.9 0.4 0.3 5.3 1.1 0.4 1.6 18.6 21.9 4.8 1.9 24.1 31.3 39.6 11.5 3.0 8.2 33.5 6.0 12.6 1.1 7.4 10.7 7.9 11.5 3.6 5.0 2.0 11.4 15.7 1.7 7.3 11.7 11.0 9.7 17.9 15.5 19.8 5.4 19.5 8.8 0.5 0.9 3.5 2.7 0.5 1.1 1.2 2.7 2.7 1.0 3.7 4.0 2.4 2.1 1.7 0.7 2.1 3.0 0.7 0.0 0.6 7.5 3.4 10.0 0.2 1.6 2.5 2.7 2.3 1.8 0.0 24.8 1.7 1.0 0.2 1.2 2.1 46.7 0.0 78.3 1.3 1.7 0.0 0.9 16.4 0.0 2.4 0.6 4.1 0.7 0.3 2.5 1.7 2.8 9.3 1.1 0.5 0.0 0.4 1.0 1.8 0.0 2.0 2.7 28.5 6.1 20.7 3.2 18.0 3.4 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 53.7" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 27.3;Hofbauer cells: 12.7;Spermatogonia: 18.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB008371: AB_591074, HPA073086: AB_2686569" "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (2.88e-8)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 1.2 0.9 0.2 12.1 0.2 3.5 3.0 0.2 0.2 1.3 3.5 0.4 0.3 5.3 0.9 1.5 8.5 0.1 1.2 1.5 0.2 0.3 0.8 0.7 1.4 8.2 0.3 0.0 0.5 0.7 0.0 0.3 3.1 0.3 0.5 3.2 0.1 1.7 0.0 0.3 4.5 3.6 0.8 0.3 4.9 1.8 7.8 0.0 53.7 0.4 9.2 10.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 31.2 7.2 11.2 6.2 0.9 1.8 9.3 9.7 7.4 13.1 11.3 5.2 10.2 9.4 6.3 3.5 15.4 9.2 10.0 5.1 13.0 27.9 9.8 15.9 3.3 8.7 0.3 9.2 17.8 0.1 0.6 5.2 7.2 2.0 6.7 11.6 12.8 19.5 10.3 10.5 13.3 14.2 10.0 10.4 13.3 15.9 20.0 10.4 5.7 1.4 9.6 9.7 9.3 10.4 7.6 4.0 6.2 9.9 4.8 8.1 20.6 9.6 16.0 19.4 19.2 38.4 3.9 19.0 15.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.4 0.0 0.4 0.0 0.2 27.3 1.0 0.9 0.0 0.0 12.7 0.0 4.1 2.5 1.6 0.0 0.9 1.8 1.7 0.0 3.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 7.1 18.1 4.5 2.9 1.7 3.7 2.1 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol NA Yes "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.9 6.0 21.9 10.6 1.5 3.4 4.3 19.1 9.6 14.3 9.5 9.5 11.4 14.2 4.9 7.0 10.0 9.4 15.7 7.7 22.6 17.7 5.8 16.7 12.6 6.9 0.2 19.8 9.7 1.0 0.6 11.4 9.6 3.2 12.0 13.0 17.3 17.0 18.3 7.6 15.6 8.9 7.0 8.5 9.4 10.5 20.5 4.7 4.0 4.2 10.1 6.0 16.9 11.8 4.6 8.8 6.7 7.0 13.0 13.8 14.5 14.3 19.5 8.3 14.2 14.8 7.7 11.1 14.6 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 3.0 2.1 0.0 1.0 3.2 7.1 1.4 0.0 0.0 1.2 0.0 7.9 2.4 0.0 0.4 3.4 2.8 0.5 93.5 0.0 22.1 1.5 1.3 6.9 0.8 11.2 0.0 1.2 4.3 7.3 0.7 0.9 5.5 0.0 8.2 1.4 1.4 1.3 0.6 2.5 0.0 2.5 0.0 2.5 69.2 47.7 2.5 3.0 2.5 4.7 0.6 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664588 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.5;lymphoid tissue: 67.5" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 1.6 1.5 1.0 10.7 1.3 19.5 1.1 0.4 0.9 2.1 5.6 0.3 0.0 4.6 1.2 1.7 9.4 0.8 0.4 1.7 0.6 0.6 1.0 0.8 3.2 6.2 0.6 0.5 1.4 0.6 0.0 0.4 6.4 0.8 0.7 4.5 0.4 1.9 0.0 0.5 4.7 6.4 1.6 1.5 3.8 2.3 9.4 0.6 67.5 0.6 7.6 7.6 1.4 2.9 0.3 0.3 0.0 0.0 0.7 1.9 0.2 32.6 18.5 39.9 20.8 1.5 2.0 15.6 20.2 8.3 12.2 12.0 14.7 20.2 31.1 12.0 11.2 11.0 20.3 24.6 13.2 20.7 27.1 15.4 25.5 28.4 20.9 0.2 36.1 14.0 0.7 1.0 17.5 20.2 3.5 12.7 14.3 23.0 18.6 21.7 12.4 21.3 14.4 35.3 9.8 8.2 22.7 56.4 10.2 11.9 8.1 18.7 25.5 27.3 18.2 10.5 22.2 21.7 13.8 16.7 22.1 26.0 18.3 41.7 14.3 15.4 29.9 9.6 26.1 19.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1.4 0.4 0.3 0.3 1.9 0.8 0.0 0.7 0.0 0.3 1.7 0.2 1.0 1.3 0.4 0.9 0.6 0.6 0.6 0.5 0.8 0.6 0.0 1.9 40.2 1.2 8.2 3.2 1.9 2.5 26.8 14.8 0.0 0.0 9.1 0.0 1.8 32.4 2.8 1.3 303.7 0.4 74.0 7.7 1.0 1.1 1.9 26.4 1.6 0.0 9.8 11.2 9.4 1.1 9.9 1.7 0.0 5.3 1.1 0.5 0.0 2.8 0.0 2.8 0.0 0.3 20.9 88.3 4.8 4.2 10.9 15.5 0.9 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.3" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 3.8;Hofbauer cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" NA Yes "Nuclear bodies" Cytosol "HPA061297: AB_2684471" "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 2.6 1.8 1.5 10.8 4.7 9.1 4.0 1.7 2.9 3.7 3.9 3.6 0.0 4.0 4.1 2.2 7.1 2.7 2.8 1.7 1.8 1.4 1.5 1.6 2.9 7.7 3.3 1.8 4.5 1.2 0.3 1.3 3.6 2.6 1.8 5.3 1.2 2.0 0.8 1.5 4.5 3.8 4.3 4.3 4.0 3.3 4.6 2.7 18.3 1.3 4.1 11.0 3.1 3.7 2.6 2.9 4.8 2.8 3.2 3.3 1.2 16.8 11.6 14.4 11.1 1.8 3.3 6.4 18.3 9.8 18.6 37.6 15.6 10.8 12.4 6.5 7.2 28.7 9.9 21.0 9.7 26.0 7.7 5.3 7.6 16.6 5.9 0.2 10.0 8.4 1.3 0.8 24.6 3.1 5.3 15.8 9.0 5.3 22.8 17.9 11.9 9.9 3.6 11.1 8.0 14.4 9.3 20.8 8.0 4.6 10.1 9.2 4.8 22.4 6.3 3.8 13.7 6.3 3.2 6.4 17.5 14.7 16.2 14.5 3.7 8.5 14.0 6.9 13.4 13.5 2.2 2.1 2.3 2.0 2.8 1.3 2.6 2.0 2.6 1.0 2.1 1.6 1.7 4.8 3.2 2.6 2.9 3.3 1.2 1.5 4.7 1.7 2.9 1.8 1.4 3.3 1.8 2.6 2.7 0.0 0.0 0.8 0.0 0.2 0.4 0.4 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 3.8 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.6 0.0 0.3 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 1.0 0.1 0.2 0.0 0.5 0.0 CENPK "CENP-K, FKSG14, SOLT" ENSG00000123219 "Centromere protein K" Q9BS16 5 65517766-65563171 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.5;testis: 29.0" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 40.2;Spermatocytes: 80.1;Spermatogonia: 74.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA Yes "unprognostic (4.04e-2)" "unprognostic (1.77e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-2)" "unprognostic (1.85e-1)" "unprognostic (3.04e-3)" "unprognostic (3.69e-4)" "unprognostic (3.22e-3)" "unprognostic (9.59e-3)" "unprognostic (3.32e-2)" "unprognostic (3.16e-3)" "unprognostic (1.98e-2)" "unprognostic (6.33e-15)" "unprognostic (2.22e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-2)" "unprognostic (3.11e-1)" 1.8 1.5 1.9 22.8 2.9 16.1 2.5 2.7 2.4 2.0 6.2 0.6 1.0 5.8 3.0 3.3 9.8 2.2 2.0 1.7 1.3 1.0 1.8 1.6 3.2 9.7 1.1 1.2 1.8 1.2 0.6 0.9 3.7 1.4 1.7 8.8 0.8 2.7 0.2 0.6 6.6 6.9 2.1 1.3 7.0 3.7 29.0 2.0 35.5 1.4 8.8 11.2 2.1 4.1 3.4 1.0 2.0 0.6 5.5 18.3 7.7 22.4 14.7 30.9 10.5 1.6 4.5 14.7 24.6 9.4 21.2 26.9 12.3 34.6 13.7 9.2 8.3 21.6 14.1 11.8 12.5 33.9 15.6 10.2 14.7 18.5 11.7 0.6 17.2 13.3 2.0 1.8 20.5 9.9 3.9 20.1 15.0 10.8 20.7 21.1 7.4 29.0 19.5 14.8 6.4 6.1 18.1 29.6 15.2 13.8 12.2 13.0 10.5 19.0 7.9 9.7 12.1 14.5 12.8 6.9 16.4 17.0 11.2 28.5 10.9 17.6 28.7 15.3 25.9 17.8 2.0 0.4 1.3 6.1 0.6 9.0 2.4 13.2 7.7 1.0 3.4 18.3 13.5 1.1 5.5 0.6 0.9 12.8 7.7 1.9 2.9 2.7 2.4 1.3 1.0 1.1 1.2 1.4 2.0 0.0 4.3 17.9 4.8 20.9 1.0 0.8 0.0 4.0 10.3 0.0 0.0 13.5 1.7 2.9 22.9 3.2 1.3 23.3 0.9 40.2 3.1 1.6 2.3 0.8 18.4 0.0 0.0 3.7 1.0 14.0 1.4 7.9 1.7 1.0 6.9 0.6 1.6 2.8 1.4 0.0 1.0 0.0 1.4 80.1 74.5 7.0 5.6 15.8 11.8 2.7 CENPL "C1orf155, dJ383J4.3, FLJ31044" ENSG00000120334 "Centromere protein L" Q8N0S6 1 173799550-173824720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 29.5" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 70.0;Spermatocytes: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044520 Uncertain NA Yes "HPA044520: AB_10794500" "unprognostic (8.72e-3)" "unprognostic (2.82e-2)" "unprognostic (3.39e-1)" "unprognostic (1.34e-3)" "unprognostic (7.89e-2)" "unprognostic (7.88e-3)" "unprognostic (6.43e-6)" "unprognostic (8.18e-2)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.60e-4)" "unprognostic (1.78e-3)" "unprognostic (5.00e-2)" "unprognostic (1.46e-10)" "unprognostic (2.16e-2)" "unprognostic (4.41e-2)" "unprognostic (3.10e-2)" "unprognostic (3.09e-1)" 4.0 2.7 3.1 3.8 3.7 10.9 3.1 5.0 3.8 3.6 3.0 2.8 1.7 3.0 2.5 1.5 4.2 1.8 2.0 2.2 3.0 2.5 2.1 1.4 2.6 7.8 3.9 1.7 2.6 1.4 1.5 2.3 3.8 4.0 2.3 3.9 1.8 2.9 1.8 2.8 3.2 2.9 3.0 2.9 6.6 2.6 13.7 4.5 29.5 2.3 1.9 7.2 3.2 3.7 6.0 5.3 4.2 1.4 10.6 8.4 3.2 16.3 4.4 8.4 11.1 2.5 4.3 6.2 14.7 8.6 15.0 10.6 5.7 8.7 11.7 7.0 7.5 6.1 10.8 8.7 6.9 16.8 10.7 4.3 9.0 4.9 3.3 1.3 13.4 9.1 2.1 2.3 10.6 8.6 2.9 8.7 9.3 15.1 17.7 13.8 3.8 10.8 5.9 8.7 11.3 24.7 11.5 10.5 10.1 5.3 4.6 8.4 7.1 11.4 14.2 9.5 7.1 10.1 10.8 5.4 18.5 12.5 9.3 16.7 9.8 16.9 19.3 6.0 9.8 16.4 4.2 1.3 2.7 6.1 1.4 6.9 4.3 5.6 6.8 1.2 6.0 7.1 7.6 1.0 10.6 0.9 5.3 8.4 3.2 3.1 3.7 5.0 3.8 3.0 2.5 3.9 1.7 4.0 4.5 8.9 3.0 10.5 4.2 4.1 4.9 3.6 2.5 1.4 2.3 1.8 13.7 6.0 0.0 2.2 1.7 3.8 2.8 70.0 3.2 13.3 5.0 5.5 4.6 0.0 5.5 1.6 1.7 1.3 2.7 2.2 4.4 4.3 5.0 4.6 4.1 2.8 2.5 2.9 1.8 0.8 3.8 0.0 6.2 34.3 11.5 5.3 4.9 10.8 3.0 3.1 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496632-93529092 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.9;testis: 19.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "T-reg: 4.4" "Lineage enriched" "Detected in single" 24 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023430 Approved Supported "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 3.2 1.4 0.5 12.1 0.4 3.1 3.6 0.3 0.6 2.0 5.2 0.3 0.2 4.6 0.8 1.5 11.6 0.6 2.5 0.7 0.4 0.5 1.5 0.7 4.4 10.1 0.6 0.2 0.8 0.6 0.0 0.7 3.8 0.5 0.8 6.5 0.4 2.3 0.2 0.7 3.0 5.2 3.5 1.1 4.8 3.2 19.3 0.3 52.9 0.7 10.8 11.0 2.7 3.3 0.1 0.1 0.0 0.0 0.0 4.4 0.0 51.9 20.8 13.8 17.6 1.5 3.2 7.7 28.6 20.3 27.2 28.2 22.1 28.0 13.9 12.7 18.5 18.3 29.7 16.7 14.0 32.7 41.8 8.7 5.2 12.9 7.5 0.1 9.0 12.2 0.7 1.0 29.0 35.4 8.1 25.0 23.1 4.7 26.4 30.7 12.0 23.7 13.7 5.4 16.2 15.2 10.3 22.7 7.6 12.3 6.5 5.7 8.0 22.0 6.8 17.3 11.0 17.9 9.2 15.6 17.3 24.2 23.6 46.9 11.8 16.0 17.0 13.5 34.0 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.5 0.4 0.3 0.6 0.4 0.5 0.6 0.2 0.5 0.3 0.0 2.2 0.8 0.6 3.2 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.6 15.9 0.0 0.3 0.0 0.2 14.7 0.4 0.1 0.0 0.2 10.9 0.0 0.0 2.5 4.1 3.8 0.3 5.4 0.0 0.0 1.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 35.6 19.5 1.1 1.3 1.9 2.3 0.9 CFLAR "c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT" ENSG00000003402 "CASP8 and FADD like apoptosis regulator" O15519 2 201116104-201176687 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 475.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 79.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 79.2" "Cell line enhanced" "Detected in all" "U-266/70: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019044, CAB022157, CAB025216" Uncertain Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB022157: , CAB025216: , HPA019044: AB_10696204" "unprognostic (4.61e-2)" "unprognostic (5.32e-2)" "unprognostic (2.49e-1)" "unprognostic (1.44e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.46e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (3.08e-2)" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (7.83e-2)" "unprognostic (9.13e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-2)" 35.4 17.6 13.7 29.8 17.4 66.8 31.6 26.9 12.6 20.5 25.7 13.5 31.3 17.5 24.7 27.6 21.0 19.2 22.1 58.1 14.7 7.7 24.9 18.9 58.5 34.3 16.8 8.9 14.6 14.3 9.1 18.7 28.3 12.6 23.2 17.7 20.9 21.8 27.4 113.7 16.7 26.8 30.5 13.8 35.7 19.4 10.9 14.8 17.2 31.2 26.2 31.4 24.1 33.7 5.3 6.6 79.2 12.6 8.7 11.8 7.8 5.2 10.7 7.7 4.5 24.0 18.4 9.5 13.3 23.3 8.8 10.8 12.4 19.7 1.4 12.7 15.5 10.7 3.9 2.4 10.1 14.1 39.4 7.5 7.9 9.2 20.1 16.7 5.9 26.3 20.0 10.0 14.9 13.1 10.8 44.7 1.8 26.7 33.2 16.0 4.4 2.7 23.5 2.6 4.2 8.2 2.8 1.9 11.3 11.0 10.8 1.7 3.1 9.0 7.9 10.5 5.4 5.6 11.0 48.4 18.5 7.7 6.8 6.5 55.3 18.2 8.9 13.1 4.8 9.1 16.3 12.1 13.5 11.7 12.3 10.3 5.3 10.1 11.0 6.6 4.0 6.4 8.3 79.2 8.7 12.6 4.6 11.8 7.8 13.7 17.4 26.9 12.6 14.7 7.7 16.8 8.9 12.6 14.8 419.9 201.2 84.2 185.4 48.7 8.5 172.6 96.8 283.7 216.1 66.3 29.5 63.9 63.0 138.6 55.5 265.4 108.1 23.3 63.2 34.2 70.8 195.5 77.6 86.3 61.3 12.7 91.3 184.1 115.5 33.0 48.1 149.2 92.8 261.5 56.6 31.3 121.1 80.7 46.7 84.8 29.0 38.8 55.6 14.4 10.1 75.3 58.6 209.9 41.3 475.0 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.9 5.6 15.9 10.2 0.7 1.5 6.5 14.4 6.8 17.1 20.1 6.8 8.5 12.8 5.0 5.2 13.0 9.7 5.4 5.1 31.2 4.0 5.3 15.3 7.8 5.1 0.2 9.8 11.0 0.6 1.0 13.3 5.5 2.8 7.6 5.9 9.4 20.7 16.7 3.9 11.8 8.8 16.4 7.1 9.8 13.6 14.8 7.0 5.2 5.3 7.7 10.2 10.6 4.2 5.9 9.7 7.1 7.0 5.5 17.6 19.9 5.3 17.3 4.8 5.3 21.2 7.8 10.7 17.9 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 8.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 3.5 0.0 2.5 1.7 2.4 0.0 0.0 0.0 0.0 6.4 10.7 0.0 0.0 3.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 140.2;Spermatocytes: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA008410, HPA027821" Enhanced Enhanced Microtubules,Cytosol No Yes Microtubules Cytosol "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavorable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 4.6 9.2 7.1 12.1 12.2 42.3 4.4 16.4 9.9 4.3 6.7 1.9 2.3 9.0 4.2 5.2 14.7 3.0 4.1 5.3 5.8 7.8 5.0 3.2 5.0 13.5 5.9 5.8 3.5 2.4 3.4 10.9 10.2 16.1 4.6 7.4 1.4 6.7 3.6 5.8 10.4 7.0 6.5 5.5 12.4 4.2 22.1 5.2 49.2 5.0 10.3 14.8 8.1 6.6 15.2 16.1 30.4 12.8 2.5 15.7 4.2 19.5 10.6 42.5 21.0 5.5 5.5 10.7 32.3 19.1 37.7 24.3 15.2 24.8 37.6 5.2 24.0 17.6 23.0 29.2 16.4 52.6 25.4 24.1 33.9 11.9 10.8 2.3 33.6 13.8 4.0 6.8 17.6 23.2 11.2 22.8 16.1 14.2 15.6 41.5 9.2 23.1 16.6 25.1 30.5 11.2 22.2 24.4 16.4 11.5 10.7 13.0 16.9 18.2 13.4 9.9 22.5 14.7 16.2 15.0 10.9 16.8 17.0 32.3 9.2 13.5 46.3 7.6 17.6 28.7 30.4 7.2 10.4 5.4 10.4 4.8 12.2 8.2 6.4 7.5 15.2 6.5 5.5 2.2 2.5 12.8 16.1 15.7 4.2 7.1 12.2 16.4 9.9 5.8 7.8 5.9 5.8 16.1 5.2 6.0 3.2 36.9 3.9 13.4 9.9 7.3 0.0 2.7 9.1 1.8 5.9 24.3 8.3 5.2 32.6 9.8 4.5 140.2 5.2 34.8 11.3 2.6 16.1 4.3 26.4 1.6 6.9 16.5 20.7 39.9 6.9 16.4 0.0 14.4 7.9 12.3 2.8 3.5 15.9 6.7 5.8 6.5 6.2 150.2 65.4 13.4 8.4 11.7 11.3 2.4 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736607-112764677 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;lymphoid tissue: 38.3" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 8.9;Spermatocytes: 31.7;Spermatogonia: 32.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 1.5 0.7 0.6 9.2 0.6 13.4 1.3 0.7 0.6 0.6 1.8 0.0 0.3 1.5 0.5 1.4 3.8 0.7 0.1 2.3 0.6 0.5 0.7 0.7 1.2 5.3 0.6 0.2 0.6 0.6 0.0 0.5 3.2 0.2 0.6 2.4 0.0 1.0 0.0 0.6 1.5 2.4 0.9 0.6 2.2 0.9 9.0 0.1 38.3 0.6 5.9 6.0 0.9 0.7 1.0 0.8 1.8 0.7 1.6 1.8 0.4 20.1 4.0 15.9 7.2 0.9 1.5 3.2 16.7 13.9 17.4 16.6 3.8 5.9 13.8 6.9 6.5 21.7 7.8 9.1 8.8 29.3 19.2 4.0 23.0 5.6 3.2 0.0 10.8 13.8 0.4 0.8 21.8 12.4 4.5 7.9 10.1 6.1 20.2 14.1 2.9 13.1 4.1 6.8 8.6 13.2 9.5 16.7 3.6 2.9 7.9 8.8 5.5 6.8 5.6 5.8 6.2 5.5 5.0 5.6 19.3 15.0 15.3 12.2 4.3 8.4 11.8 8.3 7.8 30.2 0.8 0.5 0.7 0.5 0.7 0.4 0.9 1.2 1.1 0.5 1.0 0.5 0.7 1.8 1.6 0.7 0.8 1.8 0.4 0.6 0.6 0.7 0.6 0.6 0.5 0.6 0.2 0.2 0.1 3.0 1.1 0.8 1.6 3.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 8.9 0.4 0.3 0.0 0.0 5.4 0.0 0.0 1.8 2.1 0.8 0.0 1.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 31.7 32.2 1.5 0.8 1.5 1.0 0.9 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 89.5;Spermatocytes: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 460000 "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 13.7 25.5 20.6 11.5 25.7 18.6 12.5 34.6 32.9 11.3 14.6 16.5 7.3 10.2 13.7 10.4 11.7 9.5 10.1 16.6 19.2 19.3 9.7 37.7 8.5 14.1 18.8 21.1 23.8 7.9 20.0 20.8 13.8 33.0 13.5 15.0 9.1 8.7 12.0 26.3 10.7 9.9 16.1 22.5 8.8 12.9 25.4 22.2 28.6 8.0 10.8 14.7 12.6 9.7 8.6 8.4 6.0 8.7 11.7 10.0 3.6 26.4 25.6 55.0 23.5 13.0 20.5 12.8 30.4 18.5 28.9 30.8 20.8 9.0 28.9 10.7 20.4 31.0 30.1 39.4 17.2 36.4 26.0 30.1 48.2 20.5 20.0 9.7 36.7 20.2 10.4 9.2 16.2 35.2 15.1 21.8 25.4 34.0 27.1 23.9 18.2 31.2 9.5 29.5 19.7 20.6 33.1 58.5 25.3 9.3 16.3 25.6 21.8 41.3 14.8 15.1 25.4 27.3 10.0 18.7 28.1 24.9 47.7 44.8 15.4 33.2 41.6 17.6 17.4 27.5 5.4 5.7 6.0 9.0 8.7 8.8 8.6 6.7 10.0 8.4 8.0 8.2 8.5 0.9 11.7 7.8 5.4 7.5 3.6 20.6 25.7 34.6 31.2 19.2 19.3 18.8 21.1 33.0 22.2 23.8 20.5 16.4 7.9 7.6 18.2 57.6 10.2 33.5 21.6 8.7 35.3 13.2 8.3 10.6 89.5 13.5 8.1 0.0 6.6 12.2 13.2 11.2 35.9 6.2 16.0 12.7 11.6 14.1 12.9 37.9 18.1 13.5 6.8 16.2 14.1 14.9 12.6 12.4 27.3 8.7 24.2 19.4 6.6 81.4 60.7 10.2 9.6 9.6 14.9 7.8 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979249 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 303.7;Extravillous trophoblasts: 535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavorable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.37e-1)" 25.3 14.5 13.5 13.4 19.0 36.4 24.8 4.2 14.6 15.6 17.4 12.4 19.8 14.7 14.7 13.8 28.2 15.2 14.1 16.5 15.3 8.0 16.6 29.5 12.9 23.8 29.5 8.8 14.2 12.8 8.3 9.4 35.6 15.9 11.7 18.8 7.5 12.8 13.1 5.9 22.6 22.9 12.5 19.8 18.0 14.7 22.8 21.5 30.2 15.5 19.3 25.5 11.1 23.3 23.9 30.4 2.2 32.8 9.0 12.2 8.7 59.7 82.4 61.8 33.5 8.9 9.2 49.4 27.8 21.6 60.4 48.4 79.6 88.4 56.9 47.6 18.4 33.9 55.5 61.2 39.9 56.8 51.1 39.7 38.5 36.7 55.9 2.7 46.3 35.4 5.3 17.3 51.6 71.6 12.4 30.3 39.5 62.5 77.4 45.4 59.4 43.4 35.8 78.4 57.4 74.4 43.7 50.9 72.9 21.5 21.9 25.2 63.7 42.0 39.9 46.0 74.9 53.4 64.8 16.8 39.2 40.6 32.4 66.2 47.8 92.7 80.3 24.9 39.5 54.1 0.7 4.4 2.2 7.0 26.0 8.4 23.9 9.9 9.5 7.2 22.6 12.2 11.5 0.6 9.0 32.8 30.4 10.6 8.7 13.5 19.0 4.2 14.6 15.3 8.0 29.5 8.8 15.9 21.5 11.9 26.6 58.1 85.2 193.2 2.1 8.9 68.8 40.2 40.9 27.9 0.0 103.2 68.0 71.4 12.5 39.5 35.7 303.7 98.8 535.3 106.1 48.1 20.7 75.7 110.7 1.6 19.7 30.1 33.8 18.8 70.5 54.9 108.0 55.9 35.3 15.6 87.5 41.8 43.2 64.8 2.4 19.4 106.1 117.9 120.7 178.0 110.3 47.9 49.4 87.8 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 581.2;Spermatogonia: 464.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 84.0 72.1 44.1 29.5 13.0 11.9 32.2 50.1 27.0 55.5 44.5 29.6 41.8 63.0 29.7 18.7 98.8 59.2 52.9 38.6 63.9 49.1 42.8 31.9 52.8 78.5 5.6 65.0 36.4 4.3 8.9 39.7 35.1 21.2 51.3 51.9 38.0 55.2 71.1 63.1 51.0 114.6 64.4 99.0 66.6 44.2 48.5 37.6 43.5 19.3 37.4 22.3 41.6 40.4 40.4 43.2 48.6 37.8 29.1 24.0 45.6 58.0 72.8 44.8 90.7 50.8 35.4 37.7 34.1 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 35.7 93.0 97.3 70.9 248.9 4.2 55.0 5.1 12.0 17.0 14.0 0.0 149.0 19.9 15.2 25.4 26.7 39.1 350.4 9.7 329.6 72.5 59.4 147.1 19.5 152.7 0.0 117.0 28.3 40.0 59.4 23.9 84.8 133.3 33.3 56.8 24.6 23.3 46.9 15.6 148.6 6.0 45.3 99.9 581.2 464.7 261.3 166.8 40.1 104.9 59.3 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769967 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 12 "basal ganglia: 7.0" "Low region specificity" "Detected in all" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 1.5 0.8 0.9 11.5 1.0 12.6 1.7 0.3 3.6 0.9 2.1 0.1 0.0 1.0 0.5 0.9 2.9 0.5 2.8 0.6 1.1 0.6 1.0 0.7 1.9 6.0 0.6 0.1 0.5 0.5 0.3 0.4 4.3 0.7 0.5 2.7 1.9 1.0 0.0 0.4 1.2 3.4 1.0 0.8 4.4 1.1 10.0 0.5 30.4 0.5 4.2 6.6 0.9 1.2 0.9 0.9 3.4 1.1 1.3 1.6 1.1 8.7 7.3 15.9 8.4 1.1 2.1 5.9 18.0 5.0 13.2 17.7 11.5 8.2 18.7 5.8 4.8 9.6 8.8 15.5 6.2 20.7 12.8 7.0 26.3 15.9 5.1 0.0 21.5 15.5 0.4 0.2 22.7 1.6 1.5 7.1 11.2 17.7 13.0 12.6 5.7 22.6 4.9 15.0 6.0 5.2 14.4 24.1 5.6 2.7 14.5 5.9 6.9 15.6 4.8 3.1 11.2 4.1 8.5 5.1 19.0 14.4 11.6 20.0 4.7 11.4 19.7 6.0 15.4 15.3 1.6 1.1 1.1 1.6 0.5 0.5 0.4 1.0 0.8 0.9 0.9 0.4 0.8 3.4 1.3 0.7 0.8 1.3 1.1 0.9 1.0 0.3 3.6 1.1 0.6 0.6 0.1 0.7 0.5 0.0 0.3 1.5 4.6 4.9 7.9 1.1 2.5 0.0 3.4 0.0 11.8 5.5 0.0 1.3 6.2 1.9 0.4 0.0 0.6 33.9 3.9 1.4 1.1 0.0 14.0 1.6 1.2 3.7 3.2 4.9 2.3 6.5 3.3 15.4 1.6 6.6 0.9 1.9 0.4 0.0 96.1 6.5 2.5 71.5 133.3 1.8 8.7 5.1 4.1 2.6 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Nucleoplasm "Vesicles, Plasma membrane" "HPA050020: AB_2680993, HPA061622: AB_2684569" "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.7 0.1 0.3 0.8 2.4 3.6 2.2 1.4 9.9 0.7 0.9 2.4 0.4 0.1 3.4 7.6 0.0 2.7 10.7 2.1 0.2 0.2 32.2 0.4 0.7 0.7 10.2 11.0 0.5 1.6 0.0 1.2 13.5 0.8 0.0 0.0 0.0 4.9 0.0 3.9 0.2 3.7 0.2 4.9 1.0 0.4 2.8 0.1 0.2 1.1 5.7 0.1 0.7 0.4 4.7 14.2 15.5 4.5 0.8 2.2 0.1 5.2 0.2 8.0 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 6.0 11.1 4.5 116.6 19.5 0.0 14.1 22.9 5.3 6.8 12.2 0.0 2.5 1.7 61.9 0.4 14.9 0.0 0.0 23.7 9.2 31.3 32.4 13.9 0.5 8.1 4.8 0.0 7.4 46.4 1.1 5.5 74.2 28.7 74.9 0.0 16.6 30.3 0.0 0.4 18.3 0.6 19.4 10.7 12.5 3.3 11.5 20.7 1.3 0.0 28.7 CTPS1 "CTPS, GATD5" ENSG00000171793 "CTP synthase 1" P17812 1 40979335-41012565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017111, HPA051322" Enhanced Approved "Actin filaments,Cytosol" NA Yes Cytosol "Actin filaments" "CAB017111: , HPA051322: AB_2681441" "unprognostic (6.60e-2)" "unprognostic (4.44e-2)" "unprognostic (3.21e-2)" "unprognostic (2.00e-3)" "unprognostic (2.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.42e-2)" "unprognostic (9.72e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (2.04e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-1)" "unprognostic (8.21e-3)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" "unprognostic (1.89e-2)" 7.1 10.0 4.5 10.8 7.8 9.7 5.1 5.9 9.8 14.4 23.6 5.8 16.3 4.3 25.9 8.4 11.3 21.9 13.4 6.7 4.7 5.1 8.6 26.4 7.0 9.4 7.9 4.7 10.1 6.3 16.8 5.4 7.7 6.2 14.4 9.8 9.1 56.5 19.6 13.2 5.8 13.5 35.8 5.1 7.5 9.0 11.8 6.7 14.6 4.5 11.3 13.2 21.3 9.5 6.0 12.8 0.0 7.3 6.6 7.0 3.8 21.2 19.5 27.6 22.2 7.6 9.5 43.4 37.4 16.1 41.1 27.7 38.3 18.9 39.9 17.0 17.1 11.3 15.0 29.5 27.9 41.1 16.7 22.4 24.4 26.0 12.1 25.0 32.5 19.2 10.4 15.1 42.5 30.6 7.2 18.6 29.3 24.5 17.6 28.7 11.9 35.1 12.1 37.7 17.8 23.2 27.1 33.5 25.8 20.7 19.4 37.1 18.1 23.3 25.1 9.3 28.3 8.7 45.0 15.2 27.2 35.6 18.3 46.4 11.4 13.3 35.5 17.8 25.9 28.3 0.0 4.0 0.0 4.6 7.3 6.6 6.0 5.3 4.8 12.0 3.9 4.4 7.0 0.0 6.6 6.1 12.8 6.6 3.8 4.5 7.8 5.9 9.8 4.7 5.1 7.9 4.7 6.2 6.7 6.0 20.2 17.3 10.5 7.1 9.9 4.2 20.4 2.7 5.7 5.2 5.9 14.6 1.7 15.2 22.6 7.3 2.8 0.0 15.1 21.5 6.6 4.3 1.1 24.5 9.6 11.1 2.9 2.5 2.4 21.2 10.0 6.0 1.7 12.6 2.6 5.2 14.2 0.0 23.3 9.6 4.2 38.8 14.4 9.3 42.5 6.5 4.7 5.7 5.2 5.8 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909541 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11.8;testis: 34.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 250.0;Spermatocytes: 291.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 1.1 1.2 1.4 5.9 2.0 1.8 3.0 1.9 1.9 1.4 2.1 0.0 0.6 1.2 1.2 1.4 1.7 1.1 1.5 1.0 1.5 1.4 1.2 1.1 2.4 5.0 1.3 1.0 3.4 1.3 1.2 1.8 1.4 0.8 1.2 1.2 0.0 1.2 1.1 1.9 1.3 1.5 0.9 1.2 4.6 1.1 34.2 0.7 11.8 1.4 1.9 2.7 1.6 1.1 1.3 0.9 4.0 0.4 0.9 1.6 0.5 1.3 1.4 3.0 3.8 0.7 0.6 0.9 1.4 0.3 1.5 3.0 2.3 0.9 3.1 1.1 0.9 2.6 1.3 3.1 0.8 1.6 2.3 2.1 2.0 1.7 0.5 0.2 2.4 1.6 0.7 0.8 1.7 1.6 0.5 1.3 2.9 1.7 6.5 2.0 2.4 4.2 3.0 3.0 3.1 2.9 1.1 4.7 3.7 1.2 0.2 4.4 2.8 1.9 3.3 1.5 2.5 1.4 2.5 0.6 1.8 2.2 4.7 3.0 3.7 7.7 3.1 1.3 4.4 3.9 4.0 0.4 0.4 1.2 0.3 0.3 0.8 1.1 0.6 0.2 1.3 1.1 1.3 1.1 0.9 0.4 0.9 1.6 0.5 1.4 2.0 1.9 1.9 1.5 1.4 1.3 1.0 0.8 0.7 3.0 13.0 34.9 16.3 13.9 5.8 3.6 0.0 14.7 5.7 8.7 11.8 12.2 3.3 5.4 250.0 8.5 4.5 46.7 12.9 31.0 7.6 10.6 30.1 5.4 13.9 3.2 14.3 7.4 8.8 57.4 14.4 14.2 11.8 9.0 18.6 1.9 10.7 7.0 8.9 4.4 15.5 12.9 8.2 291.4 77.1 11.0 8.0 21.5 15.8 11.4 DBF4B "ASKL1, chifb, DRF1, FLJ13087, ZDBF1B" ENSG00000161692 "DBF4 zinc finger B" Q8NFT6 17 44708608-44752264 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.8;Horizontal cells: 28.6;Spermatocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA048465 Uncertain Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "HPA048465: AB_2680405" "unprognostic (2.44e-1)" "unprognostic (1.26e-1)" "unprognostic (6.37e-2)" "unprognostic (2.15e-3)" "unprognostic (1.62e-1)" "unprognostic (6.13e-2)" "unprognostic (1.53e-4)" "unprognostic (7.61e-2)" "unprognostic (1.54e-2)" "unprognostic (4.08e-2)" "unprognostic (8.43e-3)" "unprognostic (1.83e-1)" "unprognostic (4.23e-6)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.39e-1)" 2.6 2.0 8.0 5.8 6.1 5.6 3.4 7.1 9.4 3.6 4.1 5.3 3.3 2.4 6.4 11.4 3.5 5.9 4.3 2.0 6.7 3.7 3.1 1.6 3.0 4.7 6.7 4.7 5.9 2.3 2.6 4.5 3.3 6.2 5.4 4.1 6.4 3.3 4.8 5.4 6.5 3.7 5.3 4.7 4.4 3.2 10.9 6.4 6.9 6.8 2.5 5.2 4.2 3.2 1.5 0.9 1.8 1.6 0.0 2.2 0.5 3.9 8.3 6.2 4.5 0.6 1.2 5.4 4.2 1.8 8.9 8.8 3.5 3.4 5.8 2.3 1.5 8.0 3.8 5.4 1.7 10.3 9.6 8.6 7.4 6.3 4.6 0.3 4.9 6.4 0.5 0.6 4.9 1.6 2.0 4.4 9.9 9.3 6.1 4.8 4.1 7.3 3.0 2.7 8.2 4.4 6.5 7.2 2.5 2.1 2.4 3.5 3.7 4.0 1.3 3.3 7.0 4.2 3.3 1.9 3.1 5.9 3.9 7.6 2.8 3.6 7.6 2.3 4.4 4.8 0.0 0.9 1.8 0.3 1.6 0.2 1.5 0.2 0.3 0.9 0.4 0.0 2.2 0.0 0.0 1.3 0.7 0.6 0.5 8.0 6.1 7.1 9.4 6.7 3.7 6.7 4.7 6.2 6.4 0.0 1.4 7.5 2.4 0.6 27.8 1.0 0.0 2.7 3.4 5.2 11.8 3.2 0.0 0.2 8.1 2.2 0.0 0.0 0.7 1.1 1.3 2.2 3.5 0.2 1.2 28.6 4.1 1.3 1.6 5.5 1.1 2.2 5.0 1.0 0.5 11.7 0.3 0.0 2.8 0.3 16.1 0.0 0.9 36.9 11.3 0.1 1.1 1.0 0.6 2.0 DCLRE1B "FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905141-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "monocytes: 15.4;Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "HPA064934: AB_2685387" "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 8.7 4.9 6.7 8.3 6.8 13.1 7.3 15.4 7.8 6.7 6.8 8.3 0.4 4.3 6.9 4.3 8.4 7.0 5.8 5.4 7.0 5.6 5.3 4.2 8.0 15.1 6.7 4.5 7.7 3.8 3.4 3.1 8.7 6.5 4.4 7.8 6.1 4.6 5.0 3.4 7.0 5.5 8.7 8.5 12.8 4.7 7.2 6.4 20.9 5.1 8.2 9.6 5.9 5.9 2.3 4.2 2.4 7.0 8.7 4.4 3.5 8.3 3.1 5.9 6.6 4.4 3.1 3.7 6.6 4.8 9.1 10.0 3.7 2.7 7.9 4.5 5.1 4.7 4.3 8.1 7.2 11.9 6.8 5.7 6.5 4.9 3.2 1.1 7.4 6.6 3.9 2.5 13.1 7.2 2.5 4.8 9.9 9.8 6.7 9.8 34.0 11.4 5.6 4.6 4.2 7.3 9.2 17.8 3.8 3.1 3.0 5.2 4.6 6.4 5.4 4.3 5.3 3.5 7.5 2.8 11.1 11.8 18.0 9.3 3.2 3.3 8.9 9.3 7.7 18.3 2.4 7.0 1.9 3.4 6.4 4.3 1.4 4.4 3.1 4.2 2.3 2.6 3.6 0.3 8.7 3.7 1.5 2.4 3.5 6.7 6.8 15.4 7.8 7.0 5.6 6.7 4.5 6.5 6.4 3.0 1.3 2.7 1.0 3.2 2.8 0.8 2.5 4.0 0.0 0.0 2.0 3.5 1.7 4.0 0.8 2.3 0.2 0.0 2.4 8.0 1.5 1.2 1.1 1.0 8.9 1.6 2.9 3.1 5.9 0.0 1.7 11.7 0.0 15.4 1.8 0.8 2.7 0.0 2.1 1.4 1.3 25.8 3.8 3.4 12.0 2.4 1.1 2.9 3.4 1.1 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423619-30430075 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Approved Nucleoplasm,Cytosol NA Yes 270000 "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavorable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 15.3 15.8 14.8 25.0 13.2 12.5 20.7 15.5 19.2 12.1 37.4 10.3 11.3 20.7 14.1 14.4 19.7 18.9 28.1 23.3 12.1 12.6 27.0 25.3 11.2 27.6 13.3 16.6 16.6 25.2 16.4 7.7 16.3 11.4 15.4 40.3 10.6 20.5 21.1 28.3 16.1 22.9 13.9 11.3 22.5 16.4 9.9 7.8 21.3 22.6 26.0 25.0 13.2 13.0 47.3 30.9 19.0 24.5 23.1 26.2 25.3 26.6 32.7 14.9 19.2 4.2 5.7 13.8 12.8 7.7 19.4 19.8 24.6 22.8 36.1 27.0 8.0 12.4 21.0 30.9 25.1 24.3 19.0 48.8 21.0 15.0 32.0 5.5 37.5 32.8 6.6 14.3 21.6 12.5 5.9 19.9 19.4 26.4 12.7 13.7 46.5 44.5 42.1 19.7 27.0 26.4 63.2 16.6 47.0 22.4 17.3 31.8 18.0 8.5 30.5 12.0 10.2 26.3 16.1 10.0 15.0 13.4 19.3 23.0 8.4 25.0 46.0 9.9 31.2 17.5 19.0 12.4 11.7 18.8 22.1 26.2 47.3 24.2 21.3 28.7 40.2 21.8 21.0 1.5 23.1 24.5 30.9 24.1 25.3 14.8 13.2 15.5 19.2 12.1 12.6 13.3 16.6 11.4 7.8 17.9 14.6 32.0 37.1 80.1 23.9 33.1 61.1 20.1 19.4 41.8 7.9 81.7 107.8 107.5 10.2 47.2 79.9 0.0 108.6 68.9 31.5 41.3 31.1 18.1 68.6 14.3 37.0 25.2 16.6 36.0 18.1 35.6 45.5 108.2 103.3 19.7 78.9 105.2 18.7 54.0 16.3 19.4 35.0 2.8 33.6 70.1 23.2 25.9 124.8 43.2 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073845-31104791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065197 Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No Yes Nucleoplasm "Nucleoli fibrillar center, Centrosome" "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 6.3 5.3 6.4 8.0 8.7 21.0 5.9 18.1 10.5 7.6 6.1 6.0 8.8 7.1 11.0 3.7 7.6 7.5 5.1 4.0 7.0 2.7 6.5 7.0 4.9 14.9 8.4 4.6 9.6 19.0 7.7 9.3 5.6 7.1 8.0 8.6 5.0 11.3 7.1 8.8 14.2 12.1 8.0 6.7 10.9 8.0 8.2 9.4 33.2 7.2 6.4 11.1 5.8 7.8 5.8 4.9 1.3 7.3 4.3 5.5 1.9 12.5 12.2 14.2 12.7 2.2 4.8 20.9 7.8 3.9 9.1 9.8 14.5 21.4 16.4 10.9 4.1 8.5 12.4 11.2 10.7 7.3 15.0 23.0 19.5 20.3 8.9 0.8 13.7 12.7 4.5 4.8 11.6 9.1 5.9 4.4 19.7 9.5 36.8 6.5 10.4 23.5 20.5 29.9 15.3 6.6 18.9 22.2 22.8 4.8 14.3 10.2 7.5 8.0 12.3 3.9 24.8 10.4 8.7 3.6 8.0 15.7 15.4 14.1 14.9 11.5 39.2 9.4 11.0 7.2 0.0 2.3 1.3 4.2 2.5 3.3 5.2 4.0 3.1 3.1 5.8 4.1 5.5 1.1 4.3 7.3 4.9 3.4 1.9 6.4 8.7 18.1 10.5 7.0 2.7 8.4 4.6 7.1 9.4 3.0 7.4 12.7 4.5 5.4 7.7 2.2 5.1 6.7 5.7 0.0 13.7 5.2 0.0 2.2 1.3 3.0 4.0 0.0 2.9 5.8 4.3 5.0 5.7 6.6 4.3 7.9 0.0 6.2 4.6 0.9 6.6 4.6 6.8 5.4 5.0 2.3 2.5 2.9 4.2 1.1 25.5 0.0 3.5 3.2 17.6 5.6 2.2 6.9 7.4 4.1 DEPDC1 "DEP.8, DEPDC1A, FLJ20354, SDP35" ENSG00000024526 "DEP domain containing 1" Q5TB30 1 68474152-68497221 "Predicted intracellular proteins" "Transcription, Transcription regulation" "GTPase activation, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6;testis: 19.5" "Group enriched" "Detected in many" 7 "Early spermatids: 29.0;Erythroid cells: 70.0;Extravillous trophoblasts: 29.4;Late spermatids: 57.0;Spermatocytes: 71.4;Spermatogonia: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017845 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes Nucleoplasm "Nucleoli fibrillar center" "CAB017845: " "unprognostic (2.73e-1)" "unprognostic (7.40e-2)" "prognostic favorable (8.70e-5)" "unprognostic (1.23e-3)" "unprognostic (3.06e-1)" "unprognostic (7.73e-3)" "unprognostic (4.37e-6)" "unprognostic (3.39e-3)" "unprognostic (1.57e-3)" "unprognostic (8.59e-2)" "unprognostic (9.04e-6)" "unprognostic (2.18e-1)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.83e-2)" "unprognostic (1.11e-1)" 1.3 0.8 0.7 12.1 0.5 5.1 1.9 0.3 0.7 1.2 3.3 0.1 0.5 2.9 0.5 0.7 6.5 0.6 0.3 1.3 2.1 0.6 0.7 0.8 2.0 5.5 0.5 0.2 0.6 0.5 0.3 0.4 7.4 0.3 2.5 4.3 0.5 1.3 0.0 0.4 1.7 3.7 1.5 0.4 3.1 1.4 19.5 0.0 28.6 0.5 5.4 5.7 1.5 2.0 0.3 0.0 0.0 0.0 0.8 2.6 0.3 15.5 7.2 13.8 6.3 0.9 2.0 10.8 20.0 9.2 17.1 14.8 6.0 6.5 0.0 14.9 8.2 27.4 10.5 20.0 10.4 29.0 13.6 13.1 12.7 12.8 3.4 0.2 10.9 0.0 0.7 0.5 19.5 10.9 3.5 12.3 5.6 8.7 12.4 30.3 3.5 0.0 4.1 11.9 6.5 9.9 0.0 41.2 5.1 6.9 4.2 15.5 7.2 20.0 8.5 10.4 9.3 7.7 5.5 7.2 11.0 12.6 19.4 23.1 7.8 16.7 0.1 10.4 3.8 22.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.6 0.3 0.7 0.5 0.3 0.7 2.1 0.6 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.2 3.0 0.4 0.5 0.0 0.0 0.0 1.8 0.0 3.1 0.0 0.1 29.0 0.0 0.7 70.0 0.0 29.4 1.9 1.8 0.0 0.0 6.9 0.0 0.0 0.6 1.9 57.0 0.3 1.3 0.0 0.0 1.9 0.0 0.1 0.0 0.4 0.0 0.2 0.0 1.0 71.4 20.2 1.1 2.4 1.3 2.5 1.4 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 24.0 8.2 25.0 15.2 0.5 0.8 27.4 6.5 4.4 11.5 15.0 13.6 15.3 13.7 16.1 2.0 14.9 8.0 20.0 14.6 15.5 19.5 14.5 17.1 9.4 16.9 0.4 14.4 16.7 0.5 1.5 3.7 5.4 2.2 10.6 14.7 12.2 18.8 10.1 15.1 23.2 12.6 18.4 5.2 13.3 25.8 20.3 11.7 9.3 12.0 13.9 6.4 15.3 5.5 7.2 11.7 10.2 11.5 4.9 4.9 14.4 3.9 16.5 9.5 16.6 27.1 6.1 21.2 13.6 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 0.0 2.6 0.8 0.8 4.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 1.9 0.0 0.3 1.4 0.1 1.7 0.0 0.2 18.7 0.4 0.5 3.5 0.0 5.2 0.0 0.0 0.0 1.2 1.8 0.3 2.2 0.0 0.0 1.0 0.2 0.7 2.0 0.0 0.5 0.0 6.5 0.4 32.0 8.7 1.8 39.2 0.0 6.3 0.3 DHFR ENSG00000228716 "Dihydrofolate reductase" P00374 5 80626228-80654983 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Methotrexate resistance, One-carbon metabolism" "Oxidoreductase, RNA-binding" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 163.5;Spermatocytes: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB037129, HPA051465" Uncertain Approved Mitochondria NA Yes Mitochondria "CAB037129: AB_439683, HPA051465: AB_2681494" "unprognostic (1.44e-2)" "unprognostic (1.03e-2)" "unprognostic (2.24e-3)" "unprognostic (2.91e-3)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (2.83e-2)" "unprognostic (2.35e-2)" "unprognostic (2.02e-2)" "unprognostic (4.19e-3)" "unprognostic (1.83e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (1.82e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" 17.7 6.1 16.0 11.6 13.9 28.3 10.9 10.2 14.0 7.5 12.6 18.1 11.7 14.5 5.9 9.0 9.8 4.7 6.9 9.7 17.3 14.4 13.1 35.5 8.6 23.2 18.9 9.4 7.5 4.9 9.6 7.2 8.5 13.0 5.9 15.5 8.6 8.0 8.4 10.4 5.9 14.5 7.3 25.3 9.1 7.4 10.5 11.5 13.4 9.2 2.3 22.8 7.9 6.1 2.4 3.3 3.5 2.6 2.1 4.0 2.1 19.8 13.8 35.1 25.9 6.6 7.0 12.9 15.9 12.2 27.8 32.1 13.1 24.0 40.4 7.0 9.2 22.7 14.0 45.1 20.5 45.0 17.9 27.8 19.3 23.0 12.1 1.4 22.5 8.6 4.8 2.1 24.9 2.8 4.7 13.4 29.7 21.7 31.1 28.1 19.9 55.4 9.1 17.7 9.9 8.1 36.0 68.9 40.0 16.0 12.7 28.7 20.0 22.5 10.5 11.4 18.6 20.8 22.3 8.0 8.8 13.4 24.6 30.4 14.6 29.2 43.7 19.7 45.8 22.6 0.8 1.2 1.1 2.3 2.6 1.1 2.1 2.7 3.2 1.9 2.4 2.1 2.7 3.5 2.1 1.7 3.3 4.0 2.1 16.0 13.9 10.2 14.0 17.3 14.4 18.9 9.4 13.0 11.5 6.0 9.4 21.6 5.3 6.2 3.7 13.2 7.6 8.1 6.8 14.0 2.0 13.0 8.3 6.6 4.3 3.6 20.0 163.5 3.3 35.4 9.5 2.1 2.3 41.2 36.1 3.2 4.7 9.2 13.2 4.6 13.0 8.3 0.0 2.8 11.1 10.0 4.3 5.8 15.2 33.5 3.4 12.9 9.0 92.4 48.0 4.8 11.1 10.1 21.0 3.7 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 9.3;Extravillous trophoblasts: 9.1;Hofbauer cells: 5.7;Syncytiotrophoblasts: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria NA Yes 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.2 38.3 27.1 18.4 19.5 19.1 20.8 20.1 19.8 23.7 21.3 33.1 10.1 23.6 18.9 18.1 17.6 19.2 29.5 24.0 28.1 20.4 23.0 25.9 15.8 30.3 27.7 27.8 10.8 26.3 17.1 27.9 41.9 26.9 27.3 23.6 29.6 10.0 23.0 28.8 22.7 40.9 21.8 27.7 36.0 20.7 27.0 25.9 26.7 30.1 25.7 26.2 26.8 10.8 21.8 31.9 36.3 19.6 18.6 18.3 22.5 20.7 18.1 21.9 36.6 33.8 23.3 21.5 24.0 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 DIAPH3 "AN, AUNA1, DRF3, FLJ34705, NSDAN" ENSG00000139734 "Diaphanous related formin 3" Q9NSV4 13 59665583-60163987 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.2;testis: 19.6" "Cell type enriched" "Detected in many" 6 "Early spermatids: 290.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HBF TERT88: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA032151 Supported "Plasma membrane,Microtubules" NA Yes "Plasma membrane, Microtubules" "HPA032151: AB_2674181" "unprognostic (3.78e-2)" "unprognostic (1.28e-2)" "prognostic favorable (9.04e-4)" "prognostic unfavorable (4.18e-4)" "unprognostic (2.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.27e-4)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.74e-2)" "unprognostic (2.19e-1)" "unprognostic (5.22e-5)" "unprognostic (3.59e-3)" "unprognostic (5.31e-5)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "unprognostic (2.74e-3)" 1.8 0.4 1.7 11.5 1.8 6.7 1.6 0.1 1.4 0.9 4.7 0.2 0.4 2.0 1.4 1.1 7.1 0.3 2.5 1.1 1.0 1.6 1.7 0.4 4.1 2.9 1.0 0.0 0.4 0.4 0.5 0.2 9.4 0.2 0.4 2.3 0.0 1.6 0.0 0.1 1.8 4.3 2.7 0.3 2.5 3.1 19.6 0.0 35.2 0.2 5.3 5.9 0.8 1.5 0.4 2.0 0.4 0.2 0.0 0.5 0.2 18.3 6.1 6.4 3.6 1.1 2.9 10.8 25.7 11.4 26.0 22.7 16.2 12.5 6.1 2.1 13.1 6.8 12.6 10.3 10.1 39.7 6.9 7.1 8.8 15.7 3.6 1.7 11.9 7.0 1.1 0.2 15.8 10.7 6.6 11.6 5.6 6.7 8.8 24.7 2.6 10.6 5.1 5.9 8.7 3.5 7.2 15.7 5.0 8.5 3.8 3.3 5.8 13.1 9.1 3.9 14.3 6.6 6.5 11.5 16.5 10.6 5.5 21.2 5.9 6.5 9.6 4.4 5.9 12.4 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 2.0 0.5 0.2 1.7 1.8 0.1 1.4 1.0 1.6 1.0 0.0 0.2 0.0 50.6 4.3 0.8 0.3 3.3 0.0 0.4 2.5 0.0 2.3 0.0 0.0 8.7 5.0 0.6 290.3 0.7 1.3 23.3 3.7 26.7 3.3 0.3 0.0 0.4 5.2 0.0 0.0 2.5 0.6 34.3 0.6 1.2 0.0 0.0 1.1 2.3 1.3 0.0 0.0 3.1 0.0 0.0 0.0 34.2 17.3 1.0 6.1 0.9 1.7 0.6 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.6 15.0 39.4 17.7 0.9 3.9 12.2 21.9 14.5 32.4 30.9 12.2 20.8 21.9 12.1 12.7 13.0 23.4 25.2 17.5 42.6 26.4 12.4 22.5 14.1 10.5 0.1 22.0 13.8 0.8 0.6 15.2 7.3 5.2 35.6 22.5 18.2 22.0 30.1 18.1 27.7 11.2 20.3 16.8 15.6 21.7 38.1 10.1 10.6 12.2 20.1 11.3 23.3 8.8 8.6 17.5 19.6 8.2 13.8 14.5 38.0 14.0 25.1 5.4 11.7 29.1 10.1 15.7 23.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 0.0 0.3 8.5 0.2 1.0 0.0 0.3 0.0 1.4 1.2 0.0 0.0 1.3 0.0 0.4 10.7 0.0 0.2 140.2 0.0 19.8 1.0 0.2 0.0 0.8 8.6 0.0 0.0 1.8 4.5 4.6 0.9 2.2 0.0 0.0 1.3 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 61.2 32.3 0.4 1.6 1.5 2.5 1.1 DNAJB1 "Hsp40, HSPF1, RSPH16B, Sis1" ENSG00000132002 "DnaJ heat shock protein family (Hsp40) member B1" P25685 19 14514770-14529770 "Cancer-related genes, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 291.1" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017450, HPA063247" Enhanced Supported Nucleoplasm NA Yes 9600 Nucleoplasm "CAB017450: AB_10631418, HPA063247: AB_2684971" "unprognostic (3.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.74e-2)" "unprognostic (3.83e-1)" "unprognostic (1.85e-1)" "unprognostic (7.91e-3)" "unprognostic (2.17e-1)" "prognostic favorable (5.96e-4)" "unprognostic (2.20e-2)" "unprognostic (4.44e-2)" "unprognostic (2.00e-2)" "unprognostic (6.77e-2)" 29.2 76.9 28.5 13.2 30.0 36.2 67.0 41.4 29.4 19.3 15.5 21.5 14.5 10.5 20.4 11.8 72.3 21.7 56.4 23.5 28.2 31.6 23.4 37.7 35.7 10.7 53.4 12.0 32.3 22.6 18.3 25.0 33.5 45.8 29.6 13.1 12.2 18.4 40.8 16.1 25.3 9.5 24.0 40.2 9.4 19.1 37.5 37.9 15.0 28.9 18.0 31.1 19.2 291.1 19.7 15.2 28.2 31.6 23.0 61.6 56.7 36.9 39.3 14.2 15.1 26.2 21.1 8.9 24.6 18.3 39.0 29.5 23.2 20.9 10.2 28.2 20.9 25.5 28.1 29.1 17.7 27.7 10.7 14.4 16.3 26.0 48.6 17.9 11.5 15.5 11.7 42.4 15.1 13.2 20.4 12.8 6.9 24.1 110.7 21.4 23.4 18.5 10.7 15.1 48.9 42.4 14.2 20.0 23.0 17.7 12.7 13.1 9.7 22.3 44.2 24.2 16.6 12.1 11.2 13.3 31.7 19.1 36.5 51.6 49.3 30.2 13.4 22.6 19.9 28.2 11.5 18.9 22.3 36.6 31.1 38.9 19.4 52.5 45.4 15.2 19.7 61.6 47.6 28.2 23.0 31.6 9.1 51.8 56.7 28.5 30.0 41.4 29.4 28.2 31.6 53.4 12.0 45.8 37.9 145.9 105.3 114.6 695.7 378.2 47.1 335.7 48.4 87.0 71.7 22.7 111.9 123.3 34.9 105.0 377.6 275.7 133.0 0.0 143.2 142.5 617.3 678.1 342.8 50.4 134.5 49.3 390.0 73.1 71.9 368.9 58.7 232.5 477.5 35.1 126.4 109.5 97.8 108.7 34.6 43.9 149.2 25.8 802.9 139.1 31.8 418.7 229.9 251.4 123.6 238.8 DNMT1 "CXXC9, DNMT, MCMT" ENSG00000130816 "DNA methyltransferase 1" P26358 19 10133345-10231286 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Deafness, Disease mutation, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002694, CAB005876" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB005876: AB_731983, HPA002694: AB_1847810" "unprognostic (3.51e-1)" "unprognostic (1.20e-2)" "unprognostic (1.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.62e-1)" "unprognostic (7.59e-3)" "prognostic unfavorable (1.46e-4)" "unprognostic (2.90e-1)" "unprognostic (4.23e-3)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.28e-3)" "unprognostic (7.81e-3)" "unprognostic (1.73e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" 12.1 7.6 9.8 20.2 10.8 31.9 11.5 27.1 14.4 12.0 8.6 10.0 4.3 8.1 12.1 8.0 12.0 11.5 7.8 8.0 9.3 8.1 6.9 9.2 11.8 29.7 12.5 7.9 11.1 6.2 10.2 8.8 32.5 8.7 8.3 10.7 7.8 9.3 6.5 6.8 10.8 11.3 11.2 9.1 11.0 9.0 19.9 12.6 31.4 9.5 8.8 28.8 11.4 9.7 12.6 19.0 10.2 13.4 25.0 18.2 6.8 24.3 15.4 19.7 16.7 7.3 7.5 42.3 16.5 13.1 23.8 23.9 14.9 13.3 40.8 10.4 10.1 12.0 16.1 21.7 12.9 24.4 16.0 32.3 59.1 13.8 7.7 3.2 24.0 24.0 5.0 2.5 20.8 8.2 7.2 12.9 12.6 23.4 25.2 17.7 16.2 35.1 32.8 25.9 11.0 22.5 35.6 20.7 22.4 7.5 15.4 21.0 16.3 20.0 9.0 6.4 12.6 9.4 12.2 9.7 40.0 13.7 24.2 24.4 20.6 21.5 48.3 11.6 22.4 31.0 10.2 13.4 3.3 18.2 13.2 15.9 7.9 14.6 12.5 11.3 12.6 16.6 12.3 3.1 25.0 7.9 19.0 12.9 6.8 9.8 10.8 27.1 14.4 9.3 8.1 12.5 7.9 8.7 12.6 6.0 24.5 38.8 19.1 26.3 66.8 11.9 7.6 48.2 29.6 21.0 53.0 329.4 11.6 20.3 42.9 33.0 4.7 93.5 12.4 56.3 25.7 12.5 34.8 12.1 68.9 62.0 15.1 24.5 28.2 38.6 25.9 51.5 13.5 45.1 16.3 39.9 15.7 11.5 26.9 7.6 50.4 12.9 22.0 249.6 179.2 19.6 270.7 54.2 37.6 14.1 DNMT3B ENSG00000088305 "DNA methyltransferase 3 beta" Q9UBC3 20 32762385-32809356 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7;testis: 23.3" "Cell type enhanced" "Detected in some" 7 "Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0" "Cancer enriched" "Detected in all" 25 "testis cancer: 111.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2" "Low region specificity" "Detected in some" "HPA001595, HPA001803, CAB069896" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: " "unprognostic (7.65e-3)" "unprognostic (3.52e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (3.42e-1)" "unprognostic (7.27e-2)" "unprognostic (4.39e-4)" "unprognostic (4.18e-3)" "unprognostic (8.60e-3)" "unprognostic (8.48e-2)" "unprognostic (6.79e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (6.62e-2)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (6.55e-2)" 1.1 0.8 0.9 2.5 0.9 4.7 2.4 4.5 1.4 1.6 2.1 0.7 0.5 0.9 1.3 4.7 1.6 1.1 1.6 1.8 0.8 0.7 2.7 1.2 1.2 1.9 0.9 0.5 1.2 7.5 2.5 1.1 2.8 0.8 1.1 0.8 1.2 3.5 1.6 0.5 5.5 0.8 1.0 0.5 1.3 1.1 23.3 0.8 17.7 2.6 1.7 2.5 2.7 2.2 0.7 1.0 0.0 0.2 0.9 1.3 0.1 0.8 1.1 6.0 1.4 0.1 0.5 55.3 0.7 0.5 0.8 0.8 20.8 0.9 2.1 2.2 0.3 0.9 0.5 3.9 0.3 0.6 0.2 3.1 21.7 0.7 3.9 0.2 0.9 2.2 0.5 0.4 1.2 0.2 0.4 1.4 1.3 20.8 0.6 0.3 3.3 3.3 18.4 74.7 1.9 0.7 3.3 1.0 0.5 2.0 0.9 1.9 1.2 1.3 1.9 0.5 41.2 1.2 1.1 0.3 1.2 2.8 0.6 0.5 1.3 0.6 0.8 0.5 5.9 0.5 0.0 0.2 0.0 0.1 0.1 0.1 0.7 0.2 0.0 1.0 0.0 1.3 0.0 0.0 0.9 0.1 0.9 0.0 0.1 0.9 0.9 4.5 1.4 0.8 0.7 0.9 0.5 0.8 0.8 0.0 1.0 0.0 0.1 0.8 1.4 1.1 0.0 0.0 1.2 0.0 2.0 3.7 0.0 0.9 0.0 0.4 0.0 0.0 0.5 3.8 0.9 0.6 0.0 0.0 0.6 4.8 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.8 1.1 0.0 0.4 0.6 2.1 6.5 0.4 0.0 2.5 1.1 4.0 0.0 0.8 0.0 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119856010 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 15.8;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA023780: AB_2671311, HPA024401: AB_2671557" "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.92e-6)" "prognostic unfavorable (3.93e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 4.3 4.7 3.6 8.5 3.9 9.2 5.4 9.4 5.0 5.1 4.6 3.3 3.5 4.1 6.2 2.4 5.8 3.0 4.7 3.4 3.9 2.6 2.1 2.5 3.3 11.5 4.0 2.0 4.1 7.0 1.3 1.6 4.0 5.3 4.1 6.4 2.1 11.4 4.3 3.9 4.5 4.0 4.9 4.2 4.1 4.0 4.8 5.1 34.2 2.4 5.7 9.5 3.4 5.1 1.4 0.8 0.2 0.2 2.4 3.3 0.9 11.9 5.9 11.7 10.6 1.7 3.1 5.0 8.2 1.7 5.9 6.2 5.3 7.3 21.6 7.2 2.4 3.7 8.8 13.2 5.1 6.4 14.6 11.9 27.5 6.0 6.2 0.5 10.7 9.7 1.4 0.8 7.3 3.5 1.4 1.7 14.5 9.3 9.7 7.1 11.7 28.2 6.7 17.1 31.7 14.6 10.1 11.1 10.3 4.6 7.5 10.5 6.4 4.4 35.1 5.5 9.5 6.5 5.9 1.1 6.5 17.7 6.2 11.9 13.3 19.8 22.9 3.3 17.3 9.4 0.0 0.2 0.2 3.3 0.0 2.5 1.4 0.7 1.6 0.2 0.6 0.4 1.4 0.0 2.4 0.0 0.8 1.1 0.9 3.6 3.9 9.4 5.0 3.9 2.6 4.0 2.0 5.3 5.1 0.0 0.3 0.0 1.9 3.1 0.4 0.7 0.0 2.7 0.0 0.0 0.0 1.8 0.0 1.6 0.1 2.4 0.1 0.0 2.1 15.8 3.5 1.4 4.6 0.0 4.1 0.0 0.0 6.2 1.3 0.0 1.1 0.0 3.3 0.0 0.4 1.3 0.5 0.0 2.5 1.1 0.2 0.0 2.8 1.1 22.6 2.9 1.1 1.3 1.5 0.9 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 homolog, MIS12 kinetochore complex component" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 90.5;Spermatogonia: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 6.7 10.4 5.6 15.6 7.4 11.6 8.2 5.4 7.2 5.1 8.6 4.1 9.5 6.3 9.5 12.0 9.1 5.0 8.1 6.2 5.1 4.7 5.8 8.6 6.1 11.0 4.8 3.9 5.3 5.4 3.6 7.6 12.9 5.1 6.5 10.3 10.1 9.7 8.1 4.6 7.3 8.8 5.9 4.1 11.6 7.0 27.2 4.1 21.2 6.3 11.4 13.8 5.8 5.5 10.9 25.4 21.7 5.9 5.6 6.5 3.7 13.0 11.8 13.9 11.1 5.5 7.2 9.2 16.0 13.6 24.6 27.7 20.5 17.0 15.1 10.7 8.7 27.2 17.2 13.0 12.6 23.5 6.6 8.3 29.4 11.3 13.7 1.2 16.8 13.0 2.7 3.6 17.0 5.4 4.0 12.0 16.4 11.4 12.5 16.1 9.3 21.5 13.0 6.5 23.6 20.9 16.9 42.4 10.0 6.2 7.8 14.3 6.5 19.9 20.5 9.7 10.8 20.9 11.3 6.2 22.5 13.7 22.0 17.2 10.5 14.1 17.1 18.9 15.2 16.0 21.7 3.6 7.5 4.4 5.9 4.9 8.8 4.8 5.8 3.9 10.9 5.9 5.5 6.5 5.6 5.0 25.4 6.5 3.7 5.6 7.4 5.4 7.2 5.1 4.7 4.8 3.9 5.1 4.1 6.0 4.1 9.3 10.2 4.4 8.0 4.1 2.5 10.7 10.3 5.2 27.5 42.7 6.6 5.2 6.3 5.8 6.4 0.0 5.6 29.3 7.5 7.5 3.5 4.5 12.6 6.4 2.4 9.8 3.7 5.8 8.1 6.1 1.7 8.2 9.0 4.8 4.7 5.7 7.1 2.9 15.8 0.0 7.2 90.5 91.3 6.4 39.7 6.4 10.5 10.8 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.1;esophagus: 19.2" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 28.3;CAPAN-2: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 2.9 1.3 0.4 4.8 0.5 1.5 3.2 0.4 0.2 4.8 5.7 4.1 3.0 0.0 19.2 3.2 3.8 1.8 0.5 0.5 1.6 2.8 3.2 3.9 0.7 2.7 4.3 3.8 2.1 1.8 4.6 3.2 10.5 1.3 2.8 11.6 5.5 1.3 1.1 4.9 6.1 8.3 2.7 4.0 4.6 8.8 7.0 14.7 19.1 14.1 3.3 9.0 6.4 12.9 28.3 4.2 6.2 2.4 2.3 9.1 2.8 2.4 3.1 4.3 7.9 46.8 4.0 2.0 2.8 16.4 9.7 2.2 13.4 1.9 9.0 4.8 2.3 5.8 6.9 3.2 3.3 5.8 4.2 8.2 8.0 4.3 2.4 2.3 7.2 7.0 6.1 3.7 6.3 5.1 11.6 6.1 9.8 4.3 5.6 3.9 7.2 1.4 10.1 1.7 3.5 4.5 7.8 3.8 3.9 7.8 8.9 2.4 17.5 8.4 5.9 11.2 4.6 5.4 4.6 3.8 3.6 9.0 12.4 9.2 13.3 7.6 10.9 5.5 6.0 6.4 7.5 8.4 7.0 6.6 6.9 19.1 3.3 14.1 14.7 9.0 6.4 6.0 5.3 7.3 17.3 30.1 2.6 1.7 5.1 29.4 18.2 7.0 7.9 16.0 3.3 16.6 13.7 4.7 27.5 0.0 9.5 11.1 6.0 16.5 3.5 3.2 18.8 3.2 8.7 9.2 11.1 6.7 5.2 11.6 6.8 9.0 26.8 5.0 19.5 35.3 4.6 2.9 8.7 6.5 4.1 9.2 10.1 30.9 31.5 8.3 21.7 51.5 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" Yes Yes "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: AB_2670577" "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavorable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 19.6 16.1 15.1 15.1 17.9 29.5 21.4 31.8 21.5 23.1 16.8 16.4 16.2 16.3 29.9 19.8 38.7 37.4 15.2 15.2 17.2 13.9 19.3 16.5 17.2 21.5 12.7 15.8 26.4 14.9 11.6 28.2 19.1 14.0 18.2 16.8 16.5 22.3 20.3 16.2 27.9 19.7 18.9 13.4 21.5 15.4 19.7 13.8 28.7 16.8 16.2 29.3 20.4 27.3 29.9 20.9 42.6 19.1 28.0 37.6 29.2 19.4 8.4 9.1 9.6 16.5 20.7 16.3 14.3 18.7 18.6 19.1 12.1 14.8 25.3 9.2 15.4 16.7 13.6 11.2 28.8 18.0 17.4 11.7 15.5 6.4 18.5 17.3 17.4 14.6 16.7 35.0 16.6 23.1 16.2 20.6 12.4 16.4 14.9 20.6 10.8 16.7 18.6 14.6 18.3 11.7 6.7 24.5 22.7 15.0 16.2 13.5 7.3 13.2 15.8 16.8 11.4 8.4 9.3 11.7 13.3 16.4 15.2 16.8 15.9 12.6 33.4 12.3 17.7 12.9 24.7 19.1 42.6 26.8 16.9 34.6 29.9 31.7 31.6 20.9 28.1 33.9 31.8 29.1 28.0 16.9 15.9 37.6 29.2 15.1 17.9 31.8 21.5 17.2 13.9 12.7 15.8 14.0 13.8 8.9 11.8 34.3 47.9 73.8 9.4 6.9 33.1 26.8 22.7 12.2 3.9 27.8 43.1 24.2 5.9 29.2 13.5 23.3 24.2 35.1 26.6 23.0 41.4 12.9 27.5 4.8 11.5 29.4 22.3 5.6 26.7 20.5 21.9 42.3 19.0 9.3 22.5 17.8 24.1 38.5 13.9 6.5 22.8 23.6 31.8 72.5 32.3 32.4 17.2 54.2 DUT dUTPase ENSG00000128951 "Deoxyuridine triphosphatase" P33316 15 48331011-48343373 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054422, HPA060360" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA054422: AB_2682483, HPA060360: AB_2684262" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (7.89e-2)" "unprognostic (5.27e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (4.42e-3)" "unprognostic (1.87e-2)" "unprognostic (4.25e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-2)" "unprognostic (4.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-2)" "unprognostic (1.71e-2)" 26.9 32.9 23.2 51.1 31.8 69.0 31.9 31.7 27.6 26.8 26.3 24.4 27.2 14.5 29.8 31.8 33.7 26.9 28.2 35.5 23.2 26.5 25.4 19.8 25.7 44.7 25.3 23.6 33.4 22.2 23.7 30.7 26.0 22.5 30.3 24.3 28.1 27.5 26.1 25.6 27.3 22.6 25.6 23.9 30.1 25.8 31.9 20.7 120.3 40.5 37.7 43.2 23.5 28.4 34.5 32.3 17.0 24.5 22.2 40.2 24.3 26.1 8.2 20.1 19.0 14.1 15.0 12.0 27.8 17.7 25.7 31.9 9.5 18.1 73.0 15.0 15.2 21.0 36.0 21.1 19.0 25.2 51.4 21.8 59.6 21.7 12.9 7.8 62.4 28.4 9.2 12.9 17.4 9.2 16.7 17.0 43.7 32.2 41.5 18.9 10.6 55.8 73.5 12.7 26.7 15.9 45.5 44.0 76.7 16.9 17.8 29.2 29.7 20.6 16.7 23.8 21.4 23.6 49.8 14.1 26.9 26.0 32.0 36.4 33.5 69.7 71.9 20.3 107.2 29.5 11.3 19.5 17.0 21.7 19.3 28.1 34.5 38.9 34.2 28.2 31.6 40.2 26.5 11.1 22.2 24.5 32.3 34.4 24.3 23.2 31.8 31.7 27.6 23.2 26.5 25.3 23.6 22.5 20.7 50.6 29.3 108.7 177.4 159.5 41.9 99.9 84.1 24.1 61.4 99.5 13.7 138.0 172.5 82.7 26.1 112.3 21.0 140.2 40.7 245.0 140.4 116.4 84.1 71.8 150.1 77.9 92.4 100.1 85.2 25.7 171.2 102.9 146.8 57.7 93.4 81.1 44.6 42.1 166.9 204.1 36.1 155.2 162.6 380.2 218.4 147.3 81.2 113.3 168.7 147.0 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 2849.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 650000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 45.5 48.5 128.5 34.4 97.8 21.9 54.3 48.4 120.5 50.6 61.8 61.9 31.1 31.6 47.2 64.9 113.7 107.1 46.7 44.2 124.1 105.2 49.7 40.7 40.3 41.2 92.9 90.7 49.0 45.7 30.4 46.4 49.8 67.4 39.9 64.5 24.8 34.0 54.9 15.0 117.3 38.9 75.2 93.6 30.4 45.1 59.4 56.8 35.4 37.1 84.3 65.6 59.0 63.0 55.0 80.6 73.6 55.0 46.7 63.4 50.8 78.6 89.9 89.2 68.4 78.4 83.2 28.7 108.9 50.3 88.9 53.4 84.7 53.1 44.1 58.8 104.0 87.0 71.0 106.0 91.0 88.9 58.4 69.4 43.1 64.5 114.6 79.2 45.0 71.7 50.5 97.5 66.6 54.7 98.8 92.3 47.8 54.0 50.9 117.3 104.1 58.6 97.8 73.2 101.0 104.9 59.9 46.2 54.7 127.0 72.9 61.3 45.3 88.7 77.1 98.8 97.4 76.4 65.8 71.0 68.5 58.5 60.4 93.7 30.6 58.8 43.8 75.9 70.3 87.6 73.6 49.5 63.6 37.7 51.4 28.7 55.0 39.0 39.0 49.1 36.5 25.2 31.5 9.1 46.7 55.0 80.6 63.4 50.8 128.5 97.8 48.4 120.5 124.1 105.2 92.9 90.7 67.4 56.8 181.7 88.8 250.9 293.4 819.1 137.3 144.1 321.0 1203.2 211.5 378.6 78.5 490.2 943.3 628.7 1147.1 421.8 466.9 116.8 472.1 694.2 640.5 264.0 307.3 460.6 658.6 81.0 461.6 421.7 304.4 2849.5 478.4 414.2 565.2 861.2 700.1 95.2 648.6 662.9 659.7 842.5 153.7 362.2 584.0 638.3 583.5 1407.5 841.8 195.6 373.7 348.8 DYNLT1 TCTEL1 ENSG00000146425 "Dynein light chain Tctex-type 1" P63172 6 158636474-158644739 "Predicted intracellular proteins" "Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046559 Approved Nucleoplasm NA Yes Nucleoplasm "HPA046559: AB_2679698" "unprognostic (1.80e-3)" "unprognostic (3.09e-1)" "unprognostic (3.69e-2)" "unprognostic (2.22e-3)" "unprognostic (5.31e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.62e-2)" "unprognostic (1.83e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.58e-2)" "unprognostic (2.72e-3)" "unprognostic (2.61e-1)" "unprognostic (1.74e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" 20.2 34.2 20.2 16.6 23.6 8.2 29.6 16.0 22.0 29.3 33.5 17.4 31.1 27.0 30.8 38.5 44.2 42.7 28.7 36.0 18.4 15.1 45.6 25.5 32.3 23.9 26.5 16.9 24.7 19.5 14.2 27.6 25.6 32.5 28.8 33.6 16.0 37.8 31.0 44.9 14.1 55.5 42.4 29.3 27.2 26.7 52.5 22.8 15.7 32.8 30.8 28.9 32.1 27.7 10.8 27.7 99.5 56.5 12.0 20.3 30.9 31.9 22.8 37.7 36.8 39.1 39.9 15.6 33.3 26.9 41.2 48.8 27.0 29.0 7.7 13.9 69.1 31.0 29.5 23.6 35.9 50.1 11.0 32.9 12.2 22.3 31.0 41.3 5.6 8.6 34.3 38.9 33.9 34.1 35.8 52.0 10.9 23.3 9.3 60.4 28.5 2.5 14.7 20.6 57.8 18.7 5.0 20.3 7.0 57.3 22.0 75.6 37.8 46.9 38.4 13.5 33.5 26.1 12.7 45.1 20.5 25.8 21.9 29.8 5.6 7.0 12.9 29.1 23.6 22.1 17.9 56.5 5.4 16.4 52.5 18.1 10.8 17.6 18.5 27.7 6.6 14.6 15.2 99.5 12.0 38.9 13.6 20.3 30.9 20.2 23.6 16.0 22.0 18.4 15.1 26.5 16.9 32.5 22.8 89.3 87.3 54.4 206.4 48.0 16.8 146.9 173.3 546.0 134.2 200.7 11.8 189.7 353.1 366.9 70.1 71.6 286.6 0.0 241.4 159.7 112.4 234.5 58.9 73.1 140.1 22.3 165.8 125.2 101.8 42.1 99.8 99.9 108.0 154.1 199.8 78.6 342.5 284.0 120.2 447.2 40.3 135.8 134.9 320.2 181.7 53.3 179.9 79.1 152.2 375.2 E2F1 "RBBP3, RBP3" ENSG00000101412 "E2F transcription factor 1" Q01094 20 33675683-33686404 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;lymphoid tissue: 21.9" "Cell type enriched" "Detected in many" 5 "Spermatogonia: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000329, HPA008003, CAB019308, HPA029735" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176" "unprognostic (7.46e-2)" "prognostic favorable (9.22e-6)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.33e-5)" "unprognostic (1.51e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (1.05e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.62e-4)" "unprognostic (1.91e-1)" 2.4 5.3 6.8 12.7 9.7 32.5 2.1 1.1 6.4 1.2 4.4 5.1 0.7 3.9 1.4 0.8 5.1 1.5 4.1 2.0 7.1 3.6 0.9 1.7 8.1 9.3 6.2 2.9 3.4 1.2 2.3 0.3 3.3 5.9 1.7 4.8 0.3 1.6 1.4 1.4 5.4 4.9 3.3 6.2 4.8 3.4 12.1 6.0 21.9 1.0 4.9 7.7 1.9 3.1 2.2 0.6 0.7 3.7 1.4 1.2 0.6 16.0 15.6 18.1 14.1 1.8 1.3 13.8 15.4 7.5 19.7 16.6 27.6 16.6 29.6 15.6 6.9 23.9 12.1 8.8 8.2 8.8 8.9 12.6 24.2 23.2 16.0 0.1 11.3 15.3 1.0 0.5 10.8 1.9 2.0 5.0 18.6 6.4 20.9 12.1 14.2 24.0 24.0 5.4 16.2 22.5 23.9 49.4 12.2 3.3 9.8 27.1 19.1 18.8 13.1 7.6 5.4 16.4 14.3 2.7 23.0 13.5 15.9 21.8 20.5 13.8 24.4 19.2 6.7 13.6 0.0 0.0 0.7 0.1 0.9 0.0 2.2 0.6 0.4 0.2 0.2 0.2 1.2 0.3 1.4 3.7 0.6 0.8 0.6 6.8 9.7 1.1 6.4 7.1 3.6 6.2 2.9 5.9 6.0 0.0 0.6 2.9 0.7 2.6 2.2 0.4 0.0 0.0 2.3 0.0 0.0 2.6 0.0 0.9 0.7 0.1 0.5 0.0 0.2 7.9 1.1 0.6 0.0 0.8 3.8 0.0 0.0 0.6 0.0 2.3 2.0 0.9 1.7 0.0 2.9 1.2 0.5 0.0 1.1 0.0 2.0 0.0 0.9 3.8 37.5 1.5 1.5 0.7 4.6 0.9 E2F2 E2F-2 ENSG00000007968 "E2F transcription factor 2" Q14209 1 23506430-23531220 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 22.8;lymphoid tissue: 69.7" "Group enriched" "Detected in some" 9 "Early spermatids: 45.0;Late spermatids: 84.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;Karpas-707: 20.5;U-266/84: 18.3;U-698: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB016313 Uncertain NA Yes "CAB016313: AB_2096794" "unprognostic (3.14e-2)" "unprognostic (5.74e-3)" "unprognostic (1.31e-3)" "unprognostic (4.18e-2)" "unprognostic (8.54e-2)" "unprognostic (1.70e-3)" "unprognostic (6.43e-6)" "unprognostic (7.83e-3)" "unprognostic (1.53e-2)" "unprognostic (7.33e-2)" "unprognostic (1.51e-3)" "unprognostic (1.86e-2)" "unprognostic (0.00e+0)" "unprognostic (1.00e-3)" "unprognostic (2.82e-1)" "unprognostic (8.67e-3)" "unprognostic (1.84e-1)" 0.4 0.2 0.1 6.1 0.2 22.8 1.0 0.1 0.2 1.1 3.5 0.2 0.0 1.6 0.1 0.2 11.2 0.1 0.2 1.5 0.0 0.0 0.4 0.7 1.2 3.3 0.2 0.0 0.2 0.6 0.0 0.0 2.2 0.2 0.3 2.3 0.3 1.2 0.0 0.0 4.4 3.4 0.4 0.2 6.8 0.9 4.4 0.1 69.7 0.3 3.9 6.1 0.5 2.3 0.9 1.1 6.7 2.0 0.2 2.8 0.4 2.7 2.0 3.4 5.4 0.1 0.1 2.4 1.3 0.6 1.2 1.6 1.2 1.6 23.9 1.6 0.6 0.6 5.5 6.8 0.3 1.1 6.0 2.2 3.8 5.1 1.4 0.0 2.7 5.0 0.0 0.0 0.9 0.1 0.2 0.4 11.2 2.9 20.5 0.6 1.6 12.2 2.5 0.7 2.9 1.0 13.4 7.3 8.1 0.5 0.7 4.4 6.2 2.2 2.8 0.6 0.4 2.1 2.0 0.2 1.2 3.3 3.7 1.8 15.2 18.3 19.8 1.1 3.0 2.2 6.7 0.6 1.7 0.2 1.5 0.1 0.9 0.7 0.5 1.1 0.6 0.1 0.2 0.4 0.2 2.0 0.9 2.8 0.4 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 7.0 0.1 0.7 0.0 0.5 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 45.0 0.0 2.0 0.0 0.0 4.0 0.2 0.4 0.0 0.0 2.0 0.0 1.2 0.6 4.4 84.0 0.3 0.9 0.0 0.0 5.6 0.0 0.1 7.0 0.4 0.0 0.0 0.0 0.0 1.1 3.3 0.9 0.5 0.0 7.4 1.0 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.2 33.0 26.1 13.5 2.7 5.6 13.0 20.5 16.8 30.8 30.0 18.3 49.1 11.5 31.2 12.0 29.5 20.4 21.0 13.1 42.1 16.4 11.6 7.2 18.1 9.3 1.2 11.1 8.3 1.8 2.2 18.3 18.7 8.7 13.2 17.1 7.4 16.9 24.3 16.3 11.3 8.3 21.2 38.3 18.0 8.1 25.6 14.8 23.4 10.8 17.4 11.2 25.9 29.5 10.4 13.7 49.1 8.3 11.4 15.0 14.4 20.1 42.6 8.3 11.1 21.7 13.2 9.7 19.5 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 6.0 2.7 9.0 4.3 17.3 3.4 3.1 7.6 10.7 4.5 3.5 60.9 4.9 0.0 9.0 2.7 6.4 3.2 70.0 7.9 13.0 7.0 8.8 0.0 1.5 6.1 0.0 4.6 5.5 3.1 2.3 0.9 5.1 6.8 1.8 10.8 2.9 14.3 3.5 1.4 1.9 13.4 0.0 3.3 33.1 37.4 11.2 3.2 1.5 6.2 7.8 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 804.7;Ductal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Cell line enhanced" "Detected in many" "EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.6 9.2 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.4 2.0 11.9 1.4 0.0 109.7 1.1 1.5 0.8 0.0 1.7 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 0.7 72.7 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.8 0.0 5.8 1.5 0.1 0.0 0.3 8.7 0.0 20.3 22.4 0.1 53.8 6.2 4.9 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 160.8 31.6 0.8 804.7 168.7 0.0 2.0 5.1 0.0 46.6 36.6 0.0 1.4 3.3 273.4 11.4 170.8 145.3 0.0 195.7 0.6 8.2 167.4 1.1 0.8 1.7 1.6 15.0 109.2 6.3 10.0 5.2 3.6 8.5 19.0 12.9 0.2 217.0 147.3 0.4 5.7 0.0 6.5 6.2 1.1 0.4 56.3 0.7 5.7 34.9 116.8 EID1 "C15orf3, CRI1, EID-1" ENSG00000255302 "EP300 interacting inhibitor of differentiation 1" Q9Y6B2 15 48877886-48880183 "Predicted intracellular proteins" "Cell cycle, Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051122, HPA051123" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA051122: AB_2681350, HPA051123: AB_2681351" "unprognostic (1.38e-1)" "unprognostic (6.69e-2)" "unprognostic (1.64e-1)" "unprognostic (3.18e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.41e-1)" "unprognostic (6.75e-3)" "unprognostic (2.46e-1)" "unprognostic (3.62e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.09e-1)" 42.6 75.4 69.7 33.0 66.6 18.4 38.1 65.0 77.2 56.1 47.9 36.9 33.6 30.4 58.1 46.0 41.2 46.8 52.9 95.4 63.4 73.2 53.0 42.5 35.1 35.1 58.6 63.7 71.7 38.3 42.0 71.7 32.7 67.6 56.2 24.6 44.9 34.4 53.3 92.7 19.9 29.1 55.3 59.8 39.6 33.4 26.9 44.4 32.8 48.3 38.0 26.9 57.1 35.0 36.4 72.7 55.3 62.9 43.9 65.0 73.4 20.8 17.8 40.6 38.1 35.9 47.9 2.7 55.2 45.7 33.7 44.4 15.4 9.5 28.1 51.3 31.4 24.9 18.9 19.5 19.6 36.6 77.3 20.2 48.2 39.5 0.6 28.1 29.0 22.1 41.8 16.8 22.7 13.6 32.8 37.9 24.6 28.6 27.0 37.3 30.1 20.9 24.4 0.0 14.9 15.7 29.5 50.5 45.8 41.7 23.1 38.7 38.8 34.4 13.1 62.5 33.1 23.9 38.3 42.9 53.7 29.9 50.9 48.1 34.9 95.2 20.0 44.4 64.1 37.7 55.3 62.9 53.7 47.8 56.6 45.1 34.0 54.6 49.5 72.7 36.4 39.9 36.6 8.3 43.9 56.0 72.2 65.0 73.4 69.7 66.6 65.0 77.2 63.4 73.2 58.6 63.7 67.6 44.4 360.3 149.9 104.9 122.0 155.9 338.8 422.3 160.5 255.6 306.0 247.7 113.9 301.2 514.0 334.6 14.7 353.4 52.3 116.8 234.2 122.3 472.2 84.6 181.5 144.0 183.1 225.6 224.3 276.2 202.2 21.3 650.4 211.2 462.2 264.3 93.9 629.6 172.4 94.5 612.4 325.8 264.9 316.9 445.7 102.8 59.4 127.2 91.7 198.0 88.5 76.7 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363397-43368074 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 101.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 21.2 15.6 16.2 15.3 25.3 18.3 24.1 6.8 32.5 16.1 23.6 101.5 11.7 20.7 14.1 13.0 46.6 15.1 17.3 11.5 30.3 18.3 26.6 23.8 22.9 22.7 51.4 14.1 9.3 18.3 16.7 8.4 20.9 45.6 21.6 20.1 8.6 20.6 21.6 6.8 54.0 21.7 20.7 99.5 17.2 22.8 8.4 37.2 7.2 23.9 15.6 21.7 20.4 22.6 30.9 61.1 46.9 54.8 30.5 32.3 48.8 23.8 26.9 5.2 10.3 35.6 33.5 16.3 28.3 35.7 36.1 29.1 23.8 41.9 16.5 22.0 44.3 31.2 27.5 18.4 34.8 22.2 21.2 12.4 21.4 18.6 17.2 30.9 18.4 22.9 25.6 39.6 42.6 47.1 27.1 36.1 6.5 14.8 12.6 41.3 17.6 4.3 15.5 7.6 31.1 27.9 9.7 13.9 20.1 45.5 29.1 6.4 6.7 16.7 59.7 23.8 16.2 28.1 18.4 29.8 30.6 19.4 37.0 35.8 6.3 6.8 7.9 29.8 18.9 27.5 29.0 54.8 46.9 32.3 50.6 28.6 30.9 30.7 31.4 61.1 25.5 20.1 28.1 38.2 30.5 48.1 42.9 31.4 48.8 16.2 25.3 6.8 32.5 30.3 18.3 51.4 14.1 45.6 37.2 17.9 8.4 18.1 20.4 13.9 5.4 3.6 45.9 5.3 7.9 38.4 9.8 79.2 6.6 86.7 2.5 28.7 74.3 70.0 86.6 103.3 20.2 33.0 20.7 13.7 66.2 3.2 18.4 23.4 47.0 3.4 18.7 37.1 11.8 129.8 30.5 12.4 99.9 40.7 24.1 21.3 8.4 19.4 15.3 6.7 8.6 27.0 80.2 24.6 36.9 43.7 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.3 8.8 3.6 4.3 8.2 7.1 7.2 9.1 8.4 5.5 8.3 28.8 22.3 0.0 2.9 10.9 4.0 28.3 9.3 11.2 7.3 0.0 5.9 0.0 18.5 15.7 1.4 0.0 0.1 4.3 3.0 7.3 0.7 1.2 2.3 0.0 2.1 0.6 15.2 59.5 0.1 0.1 4.2 10.3 2.1 1.6 4.2 13.8 1.2 40.9 5.1 5.8 11.2 58.8 3.3 11.0 35.9 1.4 1.2 17.6 7.6 5.9 5.0 0.1 0.2 0.0 7.7 0.1 17.2 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 3868.0 343.3 4.5 123.1 317.0 1.8 48.0 109.5 153.9 326.4 40.1 0.0 59.0 0.0 2.5 4.2 191.2 51.9 0.0 60.2 16.3 121.0 91.1 34.8 181.1 8.8 0.0 100.6 112.3 14.0 5.0 176.6 42.0 82.7 58.7 141.3 5.2 27.3 172.1 259.6 0.0 1.1 51.8 141.5 2.3 13.2 1026.6 40.2 4.3 139.9 220.6 ERH DROER ENSG00000100632 "ERH, mRNA splicing and mitosis factor" P84090 14 69380123-69398627 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 42.6 45.4 54.9 43.9 46.7 47.0 51.3 45.1 48.4 46.6 43.5 31.1 39.4 42.1 53.3 63.3 44.8 46.4 35.9 40.6 47.6 51.1 56.1 62.2 34.5 52.5 43.5 48.5 47.8 38.7 23.9 45.5 55.2 45.4 40.4 50.3 41.3 58.5 40.3 43.3 31.0 47.3 46.9 43.6 55.2 35.6 54.6 28.4 72.2 55.2 37.5 64.4 47.7 36.8 38.7 37.3 24.2 32.4 34.1 35.3 38.8 90.9 59.0 59.1 39.4 29.7 21.9 35.8 47.7 27.5 43.1 40.4 60.1 37.8 86.3 21.0 31.9 32.9 26.7 59.8 39.6 51.3 45.0 36.5 43.3 39.2 67.1 45.8 37.6 31.5 24.9 21.3 38.5 34.6 24.5 35.2 56.0 41.7 29.0 35.2 104.0 56.8 53.6 46.1 48.2 56.0 46.1 58.6 29.5 43.4 62.2 45.5 42.4 45.5 41.7 26.1 35.0 51.3 52.7 37.6 42.2 62.5 28.0 47.4 32.6 30.9 96.5 31.3 40.0 40.7 15.3 32.4 24.2 26.1 30.1 25.7 38.7 32.5 28.6 34.0 30.6 30.7 27.2 15.4 34.1 27.1 37.3 35.3 38.8 54.9 46.7 45.1 48.4 47.6 51.1 43.5 48.5 45.4 28.4 56.6 48.3 181.6 193.1 242.6 132.5 105.5 158.0 116.4 66.0 240.8 35.3 400.5 570.3 308.1 69.0 200.3 146.7 93.5 240.5 449.3 263.5 196.9 126.7 237.4 297.7 69.9 181.0 155.9 148.1 29.8 250.8 172.7 291.8 355.3 176.1 207.1 246.0 166.8 243.6 389.2 92.5 187.5 273.0 273.2 229.3 278.7 234.1 150.3 215.6 194.6 ERN1 "IRE1, IRE1P" ENSG00000178607 "Endoplasmic reticulum to nucleus signaling 1" O75460 17 64039142-64130819 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Unfolded protein response" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 76.4;Melanocytes: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.9;MAIT T-cell: 12.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 41.3;RPMI-8226: 18.5;U-266/70: 39.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB009495, HPA027730" Supported NA Yes "CAB009495: AB_2098712, HPA027730: AB_10602494" "unprognostic (2.52e-1)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (2.81e-2)" "unprognostic (9.14e-2)" "unprognostic (2.72e-2)" "unprognostic (4.55e-1)" "unprognostic (6.17e-2)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.65e-1)" "unprognostic (1.89e-1)" "unprognostic (1.36e-2)" "unprognostic (3.11e-2)" 5.5 24.9 2.2 10.6 1.6 8.0 7.7 2.3 1.8 15.8 10.0 3.5 36.1 5.1 11.9 15.0 7.4 7.9 10.6 4.1 1.9 1.7 6.4 21.5 12.3 12.6 2.1 1.6 14.7 44.1 2.9 32.8 10.1 1.8 6.6 3.9 5.0 23.2 34.9 4.2 6.6 11.5 4.1 2.2 9.9 8.8 2.8 1.6 11.6 7.5 5.9 16.7 10.0 7.7 0.1 5.7 12.9 0.7 3.0 12.2 1.0 2.2 1.8 0.9 2.4 2.2 1.8 4.5 1.9 4.3 1.3 1.2 1.2 1.2 2.9 1.3 1.4 2.1 1.5 1.2 1.9 3.3 0.8 1.1 2.6 0.9 1.8 13.9 1.2 0.9 2.1 5.3 3.7 11.8 1.9 2.5 2.8 1.8 41.3 1.2 1.5 1.8 0.5 0.4 2.1 1.6 2.0 2.0 18.5 1.1 3.0 3.2 2.0 1.8 3.1 4.5 1.8 1.7 2.7 2.4 1.1 2.7 2.6 1.2 39.0 10.2 2.2 2.1 1.4 1.9 12.9 0.7 0.2 4.6 0.4 12.2 0.1 3.0 3.2 0.3 0.1 0.7 1.3 3.3 3.0 0.2 5.7 0.7 1.0 2.2 1.6 2.3 1.8 1.9 1.7 2.1 1.6 1.8 1.6 0.0 42.2 9.0 42.2 19.6 3.2 5.6 15.3 6.7 7.9 12.2 5.9 6.5 1.7 9.4 1.8 10.8 7.1 0.0 24.0 6.6 16.0 38.4 8.1 21.3 7.7 3.2 76.4 14.1 12.1 1.1 4.4 18.6 70.9 8.2 7.8 4.0 16.0 7.6 5.6 3.7 26.0 0.0 15.1 3.9 4.1 39.4 45.9 42.7 7.6 52.1 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Cell type enhanced" "Detected in some" 6 "Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.6 12.9 13.8 11.3 0.3 1.2 8.5 8.3 4.2 14.3 9.1 7.0 11.1 22.8 4.6 3.4 8.4 10.5 16.0 4.9 7.5 7.1 16.2 15.3 11.7 5.3 0.0 9.6 12.7 0.4 0.3 8.3 4.1 1.4 7.3 11.3 20.5 20.6 4.2 13.1 15.0 8.2 11.2 7.5 7.0 14.1 14.8 9.5 2.0 5.3 10.0 7.7 7.0 10.3 5.4 6.8 17.0 6.4 3.3 7.2 14.0 6.0 11.4 15.3 14.2 15.4 4.1 9.1 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.7 0.0 0.2 0.6 0.4 4.1 0.0 0.0 1.9 1.0 0.3 0.0 4.9 2.1 0.0 3.4 1.3 0.6 1.1 0.0 1.3 0.0 0.0 1.2 0.0 1.0 0.2 0.4 5.6 0.0 0.0 0.4 6.5 2.7 0.5 0.2 0.0 3.1 0.5 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 2.1 1.0 0.9 10.3 1.0 15.6 1.0 0.3 1.3 1.3 3.1 0.3 0.1 2.9 0.7 0.8 6.2 0.4 1.3 1.5 0.7 0.6 0.9 1.3 1.5 5.6 0.6 0.3 1.3 1.3 1.8 0.4 4.6 0.7 0.7 3.9 0.3 1.4 0.1 1.0 1.7 4.2 1.0 0.6 5.7 1.5 14.8 0.1 31.3 0.6 4.0 8.1 1.6 2.0 1.4 0.6 2.9 0.7 0.9 3.3 1.0 15.1 10.1 16.7 11.0 1.0 2.7 14.1 20.2 6.8 18.1 19.8 12.6 8.6 16.6 9.9 4.7 9.5 15.1 21.1 8.4 21.5 25.6 18.5 15.4 10.8 6.4 0.3 21.9 11.5 0.6 0.4 18.0 4.9 2.2 5.6 16.3 30.8 21.9 14.4 7.0 23.6 12.4 22.8 18.5 10.0 17.1 15.6 17.7 3.7 9.6 18.7 23.7 13.2 10.7 7.1 8.2 9.9 13.6 2.0 17.6 15.5 16.5 27.2 16.1 21.3 26.7 6.1 17.9 20.9 2.9 0.7 0.0 1.1 0.0 0.0 1.4 1.1 1.1 0.6 1.3 0.6 0.2 0.3 0.9 0.0 0.1 3.3 1.0 0.9 1.0 0.3 1.3 0.7 0.6 0.6 0.3 0.7 0.1 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 0.0 0.0 0.0 14.1 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 9.8 6.9 0.1 3.3 0.7 0.6 0.1 EXT1 "LGCR, LGS, ttv" ENSG00000182197 "Exostosin glycosyltransferase 1" Q16394 8 117794490-118111853 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 55.5;fHDF/TERT166: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044394 Uncertain NA Yes 9600000 "HPA044394: AB_10963838" "unprognostic (1.29e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.73e-2)" "unprognostic (2.02e-3)" "unprognostic (2.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.70e-1)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (6.58e-2)" "unprognostic (1.27e-2)" "unprognostic (9.84e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.85e-1)" 13.8 11.9 5.8 20.5 4.6 2.1 16.5 7.3 7.4 13.3 17.1 4.1 8.7 23.2 11.5 12.5 11.2 8.8 19.3 14.4 4.6 3.1 8.8 66.4 19.9 8.3 3.0 6.8 10.4 17.9 7.1 6.4 15.6 4.8 9.8 16.0 13.2 9.8 13.3 4.2 12.3 32.0 16.8 4.3 20.1 11.5 5.0 2.7 8.7 12.0 10.3 7.2 11.0 18.5 0.8 1.7 1.2 4.5 0.7 2.4 1.0 17.3 5.0 7.6 3.0 13.7 11.1 3.5 32.5 55.5 24.0 22.1 5.2 1.7 0.3 14.6 56.1 17.9 11.0 3.3 19.1 33.8 6.5 5.6 0.7 4.7 4.1 6.4 0.0 1.2 6.9 5.1 29.1 26.8 30.1 14.7 1.6 0.4 4.8 11.1 1.4 0.8 0.0 2.4 9.2 6.5 0.0 2.8 0.5 9.4 6.3 2.4 2.2 5.0 2.3 4.8 20.2 3.2 0.2 19.5 20.2 18.6 18.6 9.5 2.8 2.7 1.6 18.8 0.0 5.4 0.3 4.4 0.2 0.2 4.5 1.3 0.8 0.5 0.6 1.0 0.1 0.5 0.9 1.2 0.7 2.2 1.7 2.4 1.0 5.8 4.6 7.3 7.4 4.6 3.1 3.0 6.8 4.8 2.7 17.9 5.9 1.4 18.7 48.7 21.1 6.2 28.1 5.3 6.8 7.0 13.7 5.2 0.0 34.9 1.3 16.6 42.3 0.0 17.2 3.2 32.1 10.0 6.9 22.6 2.2 9.5 4.6 17.8 28.9 1.6 16.1 5.4 18.6 5.4 20.7 6.0 21.6 14.0 33.9 5.0 24.5 0.0 28.1 0.5 4.3 41.4 10.2 2.2 21.2 17.9 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 7.8" "Cell type enriched" "Detected in many" 4 "neutrophil: 24.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.9" "Cell line enhanced" "Detected in many" "PC-3: 34.7;RPTEC TERT1: 57.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB012989: AB_2533199, HPA014091: AB_2668939" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favorable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 0.6 1.1 1.0 7.2 1.4 0.1 2.9 0.4 0.8 2.4 34.0 1.1 25.3 17.4 1.0 2.2 6.4 2.9 13.6 3.6 1.1 0.9 28.9 7.4 2.8 3.7 0.8 0.4 1.2 16.6 1.3 3.2 2.8 7.8 6.0 21.4 1.1 7.1 23.7 0.3 24.8 64.1 0.7 1.5 3.5 16.8 0.8 0.5 0.6 9.6 5.8 3.1 5.3 3.9 0.3 2.7 24.9 5.7 0.3 2.3 2.0 8.7 14.4 1.2 0.0 0.4 1.1 9.3 0.4 4.8 0.2 0.7 12.4 22.6 0.0 19.5 1.0 22.3 15.0 7.6 6.7 0.4 0.0 7.1 0.2 0.3 8.8 3.1 0.0 0.0 1.6 19.2 2.2 14.4 2.3 23.9 2.2 0.1 0.0 0.0 4.7 1.0 0.0 1.6 4.9 34.7 0.0 0.0 0.2 57.6 16.2 0.6 0.1 3.4 3.5 0.0 14.5 1.5 0.0 15.7 0.0 9.1 0.0 0.0 1.3 0.2 0.0 5.1 0.0 0.4 4.6 5.7 1.0 0.3 1.9 1.2 0.3 2.3 1.2 2.7 0.1 2.2 1.3 24.9 0.3 0.3 0.3 0.6 2.0 1.0 1.4 0.4 0.8 1.1 0.9 0.8 0.4 7.8 0.5 8.9 3.0 2.0 18.2 97.5 0.0 0.3 35.7 18.7 11.4 29.6 0.0 4.8 1.7 20.1 0.0 0.6 75.9 0.0 13.1 6.2 3.7 19.6 2.3 8.5 0.7 0.0 12.6 1.8 2.4 0.0 0.0 1.1 1.7 0.0 43.8 0.0 29.3 35.1 0.0 20.2 1.6 0.0 1.0 0.0 1.4 147.0 1.7 0.0 39.6 93.4 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, DNA replication, Host-virus interaction" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 16.3 13.7 4.8 28.1 6.7 9.9 14.5 3.3 4.8 14.7 14.2 8.3 13.2 12.8 18.1 16.8 10.2 11.3 15.9 6.7 5.5 3.9 14.5 11.7 17.5 19.6 7.4 3.8 11.2 10.7 17.8 17.4 10.8 8.1 22.5 11.7 13.2 13.4 13.0 5.6 11.0 19.3 14.0 12.3 29.5 12.9 5.9 6.5 73.4 19.5 12.9 21.3 10.9 13.2 4.6 6.5 7.7 6.3 6.9 8.6 2.4 21.2 5.5 2.7 2.6 6.1 7.4 1.8 30.4 16.6 13.1 19.3 8.3 20.0 31.2 12.8 9.8 17.9 7.4 9.0 13.3 16.6 27.7 0.4 11.7 7.0 2.5 6.3 18.6 15.9 5.1 3.4 12.2 3.9 7.6 12.1 19.3 1.4 25.8 14.1 6.0 28.1 12.5 1.2 6.6 6.0 19.4 9.8 7.3 8.8 19.0 0.0 0.7 15.6 13.1 5.9 1.5 26.9 8.4 11.7 21.4 19.3 14.6 14.2 13.2 13.7 5.1 11.7 13.3 25.7 6.2 6.3 6.7 6.6 5.4 8.6 4.2 4.5 4.8 6.5 4.6 4.4 3.7 7.7 6.9 2.6 1.8 4.6 2.4 4.8 6.7 3.3 4.8 5.5 3.9 7.4 3.8 8.1 6.5 59.6 39.5 24.4 9.7 7.6 2.2 3.9 12.7 46.8 26.1 15.7 0.0 8.9 8.3 10.1 0.0 17.5 12.9 0.0 6.6 1.2 14.9 15.7 26.6 7.9 24.4 0.0 5.8 27.6 31.6 1.1 12.0 25.0 6.8 12.6 19.1 29.9 8.0 15.8 6.3 7.6 6.5 0.0 10.7 0.4 1.9 7.8 3.7 21.8 15.3 10.9 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.4 6.3 9.4 0.1 1.0 1.8 0.1 18.6 9.3 11.1 16.5 13.3 9.7 30.5 12.6 5.4 9.3 19.0 13.7 12.6 19.8 15.8 3.3 3.3 12.0 5.8 0.0 0.1 3.9 0.4 0.4 10.7 0.8 2.1 5.9 8.3 0.9 28.8 13.0 9.2 19.2 0.2 0.1 14.8 7.4 20.3 14.0 11.9 5.9 21.1 1.8 6.0 15.4 17.8 3.0 3.6 19.7 1.7 3.2 8.6 18.8 26.0 16.9 22.2 16.0 0.2 12.5 0.1 12.3 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 0.0 0.0 4.8 2.0 3.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 2.4 0.1 0.5 6.3 0.9 FAM161A "FLJ13305, RP28" ENSG00000170264 "Family with sequence similarity 161 member A" Q3B820 2 61824854-61854143 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Ciliopathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 133.3;Late spermatids: 200.8;Rod photoreceptor cells: 391.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032119 Approved NA Yes "HPA032119: AB_10602806" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (4.23e-2)" "prognostic unfavorable (9.02e-4)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.56e-5)" "unprognostic (7.62e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (4.35e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (5.33e-2)" "unprognostic (3.93e-1)" "unprognostic (8.08e-3)" "unprognostic (7.04e-2)" 2.6 3.7 8.2 1.9 8.9 1.3 3.4 6.8 10.4 6.1 2.4 5.2 4.3 1.5 4.4 3.9 3.2 10.5 4.1 3.9 4.6 5.6 5.5 2.5 3.0 2.2 7.8 4.8 13.5 5.7 5.4 10.9 3.1 6.6 3.1 2.2 20.5 2.0 3.7 3.0 2.1 1.9 2.5 5.5 2.1 5.3 13.0 9.5 1.7 9.4 2.0 2.0 3.1 3.5 0.9 0.7 1.7 0.1 0.5 2.3 0.3 3.4 3.3 7.5 2.9 3.6 3.6 2.3 3.0 1.6 3.7 4.5 2.1 1.8 6.7 1.6 0.5 6.4 1.7 4.6 0.5 8.5 4.4 4.6 2.6 3.1 3.2 3.2 2.7 0.4 1.5 0.0 6.5 2.1 4.3 3.6 6.6 0.9 2.3 2.5 1.4 4.6 4.9 11.3 4.3 3.3 8.1 12.4 3.5 2.6 0.8 9.2 7.8 6.5 0.9 4.9 7.0 1.6 1.8 0.7 5.9 5.7 4.5 6.7 4.0 3.0 8.5 4.2 4.4 1.2 0.0 0.1 1.7 0.3 0.0 1.1 0.8 2.3 0.2 0.1 0.9 1.3 0.6 0.0 0.5 0.0 0.7 1.3 0.3 8.2 8.9 6.8 10.4 4.6 5.6 7.8 4.8 6.6 9.5 3.0 8.9 0.8 8.4 4.8 32.7 12.5 7.6 61.6 14.8 19.2 94.2 10.7 1.7 3.6 133.3 4.7 0.0 0.0 3.3 6.3 8.2 3.7 4.6 4.0 3.1 15.9 5.8 2.5 2.2 200.8 19.2 2.4 8.5 2.8 1.1 33.5 1.9 0.0 15.6 9.0 391.6 0.0 7.1 85.9 37.2 3.6 9.3 3.1 3.3 2.0 FAM72A "LMPIP, MGC57827, RP11-312O7.1, UGENE" ENSG00000196550 "Family with sequence similarity 72 member A" Q5TYM5 1 206186179-206204414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 14.9;Kupffer cells: 15.6;Late spermatids: 22.6;monocytes: 10.8;Spermatocytes: 13.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (3.61e-2)" "unprognostic (1.58e-1)" "unprognostic (1.80e-1)" "unprognostic (5.20e-5)" "unprognostic (3.61e-1)" "unprognostic (1.19e-3)" "unprognostic (1.01e-5)" "unprognostic (7.70e-3)" "unprognostic (1.45e-2)" "unprognostic (5.58e-3)" "unprognostic (2.87e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-16)" "unprognostic (1.82e-1)" "unprognostic (1.94e-2)" "unprognostic (4.83e-2)" "unprognostic (3.89e-1)" 3.4 2.5 1.9 4.7 1.6 6.3 3.2 8.0 1.3 0.8 1.5 2.4 0.6 0.0 2.5 1.8 2.2 0.9 2.4 1.8 1.0 1.3 2.4 8.9 2.6 0.8 0.7 2.3 0.4 2.8 0.5 1.7 0.7 0.2 0.2 5.0 2.2 1.3 3.1 6.3 0.8 6.3 0.5 6.2 1.1 1.2 2.1 5.6 1.2 9.2 0.6 3.6 2.4 9.7 8.0 8.4 3.6 1.2 1.5 10.1 7.0 3.0 8.1 6.1 4.7 14.6 25.1 6.0 1.8 9.1 11.7 9.7 3.8 9.7 13.8 8.0 11.3 7.3 6.3 0.8 19.5 12.8 2.1 0.7 7.2 12.8 2.4 5.0 21.9 22.5 17.3 5.0 5.7 12.1 17.5 15.3 6.9 10.7 13.5 14.6 18.9 4.6 1.5 8.4 4.9 5.0 4.6 4.1 10.0 9.7 10.6 2.6 6.5 7.5 8.4 11.5 14.0 20.5 22.5 5.3 16.1 8.9 0.0 7.5 0.0 0.9 9.2 0.2 2.1 1.8 1.8 5.6 0.8 0.2 0.4 1.2 0.6 5.4 2.3 3.6 2.4 0.0 1.0 0.9 0.1 1.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.4 0.0 0.8 14.9 5.2 0.9 0.0 0.7 2.8 2.4 0.4 0.0 0.0 7.8 0.0 0.0 6.7 15.6 22.6 0.0 6.0 3.3 10.8 0.4 0.5 0.3 0.0 0.0 0.1 0.1 0.0 1.7 13.5 4.5 0.9 0.6 0.9 0.4 0.5 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 4.7;Spermatocytes: 14.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 12.0 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.4 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 20.0 10.3 0.6 0.4 5.9 12.0 1.9 4.5 22.2 15.0 16.4 5.4 5.0 10.0 16.5 13.9 6.5 9.1 15.0 15.9 12.2 2.9 1.4 8.0 4.6 4.8 3.8 3.7 7.9 5.0 15.6 1.5 6.2 10.5 12.0 11.3 14.6 18.2 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 0.0 0.0 3.7 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.7 1.0 1.7 0.0 0.2 1.9 0.5 0.0 0.0 0.0 0.9 0.0 0.0 3.1 0.6 1.2 0.6 0.7 0.0 3.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 14.9 3.4 0.9 0.1 1.0 0.4 0.0 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 6.4" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 3.6;Sertoli cells: 6.5;Spermatocytes: 10.0;Spermatogonia: 3.2" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.2" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.1 0.0 1.6 3.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.1 1.9 0.0 6.4 0.4 1.1 0.4 0.0 1.0 1.7 2.2 0.6 8.6 5.0 6.1 2.7 0.3 0.8 5.9 4.3 1.4 5.8 4.5 0.8 10.4 20.6 5.7 0.5 5.5 8.3 8.1 2.6 6.3 7.1 4.8 8.9 4.4 1.5 0.3 18.1 8.1 0.2 0.0 4.5 11.9 1.3 2.5 16.6 15.5 9.7 0.3 0.6 10.7 14.0 4.9 9.7 3.3 13.6 4.4 14.6 1.0 1.1 3.1 5.6 4.2 2.4 2.3 6.6 6.0 15.6 1.7 4.6 7.6 6.0 9.4 20.3 29.2 12.2 2.5 11.3 2.9 0.0 1.0 0.0 0.1 0.3 0.0 1.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 1.7 0.6 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.0 0.0 0.0 0.2 3.6 0.3 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 10.0 3.2 0.3 0.2 0.0 0.0 0.0 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;smooth muscle: 69.8" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 0.5 0.5 0.5 4.9 0.8 7.9 0.7 0.4 1.2 1.7 29.6 0.4 0.7 3.4 0.8 1.5 39.0 0.2 5.6 1.5 0.5 0.1 2.2 1.4 2.6 1.5 0.3 0.5 0.7 0.2 0.0 0.3 2.2 0.7 7.6 3.6 1.2 3.1 1.0 0.4 4.1 16.2 69.8 0.4 1.0 22.8 3.8 0.2 9.2 0.5 8.6 17.9 24.5 6.4 1.6 0.1 0.0 0.4 2.4 4.6 1.2 31.5 19.5 15.4 12.9 1.7 2.0 27.7 14.2 8.9 28.2 17.3 29.8 14.5 8.0 14.1 9.3 21.9 27.2 21.1 24.4 26.5 2.6 8.3 9.3 15.0 21.4 1.4 4.1 4.9 1.0 1.2 16.2 9.4 3.4 15.4 3.6 8.2 11.6 16.0 17.0 6.3 6.0 12.8 18.4 24.9 6.1 28.5 4.4 8.1 8.1 7.1 11.9 41.5 34.7 6.1 15.0 21.7 4.2 7.3 18.7 23.0 21.2 31.3 3.5 5.4 8.3 8.4 6.1 13.7 0.0 0.0 0.0 0.7 0.4 2.3 1.6 2.4 2.7 0.1 1.6 2.7 3.4 0.0 2.4 0.1 0.0 4.6 1.2 0.5 0.8 0.4 1.2 0.5 0.1 0.3 0.5 0.7 0.2 0.0 2.2 0.0 5.2 2.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 2.6 0.0 0.0 0.4 0.5 2.6 23.3 0.0 36.2 0.9 0.7 0.0 5.4 4.0 0.0 1.7 1.8 2.1 0.6 0.3 0.4 0.0 0.0 2.2 0.0 0.1 3.7 0.0 4.3 0.0 19.4 2.1 11.1 14.5 1.6 127.6 2.2 2.5 4.3 FANCA "FA-H, FAA, FACA, FAH, FANCH" ENSG00000187741 "Fanconi anemia complementation group A" O15360 16 89737549-89816657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6;testis: 28.8" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 22.3;Spermatogonia: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063236 Supported Nucleoplasm NA Yes Nucleoplasm "HPA063236: AB_2684966" "unprognostic (5.99e-2)" "unprognostic (5.68e-2)" "unprognostic (2.36e-1)" "unprognostic (5.12e-2)" "unprognostic (1.87e-1)" "unprognostic (7.11e-2)" "unprognostic (1.45e-4)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (2.05e-1)" "unprognostic (4.82e-3)" "unprognostic (8.48e-4)" "unprognostic (7.82e-10)" "unprognostic (3.67e-2)" "unprognostic (2.05e-1)" "unprognostic (2.94e-1)" "unprognostic (1.62e-1)" 2.1 2.0 2.2 16.5 3.7 17.1 1.7 5.7 6.6 1.7 5.1 1.1 0.6 5.0 1.7 3.1 6.6 1.9 1.6 1.7 1.8 1.4 2.1 5.8 3.3 11.1 1.3 2.7 1.6 1.8 2.3 1.9 11.2 2.4 1.7 6.3 1.5 2.2 0.5 0.7 5.0 5.4 2.0 1.6 6.9 3.5 28.8 0.8 20.6 1.7 4.6 17.6 2.9 2.5 7.4 6.5 9.9 9.2 7.5 9.5 4.2 9.3 14.4 17.3 15.1 1.1 2.2 13.2 11.7 6.4 19.8 8.3 12.6 15.6 23.1 5.5 4.0 6.6 14.5 11.6 8.7 20.9 5.4 19.5 6.8 18.5 25.8 0.7 6.9 7.5 0.7 0.9 16.0 5.1 2.8 6.2 11.7 16.3 7.1 10.3 21.7 13.8 30.0 11.2 12.9 9.0 25.2 13.9 4.2 4.9 8.9 15.5 8.4 17.5 5.2 2.2 10.4 9.4 12.5 4.6 15.9 16.8 8.8 12.2 6.4 7.5 22.9 7.5 15.5 15.1 2.6 7.9 9.9 4.7 8.8 3.3 7.4 2.8 4.1 6.5 5.5 0.7 3.0 9.8 7.5 9.2 0.4 9.5 4.2 2.2 3.7 5.7 6.6 1.8 1.4 1.3 2.7 2.4 0.8 0.0 0.6 13.1 1.4 3.1 8.8 1.6 0.0 1.4 3.4 15.7 9.8 10.9 1.7 1.6 5.3 0.8 2.0 23.3 1.4 7.5 1.3 0.5 2.3 4.0 7.7 3.2 1.7 7.4 4.3 3.5 1.4 6.3 0.0 0.0 6.1 1.4 1.5 0.0 0.0 6.8 7.2 0.0 1.0 22.3 33.2 1.6 21.2 3.2 6.3 2.1 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 17.3;Spermatogonia: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: AB_2679292" "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.6 14.4 13.3 3.2 5.1 12.1 11.1 8.0 21.8 21.0 9.3 9.9 15.6 7.7 3.5 15.6 9.7 11.9 10.2 8.4 18.3 7.2 11.2 21.0 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 3.8 11.1 19.2 7.3 21.0 11.0 14.0 19.1 15.6 14.9 11.8 15.1 19.9 16.9 11.0 5.1 6.7 7.0 12.7 7.3 10.4 4.1 6.5 13.5 8.2 6.7 10.4 20.7 13.3 14.9 5.7 10.8 9.4 9.2 8.4 14.2 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 3.0 5.8 5.2 3.6 3.9 4.3 1.0 0.0 0.0 2.3 3.5 3.9 8.2 3.3 3.7 0.3 2.8 1.6 0.0 2.0 17.3 3.8 3.5 13.9 1.0 6.5 4.8 1.7 3.7 0.3 0.4 3.1 2.0 3.3 3.6 3.9 3.5 2.3 3.2 3.9 1.7 3.0 0.0 2.7 10.9 23.7 2.3 5.5 5.3 5.0 3.3 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "Fanconi anemia complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 62.5" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" NA Yes "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favorable (7.80e-5)" 6.3 29.2 16.0 11.2 22.9 10.6 16.2 7.1 18.1 11.6 9.6 30.7 7.9 9.2 16.6 15.7 8.6 11.7 9.8 10.2 17.0 23.5 7.1 16.7 7.7 10.9 25.0 15.2 21.3 10.8 16.8 62.5 10.0 33.5 11.6 12.4 13.7 14.8 9.1 6.5 14.4 10.1 11.3 23.4 12.0 10.5 14.7 28.2 8.6 14.2 6.9 12.0 10.1 12.7 10.8 7.1 5.6 6.9 8.8 5.5 2.7 18.5 13.5 27.6 13.5 4.9 6.5 14.7 13.6 8.5 13.5 17.6 11.9 23.3 12.8 17.7 4.4 18.6 10.8 15.3 10.3 22.6 30.1 24.2 21.0 19.0 16.1 5.3 20.2 11.6 4.8 4.9 9.9 3.9 12.0 10.6 9.2 19.5 11.7 9.2 9.4 7.1 25.1 29.8 29.7 2.8 13.5 21.0 10.0 11.8 18.3 31.3 15.7 19.4 8.0 12.7 15.5 7.4 13.6 6.2 12.1 18.2 8.8 15.0 12.1 7.6 7.5 25.7 13.7 18.3 2.7 3.7 5.6 4.9 6.9 3.8 10.8 4.1 5.4 7.1 10.0 1.4 3.1 1.1 8.8 4.9 6.5 5.5 2.7 16.0 22.9 7.1 18.1 17.0 23.5 25.0 15.2 33.5 28.2 17.9 18.3 5.8 13.7 9.2 12.4 13.2 5.1 20.1 10.3 8.7 3.9 25.0 10.0 6.9 1.7 10.5 7.3 0.0 3.6 12.2 8.9 6.8 10.4 10.4 9.4 7.9 8.6 10.4 8.5 1.7 10.0 6.9 25.3 9.0 16.3 20.3 4.6 13.1 13.4 4.1 18.8 12.9 8.1 47.7 30.4 5.9 6.2 5.0 13.6 5.9 FBXO5 "EMI1, FBX5, Fbxo31" ENSG00000112029 "F-box protein 5" Q9UKT4 6 152970519-152983579 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "bone marrow: 29.3;lymphoid tissue: 69.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 70.0;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008106, HPA029048" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB008106: AB_828450, HPA029048: AB_10602132" "unprognostic (1.22e-2)" "unprognostic (7.21e-2)" "unprognostic (4.61e-3)" "unprognostic (1.24e-2)" "unprognostic (5.92e-2)" "unprognostic (2.94e-2)" "unprognostic (2.43e-8)" "unprognostic (2.46e-2)" "unprognostic (1.55e-2)" "unprognostic (7.32e-2)" "unprognostic (2.89e-1)" "unprognostic (5.86e-2)" "unprognostic (1.25e-9)" "prognostic favorable (8.65e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-1)" 4.2 2.9 2.7 13.7 3.1 29.3 3.5 6.6 3.3 5.3 6.1 1.8 1.8 3.5 5.8 3.7 6.1 4.4 3.0 2.4 2.8 2.3 3.0 4.1 3.8 10.8 4.4 1.6 5.1 3.1 2.0 3.4 8.2 3.5 3.9 4.1 1.6 6.9 2.4 1.6 3.3 5.0 3.9 2.4 10.6 3.5 4.2 3.9 69.0 5.6 4.8 11.2 3.5 4.5 6.8 5.3 0.0 3.5 8.8 7.9 3.2 11.1 5.8 24.6 16.5 1.9 3.9 7.8 27.2 12.2 20.5 23.1 11.9 6.7 27.4 8.4 7.2 13.8 10.7 19.4 9.1 24.7 14.6 17.3 27.4 8.6 12.9 3.6 24.5 17.0 2.7 1.7 13.8 10.9 5.0 9.3 14.4 28.9 25.8 18.6 8.5 27.9 15.8 14.3 8.6 8.6 23.6 19.7 17.7 7.2 6.1 16.1 16.7 19.3 10.4 5.1 9.0 7.5 23.0 7.0 15.4 20.1 17.7 31.7 8.6 9.5 40.5 11.2 18.2 18.6 0.0 2.4 0.0 3.8 3.0 5.4 6.8 6.3 6.9 4.6 6.0 6.2 6.4 0.0 8.8 3.5 5.3 7.9 3.2 2.7 3.1 6.6 3.3 2.8 2.3 4.4 1.6 3.5 3.9 0.0 0.6 13.7 3.5 8.9 2.8 1.4 2.5 2.7 5.7 1.8 5.9 6.7 3.3 2.7 0.5 4.5 1.0 70.0 1.4 24.6 7.2 2.7 2.3 1.7 6.5 1.6 4.6 6.2 1.0 0.0 4.0 4.8 1.7 2.8 2.7 4.0 1.3 0.0 5.6 2.9 3.0 12.9 6.6 8.8 32.4 4.5 4.9 7.0 4.3 1.7 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792637-61797244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.3" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.7;Spermatogonia: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 38000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 4.8 9.6 7.9 14.6 8.5 23.9 7.4 16.9 14.9 4.9 11.0 8.5 5.0 8.1 5.0 6.6 13.3 4.2 7.0 4.6 8.6 8.5 4.9 9.3 5.0 22.5 8.3 9.8 3.9 6.3 5.2 7.9 11.2 12.6 4.7 12.0 7.3 9.3 4.6 11.2 6.8 8.2 6.4 7.1 12.3 7.2 16.2 5.9 36.3 3.5 10.6 25.5 6.1 4.2 11.5 18.1 14.5 9.4 13.3 18.0 7.3 31.2 28.8 31.6 17.0 3.1 3.9 20.1 27.7 15.8 33.9 38.6 25.1 23.6 45.1 21.6 11.7 32.0 33.1 44.4 24.2 34.8 23.7 24.5 23.8 39.3 25.6 2.4 37.0 24.7 2.7 3.3 31.3 8.3 5.0 13.2 25.5 36.0 32.7 28.1 39.4 51.6 33.3 34.7 24.6 28.2 35.4 36.6 46.6 13.5 29.6 36.0 29.9 18.5 24.2 15.9 15.5 35.1 26.0 8.8 30.2 38.2 38.4 27.8 25.9 40.2 46.9 21.1 24.8 26.0 14.5 5.0 10.2 12.4 9.4 13.1 11.5 10.0 11.8 5.8 11.5 11.2 11.3 2.1 13.3 8.8 18.1 18.0 7.3 7.9 8.5 16.9 14.9 8.6 8.5 8.3 9.8 12.6 5.9 0.0 2.1 12.6 4.8 9.2 21.1 4.0 5.1 6.7 3.4 0.0 11.8 28.6 6.6 11.6 16.8 2.7 3.1 23.3 10.5 61.7 7.6 4.4 0.0 6.8 21.8 14.3 4.6 1.3 5.1 9.8 5.2 7.1 5.0 19.0 5.3 29.9 9.3 6.0 6.7 4.7 20.5 0.0 4.2 33.0 63.4 5.4 25.9 14.1 13.0 3.7 FHL2 "DRAL, SLIM3" ENSG00000115641 "Four and a half LIM domains 2" Q14192 2 105357712-105438513 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "heart muscle: 312.0;ovary: 80.7" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 732.1;Extravillous trophoblasts: 503.8;Leydig cells: 525.0;Peritubular cells: 986.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 7.8;T-cells: 4.6" "Cell line enhanced" "Detected in many" "LHCN-M2: 79.9;RPTEC TERT1: 73.7" "Group enriched" "Detected in many" 4 "amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3" "Low region specificity" "Detected in many" "HPA005922, HPA006028, CAB008368" Enhanced Enhanced "Actin filaments,Focal adhesion sites" NA Yes "Actin filaments, Focal adhesion sites" "CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858" "unprognostic (1.04e-1)" "unprognostic (1.63e-3)" "unprognostic (3.30e-1)" "unprognostic (3.42e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.80e-2)" "unprognostic (1.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.42e-2)" "unprognostic (3.34e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (6.42e-5)" "unprognostic (2.06e-1)" "unprognostic (3.49e-1)" "unprognostic (9.92e-3)" "unprognostic (4.73e-2)" 8.3 9.8 1.5 5.7 3.6 1.5 8.9 0.8 5.6 16.3 10.5 1.4 5.1 6.0 14.8 12.1 9.2 6.8 16.5 312.0 2.5 0.4 5.5 7.8 2.1 2.7 0.9 3.0 80.7 1.6 0.2 4.1 16.7 1.1 12.8 7.4 18.5 6.2 8.7 9.4 5.6 16.9 11.9 0.8 3.9 12.7 13.4 0.7 3.1 6.6 16.9 5.1 18.1 7.6 1.4 1.3 7.8 0.8 1.5 4.6 2.6 22.5 5.3 3.1 0.1 10.1 12.8 29.6 42.8 11.3 27.5 33.1 9.5 35.3 0.0 3.6 52.1 34.0 7.0 4.6 38.9 31.4 0.9 3.5 15.8 6.5 7.1 40.0 0.0 3.5 26.6 21.4 43.2 28.8 55.2 56.0 2.6 4.1 1.3 79.9 0.8 3.6 0.1 6.5 15.8 16.7 0.0 4.8 0.6 73.7 16.0 0.1 1.0 16.0 7.2 11.1 3.2 9.0 0.5 26.9 20.0 20.3 22.1 34.4 0.4 0.0 0.1 31.9 0.0 20.6 7.8 0.8 1.0 2.2 0.4 1.5 1.1 1.8 3.6 0.7 1.4 1.4 2.9 4.5 1.5 0.3 1.3 4.6 2.6 1.5 3.6 0.8 5.6 2.5 0.4 0.9 3.0 1.1 0.7 8.9 6.1 0.0 732.1 416.1 8.9 221.1 15.3 12.0 54.6 27.9 2.0 150.7 3.3 97.9 3.5 21.5 61.9 0.0 105.2 503.8 71.2 120.1 10.3 9.2 22.4 0.0 55.8 20.9 1.2 4.9 525.0 6.6 21.9 4.6 119.3 1.5 144.0 32.8 986.1 15.3 12.4 213.4 132.8 6.6 21.1 259.6 149.4 5.0 30.8 351.4 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.2;tongue: 46.8" "Group enriched" "Detected in many" 7 "Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "myeloid DC: 6.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "PC-3: 94.2;U-2197: 63.2;WM-115: 142.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 22.4 3.7 1.5 8.2 3.1 17.9 3.6 1.1 2.8 5.4 2.8 1.5 0.2 0.8 2.1 2.0 35.2 4.4 24.4 5.8 2.3 1.3 2.2 4.4 7.7 1.7 2.6 0.5 2.6 9.9 0.4 2.0 3.2 6.5 3.1 1.7 0.6 5.4 1.0 6.6 9.2 2.0 3.6 3.5 1.6 8.7 1.5 2.3 0.3 2.1 46.8 16.5 16.6 4.6 0.0 6.9 1.0 1.6 0.0 0.6 1.1 36.6 5.4 0.6 2.4 5.5 5.5 5.3 34.3 31.5 29.7 16.7 1.7 30.5 0.0 7.5 23.7 46.9 6.9 2.2 27.6 25.5 1.1 0.0 2.2 0.5 4.0 6.9 1.4 0.8 2.3 2.8 23.3 35.2 14.5 9.5 0.0 5.3 0.2 38.9 1.5 0.0 3.0 2.5 3.1 94.2 0.1 3.0 0.1 13.8 2.4 0.0 0.0 2.0 0.0 25.7 1.6 0.1 1.3 23.7 35.2 7.2 63.2 50.2 0.0 0.1 0.1 49.5 0.6 142.9 0.0 1.6 0.0 0.3 1.1 0.2 0.0 0.6 0.3 6.9 0.0 0.6 0.0 1.0 0.0 0.5 0.8 0.0 1.1 1.5 3.1 1.1 2.7 2.3 1.3 2.6 0.5 6.5 2.3 6.0 4.1 0.0 279.5 300.3 0.0 0.6 0.0 9.4 19.4 0.0 0.0 1.1 0.0 14.2 0.1 11.3 2.8 0.0 3.1 3.8 23.0 139.2 9.2 0.0 1.8 0.0 10.9 8.0 0.6 0.0 0.3 9.0 42.2 1.8 1.2 0.0 23.7 0.2 0.0 0.0 0.0 0.0 40.8 0.2 0.7 296.9 14.8 0.0 0.7 386.7 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.5 29.0 22.5 20.7 3.4 4.5 28.7 18.7 18.4 37.9 34.4 36.6 25.6 18.5 4.0 26.7 43.1 22.2 33.7 17.1 37.2 34.5 18.0 20.8 27.8 15.6 0.5 16.7 17.1 2.3 1.9 35.2 24.8 9.0 26.7 21.2 11.6 41.5 29.8 26.8 22.7 7.9 49.7 29.7 21.7 16.5 34.2 9.6 8.9 18.3 12.7 20.1 23.9 20.1 10.9 44.4 19.6 18.7 10.7 30.8 46.8 35.9 64.8 5.5 9.1 26.8 14.3 16.1 32.6 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 0.0 2.2 0.8 0.7 2.6 1.6 0.5 2.5 0.0 1.2 1.8 3.9 1.4 1.7 0.2 16.5 0.3 1.7 23.3 0.0 15.0 1.3 0.8 0.0 0.9 7.3 4.8 0.0 3.1 1.9 20.0 0.9 1.7 0.0 1.8 3.7 0.6 0.2 0.0 0.7 0.0 4.4 0.0 0.0 7.6 5.9 1.3 1.6 2.5 3.7 1.3 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592823-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9" "Cell type enriched" "Detected in many" 9 "monocytes: 1791.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4500000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 26.3 13.3 23.7 29.6 30.1 6.3 8.1 5.5 56.9 9.9 5.5 35.1 0.0 5.4 11.7 2.3 22.3 5.9 8.9 10.6 27.7 16.8 5.5 7.1 11.3 15.2 26.9 23.6 21.8 5.1 2.3 7.0 29.4 20.1 4.1 3.0 8.1 11.0 3.9 7.8 17.3 6.6 7.0 29.6 39.3 7.6 15.9 28.3 9.3 8.5 15.9 11.4 14.7 12.3 0.2 5.4 1.0 1.9 0.0 0.1 1.4 8.0 18.6 12.4 44.5 4.8 9.2 82.1 19.3 8.6 3.3 3.6 12.9 2.0 0.1 23.6 8.5 3.2 30.5 7.1 31.0 0.2 9.1 3.8 0.5 19.8 60.8 2.5 0.0 1.6 5.7 9.2 6.2 5.1 5.5 16.2 0.0 68.7 0.1 4.2 0.8 0.2 78.0 32.5 0.5 68.7 18.1 2.9 0.3 4.8 0.7 9.9 65.9 16.1 0.2 0.6 8.4 0.4 4.9 32.8 22.9 40.3 13.3 19.8 0.1 0.1 0.0 14.8 0.0 43.0 0.0 1.9 0.1 0.0 0.5 0.0 0.2 0.1 0.0 5.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 1.4 23.7 30.1 5.5 41.3 27.7 16.8 26.9 23.6 20.1 28.3 3.0 5.5 2.4 19.0 161.1 7.2 6.9 2.5 1.4 0.0 1.8 0.0 4.4 0.0 6.8 13.1 49.6 1.3 0.0 4.2 90.3 72.6 6.3 16.1 0.8 207.2 0.0 40.2 97.6 22.0 7.9 23.6 10.6 49.0 1791.8 0.7 69.1 10.4 0.0 8.5 0.2 2.3 0.0 16.5 4.7 9.0 128.6 12.2 4.3 0.9 28.3 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 2939.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Supported Nucleoplasm "Secreted in other tissues" NA Yes 6800000 Nucleoplasm "CAB024899: , HPA045378: AB_2679300" "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.9 1.1 0.8 5.0 12.8 36.2 27.0 4.0 6.8 2.5 5.8 3.1 0.8 10.9 18.2 3.9 13.9 0.9 23.0 2.2 1.6 1.9 0.7 22.2 4.7 21.6 1.4 2.6 16.0 40.0 7.5 31.3 17.6 1.2 0.8 1.7 1.1 10.2 7.0 0.5 0.8 1.3 13.1 5.5 1.5 0.7 1.8 9.4 0.3 0.7 1.2 73.8 1.5 0.8 1.4 1.3 0.7 16.2 6.8 23.5 38.1 9.9 1.8 0.8 0.4 1.0 4.2 3.1 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 17.9 3.4 2.2 19.6 12.9 1.6 12.8 30.6 2.7 1.2 8.7 0.0 22.7 6.6 69.7 5.6 4.5 0.9 0.0 56.0 2939.6 52.2 21.7 0.0 0.9 68.4 3.2 1.2 22.1 3.8 6.5 56.7 4.0 5.0 11.8 0.9 7.8 198.1 0.0 25.1 5.6 0.5 45.3 32.5 2.3 7.7 6.8 662.4 2.9 1.7 20.7 FZR1 "CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242" ENSG00000105325 "Fizzy and cell division cycle 20 related 1" Q9UM11 19 3506273-3538330 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.7;Late spermatids: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043536 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA043536: AB_10968058" "unprognostic (2.78e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (9.20e-2)" "unprognostic (1.61e-1)" "unprognostic (9.70e-2)" "unprognostic (1.18e-1)" "unprognostic (4.15e-3)" "unprognostic (1.41e-2)" "unprognostic (3.75e-1)" "unprognostic (5.41e-3)" "unprognostic (1.75e-1)" "unprognostic (9.04e-2)" "unprognostic (1.04e-1)" 10.3 16.9 15.4 12.0 19.9 37.2 10.6 39.1 23.1 13.3 13.8 17.7 11.0 29.0 14.6 10.1 14.6 12.3 14.5 10.3 13.0 16.6 12.0 13.8 10.7 12.6 11.7 14.3 16.4 20.6 13.2 22.5 15.4 16.1 12.3 5.0 14.9 24.6 15.1 18.1 15.7 18.0 12.0 10.7 15.3 16.3 29.7 14.1 18.9 15.6 9.3 15.8 10.6 12.9 3.0 1.7 5.7 2.1 3.3 3.5 1.5 23.2 14.2 12.1 11.8 3.4 5.6 10.5 14.8 7.6 14.3 11.3 14.3 11.5 12.9 7.6 9.5 7.8 13.9 6.7 12.3 2.9 17.6 13.1 6.2 10.0 14.0 7.5 11.1 13.1 5.0 6.5 8.8 5.1 5.4 9.2 12.5 11.1 20.8 7.7 12.2 19.6 7.9 11.3 7.2 11.1 14.6 11.6 12.6 7.3 11.8 11.6 14.0 13.1 9.3 7.2 2.8 9.7 8.8 13.9 9.8 12.2 23.7 25.2 24.1 5.6 9.9 13.4 21.7 11.9 3.5 1.9 5.7 3.5 2.1 2.0 3.0 3.4 2.4 1.7 2.6 1.8 2.7 3.7 3.3 1.5 1.4 2.4 1.5 15.4 19.9 39.1 23.1 13.0 16.6 11.7 14.3 16.1 14.1 0.0 5.3 15.1 31.9 15.9 20.9 2.9 2.5 1.4 3.4 12.2 9.8 18.6 5.0 14.2 78.7 8.5 17.3 46.7 13.0 11.5 11.2 17.6 3.5 14.7 14.4 28.6 20.7 7.4 6.5 132.8 11.8 11.0 11.8 25.2 14.5 8.3 21.4 17.3 8.9 10.8 14.3 6.5 9.9 25.7 16.2 19.7 38.0 9.6 12.2 24.3 GABPB1 "E4TF1-47, GABPB, GABPB2" ENSG00000104064 "GA binding protein transcription factor beta subunit 1" Q06547 15 50275392-50355408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019653, HPA067444" Supported Supported "Nucleoplasm,Cytoplasmic bodies" NA Yes Nucleoplasm "Cytoplasmic bodies" "HPA019653: AB_1849370, HPA067444: AB_2685842" "unprognostic (7.79e-3)" "unprognostic (2.42e-2)" "unprognostic (3.84e-1)" "unprognostic (1.92e-1)" "unprognostic (9.33e-2)" "unprognostic (3.99e-2)" "unprognostic (3.25e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-2)" "unprognostic (8.94e-3)" "unprognostic (1.23e-1)" "unprognostic (4.54e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.18e-2)" "unprognostic (2.37e-1)" "unprognostic (1.13e-1)" "unprognostic (3.93e-3)" 15.4 12.6 8.1 13.8 16.8 31.7 14.3 16.0 14.0 12.7 9.5 8.4 8.6 8.1 14.1 10.8 13.8 12.0 12.6 10.3 8.8 7.2 9.1 16.2 15.2 25.7 9.1 8.7 12.1 10.6 8.7 11.5 15.1 7.3 11.4 11.8 10.7 12.1 8.1 15.2 10.4 12.8 13.9 7.3 17.1 11.2 17.3 9.9 35.7 16.2 12.5 20.8 13.4 11.9 23.1 16.8 26.8 15.0 19.1 21.1 14.3 11.8 13.7 20.1 15.6 5.3 7.5 26.9 15.7 12.4 18.6 16.4 23.3 9.8 15.6 9.6 12.9 14.7 19.7 18.0 13.4 23.7 21.6 10.7 18.5 14.3 15.8 12.8 17.7 14.4 9.9 13.2 17.4 22.7 10.5 32.4 17.2 16.9 19.8 12.3 27.0 26.1 16.0 13.8 13.1 9.3 32.3 14.7 14.9 11.2 15.2 19.0 15.7 13.9 13.2 15.8 20.1 11.5 17.6 15.4 17.0 14.1 29.6 27.9 14.1 19.2 27.5 10.5 16.4 17.0 26.8 12.2 23.6 15.9 15.0 21.1 23.1 15.7 16.9 16.8 21.3 14.6 16.8 12.4 19.1 11.1 13.3 20.4 14.3 8.1 16.8 16.0 14.0 8.8 7.2 9.1 8.7 7.3 9.9 8.9 9.1 53.0 89.7 41.9 40.4 15.3 12.7 8.1 0.0 7.0 33.4 37.1 3.3 11.0 80.1 35.3 15.8 0.0 6.7 41.1 28.6 72.8 47.2 24.6 31.6 35.0 48.5 39.3 56.1 27.9 53.5 11.6 18.6 25.2 23.1 30.3 11.9 21.0 36.0 6.5 40.6 25.8 24.5 27.4 31.1 31.2 46.3 116.7 26.4 90.9 GADD45A "DDIT1, GADD45" ENSG00000116717 "Growth arrest and DNA damage inducible alpha" P24522 1 67685061-67688338 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 86.7;skeletal muscle: 102.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2362.0;Urothelial cells: 1859.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in all" 5 "granulocytes: 24.9;T-cells: 9.3" "Cell line enhanced" "Detected in many" "HHSteC: 60.1;hTERT-HME1: 92.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053420 Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA053420: AB_2682144" "unprognostic (1.36e-2)" "unprognostic (3.29e-2)" "unprognostic (9.58e-2)" "unprognostic (3.76e-3)" "unprognostic (5.81e-2)" "unprognostic (1.36e-2)" "unprognostic (1.57e-3)" "unprognostic (2.80e-3)" "unprognostic (1.42e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-2)" "unprognostic (5.21e-2)" "prognostic favorable (8.06e-6)" "unprognostic (6.11e-2)" "unprognostic (2.89e-1)" "unprognostic (3.43e-3)" "unprognostic (1.93e-1)" 29.6 6.8 10.7 8.2 20.9 46.2 20.9 1.7 15.8 11.7 10.8 5.8 18.8 10.1 23.3 13.8 12.2 8.8 16.7 12.9 18.1 9.8 86.7 66.9 17.1 4.9 11.4 4.1 13.8 8.3 4.1 5.1 10.8 21.2 16.5 9.0 9.4 9.5 15.6 102.1 14.8 20.4 16.1 15.5 7.4 14.1 9.2 7.5 9.2 26.2 10.1 10.9 23.9 11.1 1.1 2.2 24.9 3.2 3.1 9.3 4.8 22.2 1.4 3.8 1.1 6.8 7.1 35.9 39.6 18.5 13.2 14.4 7.8 3.8 9.6 12.1 6.4 33.1 13.4 0.4 33.9 24.9 7.0 3.8 12.0 3.5 7.8 60.1 3.5 1.1 12.0 17.2 16.7 92.9 6.6 9.4 2.3 25.6 17.1 15.5 0.7 1.0 4.2 4.8 2.9 15.7 2.6 29.5 9.8 6.8 16.8 16.4 2.9 8.3 2.3 23.7 13.5 0.4 3.7 9.7 13.8 18.6 14.5 27.7 43.8 8.5 17.5 6.1 1.7 13.4 7.2 3.2 24.9 3.7 1.5 3.0 1.1 2.5 3.0 1.4 0.7 0.7 1.2 4.1 3.1 1.0 2.2 9.3 4.8 10.7 20.9 1.7 15.8 18.1 9.8 11.4 4.1 21.2 7.5 59.6 21.3 30.0 2362.0 763.0 34.8 176.4 48.4 136.5 91.0 97.7 9.8 17.5 200.6 253.6 0.6 85.9 120.7 93.5 224.9 94.3 192.2 631.8 44.9 99.0 16.2 25.4 126.2 49.1 19.7 2.2 35.4 33.2 150.1 467.1 44.4 25.0 252.2 49.1 60.8 290.2 70.0 51.8 190.0 2.7 12.4 341.6 14.8 38.8 37.5 1859.7 GAS2L3 ENSG00000139354 "Growth arrest specific 2 like 3" Q86XJ1 12 100573683-100628286 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 12.3;Spermatocytes: 12.7;Syncytiotrophoblasts: 28.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;myeloid DC: 4.2" "Group enriched" "Detected in many" 5 "dendritic cells: 4.2;monocytes: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048593 Approved NA Yes "HPA048593: AB_2680455" "unprognostic (1.03e-1)" "unprognostic (5.13e-2)" "unprognostic (5.10e-2)" "unprognostic (2.70e-2)" "unprognostic (2.32e-2)" "unprognostic (1.46e-1)" "unprognostic (1.04e-7)" "unprognostic (2.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (9.21e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.58e-7)" "unprognostic (1.34e-1)" "unprognostic (2.35e-1)" "unprognostic (3.60e-2)" "unprognostic (6.67e-2)" 5.9 2.0 1.0 3.6 1.2 6.6 2.5 0.9 1.8 2.2 9.6 0.1 3.0 3.8 2.5 2.3 3.5 1.5 14.5 5.7 2.7 0.9 9.4 2.0 5.1 1.5 3.2 0.6 3.9 1.8 0.6 8.3 6.5 1.7 2.4 5.7 6.4 3.0 2.0 3.6 4.1 9.3 2.2 2.1 1.7 3.1 13.3 0.4 2.6 1.9 2.5 2.6 3.9 3.2 0.3 4.2 0.8 4.2 0.3 0.6 0.3 17.7 7.1 10.0 7.3 3.1 4.1 3.1 8.4 8.1 11.6 13.2 5.3 5.2 0.4 2.7 6.5 11.1 6.0 6.3 3.1 16.6 5.0 4.2 0.1 6.6 3.1 1.1 0.0 4.2 1.6 0.3 7.0 19.7 5.4 10.2 0.1 1.1 0.2 9.4 5.0 0.2 0.1 2.9 3.2 8.5 1.2 16.8 0.4 4.6 4.9 4.5 4.2 9.2 6.0 11.6 3.7 11.4 0.8 6.7 7.1 7.6 6.4 8.9 3.8 4.6 0.0 2.8 2.8 20.6 0.8 0.9 0.4 0.4 4.2 0.3 0.3 0.4 0.4 4.2 0.3 0.4 0.6 0.4 0.3 0.8 1.6 0.3 0.3 1.0 1.2 0.9 1.8 2.7 0.9 3.2 0.6 1.7 0.4 0.0 0.0 0.0 0.4 3.1 0.0 0.6 5.1 1.4 0.0 0.0 0.0 7.7 0.0 1.2 4.0 2.3 3.5 0.0 0.6 3.9 2.1 0.5 1.1 1.3 12.3 0.0 3.5 2.5 5.1 0.4 0.6 11.5 6.8 1.0 9.3 2.3 0.2 7.0 0.7 2.2 0.0 0.0 0.5 12.7 1.8 3.1 28.4 0.0 4.2 0.3 GINS2 "Pfs2, PSF2" ENSG00000131153 "GINS complex subunit 2" Q9Y248 16 85676198-85690073 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.2;testis: 21.3" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 65.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 72.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA057285 Uncertain Approved Nucleoplasm No Yes Nucleoplasm "HPA057285: AB_2683398" "unprognostic (3.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.04e-3)" "unprognostic (2.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.30e-1)" "unprognostic (2.45e-3)" "unprognostic (2.58e-2)" "unprognostic (1.67e-2)" "unprognostic (2.52e-3)" "unprognostic (2.19e-2)" "unprognostic (5.82e-3)" "unprognostic (5.70e-3)" "unprognostic (4.54e-2)" "unprognostic (6.30e-2)" "unprognostic (5.44e-3)" "unprognostic (1.60e-1)" 0.9 1.5 3.5 15.9 3.7 13.2 3.6 3.8 2.1 1.9 6.5 1.9 1.5 4.7 1.8 2.6 7.1 0.9 2.2 1.6 4.8 1.5 1.3 3.3 1.4 8.7 2.2 1.5 1.9 4.4 2.6 1.4 4.6 1.6 2.6 7.4 1.9 2.0 0.7 3.2 3.1 5.9 1.5 2.3 7.6 2.1 21.3 1.8 25.2 1.8 8.0 13.3 1.9 3.0 1.4 1.7 1.5 3.3 4.3 11.1 2.4 13.4 9.7 19.0 7.9 0.5 1.9 5.0 9.3 3.7 13.7 8.5 12.8 9.0 15.9 5.1 3.2 7.2 10.3 20.0 7.6 13.3 5.5 17.3 7.8 7.4 14.4 0.1 5.4 4.3 0.5 0.9 8.2 3.2 1.7 5.8 12.9 21.4 3.8 7.9 28.2 19.1 20.5 10.6 11.9 7.4 26.8 11.5 8.8 4.4 5.6 26.2 8.3 13.4 2.7 2.7 7.9 27.6 7.4 3.5 9.0 12.1 8.4 10.6 7.1 12.5 72.1 5.2 11.5 10.2 0.7 0.3 1.5 1.4 1.3 0.2 1.4 4.7 3.1 1.7 1.0 2.2 1.6 1.2 4.3 3.3 1.0 11.1 2.4 3.5 3.7 3.8 2.1 4.8 1.5 2.2 1.5 1.6 1.8 3.0 0.0 6.7 6.6 8.1 7.1 1.1 0.0 2.7 4.5 3.5 2.0 17.0 3.3 6.0 8.2 0.6 1.6 23.3 1.3 22.7 3.1 2.7 1.1 1.7 19.7 7.9 2.9 0.0 0.6 22.2 1.1 2.8 0.0 1.0 8.2 3.4 1.5 5.8 1.8 0.3 8.0 19.4 3.1 65.9 96.9 3.3 10.6 5.1 29.9 1.6 GOLGA8A "GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 196.5;Alveolar cells type 2: 83.2;Bipolar cells: 84.1;Ciliated cells: 85.6;Club cells: 217.2;Cone photoreceptor cells: 94.2;Horizontal cells: 79.4;Rod photoreceptor cells: 127.5" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.1;HeLa: 30.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 2.6 4.7 3.6 5.1 4.4 3.1 5.8 20.1 3.5 6.3 3.5 5.8 5.3 18.0 4.1 3.7 3.6 2.9 3.9 3.7 2.6 0.4 2.3 6.5 3.3 7.4 3.3 8.0 2.4 0.7 4.6 0.8 6.7 5.3 2.6 18.4 4.0 1.2 3.8 8.3 3.3 8.3 5.7 0.6 2.6 5.3 0.7 0.0 0.8 0.0 2.7 0.2 0.0 1.0 6.0 1.7 6.0 0.0 0.0 1.3 9.3 0.0 1.6 0.7 10.5 0.0 0.0 1.7 1.1 3.5 9.8 4.3 3.1 2.5 9.1 3.6 22.1 30.5 6.6 0.7 8.4 6.0 0.0 9.0 1.0 0.2 1.0 0.1 3.3 20.0 18.7 4.2 1.9 2.3 15.4 3.2 2.9 3.3 9.0 5.3 7.5 3.5 6.2 8.1 3.8 6.2 4.2 1.0 0.0 1.6 5.1 4.9 7.5 1.7 0.0 1.6 18.0 5.9 2.5 2.3 18.0 1.6 0.0 0.0 0.8 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 196.5 83.2 10.2 10.7 23.2 84.1 26.4 2.5 85.6 217.2 1.8 94.2 2.3 0.0 3.8 22.3 15.7 6.7 0.0 2.2 2.8 11.6 7.7 12.8 0.9 2.1 79.4 15.4 14.1 6.5 5.4 29.1 11.1 21.9 1.8 9.1 17.7 4.1 6.0 19.8 0.3 127.5 0.0 17.9 29.0 20.5 18.9 2.7 13.8 11.7 7.5 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 25.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 178.6;Club cells: 128.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "basophil: 2.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "HeLa: 14.6;Hep G2: 13.0;NB-4: 20.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 2.6 3.4 0.0 2.8 0.6 6.8 4.3 2.5 2.7 2.5 2.0 0.0 4.1 6.1 0.8 3.8 2.8 1.6 0.0 0.7 3.0 2.3 4.5 8.0 0.0 9.0 25.2 0.1 4.9 0.9 5.4 0.1 4.6 5.2 1.8 3.3 5.4 0.5 0.0 5.2 4.0 5.3 16.4 3.1 3.0 1.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 2.0 2.3 0.2 4.3 2.4 4.7 6.1 1.9 0.6 2.1 3.5 2.2 2.9 0.0 4.1 2.0 0.2 1.7 0.8 1.9 1.8 3.0 7.1 0.3 14.6 13.0 3.5 1.8 2.3 6.7 2.7 1.3 3.9 2.4 2.1 3.3 0.7 0.2 1.9 1.0 0.9 20.1 2.7 4.1 3.9 0.1 0.0 0.3 1.8 4.1 3.2 4.9 1.0 0.3 2.2 3.4 1.9 3.9 0.0 3.1 7.4 0.9 3.3 1.4 1.3 3.0 1.0 0.9 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.6 44.8 21.6 8.2 19.5 41.4 30.9 17.8 53.5 128.5 29.6 68.7 5.9 1.7 7.8 32.7 8.9 3.2 0.0 11.0 3.6 7.6 6.5 9.2 25.1 1.4 42.9 6.9 12.9 8.1 3.9 36.5 6.7 20.3 9.0 8.5 9.4 15.0 3.5 35.3 2.2 68.6 12.9 8.1 34.9 26.8 12.9 2.4 37.1 6.9 6.0 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 398.1;Distal tubular cells: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol NA Yes 130000000 Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favorable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favorable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 3.3 14.0 15.7 3.6 32.1 2.0 5.9 22.9 56.4 13.5 12.0 9.7 5.9 14.7 3.4 7.0 10.3 4.6 12.2 116.9 19.4 19.0 34.6 82.9 3.5 3.4 17.8 16.4 3.8 8.2 15.9 4.9 3.7 49.9 5.9 14.7 9.0 12.4 7.2 102.1 4.5 12.7 5.4 7.7 3.6 10.1 9.3 4.7 3.3 11.7 31.3 7.1 4.9 4.0 10.6 21.4 3.9 16.8 11.4 15.6 8.8 17.2 9.6 11.3 28.6 8.7 7.5 32.0 14.2 26.1 24.7 27.1 21.7 14.1 16.9 4.9 11.9 21.0 21.7 25.8 18.7 27.4 5.8 11.0 6.4 12.3 28.2 46.5 18.3 11.0 11.9 20.2 21.0 57.1 16.8 12.0 11.2 16.5 26.5 15.8 15.6 9.8 13.8 7.2 27.0 13.4 10.7 10.8 17.6 43.2 9.5 4.9 7.2 10.7 15.2 52.9 17.4 29.0 6.3 5.5 6.3 14.1 6.8 16.2 18.9 22.3 17.3 16.6 9.6 8.4 2.4 5.3 3.9 12.4 14.7 11.4 10.6 13.5 12.9 12.9 10.2 10.2 14.5 0.5 11.4 16.8 21.4 15.6 8.8 15.7 32.1 22.9 56.4 19.4 19.0 17.8 16.4 49.9 4.7 14.9 14.4 29.9 39.5 10.5 86.5 398.1 96.8 26.8 14.8 69.8 58.9 29.8 203.9 43.4 86.1 13.5 75.3 46.7 27.1 14.9 9.9 11.6 32.2 145.9 26.2 71.5 18.9 17.2 11.6 9.5 10.3 9.5 47.2 14.4 30.8 29.4 25.5 30.3 13.4 123.7 55.6 12.9 14.1 28.9 11.5 9.2 46.1 12.1 50.2 36.7 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 42.7 34.2 0.0 0.1 0.4 0.2 2.2 12.9 4.9 8.4 6.4 6.0 164.8 0.0 1.1 10.3 8.9 43.2 0.1 6.2 12.9 0.0 0.5 0.0 14.1 0.2 3.1 0.0 0.0 0.2 8.4 3.5 0.8 10.4 5.1 0.0 0.0 0.0 0.3 30.0 0.0 0.0 0.1 15.6 5.4 0.0 0.9 0.0 16.6 8.5 0.0 0.0 60.6 4.6 1.9 6.9 1.3 0.1 0.5 0.3 10.9 19.6 0.5 0.0 0.0 0.0 4.4 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 872.5 165.8 0.0 282.3 11.1 0.0 1.0 5.1 69.6 257.0 43.6 0.0 0.7 0.0 49.3 0.0 7.5 159.2 0.0 63.3 8.9 57.8 325.5 9.3 0.0 1.5 0.0 7.9 4.9 0.0 0.0 12.4 10.7 49.0 1.0 28.8 1.3 368.5 52.7 9.6 0.0 0.2 0.0 24.7 0.0 0.2 8.0 0.9 1.3 79.7 1048.5 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 35.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 125.7;Syncytiotrophoblasts: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol NA Yes Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favorable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavorable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 3.8 4.0 16.6 4.4 17.9 13.9 8.5 10.1 20.6 7.5 13.6 17.9 2.5 8.0 6.9 4.3 30.4 2.9 3.1 3.0 15.2 14.1 2.6 1.9 6.6 5.8 19.7 9.0 2.4 2.4 4.0 2.1 7.6 19.6 6.3 15.4 1.3 7.0 5.7 8.0 35.6 10.1 10.6 25.1 2.0 5.3 11.4 18.8 14.1 2.3 23.5 12.1 6.5 10.6 1.8 1.6 8.6 1.2 0.7 4.4 0.4 41.3 5.9 13.6 10.7 13.7 8.2 10.2 8.3 21.1 10.3 15.9 6.4 10.6 9.5 2.3 11.6 7.9 9.1 8.8 21.8 13.3 9.8 5.9 7.0 11.6 7.0 1.8 9.3 6.4 1.5 44.6 11.2 44.5 3.8 11.0 7.4 5.3 14.3 22.1 12.8 7.5 4.7 3.5 18.0 10.1 6.6 22.0 2.5 8.9 6.5 10.4 9.0 11.4 23.2 8.8 3.7 9.1 9.0 6.8 7.9 12.4 21.1 15.7 6.4 5.9 9.4 12.7 15.5 36.7 0.1 1.2 8.6 0.8 0.9 0.5 0.7 0.6 1.1 1.6 1.8 1.1 0.8 1.6 0.7 0.4 0.7 4.4 0.4 16.6 17.9 10.1 13.6 15.2 14.1 19.7 9.0 19.6 18.8 14.9 3.5 5.2 16.6 55.6 46.3 2.1 0.0 6.7 14.8 7.0 125.7 42.8 10.0 2.2 39.6 3.8 8.0 0.0 1.6 37.2 12.8 3.8 2.3 0.5 7.7 41.3 8.7 1.8 5.2 16.4 17.3 4.6 25.3 6.4 12.1 7.1 3.2 7.0 4.9 0.3 43.8 0.0 5.3 15.2 25.1 35.5 74.6 7.7 11.8 13.3 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990058-143993415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 331.5;monocytes: 538.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 76.4 48.8 46.6 52.3 61.0 89.0 70.2 73.8 85.8 37.1 28.4 34.5 37.1 35.6 33.1 42.1 30.5 41.4 37.5 35.2 54.2 45.1 61.7 143.7 49.7 67.4 47.4 51.5 46.1 32.0 66.8 29.3 42.4 46.5 42.6 17.7 49.3 44.4 99.4 32.8 37.4 33.5 38.0 43.3 82.0 23.2 52.2 24.3 24.3 54.7 19.2 26.8 43.2 31.3 4.5 12.4 10.2 19.3 1.6 2.6 6.4 12.8 25.2 12.9 21.9 68.8 34.7 19.1 18.4 43.6 31.4 29.1 15.3 10.8 9.2 20.3 41.5 21.9 11.6 23.0 27.2 12.9 13.1 15.8 9.6 14.6 18.1 72.9 2.0 15.5 44.7 75.4 22.7 33.2 33.0 15.2 4.0 8.9 13.0 27.0 77.6 5.3 5.2 9.0 12.4 38.2 7.3 6.5 17.8 16.1 36.5 8.8 14.3 26.8 30.2 35.8 18.3 58.1 12.7 15.2 19.9 21.9 26.5 13.4 21.1 12.1 6.9 25.2 12.7 11.3 0.9 16.6 4.6 1.4 19.3 2.0 4.5 1.4 1.6 7.1 4.3 2.6 2.3 10.2 1.6 18.0 12.4 1.2 6.4 46.6 61.0 73.8 85.8 54.2 45.1 47.4 51.5 46.5 24.3 17.9 65.6 14.3 28.0 33.1 86.7 19.7 40.8 17.4 18.2 50.6 74.6 108.2 19.9 63.5 214.4 42.1 42.7 46.7 60.2 47.1 58.4 38.3 15.1 167.7 158.2 31.8 40.5 54.0 188.9 331.5 57.0 128.7 35.4 538.4 24.1 77.3 64.0 46.0 63.6 61.9 71.2 45.3 40.6 89.2 11.3 32.2 220.9 15.9 22.4 21.6 GTPBP2 ENSG00000172432 "GTP binding protein 2" Q9BX10 6 43605316-43629162 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031418, HPA031419" Approved Approved Vesicles NA Yes Vesicles "HPA031418: AB_2673872, HPA031419: AB_10600709" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (8.94e-2)" "unprognostic (1.08e-3)" "unprognostic (2.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.71e-2)" "unprognostic (2.58e-3)" "unprognostic (6.47e-2)" "unprognostic (8.31e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (1.44e-15)" "unprognostic (1.13e-1)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" 26.8 19.8 21.4 28.0 19.7 27.9 23.5 27.5 26.1 20.1 22.4 19.9 29.6 22.7 19.0 20.5 38.2 14.5 18.6 20.5 19.1 10.8 20.5 22.5 29.1 21.4 15.0 17.4 20.4 26.2 30.9 26.8 24.1 17.9 20.7 20.7 19.9 29.0 25.3 19.2 19.8 21.9 21.0 17.0 28.8 23.8 17.2 20.1 28.2 30.0 13.3 29.6 25.7 25.2 3.0 2.8 7.0 2.5 1.2 3.4 4.4 17.8 4.7 12.6 8.5 9.7 10.5 14.4 17.0 18.4 20.0 22.9 5.4 7.6 6.5 7.3 9.1 16.9 9.7 4.7 6.9 13.8 17.6 10.2 16.0 12.0 4.8 38.8 10.3 17.8 12.3 48.4 22.1 56.8 13.2 10.3 9.1 22.2 33.2 9.9 6.2 7.6 14.9 3.8 19.3 5.5 6.6 9.1 7.2 9.3 10.9 10.8 11.2 5.8 5.3 21.7 7.8 10.2 16.0 11.4 10.1 11.3 6.4 11.3 22.6 10.7 8.7 14.5 9.5 10.5 7.0 2.5 5.0 3.4 1.4 2.0 1.7 0.9 3.0 1.3 3.0 2.4 2.8 3.7 1.2 2.0 2.8 1.5 4.4 21.4 19.7 27.5 26.1 19.1 10.8 15.0 17.4 17.9 20.1 3.0 5.6 5.1 1.9 4.6 6.1 9.2 7.6 0.0 2.3 1.8 7.9 2.1 0.0 8.2 14.5 6.7 9.2 0.0 8.7 9.0 4.9 4.4 1.1 4.0 7.0 1.6 1.2 8.0 13.6 36.8 4.9 5.7 6.8 8.2 7.0 2.2 17.0 6.2 3.9 1.1 8.1 12.9 3.8 7.7 9.1 4.5 2.1 2.1 5.0 9.5 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.8 10.4 20.5 16.2 0.4 1.2 9.8 19.0 9.0 27.7 22.9 10.8 8.3 20.7 5.0 7.3 12.7 11.5 18.3 4.8 17.8 12.4 19.7 13.8 14.6 8.4 0.0 24.7 16.9 0.2 0.3 11.9 6.1 2.9 11.9 15.0 10.5 26.0 16.5 12.2 22.1 12.1 14.3 9.0 11.7 22.0 23.0 13.5 4.5 4.0 10.6 14.5 18.1 11.8 8.4 9.6 10.0 9.6 9.4 15.8 30.0 12.9 19.9 14.9 7.1 21.0 10.0 11.9 23.0 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 0.0 0.0 0.8 0.6 2.5 0.6 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 3.9 0.4 0.5 93.5 0.2 27.0 1.1 0.6 0.0 0.5 16.0 0.0 1.2 5.5 6.2 3.8 0.3 3.5 0.0 0.0 2.0 0.2 0.4 0.0 0.7 0.4 0.1 6.5 0.9 47.7 20.4 2.3 1.3 2.9 3.7 1.4 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 69.2;Spermatogonia: 174.0" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.9 19.7 25.5 32.3 1.0 2.4 13.8 15.3 9.9 12.8 20.2 26.0 16.2 24.7 6.1 5.1 10.8 20.2 14.6 12.2 18.3 23.9 16.8 13.1 20.0 20.8 0.6 24.7 11.9 1.3 0.7 15.3 7.3 3.5 8.8 16.7 7.1 15.8 15.1 20.1 26.0 12.3 26.4 14.6 8.8 24.3 22.7 5.7 8.7 25.8 10.2 8.3 18.1 5.2 2.7 22.2 22.1 8.0 6.2 14.0 7.1 12.8 18.3 8.2 15.6 26.4 7.0 15.3 6.4 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 8.9 3.8 23.8 8.2 19.2 13.6 0.8 7.6 8.1 17.0 21.0 0.0 25.8 3.3 5.8 0.8 4.9 2.1 23.3 5.5 31.3 11.0 3.1 5.7 2.6 12.8 6.4 10.4 8.0 1.3 3.6 8.3 6.2 1.7 9.0 6.5 5.0 3.9 0.0 5.3 1.4 9.4 19.4 6.2 69.2 174.0 8.7 9.3 12.5 23.7 4.4 HIST1H1A "H1.1, H1a, H1F1" ENSG00000124610 "Histone cluster 1 H1 family member a" Q02539 6 26017085-26017732 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 57.2" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 131.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;REH: 4.4;RPTEC TERT1: 1.5;U-2 OS: 3.9" "Not detected" "Not detected" "HPA043753, HPA056830" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA043753: AB_2678654, HPA056830: " "unprognostic (3.80e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (3.05e-1)" 0.8 1.4 1.0 3.9 0.9 1.1 0.8 0.9 3.3 3.5 0.8 0.0 0.4 0.7 3.6 3.9 6.2 1.1 3.4 2.8 1.0 0.8 3.7 5.3 0.7 1.3 0.8 0.6 7.9 0.8 0.7 1.0 0.7 0.6 0.9 0.9 0.9 0.7 1.5 0.7 2.0 0.8 0.7 0.7 0.9 0.8 57.2 0.0 15.1 2.7 10.6 12.4 1.2 0.8 1.4 1.2 0.0 0.1 0.0 4.9 0.4 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.6 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.4 0.0 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.9 0.5 0.0 0.2 0.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.0 1.4 2.8 0.3 0.6 0.0 1.7 0.1 0.0 0.0 0.0 1.2 4.9 0.4 1.0 0.9 0.9 3.3 1.0 0.8 0.8 0.6 0.6 0.0 0.0 0.3 0.0 1.0 0.1 0.0 3.4 0.0 1.4 1.2 0.0 0.0 0.1 14.9 0.0 0.3 0.0 0.0 0.0 0.2 3.6 0.6 0.2 1.1 2.1 1.6 0.0 0.0 4.3 0.3 0.9 0.9 0.2 1.7 0.0 0.0 0.5 0.2 0.0 1.8 0.3 1.0 0.0 0.4 4.9 131.8 0.4 0.3 0.0 0.0 0.3 HIST1H1E "H1.4, H1e, H1F4, H1s-4" ENSG00000168298 "Histone cluster 1 H1 family member e" P10412 6 26156354-26157107 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Muller glia cells: 63.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 9.8;U-266/70: 12.1;U-266/84: 13.5;U-87 MG: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011506, HPA055907" Supported Supported "Nuclear speckles" NA Yes "Nuclear speckles" "CAB011506: AB_470256, HPA055907: AB_2682966" "unprognostic (6.96e-2)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-2)" "unprognostic (5.78e-3)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.72e-13)" "unprognostic (4.54e-3)" "unprognostic (3.46e-2)" "unprognostic (1.30e-3)" "unprognostic (2.18e-2)" 6.7 3.6 3.1 14.3 3.5 102.3 10.3 8.1 9.0 10.7 7.7 4.7 4.2 4.1 6.8 7.5 13.7 4.0 11.3 7.4 4.0 3.5 6.6 6.7 13.1 18.4 3.4 2.4 19.3 17.1 3.7 9.0 7.3 3.5 10.2 4.4 9.8 10.0 4.0 4.1 14.4 9.0 7.4 6.8 14.6 5.3 5.9 0.7 123.9 4.6 10.0 18.4 14.3 10.7 39.6 14.6 56.4 12.9 19.2 24.4 9.4 2.4 0.3 0.5 5.3 0.1 0.0 6.4 0.0 0.4 1.2 0.8 0.1 1.5 1.2 0.7 0.1 0.5 1.2 0.3 0.7 0.5 1.7 1.5 0.8 0.5 0.4 0.1 0.7 1.1 0.1 0.3 0.3 0.5 0.1 0.5 1.4 3.9 6.8 0.1 0.5 7.9 7.2 1.9 0.7 0.8 3.6 1.2 9.8 0.3 0.0 3.9 0.9 3.1 0.8 1.1 0.6 1.0 2.6 0.4 2.4 3.7 1.5 2.4 12.1 13.5 5.4 12.3 2.1 1.1 56.4 12.7 30.0 21.1 12.9 24.4 21.4 16.7 19.2 14.3 39.6 12.7 11.6 18.6 19.2 10.9 14.6 16.4 9.4 3.1 3.5 8.1 9.0 4.0 3.5 3.4 2.4 3.5 0.7 32.8 16.3 10.4 23.8 0.6 26.5 9.8 5.1 34.8 45.5 1.8 7.9 5.2 3.3 11.4 0.5 6.7 5.1 46.7 7.4 9.1 1.9 6.7 4.7 8.7 6.9 15.9 0.0 10.4 10.0 1.1 4.4 14.0 1.7 8.2 2.5 63.4 7.0 3.5 1.8 4.1 26.6 6.5 6.4 2.8 6.3 0.0 6.1 26.1 2.5 10.2 HIST1H2AG "H2A.1b, H2A/p, H2AFP, pH2A/f" ENSG00000196787 "Histone cluster 1 H2A family member g" P0C0S8 6 27133042-27135291 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 305.4" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Group enriched" "Detected in many" 4 "B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "K-562: 9.9;SiHa: 11.5;U-266/84: 31.2" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.86e-2)" "unprognostic (6.89e-2)" "unprognostic (1.66e-1)" "unprognostic (3.94e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.95e-1)" "unprognostic (5.78e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-2)" "unprognostic (5.98e-2)" "unprognostic (6.48e-2)" "unprognostic (8.22e-3)" "unprognostic (9.54e-2)" 2.4 1.6 1.1 25.1 1.2 6.3 8.7 0.7 1.0 3.3 9.7 0.0 1.0 3.8 2.0 3.7 15.7 1.0 3.2 2.7 1.3 1.6 1.1 2.6 6.0 13.5 2.3 0.0 1.4 0.9 0.3 1.0 8.7 0.3 2.5 2.3 0.3 2.1 1.5 1.1 1.4 7.1 0.9 2.3 20.2 1.8 16.1 0.0 305.4 1.5 12.3 28.9 2.4 2.0 4.4 1.3 9.7 0.8 1.1 3.8 7.7 1.3 1.8 1.6 1.4 4.9 1.0 1.0 0.5 0.7 1.6 0.2 0.8 1.4 0.4 2.0 0.5 1.5 2.8 1.9 0.8 1.1 2.4 1.1 0.7 3.6 0.0 1.0 0.7 1.5 1.8 0.4 0.5 0.5 0.8 0.5 1.3 9.9 4.7 0.1 1.7 1.8 1.1 0.9 2.0 1.2 1.2 1.5 5.1 0.3 0.3 6.1 1.5 11.5 1.8 0.6 0.7 0.0 0.4 0.6 1.8 4.0 1.4 0.7 8.4 31.2 3.2 0.3 1.1 1.1 9.7 0.4 0.7 0.6 0.3 1.3 3.0 2.3 1.6 0.6 4.4 2.2 1.8 3.5 1.1 0.8 1.3 3.8 7.7 1.1 1.2 0.7 0.9 1.3 1.6 2.3 0.0 0.3 0.0 0.0 1.4 2.2 1.4 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 16.3 0.3 7.3 0.0 0.0 2.9 0.3 1.4 0.0 0.4 2.1 4.8 1.2 0.0 0.6 10.6 0.0 1.0 0.0 1.0 3.1 1.2 0.1 10.5 0.0 0.0 0.0 0.0 0.3 2.2 3.0 0.4 2.5 2.5 2.9 1.0 HIST1H2AH "dJ86C11.1, H2A/S, H2AFALii" ENSG00000274997 "Histone cluster 1 H2A family member h" Q96KK5 6 27147129-27147515 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 301.1" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive B-cell: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2" "CAB004030, HPA041189" Supported Approved Nucleoplasm NA Yes Nucleoplasm "CAB004030: AB_2118804, HPA041189: AB_2677357" "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.8 0.7 0.0 26.0 0.0 20.2 1.5 0.0 0.4 3.1 6.6 0.0 0.6 1.0 1.8 2.6 6.4 1.0 2.7 1.3 0.0 0.5 0.4 4.1 5.4 0.0 0.0 2.4 0.5 0.4 0.0 9.0 0.0 0.6 0.9 0.1 1.7 0.6 0.4 0.6 6.5 0.9 0.0 13.9 0.7 23.5 0.0 301.1 0.6 9.0 27.3 1.9 0.0 16.2 2.2 0.0 2.4 5.1 4.7 2.3 2.6 3.5 1.1 4.9 0.0 0.0 0.7 0.3 0.6 0.6 0.0 2.6 1.0 3.8 0.9 0.0 0.6 0.3 1.0 0.0 0.0 2.1 9.0 4.7 3.0 0.0 0.0 3.2 1.8 0.0 0.0 1.2 0.0 0.0 0.9 1.8 4.8 2.4 0.9 0.4 9.3 10.2 3.2 0.9 1.2 3.4 3.1 5.0 0.0 0.3 2.5 0.6 1.4 0.5 0.2 0.1 1.0 1.5 0.0 0.8 2.8 0.2 2.7 2.9 2.9 6.1 1.3 4.6 0.8 0.0 0.9 0.0 2.6 2.4 1.2 3.8 4.7 4.2 2.2 16.2 2.4 1.6 0.0 5.1 1.5 1.5 0.8 2.3 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.3 1.7 0.1 1.6 23.3 0.3 1.9 0.3 0.8 1.1 0.0 0.7 0.0 1.7 1.8 1.2 4.3 0.6 0.6 0.0 0.0 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.5 0.2 2.5 1.0 0.6 HIST1H2AJ "H2A/E, H2AFE" ENSG00000276368 "Histone cluster 1 H2A family member j" Q99878 6 27814354-27814740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 357.7" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8" "Low region specificity" "Detected in some" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.6 0.1 0.0 7.2 0.0 16.5 0.2 0.0 0.2 1.0 5.2 0.0 0.0 0.3 0.3 0.6 6.6 0.3 0.8 0.2 0.0 0.3 0.4 2.2 3.1 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.4 3.9 0.1 0.0 10.5 0.8 5.2 0.0 357.7 0.1 7.9 23.1 1.5 0.0 4.2 2.7 2.5 0.5 0.4 5.9 5.0 4.0 0.0 1.2 0.0 0.0 0.0 1.0 1.2 1.2 1.1 2.6 2.1 0.2 3.9 0.4 0.7 0.1 1.1 0.0 1.1 0.6 1.9 0.6 5.6 0.5 10.0 0.3 0.0 2.1 0.0 0.3 0.5 0.3 0.0 1.5 2.1 0.0 12.1 0.3 16.8 6.7 6.1 2.0 1.7 3.5 6.0 0.0 2.3 0.2 2.4 0.5 0.8 1.1 1.2 0.5 0.3 0.4 4.1 0.0 0.0 2.4 0.4 0.2 6.2 3.9 3.8 1.3 4.5 2.8 0.0 0.1 0.0 0.7 0.5 0.9 0.7 3.4 3.1 2.7 4.2 1.1 0.4 2.5 0.4 0.2 0.3 5.9 5.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.7 0.0 1.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.4 0.3 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 105.0;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.2;U-266/84: 39.2" "Low region specificity" "Detected in some" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.2 3.7 2.1 29.3 2.7 1.1 4.7 2.7 6.2 3.9 4.1 4.4 2.4 30.1 5.6 6.9 8.5 2.1 2.0 2.9 11.0 5.2 1.6 9.8 4.3 3.1 2.1 4.6 19.2 3.2 1.7 2.4 2.4 1.5 2.3 16.9 13.5 1.1 19.3 4.8 5.4 3.9 23.1 5.7 1.9 2.4 16.0 5.8 3.9 12.0 5.1 29.9 7.8 4.6 7.6 19.8 0.8 0.9 7.7 20.1 3.1 1.0 37.2 39.2 6.1 1.0 10.0 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 3.0 5.6 15.9 54.2 1.5 13.9 21.3 12.7 53.5 10.3 21.0 0.0 6.4 19.9 4.3 27.1 2.8 22.0 0.0 3.8 6.2 3.0 105.0 2.3 20.7 3.9 41.3 44.7 1.3 4.0 5.4 6.6 6.9 3.3 3.6 20.2 4.0 12.0 33.1 1.4 75.4 10.4 0.0 1.4 0.9 0.7 2.4 33.0 6.9 14.3 63.6 HIST1H3H "H3/k, H3F1K, H3FK" ENSG00000278828 "Histone cluster 1 H3 family member h" P68431 6 27810064-27811300 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 55.3;lymphoid tissue: 204.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 9.9;Intestinal endocrine cells: 5.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 15.9;neutrophil: 10.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.9" "Cell line enhanced" "Detected in many" "K-562: 17.8;SiHa: 15.5;U-266/70: 13.2;U-266/84: 32.1" HPA042570 Approved NA Yes "HPA042570: AB_2678056" "unprognostic (1.61e-1)" "prognostic favorable (4.35e-4)" "unprognostic (1.79e-1)" "unprognostic (1.63e-2)" "unprognostic (3.68e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (3.01e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.25e-6)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.73e-5)" "unprognostic (4.09e-1)" "unprognostic (4.94e-1)" "unprognostic (3.70e-1)" "unprognostic (2.82e-2)" 1.2 2.6 0.0 25.2 0.0 7.5 1.7 0.2 0.3 1.7 4.7 0.0 2.5 2.3 1.6 2.5 9.0 0.6 3.0 1.3 0.0 0.4 3.1 4.4 8.1 0.0 0.0 2.2 1.5 1.4 0.0 3.4 0.1 2.7 5.3 0.5 0.9 2.8 0.8 0.3 3.9 1.0 0.2 11.0 3.1 3.4 0.0 204.8 1.3 10.6 22.6 1.7 0.9 1.1 1.8 15.9 1.1 0.3 2.0 55.3 1.0 3.9 1.7 1.4 2.4 0.3 0.2 0.6 0.4 1.9 0.7 1.2 1.1 0.7 3.7 0.4 1.1 2.1 0.6 0.9 1.2 4.9 2.4 0.9 3.5 5.0 0.6 0.8 1.5 3.2 0.3 0.4 0.4 0.8 0.8 0.9 17.8 8.6 0.3 7.8 1.6 1.9 0.8 7.2 1.5 0.8 0.0 8.9 2.0 0.4 5.2 1.0 15.5 3.2 0.6 0.9 7.5 0.2 0.8 0.8 2.5 0.5 0.2 13.2 32.1 2.7 0.0 4.2 0.2 15.9 1.1 2.1 0.3 0.3 0.4 0.3 0.6 0.5 0.8 1.1 0.4 0.3 10.3 0.3 0.3 1.8 2.0 55.3 0.0 1.0 2.7 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 9.9 0.0 0.2 2.9 0.8 4.6 0.0 1.5 1.8 0.0 5.8 0.0 1.8 0.0 0.6 0.0 1.7 1.0 2.9 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.3 0.0 1.0 0.1 4.3 4.3 1.7 1.4 HIST1H4C "dJ221C16.1, H4/g, H4FG" ENSG00000197061 "Histone cluster 1 H4 family member c" P62805 6 26103876-26104310 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 172.4;lymphoid tissue: 88.7" "Group enriched" "Detected in all" 5 "Erythroid cells: 5349.6;Spermatocytes: 1544.2;Spermatogonia: 2680.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 12.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 26.7;PC-3: 14.4" HPA042201 Supported NA Yes 30000000 "HPA042201: AB_2677898" "unprognostic (1.28e-1)" "unprognostic (5.91e-4)" "unprognostic (6.95e-2)" "unprognostic (8.93e-3)" "unprognostic (5.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (4.31e-3)" "unprognostic (3.79e-1)" "unprognostic (1.01e-2)" "unprognostic (2.30e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (5.74e-6)" "unprognostic (2.42e-2)" "unprognostic (3.02e-1)" "unprognostic (2.82e-1)" "unprognostic (2.79e-3)" 4.8 4.3 6.9 13.2 6.2 23.5 4.6 12.5 8.8 4.6 6.9 0.9 6.4 3.9 4.8 4.2 6.5 4.8 5.0 3.4 6.2 5.6 6.6 6.4 4.2 12.0 5.5 7.9 4.5 19.4 2.3 5.2 5.9 4.3 3.8 7.5 5.2 11.1 5.0 3.6 4.5 5.4 3.5 6.4 7.0 4.8 25.5 4.4 88.7 8.0 12.4 9.9 8.0 5.2 54.3 26.9 45.5 25.4 25.4 46.6 172.4 1.5 1.4 0.5 2.3 0.0 0.2 0.0 0.7 0.6 0.4 0.8 2.1 0.3 0.5 0.7 0.2 0.6 0.8 1.7 0.5 0.4 1.3 26.7 1.0 2.8 3.2 0.7 1.2 0.9 1.2 0.0 0.3 0.0 0.0 0.6 0.4 1.4 1.1 0.4 0.2 5.8 2.9 1.5 0.9 14.4 1.7 0.8 2.5 0.9 0.1 1.5 1.0 0.7 1.0 0.6 0.7 0.7 3.8 0.4 1.6 1.6 0.8 1.3 2.2 2.0 2.5 1.0 2.1 0.8 39.9 25.4 17.8 31.4 10.2 30.0 54.3 40.5 25.6 18.5 48.6 46.6 35.1 45.5 25.4 10.2 26.9 26.7 172.4 6.9 6.2 12.5 8.8 6.2 5.6 5.5 7.9 4.3 4.4 113.2 96.8 203.6 96.4 200.8 385.3 149.9 540.1 141.8 212.7 291.4 178.7 298.1 261.9 329.5 3.7 206.3 206.8 5349.6 321.8 569.2 94.6 66.7 135.8 494.9 220.3 125.5 94.0 248.6 132.2 25.7 128.3 121.7 37.1 83.0 263.6 673.8 310.1 136.8 154.5 261.4 631.5 226.4 105.6 1544.2 2680.9 182.2 184.2 191.9 173.9 53.7 HIST2H2BE "H2B, H2B.1, H2B/q, H2BFQ" ENSG00000184678 "Histone cluster 2 H2B family member e" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.1" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 128.7;Syncytiotrophoblasts: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.9" "Cell line enhanced" "Detected in many" "Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 14.3 16.2 9.8 22.2 10.0 19.4 16.9 17.2 14.0 31.3 9.0 11.2 10.5 6.4 18.5 24.9 25.5 13.3 9.6 51.1 13.1 10.1 12.5 10.2 27.5 24.5 12.4 8.7 28.0 13.4 5.8 15.4 17.2 8.5 72.8 7.6 19.4 24.1 15.3 43.1 33.5 8.6 18.8 18.2 22.0 17.5 9.3 11.6 198.1 12.1 12.4 25.3 27.2 33.8 2.3 4.5 29.9 5.5 0.7 1.2 5.1 1.1 1.1 1.9 0.4 10.3 2.8 0.9 4.1 2.7 1.7 0.5 0.4 1.8 0.2 1.1 3.6 2.4 4.5 1.5 0.7 0.9 1.4 1.2 0.3 4.6 0.8 3.2 0.3 5.4 9.4 3.4 0.7 2.8 2.1 0.5 1.7 4.9 24.3 2.1 6.9 1.2 2.1 1.2 9.4 2.5 1.5 0.7 5.5 1.6 0.9 13.1 2.1 14.1 1.9 1.0 4.8 10.0 0.9 0.7 1.3 14.7 0.9 0.3 40.5 21.7 1.1 1.7 1.5 0.8 8.4 2.1 3.8 0.7 3.2 1.2 0.8 0.9 1.1 1.6 2.3 1.2 1.1 29.9 0.7 5.5 4.5 1.0 5.1 9.8 10.0 17.2 8.5 13.1 10.1 12.4 8.7 8.5 11.6 8.9 11.7 10.4 57.7 5.4 47.2 56.8 2.5 12.0 5.7 34.9 21.6 22.3 23.2 13.5 1.1 4.5 15.3 23.3 5.9 10.4 14.1 128.7 10.5 5.9 22.3 20.6 53.7 8.6 11.0 0.0 4.6 16.7 18.6 4.6 18.8 12.9 8.3 21.0 0.4 8.8 32.5 0.0 9.8 0.5 6.1 11.8 134.0 22.4 9.0 59.1 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331695-173335125 "Plasma proteins, Predicted intracellular proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1" "Cell type enhanced" "Detected in all" 15 "Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 166.6;MOLT-4: 171.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" NA Yes 380000 Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109" "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 18.8 5.9 10.3 48.9 13.2 325.8 19.9 6.6 9.5 17.1 24.0 8.6 7.9 15.7 18.6 16.2 28.6 15.4 13.8 23.4 9.5 10.2 13.2 6.9 25.4 59.8 12.5 8.2 29.0 5.8 2.9 8.0 18.5 9.3 19.0 21.2 12.2 13.8 8.6 46.2 15.5 21.5 25.3 13.3 36.7 13.0 26.7 10.6 187.1 18.7 23.0 61.6 27.1 18.5 11.6 16.8 95.9 20.5 11.9 39.9 14.3 34.9 8.4 72.2 32.2 9.0 9.0 27.7 26.1 19.9 28.8 25.8 23.7 48.8 118.3 5.9 14.5 15.4 13.7 47.3 14.2 45.0 72.4 22.1 130.0 21.2 34.7 8.8 115.0 50.2 8.7 4.3 14.4 32.8 15.7 29.5 62.9 49.0 166.6 26.3 29.2 171.4 106.6 26.3 20.9 14.6 86.7 37.1 43.9 16.5 15.0 62.5 56.4 26.3 15.3 11.7 26.4 21.2 83.9 16.9 12.9 38.3 15.9 39.1 53.9 30.1 135.4 11.0 84.1 33.6 95.9 20.5 57.6 15.6 8.5 14.1 11.6 22.7 21.2 16.8 8.8 15.0 14.3 47.8 11.9 6.8 6.8 39.9 14.3 10.3 13.2 6.6 9.5 9.5 10.2 12.5 8.2 9.3 10.6 26.8 58.1 117.6 176.4 141.0 43.0 211.0 35.7 147.2 66.0 52.4 33.4 154.7 121.0 20.6 24.5 124.1 53.3 2616.4 14.4 751.8 109.8 81.7 104.4 22.2 176.6 42.9 71.7 149.1 275.5 29.5 97.5 149.6 64.1 109.2 104.0 79.8 10.0 83.9 54.1 36.3 129.5 77.6 96.6 461.9 435.2 117.1 107.7 264.5 185.0 64.8 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.2 14.5 1.4 2.7 20.3 20.1 9.8 25.2 22.9 27.0 40.9 35.2 19.2 6.2 34.4 24.5 31.4 19.1 43.1 31.9 9.7 21.0 9.5 13.2 0.4 18.6 19.4 0.7 1.1 23.7 18.6 4.2 14.3 24.2 19.9 28.8 26.2 7.7 19.6 10.6 23.4 14.2 14.6 21.4 36.4 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 13.5 27.7 15.0 9.3 18.1 15.4 14.5 26.9 15.5 25.9 28.4 12.0 28.9 17.4 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 0.0 0.6 15.5 0.8 2.3 0.6 1.7 7.6 4.0 4.5 0.0 0.0 5.1 0.0 0.6 60.3 0.1 1.3 256.9 0.2 50.4 2.4 0.8 0.0 1.7 17.7 0.0 1.2 3.1 3.5 44.1 2.0 4.3 0.0 3.6 1.6 0.0 0.1 0.0 0.7 2.4 0.7 6.5 0.0 80.6 18.5 1.3 3.8 1.0 4.2 0.9 HP1BP3 HP1-BP74 ENSG00000127483 "Heterochromatin protein 1 binding protein 3" Q5SSJ5 1 20742661-20787323 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028215, HPA054295" Supported Supported "Nuclear speckles" NA Yes 50000 "Nuclear speckles" "HPA028215: AB_10601021, HPA054295: AB_2682440" "unprognostic (3.90e-3)" "unprognostic (6.83e-2)" "unprognostic (7.69e-2)" "unprognostic (3.66e-2)" "unprognostic (1.31e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.97e-1)" "unprognostic (3.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.94e-2)" "unprognostic (9.50e-2)" "unprognostic (6.86e-2)" "unprognostic (1.65e-1)" "unprognostic (6.30e-2)" "unprognostic (1.27e-1)" "unprognostic (2.43e-2)" 40.1 41.4 52.6 41.2 59.0 62.2 39.0 53.3 60.0 52.8 46.8 45.8 41.2 34.1 65.7 32.2 46.9 38.6 36.9 35.9 49.1 33.7 42.4 31.7 39.7 41.4 47.6 41.2 70.8 36.5 54.6 46.7 55.1 46.7 41.6 44.2 32.5 39.5 44.5 48.7 41.7 43.9 49.7 50.1 41.9 39.6 27.9 58.6 58.1 52.7 30.9 42.9 48.0 62.9 21.9 18.9 60.5 17.0 18.3 27.3 14.0 43.8 23.3 59.0 35.5 35.4 42.7 35.3 49.7 41.8 36.7 38.8 21.1 51.0 45.5 25.3 39.7 24.3 37.7 30.7 29.1 47.6 65.5 28.2 64.0 45.6 18.8 23.3 44.0 41.2 32.1 21.6 35.8 48.9 44.6 36.9 55.0 35.5 56.1 41.7 14.0 67.6 20.3 15.5 33.8 28.5 53.7 57.2 47.3 26.1 14.2 39.7 40.9 61.3 25.4 40.4 31.5 26.1 31.1 42.7 40.1 37.1 40.4 30.2 32.1 38.7 51.2 34.4 47.8 45.3 25.5 17.0 60.5 19.4 13.9 20.0 21.9 20.9 20.7 15.5 19.0 27.3 18.6 21.8 18.3 15.8 18.9 21.3 14.0 52.6 59.0 53.3 60.0 49.1 33.7 47.6 41.2 46.7 58.6 140.0 127.5 85.8 101.0 115.9 110.2 129.3 96.8 72.3 125.1 99.5 51.1 70.6 131.0 73.7 29.3 134.9 81.9 186.9 81.3 56.0 120.8 105.9 129.9 89.8 62.7 76.3 99.6 116.0 95.2 11.5 159.9 90.0 108.0 91.0 98.8 111.4 88.9 84.5 152.8 77.4 93.1 155.2 104.6 110.6 94.1 117.6 77.7 103.3 91.3 95.2 HSP90AB1 "HSPC2, HSPCB" ENSG00000096384 "Heat shock protein 90 alpha family class B member 1" P08238 6 44246166-44253888 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 3438.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005230, HPA055729, HPA072606, HPA074351" Enhanced Supported Cytosol "Intracellular and membrane" NA Yes 62000000 Cytosol "CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252" "unprognostic (6.12e-3)" "unprognostic (2.96e-3)" "unprognostic (4.72e-2)" "unprognostic (9.24e-2)" "unprognostic (4.20e-1)" "unprognostic (1.15e-3)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (3.02e-1)" "unprognostic (9.53e-2)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" 79.9 116.1 88.0 65.9 105.0 74.6 107.8 92.1 118.2 92.3 60.4 61.7 80.9 40.6 113.3 107.6 71.6 138.4 63.8 115.0 89.0 110.5 72.0 70.7 76.2 73.8 109.7 94.4 238.4 113.9 151.6 95.3 83.6 133.7 93.5 76.4 52.7 64.8 100.3 197.1 67.9 49.0 102.1 93.9 57.5 77.3 45.9 100.2 58.3 133.8 89.8 102.5 86.2 223.4 75.9 50.5 7.2 45.7 55.7 82.5 74.9 135.6 87.0 77.3 95.0 53.1 55.6 81.0 61.3 60.1 113.6 80.0 130.1 41.6 173.8 66.5 63.8 115.6 79.1 188.1 91.3 140.6 57.5 76.1 135.2 49.3 170.0 38.5 135.0 93.7 51.4 61.8 89.2 77.1 99.7 108.6 89.9 180.5 64.9 77.2 137.0 112.4 81.4 90.2 251.8 66.7 108.5 79.1 95.4 76.8 82.5 113.3 69.2 47.6 69.1 86.0 109.7 89.8 67.6 68.1 67.8 113.5 55.4 140.0 75.2 117.8 313.9 73.7 99.3 77.2 7.2 30.2 6.8 49.3 45.7 82.5 75.9 55.2 56.4 50.5 63.2 75.2 71.3 3.7 55.7 43.3 31.4 42.6 74.9 88.0 105.0 92.1 118.2 89.0 110.5 109.7 94.4 133.7 100.2 833.7 606.4 539.1 3438.1 940.9 289.3 1217.7 456.0 1493.6 1074.9 347.2 214.0 960.1 618.4 836.0 145.7 761.3 375.2 163.5 596.7 897.4 930.6 1319.6 967.8 307.7 711.8 321.0 544.1 275.6 256.9 156.5 635.1 727.9 698.5 738.6 374.5 296.6 721.4 313.4 574.6 560.9 223.5 342.8 894.3 197.9 740.6 807.2 939.3 460.3 567.6 2341.3 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "Cell line enriched" "Detected in some" 10 "HEK 293: 310.1" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol NA Yes 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 31.3 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.7 0.0 0.0 0.0 2.3 0.0 0.2 310.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 137.0 84.3 135.2 6419.7 321.9 290.0 857.6 71.4 100.4 76.2 120.4 357.4 38.6 34.9 77.7 73.7 681.4 145.3 0.0 18.8 85.4 940.7 2245.3 456.0 74.4 220.0 193.9 449.0 109.9 284.5 25.8 558.4 1365.8 796.3 117.2 187.3 954.1 43.5 340.1 151.0 60.4 639.2 148.8 1629.0 48.6 175.8 294.0 87.2 208.8 111.9 2114.2 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A549: 24.5;Karpas-707: 72.8" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: AB_2681854" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 24.5 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.6 1.3 0.0 1.0 0.0 0.0 0.0 0.5 7.6 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 72.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 0.1 5.1 0.0 0.1 11.9 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 104.2 64.8 61.6 2896.7 212.6 40.4 440.6 20.4 54.9 58.0 66.3 123.7 73.9 16.6 33.6 1.7 185.0 221.9 0.0 13.7 87.7 515.0 1002.7 354.9 16.3 116.6 44.5 304.9 19.6 74.0 3.1 204.3 481.3 609.0 26.2 172.9 237.3 22.8 291.0 51.6 32.9 140.4 103.5 978.7 12.8 50.3 194.0 217.2 75.6 121.8 675.8 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 2008.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles NA Yes 210000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: AB_2681854" "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favorable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favorable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 70.0 96.8 93.7 78.1 102.8 58.1 73.8 119.5 125.1 52.8 64.1 72.0 77.3 77.7 59.9 98.3 83.4 76.2 76.7 106.4 83.1 102.4 128.6 114.2 68.9 93.3 105.7 72.4 66.7 191.1 97.2 98.3 71.6 169.2 65.3 81.0 53.1 62.4 69.9 224.6 31.2 74.4 75.4 91.8 79.7 92.7 58.3 98.1 92.9 90.9 98.3 124.4 76.1 123.2 77.4 47.5 41.1 84.2 76.1 124.3 200.0 81.9 124.3 82.5 71.3 76.5 82.0 109.4 163.1 90.4 199.5 120.1 186.5 108.0 133.6 103.0 90.7 141.2 111.7 235.9 59.1 199.2 115.5 35.8 144.9 58.5 90.9 20.9 140.8 111.4 43.7 95.7 61.3 19.1 103.7 106.7 18.2 156.8 69.6 159.8 73.0 146.4 104.5 130.6 200.3 110.8 132.1 58.9 75.5 103.3 60.0 84.8 64.2 118.8 129.0 45.0 91.8 112.5 55.1 104.9 100.3 80.5 86.1 144.5 47.0 115.8 114.7 111.7 201.3 120.9 30.3 41.5 41.1 96.5 82.9 115.9 77.4 113.4 105.2 47.5 53.7 109.6 105.1 14.9 76.1 84.2 34.4 124.3 200.0 93.7 102.8 119.5 125.1 83.1 102.4 105.7 72.4 169.2 98.1 178.6 194.1 380.7 2008.3 250.8 192.6 358.3 247.1 397.5 238.8 123.9 119.8 806.4 447.6 560.1 23.5 383.9 634.1 256.9 544.3 848.9 487.1 803.7 432.1 181.5 715.5 171.6 498.1 192.8 238.1 50.8 206.0 453.5 501.0 661.9 246.7 285.3 500.3 403.3 253.8 795.2 189.9 239.3 546.5 180.9 436.7 248.7 1264.6 601.2 394.7 698.3 HSPE1 "CPN10, EPF, GroES, HSP10" ENSG00000115541 "Heat shock protein family E (Hsp10) member 1" P61604 2 197499994-197503457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Proximal tubular cells: 1679.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 198.2" "Low region specificity" "Detected in all" "CAB017366, HPA038755, HPA048272" Supported NA Yes 9000000 "CAB017366: AB_10998950, HPA038755: AB_2676190, HPA048272: AB_2680336" "unprognostic (2.75e-2)" "unprognostic (6.89e-2)" "unprognostic (1.86e-1)" "unprognostic (1.43e-2)" "unprognostic (1.98e-1)" "unprognostic (1.85e-2)" "unprognostic (5.83e-3)" "unprognostic (4.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.94e-3)" "unprognostic (1.39e-2)" "unprognostic (6.21e-3)" "unprognostic (2.63e-1)" "unprognostic (4.51e-2)" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.08e-3)" 24.9 134.7 38.4 25.0 35.0 17.8 50.6 17.1 41.2 19.1 39.9 16.3 20.3 30.8 15.8 31.7 24.3 21.1 16.7 33.8 33.7 37.3 62.5 120.9 18.6 23.8 51.5 26.8 22.7 35.9 14.9 27.2 26.0 48.3 21.9 39.0 9.1 25.1 27.6 39.1 13.0 27.7 17.9 46.7 18.6 21.7 9.4 45.7 10.4 30.6 31.5 30.8 20.2 116.3 50.8 44.9 3.6 29.0 31.5 48.1 28.0 34.6 46.0 42.6 31.4 29.5 14.8 52.7 38.0 17.1 33.1 31.0 138.9 29.4 65.3 49.0 18.1 92.3 30.0 107.1 36.9 38.6 31.4 45.8 70.0 92.2 198.2 13.0 94.3 30.4 20.2 25.2 33.3 16.5 22.8 29.4 42.4 87.6 21.7 22.3 50.0 70.8 92.1 62.3 53.6 84.6 43.2 37.9 77.1 45.2 52.2 33.5 21.6 36.0 42.5 30.0 95.0 16.5 50.1 22.7 27.4 39.0 30.2 61.5 25.9 58.8 112.0 30.7 42.7 37.0 3.6 16.7 3.3 30.2 29.0 38.4 50.8 40.3 37.1 27.0 37.1 45.8 48.1 1.8 31.5 22.1 44.9 32.0 28.0 38.4 35.0 17.1 41.2 33.7 37.3 51.5 26.8 48.3 45.7 181.7 129.3 467.6 1344.0 386.6 76.4 317.3 379.6 385.4 249.1 184.9 235.6 750.2 772.6 308.6 18.4 226.7 477.1 93.5 200.4 473.8 338.6 622.6 325.8 978.6 444.4 60.4 422.2 93.9 139.9 24.0 200.5 371.3 388.0 277.7 348.0 186.8 281.8 323.0 133.3 1679.7 139.2 129.4 405.8 130.8 230.0 325.0 816.8 296.2 541.0 1039.4 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 738.6;Urothelial cells: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 13.7 26.5 21.8 2.1 21.0 11.9 14.5 23.9 21.3 37.2 17.3 31.1 21.5 35.8 15.0 16.6 52.9 26.8 84.1 21.2 48.1 28.0 10.6 31.0 14.6 27.4 6.9 21.5 24.8 7.5 49.2 24.8 14.3 19.5 21.5 12.6 25.9 5.7 26.1 18.8 30.8 24.6 31.0 67.6 19.8 24.3 17.9 11.8 28.1 16.8 22.6 18.8 21.8 21.4 11.0 34.9 7.2 21.0 13.1 12.8 16.3 18.4 26.4 4.5 14.7 30.7 10.7 26.1 21.4 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 122.1 81.5 33.2 738.6 190.6 38.7 130.6 17.8 302.5 185.4 43.6 392.7 17.7 24.9 44.8 71.1 92.6 26.2 0.0 31.1 55.8 207.2 407.7 251.8 21.5 79.0 28.6 217.9 24.5 27.7 22.4 31.4 113.0 155.3 47.7 22.5 16.6 37.1 45.6 36.7 22.8 57.7 38.8 156.8 128.9 138.0 125.3 35.6 28.0 26.7 485.8 HYLS1 FLJ32915 ENSG00000198331 "HYLS1, centriolar and ciliogenesis associated" Q96M11 11 125883614-125900648 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.7;Late spermatids: 40.2;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 4.3 4.3 6.5 3.6 8.8 2.8 5.2 12.3 11.6 5.9 5.5 2.7 6.0 7.0 5.3 8.3 5.7 5.0 3.2 5.7 6.7 7.2 8.7 7.2 3.1 6.7 5.0 8.6 5.0 3.4 3.4 5.5 5.1 7.6 6.2 6.0 2.2 3.9 7.6 3.7 5.7 6.7 7.1 3.5 5.6 6.2 28.6 4.3 7.6 5.1 4.6 9.6 5.0 3.8 11.8 14.3 3.2 6.0 4.6 10.3 4.7 4.6 10.2 3.7 2.7 7.4 5.0 6.5 11.8 4.7 11.1 7.5 0.1 7.7 2.0 5.0 10.3 3.7 7.0 5.3 4.1 12.9 11.4 3.7 1.5 1.1 2.1 5.5 5.2 7.9 3.2 4.8 11.0 12.5 2.4 8.0 4.6 2.6 12.7 14.5 7.9 3.8 15.7 8.3 19.6 17.3 8.0 0.0 6.8 11.9 7.8 5.3 3.3 12.5 9.7 4.7 5.0 23.9 11.6 7.2 0.8 9.7 8.8 2.0 4.7 4.6 4.9 2.3 11.5 9.7 3.2 5.5 1.1 8.1 6.0 7.6 11.5 10.2 9.4 6.7 11.8 10.3 7.4 0.9 4.6 4.2 14.3 10.3 4.7 6.5 8.8 12.3 11.6 6.7 7.2 5.0 8.6 7.6 4.3 0.0 0.3 8.0 2.4 3.8 7.9 4.0 2.5 4.0 0.0 1.8 3.9 12.5 10.0 3.9 72.7 3.5 3.3 23.3 3.6 10.5 5.1 2.6 0.0 5.5 6.3 0.0 4.7 4.3 1.9 40.2 7.8 2.2 6.8 14.4 2.1 4.4 3.9 6.0 5.6 10.2 5.6 6.5 5.0 98.2 33.7 3.8 3.7 6.4 5.0 1.4 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123973-62153163 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" 4 "monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;NK-cell: 4.0" "Group enriched" "Detected in many" 6 "granulocytes: 2.9;NK-cells: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 5.1 5.0 6.9 9.2 8.2 23.8 7.7 19.3 13.6 6.9 6.5 5.7 2.8 9.5 5.7 11.7 22.2 5.3 4.7 4.1 5.9 5.0 3.9 3.8 5.0 14.1 6.9 7.9 5.3 5.4 6.0 3.1 5.7 6.9 4.2 5.3 4.9 10.6 4.6 6.7 9.8 7.5 4.9 5.1 7.5 6.4 12.3 6.4 36.1 8.5 8.5 13.2 5.9 8.6 0.2 0.0 2.9 0.3 4.0 0.5 0.0 27.0 25.9 19.7 16.8 2.6 3.2 10.5 17.0 7.4 15.9 10.2 13.6 18.4 25.1 14.1 5.8 17.6 26.6 19.5 10.3 12.5 22.3 13.5 16.4 25.5 11.1 1.0 18.8 23.4 1.6 2.3 15.3 8.9 2.6 9.5 18.3 17.3 21.0 8.7 22.0 30.3 15.4 21.2 10.5 12.7 28.4 24.8 18.9 4.5 13.6 15.0 16.3 17.1 11.1 10.5 8.2 17.4 6.8 10.6 15.7 20.1 22.4 18.1 11.2 17.2 28.2 8.7 12.4 18.8 2.9 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.2 4.0 0.1 0.0 0.0 0.0 6.9 8.2 19.3 13.6 5.9 5.0 6.9 7.9 6.9 6.4 3.0 2.9 2.2 0.8 4.9 1.9 0.9 0.0 4.0 5.7 0.0 0.0 1.6 0.0 1.7 0.8 0.8 1.3 0.0 2.1 6.0 0.8 1.0 3.5 0.9 3.5 0.0 0.0 0.0 0.8 0.2 2.6 2.5 3.3 8.2 2.0 2.3 1.7 1.5 1.4 0.3 2.2 0.0 0.4 6.9 5.8 2.9 1.8 2.5 1.7 1.0 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;intestine: 13.0" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 5.1;Late spermatids: 16.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes Yes "Nucleoli rim" Nucleoplasm "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavorable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 3.2 1.2 0.3 5.4 0.3 14.8 0.6 0.3 0.8 1.4 10.1 0.4 1.3 7.0 1.1 3.7 9.8 0.3 1.8 1.8 0.4 0.2 1.5 1.1 2.6 1.4 0.3 0.3 0.5 0.4 0.0 0.3 6.5 0.8 0.8 5.5 0.4 1.8 0.3 0.5 3.8 13.0 2.9 1.5 1.5 5.1 6.8 0.3 12.2 0.4 3.1 7.3 0.9 3.1 0.2 0.9 0.5 0.3 0.6 2.6 0.0 23.5 11.4 10.7 7.5 0.6 1.7 5.2 17.5 11.7 17.2 15.5 13.0 21.8 2.1 6.5 10.3 9.1 22.5 7.3 9.0 15.5 0.0 6.5 3.1 22.4 6.4 0.1 3.8 0.0 0.5 1.0 14.4 21.3 4.2 10.0 5.1 6.3 3.4 12.6 12.4 2.2 5.5 7.8 23.3 11.5 7.6 12.0 2.4 4.4 8.1 6.8 10.5 15.9 18.7 6.4 13.1 14.9 10.3 6.5 15.6 18.7 12.7 20.6 1.6 0.8 1.0 5.2 6.1 17.6 0.5 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.1 0.1 0.1 0.2 0.6 0.3 0.9 2.6 0.0 0.3 0.3 0.3 0.8 0.4 0.2 0.3 0.3 0.8 0.3 0.0 0.0 0.5 0.0 1.1 0.0 0.8 5.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 1.1 0.0 0.0 3.1 0.5 0.2 0.0 0.0 3.4 0.0 1.2 4.3 0.3 16.8 0.3 2.2 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 3.8 2.4 0.9 0.7 0.0 2.9 0.4 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028699 "Plasma proteins, Predicted intracellular proteins" Transferase "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 24.2 21.6 12.7 13.7 13.0 7.9 24.4 20.3 17.9 21.0 21.0 9.8 18.2 11.0 19.3 13.3 16.3 26.3 23.4 21.3 12.9 12.3 19.7 16.3 15.6 12.7 13.8 7.4 36.9 18.2 35.8 17.2 13.7 15.7 20.2 6.0 19.7 26.2 20.2 15.9 17.0 11.1 18.4 13.5 18.4 13.9 15.3 13.4 27.4 27.6 7.1 9.8 21.8 24.6 2.1 12.2 9.9 2.4 6.5 3.4 0.7 6.8 6.0 14.9 16.7 4.5 4.2 21.3 7.2 5.9 2.0 2.7 2.8 11.3 2.4 5.3 6.1 5.8 10.7 2.5 5.3 1.7 11.4 8.8 3.0 5.9 3.8 5.9 0.8 13.8 5.6 4.2 3.6 3.2 16.3 2.7 5.0 4.5 27.4 2.6 18.7 9.2 6.4 6.7 2.9 31.3 1.9 4.2 5.6 7.1 10.1 11.6 16.8 10.2 10.7 17.8 4.2 7.4 1.5 4.7 9.5 9.3 3.1 4.6 10.6 11.3 4.1 14.7 2.1 11.8 1.5 1.6 1.4 3.4 2.2 3.2 1.7 3.0 3.1 1.4 2.1 2.5 2.6 9.9 6.5 2.4 12.2 2.9 0.7 12.7 13.0 20.3 14.1 12.9 12.3 13.8 7.4 15.7 13.4 20.8 14.7 25.3 28.2 65.5 56.8 14.7 38.2 8.1 9.1 61.1 27.5 17.1 31.5 19.5 1.2 24.8 5.6 0.0 16.4 44.6 44.5 25.7 25.5 42.3 28.3 9.5 45.8 48.5 47.9 2.7 27.9 17.0 33.7 0.0 13.5 45.5 16.0 3.5 32.2 19.3 10.0 38.8 33.3 1.7 28.8 44.3 38.4 25.5 11.9 17.6 KANK2 "ANKRD25, KIAA1518, MXRA3" ENSG00000197256 "KN motif and ankyrin repeat domains 2" Q63ZY3 19 11164267-11197791 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 310.0;Leydig cells: 116.8;Peritubular cells: 212.2;Smooth muscle cells: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 64.6;ASC TERT1: 71.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015643 Approved NA Yes "HPA015643: AB_1844839" "unprognostic (2.37e-1)" "unprognostic (8.03e-2)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" "unprognostic (3.23e-3)" "unprognostic (1.54e-1)" "unprognostic (8.63e-2)" "unprognostic (8.98e-2)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (8.73e-5)" "unprognostic (4.01e-2)" "unprognostic (1.37e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-2)" 28.7 10.5 4.6 27.5 9.2 2.7 21.3 3.1 6.2 78.9 68.2 5.0 42.3 7.1 81.3 29.9 45.3 35.1 45.3 52.1 4.9 3.0 12.2 9.2 22.4 6.8 8.2 5.3 57.6 6.8 2.8 5.9 12.3 5.8 47.0 12.2 32.7 6.9 38.1 17.6 8.5 19.3 90.6 8.5 14.4 24.9 16.6 6.3 2.5 14.1 10.5 4.7 72.9 74.9 0.6 0.2 1.7 1.1 1.0 1.1 0.7 7.9 17.1 5.4 5.7 64.6 71.9 3.8 35.2 30.6 17.7 14.7 6.8 5.1 32.9 17.0 43.6 11.6 7.4 4.9 2.5 11.8 1.6 3.5 14.1 20.4 6.8 24.2 2.1 4.1 30.9 3.8 12.9 1.7 45.9 7.1 1.0 9.3 2.7 27.1 13.8 0.4 1.8 5.9 5.1 18.8 11.0 44.4 7.7 12.3 4.2 3.1 10.1 35.1 3.1 4.3 6.6 4.7 7.4 25.8 25.5 10.3 32.5 13.9 2.6 5.8 11.3 21.8 12.3 25.9 1.1 0.9 0.2 0.5 1.1 1.1 0.6 0.2 0.2 0.0 0.4 0.3 0.2 1.7 1.0 0.6 0.2 0.5 0.7 4.6 9.2 3.1 6.2 4.9 3.0 8.2 5.3 5.8 6.3 53.6 21.2 0.5 4.8 5.6 1.9 310.0 30.6 6.7 14.8 19.2 19.6 5.1 3.3 7.0 1.9 24.8 1.3 70.0 4.0 4.0 44.3 5.8 7.0 21.2 17.2 0.0 0.0 34.4 8.2 1.5 116.8 4.3 8.5 0.0 0.7 35.2 8.4 0.0 212.2 3.5 24.7 90.5 132.8 1.5 7.5 6.8 1.9 1.3 5.4 4.2 KBTBD2 "BKLHD1, DKFZP566C134" ENSG00000170852 "Kelch repeat and BTB domain containing 2" Q8IY47 7 32868172-32894131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021133 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA021133: AB_1852093" "unprognostic (1.01e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.17e-2)" "unprognostic (9.19e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (3.96e-3)" "unprognostic (1.05e-1)" "unprognostic (2.61e-1)" "unprognostic (2.80e-3)" "unprognostic (5.05e-1)" "unprognostic (6.79e-3)" "unprognostic (3.81e-3)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.96e-1)" 20.9 12.3 13.9 15.0 15.7 34.4 16.4 18.3 18.0 13.6 12.2 12.9 10.2 11.3 17.3 8.1 12.8 12.0 18.5 17.0 13.8 14.3 11.2 15.3 17.5 24.9 18.2 13.4 13.9 9.6 16.2 13.8 18.4 17.5 12.5 14.6 12.1 11.7 11.6 36.5 12.2 13.4 18.3 21.1 21.1 10.9 12.5 13.8 26.3 15.2 18.2 16.8 13.6 20.4 6.9 3.5 25.1 8.6 6.8 7.4 2.3 18.3 9.2 23.9 11.8 14.4 14.6 8.6 16.5 16.8 15.7 19.1 9.1 14.3 15.5 11.5 17.0 26.5 13.6 12.1 12.9 19.9 6.1 8.7 13.1 15.2 11.7 14.9 14.0 17.3 15.4 13.6 17.1 16.7 14.6 17.3 14.2 23.7 23.1 23.1 15.1 11.7 23.0 19.3 12.8 8.8 11.3 20.9 13.0 13.9 11.1 12.5 23.5 10.6 14.5 18.2 20.9 10.3 24.0 14.9 15.3 19.8 14.2 22.5 19.2 18.9 28.4 15.0 17.0 38.1 9.2 4.2 13.0 7.4 7.7 6.2 4.5 3.6 6.5 3.5 6.9 2.8 4.7 25.1 6.8 8.6 1.8 4.7 2.3 13.9 15.7 18.3 18.0 13.8 14.3 18.2 13.4 17.5 13.8 26.8 19.2 12.7 14.0 35.8 14.2 16.5 15.3 4.0 31.8 1.8 9.8 5.5 0.0 10.3 3.9 43.6 14.7 0.0 10.5 7.5 19.3 14.5 42.7 13.2 11.6 7.9 14.3 32.5 21.6 4.3 12.0 20.7 23.6 4.6 11.9 9.0 12.8 13.1 5.6 3.6 7.9 19.4 18.1 15.8 7.0 31.6 6.3 13.8 10.5 13.9 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724491-202809470 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.0" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 181.0;Spermatocytes: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 7.7 7.1 5.9 8.2 7.8 14.8 12.3 12.7 9.0 12.9 9.6 5.1 9.7 5.0 13.6 9.4 17.6 8.6 8.4 5.7 6.1 4.5 6.0 4.6 9.0 5.4 3.7 7.3 13.3 9.0 9.8 8.6 23.1 5.0 11.3 9.0 16.0 11.1 8.8 4.3 19.5 7.3 10.1 4.9 6.9 8.2 74.0 5.2 25.8 9.1 6.2 10.4 12.2 12.6 4.1 3.0 16.0 5.2 7.3 4.4 2.6 10.6 4.3 28.9 13.9 13.7 12.4 24.4 7.3 11.3 7.7 8.2 3.6 11.3 0.0 5.0 11.4 5.7 16.4 13.6 12.0 9.9 0.1 5.2 5.8 4.1 5.8 11.7 18.0 7.7 12.9 20.0 11.0 14.5 20.8 17.1 7.2 18.0 0.0 7.7 10.8 5.0 21.5 19.6 7.4 7.6 21.2 0.0 0.0 11.1 18.4 8.8 19.5 15.5 9.5 12.9 39.6 19.5 12.9 12.6 6.8 5.1 0.8 4.2 1.1 0.7 4.5 6.0 6.7 2.8 16.0 2.9 6.4 3.7 3.4 3.1 2.8 3.3 2.7 3.0 4.1 4.2 1.8 9.5 7.3 5.2 2.1 4.4 2.6 5.9 7.8 12.7 9.0 6.1 4.5 3.7 7.3 5.0 5.2 83.4 33.4 5.4 32.8 57.2 30.9 7.3 10.2 54.9 40.9 15.7 58.9 35.8 5.0 41.9 155.3 25.3 16.1 0.0 19.5 25.5 34.2 40.2 25.5 9.6 7.0 14.3 41.9 19.0 17.8 181.0 33.6 10.8 25.3 10.0 31.3 68.3 38.0 17.3 30.8 5.9 133.9 32.3 21.7 261.1 71.6 101.6 68.9 12.5 27.0 45.7 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92593286-92655395 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 74.2" "Group enriched" "Detected in many" 4 "Early spermatids: 9.6;Erythroid cells: 23.3;Extravillous trophoblasts: 11.2;Hofbauer cells: 6.7;Spermatocytes: 24.7;Spermatogonia: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 2.3 1.6 1.0 20.2 2.6 14.3 1.6 0.7 1.5 2.4 4.6 0.7 0.5 3.7 1.4 1.9 11.5 0.8 2.6 2.0 1.1 1.2 1.1 1.1 2.8 12.1 1.0 1.0 1.1 1.1 0.5 0.7 3.1 1.4 1.0 5.4 0.5 2.7 0.2 0.6 4.2 4.4 1.6 1.8 5.2 2.7 10.5 1.1 74.2 1.2 7.5 13.4 2.2 3.8 2.4 0.9 2.5 1.2 3.5 3.9 1.0 31.0 13.9 31.4 29.2 2.3 3.5 7.8 22.4 19.6 24.9 24.8 12.1 20.6 34.4 11.5 10.4 10.6 22.5 22.4 11.4 29.3 20.5 12.9 21.5 13.3 12.7 0.4 34.6 20.1 1.1 1.0 19.2 18.0 5.8 15.4 14.4 15.2 40.2 18.8 12.4 29.4 19.5 12.5 12.6 9.6 31.7 31.1 12.1 6.5 9.1 9.6 13.8 17.5 7.9 9.1 11.2 21.5 11.1 8.7 11.4 16.4 11.6 29.4 11.2 17.3 35.4 9.2 25.0 15.4 2.5 0.5 0.5 0.4 1.2 1.1 2.4 1.4 1.9 0.9 1.0 0.5 0.7 1.4 3.5 0.4 0.4 3.9 1.0 1.0 2.6 0.7 1.5 1.1 1.2 1.0 1.0 1.4 1.1 0.0 1.3 0.8 0.8 2.6 1.3 1.4 0.0 4.0 3.4 1.8 0.0 1.5 1.7 0.4 9.6 0.3 0.4 23.3 0.6 11.2 1.6 0.8 0.0 0.0 6.7 0.0 0.0 2.5 2.5 3.9 0.9 2.6 0.0 1.0 1.9 0.8 0.3 0.0 0.7 0.5 0.4 0.0 1.2 24.7 25.8 2.9 1.3 3.8 2.9 0.9 KIF14 KIAA0042 ENSG00000118193 "Kinesin family member 14" Q15058 1 200551497-200620734 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 9.0;lymphoid tissue: 34.4" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 20.6;Spermatogonia: 18.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038061, HPA058220" Uncertain Supported "Midbody ring,Cytosol" NA Yes Cytosol "Midbody ring" "HPA038061: AB_10669515, HPA058220: AB_2683642" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.00e-2)" "unprognostic (1.87e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.47e-3)" "unprognostic (1.02e-1)" "unprognostic (2.54e-5)" "unprognostic (2.31e-2)" "unprognostic (0.00e+0)" "unprognostic (6.28e-3)" "unprognostic (3.31e-1)" "unprognostic (8.14e-2)" "unprognostic (7.44e-2)" 0.4 0.6 0.2 2.7 0.4 9.0 2.6 0.3 0.3 0.7 2.0 0.4 0.2 1.8 0.4 0.5 3.8 0.2 0.2 0.5 0.3 0.3 0.4 0.8 1.2 4.7 0.2 0.2 0.3 0.3 0.0 0.2 2.8 0.6 0.6 1.8 0.4 0.9 0.2 0.2 1.4 2.4 0.8 0.6 2.0 1.1 4.5 0.2 34.4 0.3 0.6 4.9 0.8 1.3 0.5 0.1 2.4 0.2 0.7 1.9 0.2 15.6 9.3 14.7 8.2 0.4 1.7 8.2 10.8 6.4 10.3 9.4 5.6 8.2 9.5 3.9 5.1 6.4 12.5 11.7 7.2 14.9 11.6 6.2 15.2 13.2 5.4 0.0 23.8 8.7 0.3 0.3 11.5 9.9 2.2 7.3 14.3 22.8 12.4 12.8 6.4 13.9 7.4 12.4 4.6 8.2 12.8 19.5 12.1 3.5 4.5 7.0 7.8 15.3 5.2 6.2 11.5 7.0 6.1 6.0 8.2 9.7 8.9 18.7 4.5 4.5 13.9 4.8 12.8 16.6 2.4 0.1 0.1 0.1 0.2 0.1 0.5 0.5 0.4 0.0 0.4 0.2 0.1 0.5 0.7 0.1 0.1 1.9 0.2 0.2 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 0.0 0.0 1.5 0.9 2.2 2.0 0.8 0.0 1.4 1.2 0.0 2.0 1.0 0.0 0.2 2.5 0.5 0.0 0.0 0.0 6.3 1.7 0.8 2.3 0.9 4.3 0.0 0.0 1.8 2.6 1.5 0.6 1.0 0.0 0.0 0.8 0.6 0.2 0.0 0.7 0.0 0.7 6.5 0.4 20.6 18.9 0.6 1.1 0.7 1.2 1.4 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020620-28108308 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3;testis: 16.9" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 22.1;Erythroid cells: 23.3;Spermatocytes: 76.3;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" Yes Yes "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.9 0.5 0.6 3.9 0.8 7.9 0.6 0.9 0.9 0.8 2.1 0.3 0.0 1.5 0.5 0.8 3.1 0.5 0.4 0.5 0.7 0.5 1.8 0.5 1.5 4.8 0.5 0.0 0.6 0.5 0.0 0.6 3.4 0.8 0.5 2.2 1.3 0.9 1.6 0.8 1.3 1.9 0.6 0.9 2.7 1.0 16.9 0.2 31.3 2.8 2.0 4.9 1.0 1.2 2.3 0.7 6.4 0.4 2.8 2.2 0.4 12.5 12.6 12.8 8.9 0.4 1.8 4.3 13.1 6.1 20.9 22.0 4.2 5.1 10.6 4.7 6.7 11.4 12.7 10.9 5.1 29.4 10.5 6.6 6.9 8.6 5.3 1.0 10.1 6.3 3.3 0.6 7.3 8.6 3.7 8.0 8.8 10.9 9.3 11.8 6.6 10.2 7.5 6.3 8.2 5.2 8.0 30.6 5.2 5.9 3.7 7.7 5.9 10.9 5.2 3.6 8.2 11.1 3.1 4.6 16.7 13.0 15.6 17.0 3.7 8.7 10.7 10.0 7.5 11.7 6.4 0.0 0.8 0.2 0.4 0.8 2.3 0.9 0.5 0.7 1.0 0.8 0.3 0.0 2.8 0.1 0.6 2.2 0.4 0.6 0.8 0.9 0.9 0.7 0.5 0.5 0.0 0.8 0.2 3.0 0.0 6.0 1.0 2.1 0.2 0.4 0.0 2.7 3.4 0.0 5.9 2.6 0.0 0.5 22.1 0.3 0.5 23.3 0.8 6.4 0.4 0.2 4.6 0.0 1.9 0.0 1.7 1.3 1.0 4.0 0.6 1.1 0.0 1.8 0.9 0.3 0.4 0.0 0.4 0.5 1.6 0.0 0.3 76.3 16.2 0.9 1.4 3.2 1.4 0.1 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947711 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 12.3;lymphoid tissue: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.7 0.6 0.5 8.2 0.4 12.3 0.4 0.4 0.5 0.9 1.6 0.3 0.7 2.9 0.5 0.6 3.2 0.3 1.3 1.5 0.5 0.5 0.5 0.7 0.8 5.9 0.6 0.1 0.6 0.4 0.0 0.4 1.9 0.2 0.5 1.5 0.1 0.7 0.1 0.4 2.9 2.5 0.8 0.4 1.7 1.5 3.8 0.1 34.7 0.4 2.7 7.6 0.7 1.1 1.1 0.8 2.0 0.6 1.0 1.4 0.4 14.4 18.8 16.2 15.1 0.4 1.4 13.6 12.4 4.6 15.6 12.3 15.6 12.5 12.8 5.3 4.7 10.0 15.9 11.1 5.0 7.9 26.3 16.6 16.5 21.2 9.6 0.0 13.6 14.5 0.3 0.2 13.5 5.4 2.1 7.9 13.3 12.4 21.8 8.0 11.2 25.3 13.4 11.9 13.1 13.0 19.4 24.7 8.5 2.5 7.9 12.2 11.8 8.3 7.5 4.6 7.8 14.1 9.7 5.2 23.3 23.1 13.7 26.0 7.0 6.9 15.7 7.5 10.4 15.0 1.8 0.6 0.4 0.5 0.3 0.4 0.8 0.7 0.5 0.3 1.1 0.4 0.5 2.0 1.0 0.3 0.8 1.4 0.4 0.5 0.4 0.4 0.4 0.5 0.5 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.5 0.4 0.7 0.5 0.6 0.1 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Cell type enhanced" "Detected in some" 23 "Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" Yes Yes "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.2 15.0 33.2 22.0 1.7 3.3 14.3 19.3 17.7 42.1 31.8 28.2 20.8 9.6 10.4 24.3 15.8 22.1 31.1 36.1 42.2 14.0 14.7 14.2 26.8 17.9 0.1 6.9 6.6 1.2 0.6 22.4 12.9 7.1 27.2 13.7 5.9 18.4 29.1 20.4 11.6 6.8 21.0 13.1 16.4 12.8 33.3 9.9 11.5 11.0 9.9 9.8 36.5 12.4 8.5 44.5 15.8 7.2 12.9 11.0 16.4 9.9 32.2 9.5 9.1 10.7 7.1 20.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 0.0 1.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 46.7 0.0 10.5 0.4 0.1 4.6 0.0 4.9 0.0 0.0 3.7 1.0 1.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 17.9 4.6 0.4 0.8 0.0 1.6 0.0 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 36.0 7.4 10.8 9.6 2.1 3.7 9.0 14.8 13.6 15.6 16.4 9.7 16.7 14.0 4.7 7.5 5.8 18.4 12.0 8.3 21.0 16.8 8.2 14.2 12.9 8.4 0.6 24.1 11.8 1.5 1.2 15.0 15.4 5.5 10.0 7.4 13.5 16.2 13.8 6.2 14.1 4.6 11.1 5.9 7.1 9.8 21.3 6.1 4.8 4.8 3.4 6.2 10.6 4.8 5.6 8.1 12.6 7.0 7.8 10.0 10.1 13.0 23.8 4.5 12.2 18.8 9.5 21.5 7.4 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 3.0 15.7 46.6 7.4 15.8 11.8 7.1 2.5 6.7 7.9 0.0 9.8 9.8 3.3 5.1 8.6 7.8 5.9 70.0 4.0 30.5 12.7 3.4 43.8 3.8 17.2 12.7 1.2 8.6 11.6 9.6 7.5 16.4 5.0 9.0 5.4 6.4 2.9 5.7 8.1 2.4 9.1 6.5 15.5 149.9 96.9 12.3 4.3 26.1 13.0 2.2 KIF22 "Kid, KNSL4, OBP-1, OBP-2" ENSG00000079616 "Kinesin family member 22" Q14807 16 29790719-29805385 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.2" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 228.4;Hepatocytes: 445.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048213, HPA075670" Enhanced Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA048213: AB_2680316, HPA075670: " "unprognostic (3.71e-2)" "prognostic favorable (3.87e-8)" "unprognostic (1.86e-1)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (6.06e-3)" "unprognostic (5.06e-3)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (4.73e-2)" "unprognostic (7.84e-2)" "unprognostic (2.10e-2)" "unprognostic (2.21e-2)" "unprognostic (3.67e-2)" "unprognostic (2.62e-1)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" 5.6 4.3 8.5 21.7 11.2 38.9 7.0 6.4 10.9 5.1 12.5 8.8 3.0 8.4 5.1 10.1 13.6 6.5 6.0 5.6 6.2 5.9 7.2 4.5 5.8 16.1 6.3 6.2 5.8 3.9 18.6 5.7 22.1 5.8 13.2 10.7 8.9 6.3 9.6 4.0 16.7 9.6 4.1 5.8 11.6 5.9 17.9 5.9 78.2 16.8 13.1 19.0 6.5 7.6 13.6 6.6 19.7 9.1 13.3 25.0 17.1 21.5 23.2 30.6 22.1 2.1 3.1 26.9 16.4 13.2 31.4 29.4 22.2 25.9 31.5 15.4 8.5 15.6 22.5 29.8 16.8 14.8 20.5 23.9 17.4 25.2 28.1 0.7 19.0 19.4 1.7 4.5 17.4 13.2 4.4 16.9 36.5 25.5 26.3 16.4 43.9 41.3 47.7 25.7 16.1 14.3 57.9 27.2 30.0 11.3 10.1 25.5 16.5 11.9 23.9 8.3 10.5 21.4 25.7 7.4 16.4 17.3 14.5 17.6 24.7 24.4 34.0 10.7 31.3 20.9 19.7 6.4 17.0 23.6 9.1 17.6 13.6 23.7 25.0 6.6 11.3 19.5 18.5 2.8 13.3 7.7 4.2 24.0 17.1 8.5 11.2 6.4 10.9 6.2 5.9 6.3 6.2 5.8 5.9 29.8 104.5 22.9 29.2 27.4 27.2 228.4 58.6 28.1 38.7 66.3 23.6 50.7 53.0 13.7 7.8 21.8 20.4 46.7 43.2 72.5 31.0 20.0 40.6 445.7 42.2 6.4 39.7 38.6 48.9 6.4 14.4 41.1 33.7 20.8 36.3 35.5 16.6 42.1 12.0 77.3 19.7 12.9 32.6 52.8 47.7 24.1 64.3 26.6 38.5 11.1 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290090-70420832 "Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;lymphoid tissue: 19.3" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.9 0.6 0.8 3.3 1.0 11.1 0.5 0.4 3.4 1.2 4.1 0.4 0.4 3.4 0.8 0.4 7.4 1.5 2.5 2.0 0.8 1.3 0.7 0.7 1.5 5.8 0.5 0.9 0.4 0.4 0.0 1.3 2.4 0.8 0.7 5.2 0.4 1.2 0.4 0.8 2.3 3.6 1.2 0.5 4.9 2.1 7.5 1.1 19.3 0.4 0.4 7.2 1.1 2.0 0.7 0.0 0.0 0.2 0.2 3.2 0.3 22.5 15.8 23.9 11.7 1.1 2.0 9.4 17.2 9.2 23.5 20.5 17.7 13.3 13.9 10.8 8.4 18.2 13.6 25.8 9.3 26.6 15.9 13.0 15.7 19.3 12.5 0.2 17.4 10.9 0.7 0.5 19.5 11.2 2.8 14.3 10.7 19.9 30.9 22.1 14.5 15.9 8.6 24.1 24.1 16.8 17.7 32.3 13.0 5.6 8.9 15.8 13.2 28.0 11.9 7.3 12.6 9.5 6.8 9.9 15.6 20.3 16.7 20.4 8.9 15.3 20.1 8.2 19.1 23.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 3.2 0.3 0.8 1.0 0.4 3.4 0.8 1.3 0.5 0.9 0.8 1.1 0.0 0.3 0.0 0.2 1.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 46.7 0.0 10.3 1.0 0.1 0.0 0.0 4.3 0.0 1.2 1.8 0.6 0.5 0.0 0.9 0.0 0.0 1.2 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 7.2 5.8 0.3 1.5 0.5 2.1 0.3 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009010-32056431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" NA Yes 260000 "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 26.3 19.9 55.7 20.2 55.5 34.1 23.0 22.2 42.4 23.8 34.2 21.7 20.9 23.5 25.7 17.8 28.0 20.3 28.0 48.4 51.5 39.3 21.1 15.3 23.8 16.5 62.9 26.1 18.2 18.9 56.8 22.4 27.7 38.3 31.8 30.0 8.9 20.1 25.6 34.3 17.6 28.6 37.2 80.4 21.1 23.1 27.7 43.7 25.0 23.5 21.5 16.1 33.8 28.1 13.8 27.6 30.0 18.9 13.4 16.5 9.2 30.0 25.6 34.6 24.3 24.8 27.5 14.8 41.5 19.7 32.1 27.5 28.1 33.3 20.6 18.0 49.2 18.3 25.0 31.6 26.5 43.1 17.7 17.2 26.2 23.9 27.3 28.6 18.2 28.9 22.2 37.7 37.0 25.9 25.6 41.0 18.3 31.5 21.8 44.3 18.1 18.9 10.3 5.6 28.9 11.7 24.9 64.6 8.5 24.7 21.1 33.7 24.6 32.1 12.8 30.9 25.2 15.5 26.1 34.1 32.7 30.7 37.8 30.7 6.6 7.5 24.3 31.1 37.7 30.7 20.8 15.2 24.2 11.8 18.9 11.4 13.6 14.9 12.5 14.2 13.8 13.3 13.0 30.0 13.4 18.9 27.6 16.5 9.2 55.7 55.5 22.2 42.4 51.5 39.3 62.9 26.1 38.3 43.7 169.7 163.3 57.7 133.6 189.3 172.7 357.9 96.8 192.7 126.3 99.5 94.2 100.8 38.1 183.2 92.5 169.2 111.4 46.7 153.7 110.6 139.0 208.1 87.9 41.0 117.4 143.0 127.0 87.2 110.1 28.3 54.7 125.3 96.2 194.8 188.9 82.6 173.1 143.2 123.1 50.5 125.5 84.1 199.1 513.7 177.6 206.9 277.6 86.3 159.0 207.4 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391536-33409924 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 60.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 21.5;Erythroid cells: 70.0;Extravillous trophoblasts: 32.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055997, HPA062674" Enhanced Approved Centrosome NA Yes Centrosome "HPA055997: AB_2683001, HPA062674: AB_2684829" "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 0.9 0.8 0.0 18.0 0.3 9.6 1.5 0.0 0.5 1.7 5.7 0.1 0.3 3.0 0.9 1.6 10.1 0.5 2.2 0.8 0.0 0.0 0.7 0.7 2.2 6.3 0.1 0.2 1.5 0.3 0.2 0.2 3.6 0.4 0.6 2.5 0.6 1.7 0.1 0.4 3.3 4.2 0.7 0.4 4.7 2.5 9.7 0.2 60.9 0.4 7.4 14.6 0.6 2.8 0.8 0.3 0.0 0.1 0.2 1.4 0.7 10.7 1.8 10.3 10.9 0.2 0.4 6.3 7.8 2.0 6.2 5.2 3.8 4.8 7.1 3.0 1.6 8.2 5.8 2.6 3.6 6.8 4.2 5.9 5.7 8.7 5.5 0.0 4.7 6.4 0.0 0.9 5.1 1.5 0.7 0.6 5.2 1.7 17.6 4.6 2.7 2.8 9.4 4.7 3.0 2.2 7.1 5.8 2.4 0.9 2.4 9.4 4.2 2.8 6.0 1.5 4.1 6.3 4.9 1.4 3.3 10.1 5.4 11.6 5.8 11.0 6.9 0.0 7.0 5.8 0.0 0.1 0.0 0.4 0.0 0.6 0.8 0.3 1.4 0.3 0.8 0.3 0.3 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.2 0.0 4.5 5.2 0.7 4.9 0.4 0.4 0.0 0.0 2.3 0.0 0.0 6.7 0.0 0.6 21.5 1.4 2.9 70.0 0.0 32.5 2.9 0.8 1.1 0.0 11.9 0.0 0.0 2.5 2.5 9.8 0.3 4.9 3.3 5.4 3.4 0.2 0.2 2.8 0.7 0.0 0.5 0.0 1.0 11.2 6.9 3.1 5.6 4.3 4.6 2.4 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409358 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 7.6 5.4 8.9 14.0 7.5 20.2 7.9 9.8 14.1 13.9 9.1 9.9 21.4 7.3 15.7 9.5 22.3 12.3 8.3 10.9 8.1 5.5 6.7 7.4 8.7 8.4 7.8 10.6 7.2 13.1 6.8 7.4 9.9 12.8 18.6 9.1 7.9 19.3 12.5 13.6 15.6 9.1 11.0 10.3 13.3 9.0 5.2 8.6 42.2 17.2 8.9 19.7 12.3 14.2 3.5 3.8 7.8 3.8 4.1 5.4 0.6 12.4 7.9 9.5 14.6 6.1 10.9 13.0 18.6 8.9 10.8 9.5 9.0 7.3 28.7 10.8 12.3 4.0 11.6 13.6 6.8 11.6 12.1 14.1 24.1 8.3 4.5 9.1 18.7 6.1 4.6 8.6 11.7 10.9 10.4 8.8 12.3 43.6 13.4 8.8 9.0 18.9 27.9 4.4 11.3 9.0 22.5 8.1 7.8 7.5 15.2 13.0 10.2 18.5 9.4 8.5 8.8 13.1 23.9 11.2 12.2 8.9 14.5 13.3 7.5 7.8 26.3 8.4 9.8 10.2 4.1 2.5 7.8 2.8 3.8 5.4 3.5 3.3 4.3 2.0 2.3 1.8 2.3 3.4 4.1 3.6 3.8 2.7 0.6 8.9 7.5 9.8 14.1 8.1 5.5 7.8 10.6 12.8 8.6 11.9 12.6 0.0 14.2 0.0 19.6 0.0 5.1 21.4 12.5 26.2 5.9 10.7 6.6 8.0 7.4 11.3 8.5 0.0 8.1 13.9 8.7 20.1 2.3 13.4 15.1 3.2 4.7 28.8 17.1 2.1 15.0 10.3 0.0 1.0 28.5 22.4 11.3 10.5 40.3 8.3 16.8 6.5 0.0 8.9 11.7 0.0 11.9 8.2 12.4 19.3 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 54.7;testis: 35.6" "Cell type enhanced" "Detected in some" 12 "Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.7 0.5 0.3 7.1 0.4 5.4 0.7 0.3 0.3 0.6 4.0 0.1 0.0 1.5 0.4 0.8 3.9 0.4 0.9 0.5 0.4 0.4 0.9 1.0 1.3 4.7 0.3 0.0 0.5 0.5 0.0 0.4 2.8 0.1 0.5 1.5 0.0 0.8 0.0 0.4 0.8 3.9 0.5 0.4 3.3 0.8 35.6 0.0 54.7 0.5 4.1 3.7 0.7 0.9 2.9 1.2 0.7 0.5 0.7 2.5 0.0 10.9 5.6 11.5 8.3 0.3 1.7 5.1 12.8 5.2 10.0 8.5 6.9 4.4 7.3 4.1 5.5 7.6 13.7 10.8 6.0 10.6 12.6 3.0 21.4 9.6 2.0 0.0 16.3 10.8 0.3 0.2 6.7 4.2 1.3 8.5 13.0 13.7 12.2 11.7 3.7 13.9 3.3 5.6 6.6 6.0 12.7 16.5 3.6 1.5 9.7 9.9 4.6 11.1 6.3 1.3 3.8 6.8 5.0 7.9 11.7 10.4 13.4 7.1 4.7 15.9 14.2 4.7 11.1 11.1 0.4 0.2 0.1 0.1 0.1 0.0 2.9 1.1 0.1 1.2 2.2 0.0 0.7 0.7 0.7 0.5 0.1 2.5 0.0 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 1.8 0.0 2.4 1.7 0.2 0.0 0.0 0.0 0.0 0.5 9.3 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin/SPAG5 binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8" "Group enriched" "Detected in many" 4 "Early spermatids: 321.9;Late spermatids: 423.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 5.5 4.4 6.7 5.5 6.3 7.3 9.0 8.1 7.0 3.3 4.5 4.0 8.0 5.3 3.9 7.8 6.2 3.4 2.5 4.1 6.0 5.3 4.2 7.0 4.1 8.0 4.6 7.1 3.4 3.5 6.0 4.2 7.4 6.8 4.4 6.3 2.5 6.4 5.0 7.5 4.2 4.1 5.9 4.3 4.8 6.2 40.1 4.5 18.4 59.8 6.0 9.1 3.8 3.7 5.9 11.0 10.0 26.2 5.5 5.5 4.0 31.2 14.7 29.4 19.2 6.5 10.1 15.3 21.7 16.9 44.9 39.7 31.5 13.8 12.1 11.1 14.6 35.8 36.2 31.3 20.1 40.7 21.5 15.3 35.9 33.0 19.8 6.1 19.2 18.8 5.2 11.6 22.6 22.7 11.0 25.1 30.5 25.8 21.0 37.7 15.8 16.6 15.5 18.5 26.8 22.4 17.1 22.1 14.0 15.6 13.0 28.7 19.9 18.1 20.0 4.8 18.6 20.9 13.8 12.9 21.7 22.2 22.1 30.0 18.0 29.1 21.8 13.4 25.8 17.7 4.8 10.3 10.0 4.8 14.5 4.4 5.9 3.6 4.4 11.0 5.4 3.5 3.6 5.9 5.5 26.2 7.5 5.5 4.0 6.7 6.3 8.1 7.0 6.0 5.3 4.6 7.1 6.8 4.5 8.9 0.6 0.8 3.1 1.9 7.8 4.7 2.5 9.4 5.7 0.0 7.9 14.3 3.3 9.5 321.9 1.7 1.6 46.7 8.1 35.4 6.2 3.8 1.1 5.7 18.4 4.8 2.4 3.1 7.5 423.6 8.3 7.6 3.3 8.2 3.6 7.0 8.7 0.0 6.7 4.4 7.4 0.0 2.7 83.7 18.1 1.3 17.6 3.2 3.0 2.8 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 663.6;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 62.2 81.9 78.2 31.3 11.6 11.3 49.7 55.0 42.7 88.9 69.4 56.3 29.2 58.5 17.4 31.7 44.3 34.5 86.4 42.9 102.4 23.5 50.9 51.8 39.6 53.7 12.2 44.5 35.7 7.0 8.1 51.1 31.5 12.5 85.5 25.0 41.1 42.3 78.8 58.1 55.5 28.7 52.8 50.8 42.5 30.7 71.4 32.0 35.0 29.2 31.1 34.6 30.9 99.8 32.3 74.7 58.1 22.4 33.3 49.3 61.0 34.7 73.9 35.1 50.2 58.4 24.0 38.3 52.9 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 11.9 32.3 47.6 33.0 97.4 19.1 12.6 7.6 8.1 18.2 17.4 7.9 59.0 13.3 31.3 663.6 49.2 9.8 70.0 22.3 244.0 94.4 18.1 43.8 15.3 104.7 30.2 41.1 16.0 36.5 186.9 17.8 52.4 50.6 104.6 9.7 29.4 18.3 10.5 13.8 26.9 17.8 32.3 72.6 296.7 211.0 77.3 99.4 34.5 15.8 20.4 LBR "DHCR14B, TDRD18" ENSG00000143815 "Lamin B receptor" Q14739 1 225401502-225428925 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "DNA-binding, Oxidoreductase, Receptor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 88.7" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049840, HPA062236" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "HPA049840: AB_2680908, HPA062236: AB_2684721" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (2.14e-3)" "unprognostic (1.32e-2)" "unprognostic (7.96e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.60e-2)" "unprognostic (1.11e-2)" "unprognostic (3.43e-2)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (6.42e-2)" "unprognostic (2.08e-1)" "unprognostic (5.45e-1)" "unprognostic (8.32e-2)" "unprognostic (2.78e-1)" 16.7 4.2 5.6 22.9 7.8 37.0 14.6 5.5 7.2 23.4 37.7 14.5 10.8 16.8 31.4 19.5 17.2 21.8 11.1 7.2 6.5 6.1 15.4 18.9 12.3 31.0 9.9 4.2 14.3 11.8 2.4 5.0 11.2 9.4 19.6 19.7 6.2 8.2 16.6 6.8 7.3 20.4 32.8 9.9 25.4 21.5 8.0 8.9 88.7 8.7 6.9 28.1 28.8 16.2 14.1 13.1 70.9 15.0 12.2 19.9 20.2 25.1 9.9 33.5 14.9 14.1 8.8 16.9 6.6 8.4 13.9 14.9 19.8 43.4 51.9 14.8 6.9 8.3 19.2 23.9 7.0 21.0 30.2 24.8 12.9 9.6 16.9 8.7 56.1 22.9 7.6 4.5 12.6 11.2 7.2 17.6 25.7 39.1 35.3 9.3 3.5 51.4 31.7 30.2 24.7 3.4 34.7 30.5 48.3 15.9 11.8 9.0 11.9 11.3 8.4 5.5 15.2 11.5 37.0 11.5 3.8 20.0 10.7 23.8 12.7 17.3 58.0 5.2 25.4 13.0 22.2 15.0 21.1 15.3 10.1 17.1 13.8 14.6 16.2 13.1 14.1 14.7 17.4 70.9 12.2 7.8 6.6 19.9 20.2 5.6 7.8 5.5 7.2 6.5 6.1 9.9 4.2 9.4 8.9 26.8 31.3 74.4 22.1 24.0 4.2 5.1 50.9 28.1 45.5 29.6 5.9 27.8 5.0 20.9 0.7 42.7 17.2 163.5 17.2 18.7 25.9 27.1 9.3 64.4 38.4 11.1 25.9 44.2 84.0 2.3 31.4 51.1 25.3 15.4 30.9 12.0 18.1 21.0 30.4 22.5 9.8 38.8 33.0 14.0 27.7 31.0 9.3 46.3 62.8 28.9 LIMK2 ENSG00000182541 "LIM domain kinase 2" P53671 22 31212239-31280080 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 14.7;neutrophil: 37.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 37.2" "Cell line enhanced" "Detected in all" "BEWO: 37.6;hTCEpi: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008183, CAB019313, HPA053882" Approved Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (4.02e-2)" "unprognostic (5.99e-2)" "unprognostic (1.21e-1)" "unprognostic (2.95e-1)" "unprognostic (3.96e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.57e-6)" "unprognostic (4.48e-2)" "unprognostic (1.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.37e-1)" 9.4 6.6 23.5 23.6 26.2 29.4 17.0 9.9 16.8 11.0 20.9 15.6 10.7 13.1 12.9 8.7 33.7 22.1 28.7 6.0 15.4 10.7 15.4 19.9 21.6 18.1 20.8 7.2 11.4 19.9 20.0 12.8 64.3 23.3 17.1 22.1 10.1 25.7 16.2 9.7 36.7 13.3 10.1 28.3 17.4 18.5 16.8 17.9 12.4 25.8 15.6 15.3 13.1 20.0 1.0 1.6 37.2 1.9 2.4 5.6 1.6 7.0 1.1 4.9 2.7 2.1 2.5 37.6 4.6 2.2 4.7 4.0 6.0 3.3 6.9 8.3 7.0 2.2 14.3 5.7 24.5 2.9 5.0 6.2 5.0 5.5 6.5 3.2 9.2 9.2 4.0 69.7 3.8 11.5 32.0 11.9 5.6 2.7 5.0 6.4 5.5 5.6 3.1 4.6 18.2 1.8 7.4 8.3 3.8 5.4 16.7 6.3 5.6 3.5 22.6 9.3 15.9 18.8 3.7 7.2 4.2 6.6 2.3 4.3 2.8 4.1 6.0 2.6 4.3 1.8 2.1 1.9 14.7 1.3 1.3 2.4 0.8 2.3 1.7 0.7 1.0 2.3 1.8 37.2 2.4 0.5 1.6 5.6 1.6 23.5 26.2 9.9 16.8 15.4 10.7 20.8 7.2 23.3 17.9 29.8 17.0 3.0 42.2 31.9 7.0 19.8 12.7 33.5 28.4 5.2 19.6 59.9 3.3 10.9 1.0 19.3 16.9 0.0 38.9 46.0 10.8 19.1 23.1 6.8 15.7 3.2 12.7 12.9 7.9 1.3 4.0 11.8 3.3 2.8 41.8 15.6 22.5 10.5 4.2 8.1 23.2 19.4 4.1 9.8 10.4 34.3 96.6 8.7 49.0 20.7 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055608-120067074 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 100.5;Spermatocytes: 142.5;Spermatogonia: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (5.15e-5)" "prognostic unfavorable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavorable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 1.4 1.8 2.4 4.2 5.7 10.3 2.4 4.4 4.1 1.9 4.4 1.2 0.3 3.8 1.7 1.4 6.5 2.9 1.1 1.7 2.7 2.7 1.2 1.2 1.5 7.6 2.3 3.6 1.7 1.2 0.7 1.0 3.5 2.4 1.6 5.5 0.7 2.4 1.2 1.2 2.3 4.2 1.8 2.8 3.8 1.9 13.7 1.2 27.3 1.2 8.2 7.3 2.1 2.4 1.8 2.2 2.0 0.8 2.5 3.9 1.7 14.7 6.4 15.2 9.9 1.6 2.0 6.5 11.7 6.6 12.2 9.5 8.6 9.1 21.7 3.9 4.2 5.4 4.0 15.1 8.9 17.2 10.2 10.6 12.0 6.3 8.1 0.5 19.5 6.9 1.1 1.3 8.3 5.2 3.1 7.0 9.3 14.3 12.4 6.4 6.5 18.7 8.5 10.4 7.7 7.4 9.7 20.4 8.9 5.0 5.7 16.2 11.5 5.8 7.2 3.6 7.8 4.8 7.2 4.4 8.3 9.4 8.3 14.7 11.6 12.4 14.2 7.7 10.1 10.8 2.0 0.5 0.4 1.6 0.5 2.1 1.8 3.8 3.0 0.4 1.4 3.5 3.5 1.3 2.5 0.8 2.2 3.9 1.7 2.4 5.7 4.4 4.1 2.7 2.7 2.3 3.6 2.4 1.2 0.0 2.2 6.0 6.3 15.3 8.5 3.0 2.5 6.7 2.3 7.0 2.0 18.3 0.0 2.9 1.8 3.1 2.9 23.3 1.4 100.5 6.1 4.5 15.0 1.6 23.3 19.1 1.7 2.5 6.3 3.6 4.4 6.2 8.5 4.6 8.1 10.6 1.7 2.9 1.4 4.3 3.6 12.9 6.6 142.5 91.0 7.9 9.0 17.9 16.2 4.5 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215560-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 35.8" "Group enriched" "Detected in some" 11 "Sertoli cells: 12.9;Spermatocytes: 16.1;Spermatogonia: 45.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 26.1;K-562: 18.8;Karpas-707: 22.8;U-2 OS: 27.2;U-266/70: 44.8;U-266/84: 46.8" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 27.2 0.0 0.0 44.8 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 16.1 45.1 0.0 0.0 0.0 0.0 0.0 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 18.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.6 2.6 1.5 2.9 0.6 0.1 18.9 2.7 0.3 0.3 0.6 2.0 1.6 1.4 0.6 0.7 0.8 2.2 0.3 1.3 0.0 2.1 0.9 0.8 5.3 2.3 1.2 0.2 4.9 0.8 1.7 1.4 0.6 1.4 0.6 2.5 2.7 1.2 0.2 4.2 1.0 3.7 1.4 1.1 0.7 1.6 0.4 2.5 0.9 1.4 1.7 2.1 0.6 1.3 1.1 1.0 4.4 0.9 0.8 7.6 4.8 1.5 0.4 3.1 1.6 0.4 1.7 2.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 0.0 4.3 0.0 0.8 0.7 5.4 6.2 12.7 2.7 0.0 1.8 0.0 2.2 1.7 0.8 1.7 1.4 19.8 0.0 4.4 2.8 2.6 1.3 0.0 16.6 2.4 15.9 0.0 2.5 2.4 1.9 1.7 2.2 0.0 1.0 19.5 2.6 0.9 12.5 1.4 2.1 7.4 0.0 1.4 1.2 2.2 0.4 1.9 1.3 10.3 0.7 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell type enhanced" "Detected in many" 9 "monocytes: 1596.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Cell line enhanced" "Detected in many" "AF22: 108.3;NTERA-2: 104.4" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" NA Yes 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: AB_2673514" "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavorable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.4 7.6 108.3 44.2 2.4 0.9 19.2 3.5 2.2 10.6 7.0 18.0 6.2 19.0 13.3 2.4 0.0 4.5 34.9 0.4 7.8 0.4 25.8 1.0 2.9 39.7 7.5 4.9 0.1 12.4 1.4 7.9 0.2 16.5 30.9 32.8 29.1 0.2 14.2 20.0 61.7 20.9 104.4 27.4 17.6 77.1 11.6 9.0 15.9 16.8 67.2 63.9 18.6 20.6 58.5 46.0 14.3 8.8 9.1 4.5 26.3 0.4 6.7 2.9 0.2 49.9 0.5 7.5 23.7 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 0.0 2.2 147.6 95.4 83.2 17.7 7.3 163.1 2.7 4.5 57.6 5.9 9.9 69.6 353.9 21.7 181.6 54.0 0.0 269.1 98.8 68.7 341.5 23.0 3.8 20.1 9.5 716.9 486.2 57.0 35.8 567.8 77.4 285.1 1596.0 443.0 406.9 517.8 228.0 602.9 1.2 12.4 129.4 72.9 6.2 129.4 72.6 11.2 47.2 387.2 506.2 MASTL "FLJ14813, Gwl, THC2" ENSG00000120539 "Microtubule associated serine/threonine kinase like" Q96GX5 10 27154824-27186924 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027175, HPA054273" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA027175: AB_1853591, HPA054273: AB_2682433" "unprognostic (4.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.22e-2)" "unprognostic (3.14e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (2.19e-2)" "unprognostic (4.00e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.81e-5)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (1.55e-3)" "unprognostic (2.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.79e-1)" 9.1 7.0 3.6 8.9 6.1 21.1 8.3 4.0 7.5 7.4 7.6 3.8 5.7 5.7 6.0 6.7 12.3 5.4 5.3 5.6 6.8 4.5 6.5 7.1 10.2 14.8 5.4 5.7 7.0 12.7 6.7 6.3 14.2 6.7 5.5 7.1 5.6 8.0 4.7 4.0 10.1 10.0 6.1 5.6 8.7 6.2 11.3 2.3 21.1 6.5 4.3 12.3 8.7 7.5 3.9 2.6 5.6 4.9 2.3 4.0 1.8 11.9 9.6 18.4 6.8 2.8 4.2 10.9 17.9 7.5 29.7 36.6 11.6 12.0 9.6 6.8 7.5 14.4 11.6 11.7 7.1 21.1 8.1 11.3 11.3 6.7 6.7 1.6 4.3 8.5 2.5 3.2 17.9 3.5 3.9 6.4 7.8 8.6 21.6 18.0 7.9 14.0 4.7 13.7 6.7 3.9 9.0 30.7 7.9 7.3 4.5 8.2 11.8 11.3 7.6 7.9 12.7 7.6 9.1 5.5 7.4 15.6 18.9 15.7 2.6 4.2 14.1 8.1 13.1 6.1 0.1 4.4 3.8 2.0 4.3 3.0 2.6 2.5 1.8 2.5 3.9 2.5 2.3 5.6 2.3 4.9 2.6 4.0 1.8 3.6 6.1 4.0 7.5 6.8 4.5 5.4 5.7 6.7 2.3 6.0 8.5 7.2 4.0 9.7 1.9 1.6 0.0 4.0 9.1 1.8 0.0 3.3 0.0 3.2 1.7 3.6 3.0 0.0 2.2 20.7 5.8 3.3 12.7 1.7 5.1 3.2 4.1 2.5 12.0 1.5 2.8 5.6 0.0 1.8 3.4 1.5 3.6 1.9 2.5 1.4 0.9 0.0 5.9 11.2 16.4 8.7 5.1 8.7 3.5 5.9 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.7 15.5 18.4 13.9 0.6 1.1 8.0 14.4 2.2 16.2 16.9 15.1 9.8 20.7 6.5 3.6 6.0 16.1 25.8 8.5 15.0 10.8 12.3 25.8 6.9 10.0 0.0 13.2 11.7 0.2 0.3 16.4 1.5 1.3 5.2 16.8 30.4 14.2 8.8 12.3 31.3 5.7 10.9 13.2 3.8 24.8 16.3 12.8 3.7 5.0 3.7 14.0 11.6 8.3 2.2 10.0 10.4 9.1 3.2 10.3 19.4 15.5 15.5 4.4 17.1 27.2 6.6 14.6 8.0 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 0.0 0.0 1.5 0.2 1.4 0.0 1.2 0.0 0.0 1.2 0.0 0.0 4.1 0.0 0.4 1.1 0.1 0.0 23.3 0.2 17.2 1.0 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.9 5.9 14.0 0.4 2.9 1.0 1.8 0.0 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598223-127622436 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 69.9" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 8600 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 2.9 3.7 2.1 24.3 4.0 32.5 3.5 6.7 3.2 4.7 7.1 3.3 2.2 4.7 4.7 5.9 11.2 4.8 5.4 3.6 2.0 2.3 3.9 3.4 3.4 14.6 2.2 3.5 5.1 3.0 2.4 2.4 26.4 3.0 3.2 6.0 2.5 4.7 1.9 7.0 6.0 7.1 2.9 2.9 13.3 3.8 20.3 3.9 69.9 4.1 16.6 20.7 3.4 5.1 10.4 3.6 0.9 1.4 5.8 10.6 3.4 25.1 21.4 23.5 20.5 1.4 3.0 23.0 13.2 8.5 26.6 29.0 35.5 16.7 27.1 12.9 6.5 22.8 20.3 41.9 15.2 16.6 22.4 26.2 44.9 28.7 25.8 0.9 41.9 19.6 1.6 1.7 18.0 2.7 3.2 8.3 29.6 22.3 24.9 9.8 33.3 38.8 30.7 34.4 21.6 18.9 43.6 33.7 38.8 5.5 19.5 29.3 22.2 33.9 10.1 3.5 9.9 21.7 32.9 4.2 20.7 17.7 25.5 17.8 25.8 29.2 67.4 14.3 31.7 7.9 0.0 0.6 0.2 4.7 1.4 5.9 10.4 4.1 5.5 2.8 9.2 3.9 5.0 0.9 5.8 0.3 3.6 10.6 3.4 2.1 4.0 6.7 3.2 2.0 2.3 2.2 3.5 3.0 3.9 3.0 1.3 6.7 1.7 4.0 2.2 7.6 0.0 10.7 5.7 0.0 0.0 45.7 0.0 4.1 0.7 1.7 1.0 0.0 1.6 22.4 3.3 0.7 1.1 1.7 15.2 0.0 3.5 1.3 1.6 0.7 1.7 1.6 1.7 15.4 5.1 1.5 1.7 0.0 1.4 0.5 1.7 0.0 2.8 6.2 27.1 2.6 28.0 3.2 12.0 0.6 MCM3 ENSG00000112118 "Minichromosome maintenance complex component 3" P25205 6 52264009-52284881 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 82.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002162, HPA004789, HPA004790" Supported Supported Nucleoplasm NA Yes 29000 Nucleoplasm "CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335" "unprognostic (9.14e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.37e-1)" "unprognostic (1.53e-2)" "unprognostic (2.14e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (1.16e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.34e-2)" 17.3 10.9 8.5 29.7 10.5 22.3 15.3 10.7 9.7 15.9 17.2 9.5 20.2 9.0 21.2 13.0 21.7 15.5 15.8 15.4 7.4 6.6 16.1 12.6 13.7 30.1 8.9 5.8 20.0 13.8 16.0 7.4 24.7 10.0 15.9 19.2 12.7 12.6 23.4 12.1 15.0 17.8 17.7 9.5 23.2 15.3 16.1 10.5 82.5 12.9 20.1 35.7 19.1 15.3 21.1 12.9 11.4 13.3 22.2 29.4 18.6 30.2 20.1 35.1 33.0 7.6 6.8 23.0 22.5 17.3 38.4 39.4 41.1 16.5 33.0 22.6 13.1 25.1 24.1 46.2 27.5 38.8 37.1 43.7 62.4 40.4 57.9 2.0 61.2 25.6 4.1 6.4 28.2 7.9 9.4 19.5 40.0 50.7 76.2 19.7 19.9 61.6 47.3 29.1 60.3 14.2 54.7 53.7 44.1 17.0 32.2 35.6 27.3 23.6 13.6 20.4 51.4 26.8 43.4 10.0 26.2 28.2 27.1 33.5 22.6 25.8 58.8 22.5 53.1 30.7 11.1 8.0 11.4 22.9 13.3 19.7 21.1 23.3 23.0 12.9 19.2 22.6 24.0 1.1 22.2 7.4 8.3 29.4 18.6 8.5 10.5 10.7 9.7 7.4 6.6 8.9 5.8 10.0 10.5 20.8 10.5 30.5 14.0 17.1 13.8 13.9 12.7 22.7 20.5 21.0 3.9 85.3 11.6 21.3 0.6 24.8 4.9 23.3 17.7 53.2 16.0 7.5 36.9 9.3 30.8 0.0 7.0 14.7 8.9 2.3 25.0 13.8 6.8 10.8 16.7 19.0 13.0 10.5 19.8 6.5 11.2 6.5 24.7 21.7 59.4 8.8 22.9 27.7 31.0 11.2 MCM4 "CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21" ENSG00000104738 "Minichromosome maintenance complex component 4" P33991 8 47960185-47978160 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 117.9;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004497, HPA004873, HPA031052" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712" "unprognostic (4.55e-2)" "unprognostic (3.16e-3)" "prognostic favorable (2.19e-4)" "prognostic unfavorable (2.84e-5)" "unprognostic (7.71e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.70e-2)" "unprognostic (1.40e-1)" 4.9 8.7 6.7 18.4 12.6 33.1 9.3 13.9 14.8 6.7 11.9 6.9 3.6 8.3 4.7 7.8 21.6 5.9 6.8 8.3 6.6 7.1 8.0 6.6 4.4 20.3 5.9 7.7 5.3 5.5 4.3 4.1 29.2 7.7 4.2 13.2 5.3 9.0 3.1 8.7 16.2 10.3 5.9 6.4 10.1 6.3 39.0 4.1 56.6 4.0 21.8 23.7 8.0 9.5 5.1 4.9 3.4 4.3 4.9 12.9 4.5 34.5 21.5 39.9 14.6 3.9 6.9 17.6 26.4 17.3 33.3 37.7 22.8 31.5 37.5 14.8 13.1 25.0 25.5 50.3 21.4 37.6 11.8 33.2 64.3 25.8 25.3 1.1 34.3 14.1 4.1 4.3 26.5 9.5 5.1 11.7 25.3 35.4 31.2 22.9 21.4 75.8 25.0 43.3 41.1 9.3 48.2 31.3 24.4 12.0 31.0 38.4 18.4 53.4 22.3 7.9 23.8 26.6 18.1 7.8 25.4 24.7 28.5 24.2 10.3 24.6 76.5 20.4 31.9 22.7 3.4 2.1 1.5 5.5 3.7 2.7 5.1 5.0 6.8 4.9 2.1 4.6 3.4 0.1 4.9 4.3 1.7 12.9 4.5 6.7 12.6 13.9 14.8 6.6 7.1 5.9 7.7 7.7 4.1 0.0 4.6 3.0 9.5 19.3 11.6 22.4 0.0 17.4 10.3 5.2 9.8 26.7 3.3 6.0 117.9 5.2 5.0 46.7 5.2 33.9 7.4 4.3 1.1 3.4 10.4 15.9 6.4 1.3 3.5 57.7 4.9 9.9 3.3 2.8 9.6 6.5 4.1 3.5 2.8 2.2 15.3 0.0 8.0 45.2 31.3 16.7 24.9 3.8 20.2 8.2 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400063-35425430 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.0;lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 115.2;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 12.1 4.9 6.1 27.5 9.0 57.0 9.1 6.7 5.7 10.4 11.5 12.3 5.0 9.5 10.8 10.8 15.8 8.7 9.4 5.2 4.4 3.4 6.8 8.0 9.3 31.1 8.8 3.7 17.9 10.8 6.2 3.6 19.3 5.8 7.2 8.3 6.5 8.9 5.1 8.8 10.3 16.7 6.0 7.8 31.2 8.4 16.4 8.8 60.6 9.0 17.7 33.0 8.7 9.6 46.8 30.9 19.0 26.0 21.3 32.9 24.0 39.3 28.6 22.6 23.0 2.2 4.5 19.9 26.3 14.0 39.4 37.5 19.0 19.7 26.1 15.3 13.4 16.3 19.7 22.6 20.9 12.6 21.0 41.5 37.2 28.7 38.0 0.8 76.8 33.7 2.4 1.9 23.5 6.4 3.6 17.4 23.9 23.0 39.0 14.9 32.5 62.5 25.6 30.1 26.9 17.0 70.8 32.1 32.8 7.7 22.9 17.5 18.6 36.2 14.5 8.1 12.4 15.2 29.4 10.3 39.8 30.2 24.7 27.1 21.7 26.8 49.1 25.8 29.1 30.3 19.0 20.7 14.5 18.4 24.1 13.1 46.8 16.1 19.4 27.1 37.0 13.1 14.8 9.9 21.3 26.0 30.9 32.9 24.0 6.1 9.0 6.7 5.7 4.4 3.4 8.8 3.7 5.8 8.8 6.0 8.2 53.6 8.0 9.4 1.5 3.4 12.7 5.3 4.5 7.0 0.0 115.2 5.0 14.8 1.9 7.5 3.8 70.0 11.1 61.5 6.2 3.3 15.0 5.1 47.1 1.6 3.4 13.5 21.1 3.6 10.0 25.5 6.8 225.4 9.2 4.5 9.4 7.0 5.6 3.7 3.2 19.4 6.4 11.2 52.2 5.5 68.8 20.8 32.2 4.7 MCM6 Mis5 ENSG00000076003 "Minichromosome maintenance complex component 6" Q14566 2 135839626-135876426 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 66.3" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004818, CAB009577" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB009577: AB_2266309, HPA004818: AB_1079339" "unprognostic (6.73e-2)" "unprognostic (6.68e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-3)" "unprognostic (8.98e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (5.70e-7)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.36e-2)" "unprognostic (1.36e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (8.29e-12)" "unprognostic (2.84e-1)" "unprognostic (9.02e-2)" "unprognostic (7.42e-2)" "unprognostic (1.68e-1)" 11.3 6.3 7.2 17.7 8.4 23.1 9.5 12.3 9.4 9.1 11.9 5.1 2.9 8.7 10.4 8.8 12.6 8.7 7.6 6.0 5.0 5.5 6.8 7.0 8.5 23.9 4.9 8.0 10.9 4.3 6.2 3.4 10.9 5.9 8.6 12.2 6.2 6.9 6.7 8.2 8.9 16.7 10.4 7.2 14.1 8.0 13.2 3.7 66.3 5.1 11.4 27.5 10.8 9.8 5.5 9.4 5.3 4.0 7.0 13.9 5.6 23.3 14.3 31.3 19.9 6.7 8.8 12.3 17.0 12.9 19.8 22.1 29.3 17.9 40.8 12.5 12.3 8.7 13.9 31.6 15.5 21.2 20.9 21.8 40.5 21.3 9.2 3.1 48.5 18.1 5.2 2.0 14.4 4.4 4.0 13.4 32.2 28.9 34.5 14.5 23.8 59.2 35.7 28.2 20.6 14.4 29.4 37.5 37.3 9.9 20.6 19.7 16.8 22.4 10.7 10.7 23.4 12.3 30.6 6.6 13.8 11.5 14.8 12.8 20.7 33.7 53.7 19.3 37.2 16.4 5.3 1.4 0.9 7.6 4.0 7.1 5.5 10.5 9.2 4.6 3.2 9.6 11.8 0.8 7.0 3.6 9.4 13.9 5.6 7.2 8.4 12.3 9.4 5.0 5.5 4.9 8.0 5.9 3.7 0.0 2.4 2.2 3.8 6.0 2.2 3.2 2.5 4.0 6.8 3.5 0.0 26.1 0.0 4.4 2.1 7.1 1.3 46.7 5.8 20.9 11.3 1.5 9.2 3.0 20.4 3.2 2.4 9.8 4.0 1.6 8.6 5.8 5.0 3.6 9.2 2.3 2.8 3.5 15.9 1.0 0.5 0.0 4.2 15.6 41.4 3.6 8.9 17.5 9.7 1.0 MCM7 "CDC47, MCM2, PPP1R104" ENSG00000166508 "Minichromosome maintenance complex component 7" P33993 7 100092728-100101940 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002163, HPA003898, CAB016312" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.36e-1)" "unprognostic (5.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (2.18e-4)" "unprognostic (2.08e-2)" "unprognostic (5.79e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (9.34e-3)" "unprognostic (3.83e-2)" "unprognostic (5.41e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (2.38e-1)" 8.6 5.2 17.5 13.6 21.7 37.3 11.2 20.0 20.6 8.2 14.2 19.2 15.0 10.4 16.0 6.3 10.7 8.6 9.9 5.1 18.1 12.4 5.5 8.5 7.4 22.4 23.7 9.5 12.6 13.1 7.5 10.3 10.7 15.5 10.0 15.7 7.2 9.2 9.2 11.5 10.1 10.3 11.7 23.5 10.7 7.8 14.9 22.3 7.5 9.4 4.1 28.2 10.3 10.0 7.3 5.7 1.9 5.7 7.6 9.0 6.0 24.9 28.8 31.8 24.0 3.1 4.1 16.3 15.2 18.4 42.5 45.3 22.0 26.4 42.3 14.5 10.8 27.1 19.8 46.7 22.1 35.9 21.6 39.9 26.9 16.2 15.2 1.7 45.7 17.5 2.8 4.2 31.1 18.7 5.4 16.1 24.4 51.5 34.7 21.5 53.3 77.6 18.7 27.9 23.2 20.9 41.8 46.7 51.6 8.2 15.1 20.8 31.7 24.0 22.3 7.5 18.6 10.2 19.2 6.8 16.0 29.1 31.4 30.1 14.5 24.8 76.1 11.1 36.7 28.6 1.8 2.5 1.9 8.1 4.1 6.2 5.3 5.7 7.9 5.5 7.3 5.9 5.7 1.6 7.6 5.7 5.7 9.0 6.0 17.5 21.7 20.0 20.6 18.1 12.4 23.7 9.5 15.5 22.3 8.9 17.0 23.7 20.7 41.4 8.7 7.9 15.3 24.1 9.1 3.5 13.7 90.8 8.3 17.6 40.0 14.5 15.8 70.0 22.4 78.1 17.3 11.3 24.2 10.4 34.4 6.4 16.7 8.0 10.8 22.7 19.5 16.5 18.6 17.2 34.7 10.1 16.0 20.1 14.5 9.1 11.9 12.9 22.7 83.2 67.3 30.9 60.2 28.7 60.9 12.3 MELK KIAA0175 ENSG00000165304 "Maternal embryonic leucine zipper kinase" Q14680 9 36572862-36677683 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.4" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 36.8;Spermatocytes: 10.2;Spermatogonia: 19.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 4.8" "Lineage enriched" "Detected in many" 5 "T-cells: 4.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017214 Uncertain NA Yes "HPA017214: AB_1853798" "unprognostic (5.03e-2)" "unprognostic (9.57e-2)" "unprognostic (2.27e-2)" "unprognostic (3.42e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.91e-7)" "prognostic unfavorable (3.99e-4)" "unprognostic (1.26e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (4.69e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (8.86e-3)" "unprognostic (1.37e-1)" "unprognostic (2.40e-1)" "unprognostic (1.35e-1)" 1.5 1.1 0.3 11.4 0.6 7.7 2.6 0.2 0.8 2.1 5.9 0.3 0.1 4.5 1.2 1.5 12.2 0.4 1.6 1.3 0.5 0.4 1.2 1.3 2.0 8.3 0.4 0.1 0.7 0.8 0.0 0.3 6.3 0.5 0.7 7.8 0.4 2.3 0.1 0.9 2.8 4.6 1.9 1.0 5.2 2.9 11.3 0.4 42.4 0.5 7.2 12.6 1.5 3.3 0.1 0.6 1.0 0.1 0.4 4.8 0.5 35.6 18.4 24.8 14.6 3.4 5.9 14.4 26.5 18.7 37.2 45.9 14.0 14.1 11.9 8.5 13.0 32.5 12.3 21.6 16.6 41.1 32.5 8.6 9.4 21.8 14.0 1.3 14.5 11.9 2.1 3.0 28.6 16.3 4.8 18.7 18.6 11.9 19.1 30.4 11.9 18.0 6.8 19.8 16.1 14.4 16.7 16.7 7.6 11.4 12.0 16.8 12.5 14.1 13.6 8.6 14.4 11.4 6.9 9.2 20.1 25.4 16.9 24.1 3.8 13.6 17.9 12.7 10.8 27.2 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.8 1.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.6 4.8 0.5 0.3 0.6 0.2 0.8 0.5 0.4 0.4 0.1 0.5 0.4 0.0 0.0 0.0 0.4 4.0 0.0 0.3 0.0 1.4 2.3 0.0 0.0 4.2 0.0 0.8 1.8 0.0 1.2 0.0 1.0 36.8 2.1 0.2 0.0 0.2 8.4 0.0 0.0 1.3 0.6 1.8 1.1 2.3 0.0 5.4 1.3 0.0 1.1 2.9 0.0 0.0 0.0 0.0 0.9 10.2 19.0 1.5 7.4 0.0 3.7 1.4 MGME1 "bA504H3.4, C20orf72, DDK1" ENSG00000125871 "Mitochondrial genome maintenance exonuclease 1" Q9BQP7 20 17968913-17991122 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040913 Approved Supported Mitochondria NA Yes Mitochondria "HPA040913: AB_10962835" "unprognostic (5.81e-3)" "unprognostic (5.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-3)" "unprognostic (5.42e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (5.31e-2)" "unprognostic (7.05e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (8.70e-2)" "unprognostic (6.89e-2)" 8.7 14.2 6.4 12.0 7.6 10.9 14.9 7.0 6.7 8.4 10.5 11.7 8.2 10.2 7.3 8.6 14.3 5.4 6.5 10.5 7.3 4.8 10.5 11.3 6.5 13.9 11.5 7.2 5.8 9.6 7.1 14.1 19.9 8.4 8.5 10.7 10.4 11.0 7.8 17.8 26.9 10.9 5.2 9.8 19.5 7.6 12.9 8.3 31.8 15.5 7.6 16.9 10.6 9.6 13.2 10.9 24.1 8.5 8.8 9.2 4.5 17.1 20.0 16.4 15.4 6.7 12.0 22.0 14.5 10.7 14.0 19.2 24.6 17.5 20.4 8.2 6.4 15.9 25.8 16.9 21.6 21.3 7.5 13.9 13.3 11.1 37.1 5.0 8.6 22.8 7.2 15.1 20.8 11.0 6.6 11.1 10.4 18.0 13.4 28.1 12.8 15.4 11.8 14.4 10.3 17.7 11.7 36.8 19.4 12.1 12.6 12.7 10.6 10.2 25.1 21.9 13.9 23.9 6.1 8.9 24.3 19.7 12.0 15.6 10.1 22.3 17.5 6.2 6.7 17.7 24.0 8.5 24.1 4.9 8.1 6.4 11.4 6.3 6.4 6.8 13.2 4.5 4.3 8.2 8.8 7.5 10.9 9.2 4.5 6.4 7.6 7.0 6.7 7.3 4.8 11.5 7.2 8.4 8.3 0.0 11.4 23.1 13.1 41.2 6.4 10.5 20.4 5.3 12.5 7.0 7.9 18.8 33.2 9.6 4.5 11.3 18.3 0.0 8.9 21.7 7.5 9.0 45.2 8.9 26.4 7.9 6.9 17.8 29.3 4.2 7.8 16.2 20.3 6.4 12.9 10.8 8.6 7.0 5.3 20.9 9.6 12.9 5.7 31.1 51.2 40.9 15.1 15.3 19.0 10.2 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 10.3 5.2 5.1 22.5 5.7 26.3 14.1 1.8 5.7 9.0 11.8 2.3 7.6 6.0 9.8 9.5 10.2 8.6 5.7 5.3 5.1 2.8 5.0 4.3 14.3 23.9 4.5 4.1 12.5 7.1 1.8 5.2 9.5 6.7 7.9 7.6 1.9 12.5 10.2 3.0 8.4 10.7 7.3 10.2 22.5 6.9 9.5 3.1 38.4 7.1 8.2 15.5 8.2 7.7 13.1 14.7 23.6 22.6 4.5 4.8 4.0 21.0 7.9 16.5 7.2 5.1 7.3 12.2 14.6 7.7 12.2 15.2 4.2 20.4 29.1 6.4 7.2 5.2 14.8 9.7 7.4 23.0 15.3 6.1 17.4 9.8 5.4 3.4 40.1 16.3 5.2 3.0 7.2 6.8 7.9 14.8 5.6 7.6 6.9 11.8 7.7 16.7 17.7 12.5 10.4 9.9 20.0 6.7 11.2 6.2 8.8 11.6 5.1 5.9 10.0 5.3 10.3 11.9 23.0 8.1 6.5 19.8 7.9 6.4 6.2 8.2 13.6 3.6 16.8 9.1 23.6 14.2 16.2 3.9 13.2 4.1 13.1 3.6 3.2 9.6 12.9 2.4 2.5 8.5 4.5 22.6 14.7 4.8 4.0 5.1 5.7 1.8 5.7 5.1 2.8 4.5 4.1 6.7 3.1 23.8 23.8 43.1 9.7 17.9 7.9 11.8 10.2 20.1 35.2 8.7 15.7 30.2 5.0 11.5 2.9 28.7 11.1 23.3 9.7 38.0 14.2 17.4 41.7 6.7 32.5 0.0 26.5 30.1 69.4 3.6 51.2 58.2 5.0 70.3 23.5 4.8 11.1 34.8 57.0 3.6 8.2 0.0 14.2 67.2 107.7 23.1 16.2 47.3 24.4 11.0 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 163.5;Extravillous trophoblasts: 71.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "Low cell line specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 48.1 24.5 25.5 18.0 1.0 2.2 7.9 18.3 13.5 17.4 15.6 20.0 20.0 36.3 5.3 12.5 11.5 29.4 26.7 13.7 26.2 38.2 12.9 31.1 18.1 12.5 0.0 43.6 16.9 0.5 0.6 17.8 18.3 4.3 17.0 16.9 14.2 34.9 17.2 19.1 26.0 13.3 10.1 12.5 11.2 19.4 33.4 4.8 6.3 13.5 8.9 9.6 25.9 9.3 4.4 8.8 7.7 9.3 15.7 9.2 18.5 13.0 49.4 15.9 12.6 44.0 7.7 20.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 0.0 4.8 10.7 0.5 5.7 0.0 1.2 2.5 2.7 7.9 0.0 0.0 2.7 0.0 0.4 2.5 0.0 2.7 163.5 0.0 71.7 3.4 1.4 1.1 1.0 34.1 0.0 6.4 3.7 8.0 0.5 0.3 12.7 3.3 0.0 4.8 0.0 0.1 2.9 0.4 0.0 0.0 0.0 0.4 8.8 14.6 2.6 6.5 13.4 20.7 4.1 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47402969-47663146 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 7.3 9.8 14.2 12.2 25.5 11.4 14.1 22.6 18.1 9.4 11.6 7.6 5.6 6.5 10.5 13.3 10.8 11.1 4.9 8.4 13.0 14.0 7.3 5.5 7.1 19.7 12.5 17.0 7.9 8.4 15.3 9.1 9.9 18.5 7.9 13.8 12.3 9.4 7.3 6.7 10.3 8.0 7.8 13.8 9.4 6.7 13.4 13.5 37.0 13.9 6.6 21.4 8.5 7.6 7.4 2.9 3.9 4.2 12.2 12.6 6.2 28.3 9.7 26.5 14.3 2.0 5.6 16.1 16.9 8.4 21.0 20.3 18.2 12.3 34.9 22.8 5.9 14.8 12.1 19.8 9.6 31.7 18.0 14.8 25.1 11.2 16.5 2.0 24.5 8.8 3.1 2.8 17.8 4.8 4.7 11.5 0.8 41.8 8.1 16.0 11.3 28.4 18.5 49.9 17.2 11.5 38.1 47.4 20.4 9.1 15.0 22.0 23.9 14.9 11.6 11.9 22.3 11.6 9.6 4.6 13.9 18.3 14.4 18.8 5.2 18.5 48.9 8.5 18.1 8.6 2.8 1.0 3.9 7.9 4.2 8.6 6.3 7.4 9.5 2.3 7.4 12.6 11.9 0.7 12.2 3.2 2.9 10.1 6.2 14.2 25.5 22.6 18.1 13.0 14.0 12.5 17.0 18.5 13.5 8.9 11.5 13.7 5.7 7.3 16.8 13.8 5.1 25.4 13.6 8.7 43.2 14.2 3.3 9.6 13.1 11.7 4.6 23.3 7.3 16.3 8.7 3.4 11.5 1.0 9.6 11.1 3.4 3.7 4.0 17.6 4.9 4.0 8.5 6.4 9.1 20.0 6.0 5.8 6.0 3.5 38.3 0.0 5.5 34.2 59.5 5.6 4.2 8.7 9.8 2.7 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 13.0 20.5 9.7 13.1 18.8 13.6 13.0 20.5 13.1 17.9 13.3 17.6 10.7 6.1 28.2 11.0 12.4 18.3 8.4 8.6 11.4 8.8 9.5 14.6 11.0 21.7 23.9 9.6 43.2 27.6 16.2 17.3 14.9 15.0 14.6 10.3 8.7 12.0 13.2 10.4 10.3 10.5 22.1 14.9 11.6 11.1 25.1 22.0 40.4 13.4 10.4 25.8 14.2 16.4 8.4 8.4 7.6 9.8 9.7 15.1 5.7 27.5 20.6 38.3 9.1 11.6 12.2 17.3 15.3 13.5 15.9 16.7 15.1 9.6 45.5 23.0 16.6 21.9 11.6 34.5 19.5 20.8 19.8 17.2 29.1 16.3 15.3 7.1 29.2 10.7 9.9 6.2 16.2 10.8 14.9 9.9 1.1 25.3 16.7 15.5 19.9 31.1 13.8 33.6 18.6 9.5 73.8 50.2 20.5 9.7 17.9 21.5 23.3 21.3 10.2 9.3 35.1 12.2 10.3 6.0 18.5 22.6 14.0 19.8 15.7 21.2 76.2 15.6 18.7 11.3 7.6 5.8 4.9 8.4 9.8 10.4 8.4 9.5 8.3 8.4 8.1 15.1 7.6 3.9 9.7 9.3 4.2 9.5 5.7 9.7 18.8 20.5 13.1 11.4 8.8 23.9 9.6 15.0 22.0 26.8 18.4 9.7 20.1 22.3 26.4 6.9 0.0 28.1 31.8 7.0 33.4 24.9 3.3 12.8 25.7 15.3 2.6 0.0 8.4 16.9 17.4 11.4 17.3 8.5 11.1 14.3 4.6 12.3 5.1 11.5 23.6 12.1 3.3 7.2 7.9 27.0 8.8 3.5 21.2 5.3 29.7 6.5 17.2 40.0 40.2 15.3 8.0 13.3 9.3 10.7 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Extravillous trophoblasts: 18.8;Spermatocytes: 11.8;Spermatogonia: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029792, HPA029794" Approved Uncertain Vesicles NA Yes Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavorable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 1.7 0.9 0.6 5.1 1.5 15.2 0.9 0.9 1.1 0.8 2.9 0.8 0.4 2.8 0.7 0.9 4.5 0.5 1.7 1.0 0.6 0.6 2.5 0.7 1.5 6.4 0.8 0.4 0.9 0.7 0.0 0.7 3.2 1.2 0.7 4.1 0.6 1.3 0.4 1.4 1.9 3.2 0.9 1.1 3.8 1.9 13.5 0.4 16.8 0.4 3.2 5.8 1.1 1.4 1.6 3.0 0.1 2.9 0.0 2.6 1.1 7.2 5.6 4.8 9.0 0.8 1.4 8.6 9.6 6.7 11.4 15.9 9.9 5.9 18.8 5.9 3.8 15.1 11.3 10.9 7.1 17.0 10.5 8.4 14.8 4.1 9.0 0.5 27.1 14.0 1.1 1.5 12.6 8.1 1.3 6.1 16.5 15.9 14.6 8.5 9.6 15.2 22.7 4.8 9.7 6.9 14.0 7.7 9.4 4.9 5.6 3.8 3.8 6.0 10.6 5.5 6.2 4.5 18.7 3.3 5.7 5.9 19.9 14.6 5.6 13.1 12.4 3.3 18.5 8.6 0.0 0.6 0.0 1.2 2.9 0.4 1.6 1.6 2.6 3.0 1.3 0.2 1.3 0.1 0.0 2.3 2.2 2.2 1.1 0.6 1.5 0.9 1.1 0.6 0.6 0.8 0.4 1.2 0.4 0.0 0.6 6.2 0.3 0.9 0.0 0.3 0.0 1.4 1.2 0.0 0.0 4.9 0.0 0.8 6.5 0.3 0.9 23.3 2.2 18.8 0.4 0.8 1.1 0.5 5.6 0.0 0.0 1.3 4.3 4.2 0.3 1.8 0.0 2.8 1.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.3 11.8 9.9 0.3 2.5 1.5 1.4 0.9 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.5 41.3 15.7 34.2 16.9 13.8 25.5 28.5 19.6 37.0 36.7 40.1 33.4 30.5 13.5 16.9 18.6 35.7 48.4 28.3 43.3 30.3 31.9 37.8 41.4 30.4 12.5 29.0 20.6 10.7 9.2 33.0 17.9 15.3 23.0 30.9 28.1 25.1 28.0 60.2 46.7 17.0 28.7 46.2 43.8 37.3 54.6 27.6 27.8 42.5 34.0 13.2 47.6 25.9 14.3 15.3 40.3 14.7 14.1 27.9 48.4 25.7 34.1 16.8 20.6 53.8 25.6 33.5 31.6 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 17.9 26.3 11.5 9.9 12.2 0.0 38.1 17.8 12.0 20.5 15.7 0.0 20.0 34.9 15.4 0.9 9.9 5.2 0.0 9.0 24.2 10.6 8.3 49.7 125.3 21.6 0.0 2.9 7.4 11.3 0.9 12.0 10.9 13.5 14.4 11.9 0.0 10.8 2.9 12.4 49.9 0.0 19.4 18.6 0.9 7.5 9.4 8.2 20.0 21.3 9.9 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.1;lymphoid tissue: 59.4" "Cell type enriched" "Detected in many" 7 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Group enriched" "Detected in many" 6 "granulocytes: 14.1;monocytes: 8.7" "Cell line enhanced" "Detected in many" "HDLM-2: 59.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 2.5 1.8 1.3 28.2 1.9 32.1 5.4 1.2 3.4 2.4 6.8 1.2 2.8 6.9 2.7 6.2 6.6 3.6 2.8 2.4 1.6 0.8 2.7 6.6 5.4 7.3 2.2 1.2 2.6 5.8 0.7 4.3 4.5 2.1 5.0 0.9 1.1 4.7 2.1 3.6 10.3 5.6 1.4 1.3 10.3 3.8 3.1 2.9 59.4 3.5 3.7 13.5 2.7 3.6 2.0 1.6 14.1 8.7 0.7 0.8 1.1 8.1 5.6 3.5 9.5 0.2 0.5 5.8 10.6 3.5 4.8 4.6 3.7 8.5 4.3 4.4 1.4 2.6 4.0 0.4 1.2 0.2 59.2 7.2 2.4 8.1 5.4 0.5 2.3 7.5 0.3 0.6 0.3 0.2 0.4 4.4 19.2 1.5 13.6 0.9 10.4 21.6 6.5 1.2 2.5 9.8 10.6 10.8 6.2 1.0 1.1 8.6 7.1 6.8 6.9 3.7 0.5 10.9 6.2 3.2 5.8 15.0 4.6 5.6 18.0 5.9 4.7 4.5 8.1 3.3 3.5 2.6 7.7 0.7 7.2 0.0 1.6 0.1 0.1 1.6 2.0 0.0 0.3 14.1 0.7 8.7 1.0 0.8 1.1 1.3 1.9 1.2 3.4 1.6 0.8 2.2 1.2 2.1 2.9 3.0 2.2 0.0 1.5 4.9 2.8 1.2 5.1 5.3 4.5 5.2 0.0 4.5 0.0 1.3 16.3 2.3 4.0 116.8 3.5 7.2 3.4 2.4 9.2 3.9 8.8 3.2 1.7 4.3 4.9 1.9 1.7 5.1 3.3 1.0 5.0 1.0 1.9 3.1 1.4 0.3 2.2 0.0 3.1 0.7 5.9 5.0 11.0 5.1 6.9 1.8 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716496 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 30 "plasmacytoid DC: 35.9" "Lineage enriched" "Detected in many" 30 "dendritic cells: 35.9" "Cell line enhanced" "Detected in many" "MCF7: 103.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.7 0.7 0.2 48.3 0.2 33.0 1.0 0.2 0.2 1.0 4.4 0.2 0.1 2.7 1.1 1.1 8.4 0.3 1.7 0.9 0.2 0.2 1.0 1.2 1.8 22.3 0.3 0.1 0.8 9.4 0.0 0.4 4.0 0.2 0.7 2.7 0.3 2.9 0.1 0.3 1.8 6.4 0.6 0.3 43.9 2.9 12.6 0.1 49.2 0.6 6.4 33.8 1.9 2.1 1.1 35.9 0.0 0.0 0.0 0.4 0.3 26.3 16.8 14.9 15.4 0.1 0.5 19.3 11.9 4.0 37.8 27.9 82.4 16.6 53.3 6.9 5.2 7.9 16.1 26.9 8.2 14.2 9.9 17.2 24.9 16.8 22.2 0.0 22.7 17.3 0.3 0.7 14.4 3.2 0.8 10.1 26.5 24.8 66.3 3.3 103.7 46.1 32.0 17.1 21.2 14.7 32.1 30.6 30.5 7.0 5.4 13.7 20.0 35.5 35.7 3.6 16.4 23.5 24.9 4.7 2.3 38.0 16.7 20.5 23.0 47.4 83.8 4.9 19.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 35.9 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.0 13.4 0.2 3.8 0.0 1.7 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.5 93.5 0.8 28.3 0.4 0.1 0.0 0.0 11.2 0.0 0.0 1.3 1.6 10.0 0.0 0.5 1.7 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.4 25.7 2.0 3.1 2.1 2.2 0.9 MYL12A "MLCB, MRCL3, MRLC3, MYL2B" ENSG00000101608 "Myosin light chain 12A" P19105 18 3247481-3256236 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 5937.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004503, HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes 70000000 "Nucleoplasm, Nucleoli fibrillar center" "CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (2.14e-3)" "unprognostic (5.30e-2)" "unprognostic (1.80e-1)" "unprognostic (5.31e-2)" "unprognostic (3.03e-2)" "unprognostic (7.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.57e-3)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-3)" "unprognostic (2.30e-1)" "unprognostic (9.86e-2)" "unprognostic (1.30e-1)" "unprognostic (4.98e-2)" "unprognostic (4.58e-3)" "unprognostic (7.13e-2)" 60.9 19.9 7.1 31.1 13.1 21.7 63.9 5.1 7.6 25.1 31.2 7.4 22.5 15.6 24.1 29.0 43.6 22.8 32.4 248.0 8.2 6.8 52.7 43.1 58.3 58.4 14.6 5.7 28.6 24.8 24.9 11.1 49.5 18.9 24.3 27.2 14.7 26.5 18.6 423.8 24.2 41.5 27.9 22.1 68.6 22.5 20.4 10.3 40.3 38.6 80.1 42.0 30.6 31.2 103.4 166.8 173.4 91.9 104.2 168.7 245.4 31.3 20.0 45.6 19.1 53.9 56.8 27.9 71.6 94.5 68.1 74.3 30.2 39.8 15.2 18.9 103.9 47.6 13.7 26.4 44.9 61.1 21.4 9.4 15.5 23.8 26.5 90.3 44.1 30.3 88.8 63.7 52.8 32.0 62.5 106.8 20.4 19.4 53.2 139.6 53.7 20.5 44.4 18.7 36.4 14.8 11.9 23.9 26.7 149.3 50.9 6.4 15.6 56.6 24.4 49.5 44.0 17.2 65.2 114.2 16.9 38.5 46.2 56.5 12.1 17.5 24.6 50.7 17.7 60.4 173.4 74.5 154.6 166.4 77.4 166.7 103.4 156.8 168.7 109.0 80.4 142.5 167.0 122.8 104.2 91.9 166.8 133.2 245.4 7.1 13.1 5.1 7.6 8.2 6.8 14.6 5.7 18.9 10.3 684.9 287.2 341.2 723.8 564.8 28.8 5937.2 466.2 370.7 324.2 485.1 11.8 673.0 399.6 1177.4 18.9 908.8 703.7 0.0 1306.6 996.1 418.1 441.5 501.9 258.7 758.2 54.0 101.2 852.6 651.0 20.6 309.8 806.5 420.1 2189.4 519.0 67.5 1678.2 662.9 372.7 509.4 40.9 562.7 473.8 61.2 173.0 476.5 557.0 1044.7 325.5 594.7 MZT1 "C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2" ENSG00000204899 "Mitotic spindle organizing protein 1" Q08AG7 13 72708357-72727687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.6" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063299, HPA066715" Approved NA Yes "HPA063299: AB_2684980, HPA066715: AB_2685709" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.48e-1)" "unprognostic (4.89e-1)" "unprognostic (2.46e-1)" "unprognostic (2.38e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.65e-2)" "unprognostic (6.88e-2)" "unprognostic (5.28e-2)" "unprognostic (7.09e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.01e-5)" "unprognostic (9.01e-3)" "unprognostic (5.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" 7.5 14.1 19.8 9.7 44.6 19.9 10.6 26.9 24.1 8.3 7.6 4.4 7.3 7.2 7.6 8.5 8.9 5.4 5.4 10.3 17.3 16.6 10.1 4.6 8.6 14.1 11.3 14.8 6.8 6.1 5.3 7.2 9.3 9.2 9.5 9.1 5.3 8.0 10.7 15.5 8.4 6.4 7.0 9.1 8.1 7.9 5.3 8.2 12.1 10.9 7.8 11.2 9.2 6.2 9.6 7.5 13.8 8.6 9.0 11.5 4.8 30.7 4.9 17.6 12.9 3.6 6.1 14.4 25.0 10.4 15.8 18.4 9.3 20.3 21.4 19.2 9.9 10.0 10.0 17.5 9.3 28.9 25.5 17.9 27.7 10.5 13.9 5.1 46.3 22.7 3.3 9.5 9.5 19.9 9.6 16.0 25.0 15.2 16.8 31.2 5.5 23.4 25.9 13.4 18.8 9.4 16.7 20.1 10.5 14.1 7.7 20.7 19.0 10.6 15.7 15.1 10.1 11.8 23.0 10.8 14.0 16.0 19.7 30.2 15.5 23.8 16.8 32.9 28.4 28.6 13.8 4.7 9.9 6.2 8.3 7.7 9.6 8.4 7.7 5.8 8.5 11.1 8.8 2.4 9.0 8.6 7.5 11.5 4.8 19.8 44.6 26.9 24.1 17.3 16.6 11.3 14.8 9.2 8.2 0.0 17.5 49.1 23.0 48.9 27.5 16.1 10.2 5.3 11.4 29.6 13.7 37.4 49.7 24.7 2.4 23.0 7.8 116.8 21.2 78.8 23.9 23.9 18.4 6.6 36.9 60.4 20.8 18.4 23.5 3.1 18.4 31.4 57.3 36.1 14.4 16.2 20.9 17.5 15.6 27.5 22.1 32.3 21.7 45.4 41.0 50.2 25.3 38.3 17.5 28.1 NACA NACA1 ENSG00000196531 "Nascent polypeptide-associated complex alpha subunit" "E9PAV3, Q13765" 12 56712428-56731628 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Activator, Chaperone, DNA-binding" Allergen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA073152, HPA073648" Approved Cytosol NA Yes Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (3.35e-2)" "unprognostic (9.98e-3)" "unprognostic (1.56e-1)" "unprognostic (2.30e-3)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.24e-3)" "unprognostic (1.55e-1)" "unprognostic (3.92e-2)" "unprognostic (2.95e-2)" "unprognostic (5.64e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (4.58e-11)" "unprognostic (9.47e-2)" "unprognostic (6.28e-2)" "unprognostic (7.00e-2)" "unprognostic (9.79e-2)" 106.9 85.3 72.2 77.6 63.0 120.7 149.8 71.7 65.5 115.5 89.1 40.5 76.7 57.3 83.3 107.7 142.6 95.2 69.2 111.5 58.9 52.7 79.8 130.1 68.5 148.3 63.7 51.3 213.8 119.9 58.1 61.3 80.8 63.7 112.3 79.7 45.9 95.5 72.9 241.6 124.5 71.2 115.1 74.1 81.9 72.3 53.2 53.8 97.8 109.0 149.1 125.1 144.8 139.1 91.8 101.6 45.4 160.0 66.3 97.4 146.6 78.5 91.5 109.0 86.1 130.5 223.6 108.3 78.8 113.8 107.4 74.8 110.2 87.3 141.4 88.3 73.9 44.3 69.2 96.5 126.6 114.5 69.2 150.1 102.6 64.1 109.6 122.4 144.6 66.2 176.7 162.8 87.2 178.1 193.1 118.5 83.8 127.1 184.9 104.9 76.4 93.4 178.8 111.2 76.1 102.2 106.3 91.9 150.0 149.2 79.8 80.9 87.4 58.5 139.6 121.0 79.5 152.0 166.3 76.7 56.8 69.7 60.3 79.1 88.6 98.6 125.9 83.3 99.2 72.2 33.2 88.1 45.4 58.5 124.6 85.6 91.8 83.4 72.5 94.4 74.6 97.4 83.9 33.2 66.3 160.0 101.6 85.9 146.6 72.2 63.0 71.7 65.5 58.9 52.7 63.7 51.3 63.7 53.8 413.9 563.5 1474.2 1870.1 1800.9 294.5 578.3 937.6 440.3 720.0 375.1 62.8 1562.4 1507.1 1062.8 561.3 1209.8 673.8 420.4 1761.3 2399.9 1079.6 1341.5 713.0 646.1 1391.2 173.2 622.3 710.2 1196.9 484.6 2231.3 1465.0 1175.9 1424.7 1175.0 458.5 1465.8 1052.1 1345.3 1857.7 337.7 789.0 1297.8 499.0 489.8 1950.7 1943.0 1208.8 1657.0 2037.8 NASP "DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999" ENSG00000132780 "Nuclear autoantigenic sperm protein" P49321 1 45583846-45618904 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 344.6;Spermatogonia: 575.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028136, HPA030518, HPA030520" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510" "unprognostic (5.59e-2)" "unprognostic (1.34e-3)" "unprognostic (5.02e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (5.36e-3)" "prognostic unfavorable (4.96e-6)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (1.91e-8)" "unprognostic (1.62e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" "unprognostic (5.32e-2)" 20.7 15.2 19.3 33.4 32.0 64.0 21.2 20.1 24.0 22.8 21.9 30.2 26.4 15.9 22.3 19.8 20.1 23.0 12.5 18.1 22.4 17.3 17.5 21.0 17.6 39.0 40.2 17.8 28.3 17.4 21.9 22.9 28.5 24.2 18.9 24.7 12.6 17.8 21.8 14.3 16.1 20.5 21.3 30.3 31.7 17.5 35.8 40.2 49.1 17.7 28.2 43.0 18.5 19.6 16.9 11.8 8.1 9.7 7.3 17.5 6.9 24.6 14.6 70.1 24.8 11.8 6.2 33.0 20.0 14.9 31.1 39.1 26.9 17.9 46.5 14.1 8.6 34.2 23.9 46.7 21.3 39.9 21.2 29.6 60.1 26.3 42.1 4.1 62.7 25.3 7.2 5.2 34.3 11.9 8.1 21.2 39.2 50.5 27.5 21.0 16.8 71.4 57.5 101.9 24.6 12.4 90.3 61.5 44.7 15.4 24.9 26.9 32.6 32.9 18.8 20.3 55.3 13.5 49.1 11.4 14.4 44.2 27.6 32.5 16.9 31.8 80.7 14.7 40.1 14.3 4.9 7.3 8.1 12.3 9.7 14.2 13.5 13.9 14.0 11.5 16.9 12.3 11.8 3.1 7.3 5.7 11.8 17.5 6.9 19.3 32.0 20.1 24.0 22.4 17.3 40.2 17.8 24.2 40.2 53.6 89.6 88.0 115.5 69.4 46.4 46.2 35.7 160.6 146.7 34.9 35.3 265.5 26.6 48.1 12.2 85.7 26.9 23.3 32.6 179.3 75.1 49.2 111.0 32.6 90.0 41.3 49.2 76.1 37.0 19.1 87.8 52.1 38.8 54.1 39.4 64.0 29.7 41.2 73.6 27.1 77.6 84.1 71.5 344.6 575.6 49.8 224.3 87.3 90.3 75.0 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCAPG "CAP-G, FLJ12450, hCAP-G, YCG1" ENSG00000109805 "Non-SMC condensin I complex subunit G" Q9BPX3 4 17810902-17844862 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 65.4" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 23.3;Extravillous trophoblasts: 22.2;Spermatocytes: 40.4;Spermatogonia: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.9" "Lineage enriched" "Detected in single" 5 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039613 Uncertain NA Yes "HPA039613: AB_10805481" "unprognostic (5.23e-2)" "unprognostic (3.37e-1)" "unprognostic (1.59e-3)" "prognostic unfavorable (8.28e-4)" "unprognostic (4.22e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (1.18e-3)" "unprognostic (1.63e-2)" "unprognostic (6.70e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.44e-2)" "unprognostic (0.00e+0)" "unprognostic (1.94e-2)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" 1.4 1.1 0.3 18.0 0.4 12.5 2.5 0.7 0.5 1.4 2.9 0.3 0.2 3.7 0.8 1.2 7.1 0.3 0.7 1.6 0.4 0.7 0.9 1.1 1.8 8.3 2.0 0.3 0.6 0.5 0.0 0.4 3.7 0.5 0.7 2.4 0.3 1.6 0.9 0.6 3.4 3.3 0.7 1.0 6.4 1.9 11.8 0.3 65.4 0.5 6.7 8.6 1.6 2.0 0.5 0.5 0.0 0.4 0.3 2.9 1.7 16.4 10.6 24.3 15.9 1.5 3.0 8.9 21.4 8.4 21.1 21.7 13.4 10.1 24.7 4.3 5.9 18.3 7.5 20.6 8.2 29.1 11.2 10.1 19.6 14.5 10.9 0.1 13.8 7.7 0.5 0.5 15.6 7.2 3.3 10.5 10.8 19.1 28.2 20.9 4.9 15.8 13.4 12.5 9.6 10.5 15.6 22.0 10.3 6.4 5.1 19.2 11.4 19.2 4.1 6.1 10.9 9.7 7.8 8.6 20.3 9.2 11.4 29.1 8.8 8.3 21.0 8.4 14.4 13.4 0.0 0.0 0.0 0.5 0.2 0.0 0.5 1.0 0.6 0.5 0.2 0.1 0.7 0.0 0.3 0.4 0.0 2.9 1.7 0.3 0.4 0.7 0.5 0.4 0.7 2.0 0.3 0.5 0.3 0.0 1.4 1.5 0.2 2.2 0.0 0.1 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.0 12.5 0.0 0.2 23.3 0.0 22.2 0.6 0.3 1.1 0.0 7.7 0.0 1.7 3.1 2.2 8.4 0.6 2.2 1.7 1.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 40.4 29.7 1.0 1.8 1.5 2.3 0.1 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Cell type enhanced" "Detected in many" 22 "Spermatocytes: 77.0;Spermatogonia: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 31.2 11.9 30.2 15.6 1.1 1.6 20.0 14.8 10.4 28.7 30.3 21.9 17.5 29.2 10.5 6.5 26.2 14.1 25.8 10.1 30.8 25.6 17.1 30.1 12.4 19.8 0.2 27.8 25.7 0.5 1.1 22.2 9.4 2.7 11.3 23.4 20.8 21.6 13.6 14.7 40.7 29.0 21.6 13.8 15.1 31.7 27.5 23.7 5.7 12.1 17.9 13.7 8.6 12.1 5.2 11.9 8.9 20.6 6.5 21.2 32.4 19.8 23.9 11.6 16.5 31.0 9.1 27.9 23.9 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 0.0 0.0 0.8 0.2 0.6 0.4 0.4 0.0 2.7 2.3 0.0 7.9 1.1 0.0 0.4 3.9 0.5 0.0 0.0 0.0 14.1 0.4 0.5 1.1 0.5 6.8 0.0 0.0 0.6 3.2 4.0 0.9 3.0 1.7 0.0 1.0 4.7 0.2 0.0 0.4 0.0 2.3 0.0 0.9 77.0 26.2 0.6 1.6 5.4 1.2 0.6 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes 600000 "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 71.2 68.2 59.6 67.7 77.0 96.6 71.0 72.8 69.2 72.1 63.0 79.2 46.0 48.1 80.3 63.7 85.2 65.7 45.9 55.9 57.7 53.3 66.7 94.7 55.6 78.4 67.4 51.8 93.9 77.5 94.8 83.4 69.5 79.8 64.6 75.4 47.1 58.1 51.8 120.6 70.3 56.9 70.9 88.4 80.2 59.4 41.7 76.4 118.9 67.8 82.6 105.5 79.9 60.6 40.8 41.3 20.4 36.4 52.6 53.9 40.8 63.3 59.3 71.9 52.7 42.5 46.2 74.0 71.7 48.7 67.7 60.0 97.9 45.6 84.2 61.8 55.3 90.9 62.2 143.9 96.3 116.1 49.2 60.3 140.5 56.3 131.9 46.6 160.1 53.3 43.8 55.9 84.5 89.0 38.9 71.0 76.8 125.1 28.9 59.5 86.2 140.1 99.4 107.1 66.9 42.6 104.6 129.7 73.9 49.7 84.2 62.3 44.4 48.0 55.1 63.3 61.3 41.4 81.1 60.3 54.3 56.2 63.4 94.2 54.8 53.8 181.3 39.5 104.5 56.2 9.5 27.9 20.4 47.4 33.2 53.9 40.8 41.7 42.6 41.3 38.9 46.6 42.1 6.0 52.6 36.4 35.5 34.4 40.8 59.6 77.0 72.8 69.2 57.7 53.3 67.4 51.8 79.8 76.4 271.0 357.6 280.1 370.4 408.5 137.1 290.7 137.6 385.4 589.2 184.9 45.2 333.3 195.6 173.5 15.4 228.8 106.1 210.2 218.7 336.0 249.6 218.4 431.8 217.9 213.5 76.3 191.8 122.8 135.8 18.9 201.0 194.7 156.9 238.1 192.5 194.0 213.8 138.2 150.3 209.2 125.5 148.8 282.2 390.1 563.8 385.9 316.9 226.1 268.8 321.5 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80, kinetochore complex component" O14777 18 2571511-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066330 Supported Nucleoplasm,Centrosome NA Yes Nucleoplasm Centrosome "HPA066330: AB_2685661" "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavorable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 2.9 1.3 0.8 15.3 0.8 14.6 0.9 0.7 0.9 2.9 3.8 0.8 0.6 2.7 4.2 3.8 8.3 1.3 1.8 2.7 0.6 0.4 1.6 1.4 2.9 10.1 0.6 0.8 1.2 0.8 0.0 0.6 6.0 1.1 4.3 5.1 0.8 1.9 7.6 0.6 4.0 4.8 2.2 0.6 7.9 3.0 15.9 0.6 51.3 0.9 8.1 9.9 2.2 6.7 7.9 1.6 9.3 0.7 2.2 11.5 1.4 21.9 5.0 24.8 11.0 1.3 3.0 12.8 25.8 13.9 33.8 28.9 13.6 12.5 24.0 11.7 10.0 14.3 13.6 27.7 11.1 35.8 9.0 7.0 18.9 14.2 10.4 0.5 36.2 15.9 1.5 1.0 19.4 13.8 3.5 15.3 14.9 15.4 30.6 29.5 9.9 17.6 15.8 12.8 14.2 7.3 19.5 25.4 19.2 8.8 10.6 20.1 9.0 23.6 6.2 9.4 10.3 10.4 14.5 9.3 22.1 49.2 17.4 34.0 13.4 21.1 32.2 9.7 16.8 18.6 3.7 0.7 2.8 2.2 0.6 2.0 7.9 3.7 4.3 0.3 5.7 2.4 2.4 9.3 2.2 0.5 1.6 11.5 1.4 0.8 0.8 0.7 0.9 0.6 0.4 0.6 0.8 1.1 0.6 0.0 1.1 3.7 0.8 2.1 0.0 17.3 0.0 1.4 3.4 0.0 0.0 1.7 0.0 0.9 9.7 0.3 0.2 23.3 0.3 20.1 1.9 0.1 0.0 0.0 9.3 0.0 0.0 6.2 2.5 3.6 6.9 2.2 0.0 0.0 0.9 0.0 0.2 0.0 21.9 0.1 0.0 19.4 3.1 84.6 25.0 0.5 1.7 6.9 2.3 0.9 NDE1 "FLJ20101, NDE, nudE" ENSG00000072864 "NudE neurodevelopment protein 1" Q9NXR1 16 15643267-15726353 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein" Lissencephaly "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 43.7;monocytes: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024075 Approved NA Yes "HPA024075: AB_1854336" "unprognostic (1.09e-1)" "unprognostic (1.66e-1)" "unprognostic (3.26e-1)" "unprognostic (1.47e-1)" "unprognostic (3.84e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.43e-2)" "unprognostic (1.59e-1)" "unprognostic (4.55e-2)" "unprognostic (3.70e-3)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.19e-4)" "unprognostic (1.29e-1)" "unprognostic (3.28e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" 7.1 5.9 8.0 14.2 23.5 21.5 7.5 3.4 17.7 9.3 16.9 36.4 5.7 8.3 11.2 4.5 16.3 7.6 8.9 8.2 12.5 7.1 4.8 3.9 8.4 17.5 29.8 7.7 6.3 3.7 4.9 2.9 9.1 19.5 10.9 8.8 8.3 9.5 6.6 5.4 19.7 9.8 11.9 30.7 11.0 8.3 9.6 26.5 21.7 5.2 5.7 20.1 11.8 14.2 4.6 2.9 29.9 6.0 5.7 4.0 1.7 12.8 10.9 14.8 13.1 4.1 6.4 4.1 6.7 7.6 11.0 12.1 7.3 20.2 11.8 9.1 10.8 7.5 13.7 11.7 16.2 9.3 13.8 6.8 13.9 12.6 15.2 6.0 10.9 15.7 2.6 11.5 11.0 22.5 6.3 15.1 15.1 7.5 29.0 9.8 14.0 14.7 13.2 10.3 9.2 6.8 22.4 15.7 11.0 4.6 6.8 6.1 8.5 15.8 13.3 9.5 9.5 13.4 11.8 9.9 9.5 8.9 16.6 13.2 7.7 5.8 15.0 9.7 17.7 20.7 9.4 4.5 11.2 4.0 3.0 2.0 4.1 3.9 3.5 2.4 4.6 3.7 3.9 29.9 5.7 6.0 2.9 3.8 1.7 8.0 23.5 3.4 17.7 12.5 7.1 29.8 7.7 19.5 26.5 3.0 4.1 27.6 30.6 23.1 5.8 1.8 5.1 12.0 5.7 5.2 5.9 2.1 0.0 3.6 33.7 7.1 4.2 0.0 4.6 4.4 8.8 12.9 10.4 1.5 8.9 3.2 4.1 4.9 10.8 43.7 14.7 10.2 11.8 64.1 6.1 7.2 5.5 5.5 5.6 1.4 6.6 6.5 6.2 9.2 11.8 26.8 2.1 19.7 6.8 20.3 NDUFAF4 "bA22L21.1, C6orf66, HRPAP20, HSPC125, My013" ENSG00000123545 "NADH:ubiquinone oxidoreductase complex assembly factor 4" Q9P032 6 96889313-96897881 "Disease related genes, Predicted intracellular proteins" Calmodulin-binding "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046560 Uncertain Supported Mitochondria NA Yes Mitochondria "HPA046560: AB_10966700" "prognostic unfavorable (1.31e-4)" "unprognostic (1.32e-1)" "unprognostic (1.09e-2)" "unprognostic (1.14e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (6.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (2.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" 7.9 10.1 16.1 5.4 19.0 2.7 9.0 20.4 27.4 8.9 9.1 5.0 5.7 6.2 7.3 6.4 7.1 6.0 6.0 30.2 18.7 17.3 17.3 18.1 4.3 5.4 18.1 12.3 10.4 7.2 7.3 6.5 6.1 28.5 9.5 9.7 4.5 7.7 12.8 25.0 6.2 6.5 7.3 9.6 7.6 6.4 5.7 8.4 4.9 9.5 11.2 5.8 8.2 5.1 6.4 4.5 0.6 4.3 3.3 10.0 4.1 1.5 4.3 7.5 10.1 7.5 4.4 4.0 4.2 4.0 6.3 4.8 5.8 2.6 14.1 7.7 3.8 6.0 3.1 17.4 6.5 6.1 9.9 13.7 15.7 2.3 5.0 8.2 16.4 6.6 4.1 10.1 5.4 5.5 3.2 4.9 10.0 14.1 9.6 9.8 4.8 10.5 8.9 14.2 7.8 7.1 5.0 4.2 7.3 10.4 4.2 12.8 6.0 2.1 7.6 11.9 7.7 2.3 11.0 4.0 3.3 2.5 11.5 6.8 2.2 3.6 13.9 4.5 12.4 4.8 0.2 2.2 0.6 5.1 4.3 6.6 6.4 6.7 6.7 3.8 6.3 10.0 8.8 0.4 3.3 2.6 4.5 6.8 4.1 16.1 19.0 20.4 27.4 18.7 17.3 18.1 12.3 28.5 8.4 8.9 16.6 43.3 52.1 96.7 15.5 108.1 25.5 17.4 27.3 22.7 0.0 40.6 142.6 37.3 2.3 31.6 17.5 23.3 23.9 34.6 34.7 26.3 19.7 43.9 47.0 25.4 37.6 25.8 18.0 4.4 24.2 27.4 52.3 15.4 38.0 14.0 21.1 10.5 23.3 99.4 12.4 25.8 69.8 36.9 55.8 84.6 27.5 27.9 48.2 38.3 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309836-177362943 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 70.8" "Cell type enhanced" "Detected in some" 8 "Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065761 Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.5 0.4 0.2 7.4 0.2 9.3 0.7 0.1 0.2 0.8 1.5 0.1 0.1 1.5 0.5 0.1 5.6 0.2 0.3 0.5 0.2 0.2 0.4 0.4 0.9 5.1 0.2 0.1 0.3 0.2 0.0 0.2 1.6 0.2 0.2 2.1 0.2 0.8 0.1 0.2 3.4 1.7 0.5 0.7 1.5 0.8 3.5 0.3 70.8 0.2 1.1 5.0 0.7 1.3 0.2 0.3 0.8 0.0 1.6 1.6 0.2 7.1 5.9 6.3 3.1 0.7 1.3 3.1 8.8 3.3 9.8 5.8 2.1 6.3 7.9 1.3 2.3 9.7 3.3 6.6 3.5 14.3 26.6 4.3 5.4 4.7 5.6 0.2 29.0 3.7 0.1 0.2 10.1 2.2 2.0 3.7 20.5 5.6 38.1 6.3 3.1 29.3 11.1 2.9 2.1 4.4 6.0 4.3 2.5 2.5 0.9 5.0 3.4 4.4 5.1 2.4 2.9 4.2 7.6 1.7 5.9 4.6 3.0 8.9 2.6 1.7 12.5 3.9 10.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.2 0.0 1.1 0.8 1.6 0.0 0.3 1.6 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.6 2.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 3.0 1.1 0.2 0.5 0.4 0.1 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0;testis: 41.0" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Not detected" "Not detected" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: AB_2685393" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (9.47e-6)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 1.1 0.7 0.6 6.7 0.5 7.4 1.3 0.3 0.9 0.9 2.5 0.3 0.3 3.4 0.3 1.2 4.2 0.7 1.4 0.9 1.0 0.3 0.6 0.6 1.0 3.9 0.3 0.3 0.6 0.3 0.0 0.3 1.2 0.4 0.9 3.6 0.4 1.0 0.3 0.3 1.8 3.0 0.6 0.6 1.6 1.1 41.0 0.4 14.0 0.3 1.5 4.8 0.6 1.6 1.8 0.9 2.7 0.5 3.9 4.3 0.9 30.7 22.2 17.0 12.2 1.0 1.7 18.8 11.9 11.2 21.0 18.1 11.8 30.3 16.4 5.7 9.2 13.3 16.5 14.8 8.9 26.5 25.0 12.3 7.8 19.4 15.9 0.1 15.4 10.7 0.5 1.1 16.1 17.4 5.1 13.5 16.7 21.4 28.8 21.0 8.6 16.8 10.4 16.1 19.9 11.4 16.6 26.1 24.9 7.3 8.8 15.4 17.1 17.2 19.2 14.9 15.2 29.6 9.2 7.0 10.5 20.8 20.6 31.9 11.9 22.0 21.7 9.1 11.9 17.4 2.7 0.5 0.4 0.5 0.3 0.2 1.5 0.6 0.3 0.1 1.8 1.1 0.7 2.4 3.9 0.4 0.9 4.3 0.9 0.6 0.5 0.3 0.9 1.0 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.8 0.5 2.6 0.7 0.4 0.0 2.7 3.4 0.0 0.0 0.9 0.0 0.1 44.4 0.1 1.1 93.5 0.2 11.4 0.2 0.3 0.0 0.0 4.7 3.2 0.0 2.5 2.8 28.5 2.3 1.1 0.0 0.0 1.2 0.8 0.0 0.8 0.7 0.0 1.9 6.5 0.0 191.1 25.4 1.5 1.1 0.7 2.3 0.9 NEURL1B "DKFZP761M1511, Neur2, RNF67B" ENSG00000214357 "Neuralized E3 ubiquitin protein ligase 1B" A8MQ27 5 172641266-172691540 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 32.6;Enterocytes: 45.0;Ito cells: 36.2;Leydig cells: 50.6;Paneth cells: 33.1;Smooth muscle cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 27.6;T-47d: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037612 Approved Supported "Actin filaments,Cytosol" NA Yes Cytosol "Actin filaments" "HPA037612: AB_10795573" "unprognostic (3.56e-2)" "unprognostic (8.46e-2)" "unprognostic (6.72e-3)" "unprognostic (2.70e-1)" "unprognostic (1.64e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (2.95e-1)" "unprognostic (2.86e-1)" "unprognostic (1.09e-1)" "unprognostic (7.13e-3)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.00e-6)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "unprognostic (3.22e-3)" 26.6 11.8 7.5 10.3 3.2 1.5 23.9 0.6 7.0 21.4 17.5 5.6 31.2 5.7 26.7 24.7 14.0 15.8 23.0 19.2 10.7 4.2 7.6 4.4 10.5 7.8 3.1 3.2 20.9 4.8 4.1 6.0 5.1 2.7 20.7 11.6 6.1 4.9 28.4 12.3 14.7 12.1 29.1 1.5 0.6 5.9 6.6 2.8 3.6 7.2 13.9 5.4 16.0 30.8 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.5 2.4 1.3 5.8 0.4 0.2 0.1 5.1 2.3 2.7 4.0 8.7 2.1 0.0 1.4 3.3 3.3 1.3 0.5 2.3 1.8 8.3 0.3 6.2 8.3 0.0 0.4 0.0 1.9 0.0 9.9 0.6 2.7 0.8 0.4 0.9 0.0 2.0 5.8 5.0 1.4 0.1 0.8 2.0 0.2 27.6 6.1 0.9 0.1 1.0 1.0 5.9 4.9 7.8 0.2 2.4 13.0 0.9 0.8 2.0 12.2 1.4 3.2 0.8 0.2 0.0 5.9 0.1 1.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.5 3.2 0.6 7.0 10.7 4.2 3.1 3.2 2.7 2.8 0.0 3.4 0.0 0.6 4.2 0.1 7.8 0.0 8.1 4.5 0.0 0.0 0.2 0.0 0.3 1.9 32.6 45.0 0.0 0.6 0.2 3.5 1.8 0.0 0.5 0.2 0.0 13.4 36.2 2.4 4.1 50.6 1.8 6.8 1.0 12.5 0.7 3.5 33.1 11.7 0.8 0.3 25.8 30.8 2.1 1.5 4.6 0.1 0.0 15.7 0.9 NOL4L "C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424" ENSG00000197183 "Nucleolar protein 4 like" Q96MY1 20 32443059-32585074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;HEL: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041768, HPA043600" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA041768: AB_10964172, HPA043600: AB_10961001" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.10e-1)" "unprognostic (7.88e-2)" "unprognostic (2.75e-3)" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (3.88e-2)" "unprognostic (9.32e-2)" "unprognostic (3.42e-1)" "unprognostic (6.08e-3)" "prognostic favorable (2.63e-4)" 7.7 8.0 13.1 9.0 14.9 18.9 8.7 19.4 14.8 6.5 16.3 35.6 8.7 19.9 6.5 13.8 2.8 9.9 11.0 5.0 13.9 11.7 9.8 5.7 10.6 8.0 20.5 8.7 3.7 12.1 5.0 19.9 12.1 16.3 7.5 15.0 12.5 11.0 9.8 1.9 3.8 20.7 7.4 17.9 11.3 14.3 33.2 20.1 16.7 8.5 2.6 6.5 10.0 8.7 1.9 2.2 7.2 11.7 8.9 8.7 4.7 3.9 12.1 7.6 5.2 1.6 2.5 1.0 2.5 2.1 3.2 2.2 32.2 9.2 0.2 7.5 3.3 5.0 1.1 2.4 7.0 1.4 0.9 1.9 25.3 5.9 23.0 4.3 0.3 1.5 6.3 1.0 2.3 1.5 7.3 19.2 5.5 7.5 3.4 1.5 2.2 8.2 7.7 4.4 12.0 11.3 3.5 0.9 1.3 5.3 0.7 10.1 8.2 7.9 0.2 4.3 8.2 1.6 7.7 20.1 3.0 10.5 2.7 2.6 2.5 0.8 1.7 3.3 13.7 9.0 3.0 2.2 1.1 6.6 4.9 5.8 1.9 4.4 3.8 2.2 1.4 8.7 7.1 7.2 8.9 11.7 0.3 7.0 4.7 13.1 14.9 19.4 14.8 13.9 11.7 20.5 8.7 16.3 20.1 6.0 3.5 1.7 9.0 0.0 34.0 7.4 5.1 4.0 2.3 12.2 62.8 0.2 8.3 6.4 78.2 21.3 50.9 0.0 6.9 1.6 5.0 14.5 11.5 3.9 8.2 7.9 16.8 26.4 3.0 112.0 5.2 4.7 0.0 5.4 33.1 14.8 10.1 34.5 4.6 17.7 55.8 19.4 6.3 53.6 3.9 0.0 0.3 12.8 28.2 20.1 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615327-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 35.8 40.5 45.2 41.4 42.3 44.9 36.6 26.7 38.7 30.5 36.7 25.9 29.2 37.2 35.2 36.7 38.6 33.0 36.6 53.4 39.9 38.4 56.9 58.6 28.8 36.6 41.6 30.2 42.4 42.6 54.0 40.5 45.6 36.8 39.5 32.4 23.1 42.3 35.6 59.3 30.6 46.4 36.7 47.7 45.2 34.8 32.5 40.4 34.3 49.5 36.9 36.0 43.3 56.0 50.7 45.5 38.3 38.0 28.8 49.6 30.9 29.8 15.5 14.6 21.0 11.4 13.2 29.7 27.4 14.9 25.7 24.4 29.4 12.6 38.5 54.3 16.6 31.4 18.5 22.0 20.7 25.2 21.6 36.0 33.1 15.4 49.4 24.5 49.1 26.1 12.4 21.8 23.5 14.5 13.4 16.7 21.7 51.3 10.5 22.2 19.2 27.9 54.5 19.1 17.5 26.6 30.2 20.8 59.2 25.6 9.9 37.2 23.9 16.0 38.8 35.8 19.0 24.1 17.9 25.3 23.7 22.3 24.3 48.1 24.6 47.7 47.0 13.6 29.1 35.8 16.0 30.2 38.3 31.0 35.3 36.6 50.7 45.5 38.3 35.9 41.4 49.6 37.8 14.0 28.8 38.0 45.5 46.9 30.9 45.2 42.3 26.7 38.7 39.9 38.4 41.6 30.2 36.8 40.4 86.4 58.0 93.0 81.6 80.6 62.4 203.3 63.7 148.5 80.8 54.1 21.6 114.5 104.5 133.3 133.2 97.2 61.4 70.0 226.4 127.6 86.4 80.3 87.8 56.9 100.9 46.1 35.6 46.6 45.5 19.9 76.5 83.5 96.2 155.9 59.8 89.8 148.3 72.9 74.6 135.1 46.0 64.7 96.7 142.1 122.5 79.2 129.9 82.8 73.6 94.7 NOLC1 "KIAA0035, NOPP130, NOPP140, P130" ENSG00000166197 "Nucleolar and coiled-body phosphoprotein 1" Q14978 10 102152176-102163871 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032654, HPA037366, HPA050388" Supported Enhanced "Nucleoli fibrillar center" No Yes 10000 "Nucleoli fibrillar center" "CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109" "unprognostic (3.23e-1)" "unprognostic (5.58e-2)" "unprognostic (9.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.89e-2)" "unprognostic (7.03e-3)" "unprognostic (2.36e-3)" "unprognostic (7.34e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (5.64e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (9.19e-5)" "unprognostic (3.15e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (8.25e-5)" "unprognostic (7.68e-2)" 29.5 17.1 18.8 27.8 35.0 23.2 21.3 37.9 39.2 19.1 20.4 23.5 13.8 14.2 25.1 12.4 30.4 25.1 20.7 20.0 18.5 19.2 16.1 38.1 23.6 27.7 20.2 21.4 28.0 25.5 33.9 34.3 25.4 28.0 20.7 27.0 14.8 21.0 18.0 46.6 20.3 17.3 23.4 20.2 26.2 21.0 13.8 19.9 32.9 26.1 19.8 35.1 24.3 20.9 12.7 11.6 7.8 11.2 11.8 19.3 11.2 32.7 30.2 17.1 36.0 14.2 11.3 29.1 18.7 15.0 26.4 22.6 51.9 23.0 68.6 20.9 11.9 13.2 38.1 49.2 40.9 28.3 21.5 32.2 45.9 25.1 30.2 19.1 66.5 21.5 14.5 26.8 28.0 58.7 15.1 16.1 32.9 48.1 30.4 15.8 28.8 62.1 14.0 32.7 22.8 23.7 46.6 46.9 38.2 15.3 21.1 25.6 24.1 18.1 20.8 22.9 16.3 36.1 14.4 13.8 11.9 16.5 13.9 42.0 28.5 42.1 77.3 19.2 68.5 10.2 1.4 8.4 7.8 15.5 10.3 19.3 12.7 12.4 14.5 11.6 10.0 14.5 17.1 0.9 11.8 11.2 9.0 8.8 11.2 18.8 35.0 37.9 39.2 18.5 19.2 20.2 21.4 28.0 19.9 56.6 59.5 35.0 80.3 107.0 19.9 27.3 7.6 83.0 97.8 15.7 13.7 42.4 21.6 30.1 23.7 36.5 9.7 23.3 20.0 49.5 43.1 49.9 41.7 18.7 24.1 9.5 26.5 17.2 13.2 7.7 21.3 28.5 25.3 20.8 27.7 13.7 35.8 20.1 19.8 13.4 17.1 6.5 49.5 23.2 47.2 102.8 40.6 26.6 35.2 75.0 NOP58 "HSPC120, NOP5" ENSG00000055044 "NOP58 ribonucleoprotein" Q9Y2X3 2 202265716-202303666 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018472, HPA021062" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA018472: AB_1854564, HPA021062: AB_1854565" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (9.20e-2)" "unprognostic (2.15e-3)" "unprognostic (2.39e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (6.64e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.86e-4)" "unprognostic (4.52e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.38e-9)" "unprognostic (1.79e-2)" "unprognostic (3.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.60e-1)" 25.1 26.5 16.7 41.6 24.6 47.1 32.2 30.2 24.2 28.8 21.6 13.7 19.5 20.3 31.0 25.9 31.9 26.4 17.7 21.7 21.4 20.3 23.4 36.2 21.7 40.4 16.9 19.1 32.9 31.5 22.3 47.8 24.0 21.9 26.7 27.0 17.1 25.5 29.5 36.9 22.7 25.2 24.1 19.3 33.0 23.5 17.5 17.8 40.0 24.6 32.8 41.4 31.1 41.3 23.5 22.2 4.3 15.2 21.2 26.7 13.5 26.9 19.2 19.0 23.6 14.2 12.8 45.0 26.0 14.0 20.1 18.8 42.3 24.4 41.8 21.7 15.7 25.1 25.1 37.6 32.0 35.5 16.3 34.5 50.4 28.8 41.6 21.1 49.8 24.3 16.5 19.1 28.0 64.3 10.9 18.0 24.9 55.0 31.9 25.1 28.7 45.4 55.1 47.4 30.1 33.3 38.4 28.7 55.1 23.7 32.7 29.3 21.7 24.1 34.7 29.9 31.8 23.7 39.4 15.5 25.7 30.2 22.9 44.4 26.0 47.4 59.8 19.0 35.5 30.5 4.3 10.2 3.1 16.8 15.2 24.5 23.5 24.0 22.7 15.9 18.7 26.4 26.7 1.0 21.2 10.9 22.2 23.7 13.5 16.7 24.6 30.2 24.2 21.4 20.3 16.9 19.1 21.9 17.8 101.3 103.5 73.0 102.7 76.2 27.1 68.8 38.2 96.4 150.2 38.4 39.3 67.7 24.9 45.7 11.5 57.0 15.0 23.3 58.3 76.0 49.7 70.7 131.9 44.1 43.1 23.8 33.8 29.4 17.4 7.9 40.0 46.4 23.6 73.1 32.3 17.7 45.7 10.5 28.0 32.1 43.5 25.8 81.9 59.1 54.7 65.4 56.9 61.8 56.1 83.8 NR1D1 "ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL" ENSG00000126368 "Nuclear receptor subfamily 1 group D member 1" P20393 17 40092787-40100725 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 57.4;Bipolar cells: 62.8;Suprabasal keratinocytes: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 16.3" "Group enriched" "Detected in many" 6 "monocytes: 4.2;T-cells: 16.3" "Cell line enhanced" "Detected in many" "Karpas-707: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007935 Uncertain Supported "Nuclear bodies" NA Yes "Nuclear bodies" "HPA007935: AB_10601277" "unprognostic (1.38e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.53e-1)" "unprognostic (2.24e-2)" "unprognostic (1.05e-1)" "unprognostic (4.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.93e-3)" "unprognostic (9.93e-3)" "unprognostic (2.73e-1)" "unprognostic (9.15e-3)" "unprognostic (4.54e-3)" "unprognostic (2.49e-1)" "unprognostic (3.09e-1)" "unprognostic (1.34e-1)" 19.4 15.1 12.2 7.6 14.7 6.0 30.5 30.7 32.5 45.9 13.9 6.4 17.3 15.2 16.5 6.1 16.8 10.7 8.2 43.7 8.8 5.2 9.8 14.8 12.7 8.8 4.7 11.7 33.3 8.3 4.8 10.9 7.3 6.1 15.5 5.5 28.0 53.0 18.6 51.2 79.3 8.8 27.3 6.0 7.8 7.9 7.3 6.8 1.8 13.9 11.7 10.6 28.0 25.4 1.8 1.1 0.1 4.2 0.8 16.3 1.5 2.8 4.2 0.9 3.4 5.0 3.4 1.2 6.4 10.5 2.1 2.7 2.7 10.5 3.5 3.9 7.3 7.1 8.3 2.2 9.6 1.6 3.0 2.3 2.5 4.2 7.1 8.1 3.8 3.8 7.5 7.0 7.2 15.5 7.0 2.6 4.2 3.7 32.9 2.0 2.0 5.6 3.3 1.6 5.8 6.7 4.0 1.3 10.8 2.9 2.6 2.8 1.6 4.0 5.3 6.5 1.6 2.5 3.2 2.6 9.5 9.4 7.7 5.0 11.9 18.1 1.4 12.9 2.2 7.3 0.0 0.4 0.0 3.9 1.6 16.3 1.5 4.9 5.7 0.9 1.8 4.5 3.2 0.1 0.8 4.2 1.1 6.5 1.5 12.2 14.7 30.7 32.5 8.8 5.2 4.7 11.7 6.1 6.8 3.0 1.3 2.4 32.1 57.4 62.8 5.2 5.1 0.0 6.8 1.8 3.9 2.2 6.6 11.9 1.6 10.5 24.4 0.0 10.1 1.0 6.6 19.6 2.3 25.4 2.2 39.7 7.9 4.3 1.8 0.4 20.1 4.6 18.6 0.0 4.3 27.8 19.9 6.6 36.4 6.9 29.2 6.5 18.6 0.5 7.5 70.9 1.9 6.1 3.6 21.3 NR2F6 "EAR-2, ERBAL2" ENSG00000160113 "Nuclear receptor subfamily 2 group F member 6" P10588 19 17231883-17245940 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 123.8;Hepatocytes: 131.0;Horizontal cells: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 59.1;EFO-21: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079917 Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "CAB079917: AB_2635238" "unprognostic (1.48e-1)" "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.07e-1)" "unprognostic (3.67e-1)" "unprognostic (7.20e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (6.62e-2)" "unprognostic (9.68e-2)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (7.28e-3)" "unprognostic (1.37e-3)" 10.0 8.0 5.4 9.3 5.6 1.1 15.2 6.9 7.4 9.0 23.4 4.7 10.9 26.0 7.9 26.3 16.8 7.7 11.3 14.8 4.6 5.9 17.7 49.3 10.0 2.8 4.8 4.7 9.8 23.5 7.0 8.6 26.5 4.0 10.5 8.2 8.0 13.4 10.3 20.2 9.4 36.2 6.6 2.4 5.0 26.8 9.7 4.5 1.7 13.8 9.3 6.7 10.7 11.5 2.7 1.8 1.6 1.1 7.4 6.5 1.3 19.4 11.7 6.4 11.6 2.5 2.8 59.1 11.0 4.0 4.8 4.1 7.9 17.2 4.6 34.6 4.9 2.8 9.7 4.8 6.3 2.1 6.1 28.0 4.2 7.5 14.2 5.6 2.0 5.9 3.7 7.3 2.2 3.6 5.0 2.9 2.1 9.9 1.1 2.0 10.4 1.7 7.4 17.6 14.6 18.2 3.5 4.0 3.9 6.6 12.7 5.1 14.8 6.1 21.5 12.4 6.5 11.9 6.4 4.8 3.4 8.3 6.5 8.7 6.6 2.3 3.3 4.2 3.0 4.1 0.0 1.1 1.6 2.7 0.0 2.4 0.5 3.9 2.5 1.8 2.7 6.5 2.2 0.2 7.4 0.1 0.8 3.5 1.3 5.4 5.6 6.9 7.4 4.6 5.9 4.8 4.7 4.0 4.5 8.9 18.5 4.7 14.9 9.4 63.1 33.0 33.1 10.7 11.4 24.4 72.6 54.8 24.9 20.6 7.8 12.6 123.8 0.0 41.6 54.2 11.1 17.2 1.1 131.0 13.7 143.0 44.1 17.8 2.9 4.1 16.4 3.3 10.1 1.8 71.7 40.3 40.0 73.0 17.7 29.4 53.0 6.5 15.5 1.0 7.7 9.3 66.7 2.9 56.2 14.1 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUMA1 ENSG00000137497 "Nuclear mitotic apparatus protein 1" Q14980 11 72002864-72080693 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019841, HPA019859, HPA029912" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811" "unprognostic (1.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.06e-2)" "unprognostic (2.84e-1)" "unprognostic (1.14e-1)" "unprognostic (6.47e-2)" "unprognostic (5.75e-2)" "unprognostic (8.74e-3)" "unprognostic (5.91e-2)" "unprognostic (9.45e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "prognostic favorable (7.92e-4)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.49e-1)" "unprognostic (1.39e-1)" 29.7 33.5 23.6 20.6 28.1 26.8 33.1 38.4 31.8 51.9 37.7 55.6 40.1 25.5 58.3 30.9 34.1 37.8 31.2 21.2 21.6 19.4 23.0 13.1 28.3 23.3 37.6 24.8 51.4 30.0 70.7 29.5 26.0 28.3 50.3 24.2 41.2 35.3 40.1 43.7 41.9 30.2 45.3 29.5 23.0 31.2 25.9 39.5 39.4 32.6 22.5 31.8 50.5 37.2 10.3 12.9 4.9 5.7 7.0 9.7 6.6 18.5 23.6 29.6 19.9 26.4 27.5 15.1 25.1 29.1 26.2 22.9 24.5 34.4 25.3 22.0 30.7 18.8 39.9 27.0 25.4 24.0 26.0 12.7 31.0 37.1 18.6 21.2 23.4 22.6 29.0 16.8 25.6 25.9 40.7 22.1 22.9 18.2 30.6 17.9 35.8 30.2 13.1 18.4 35.6 17.1 37.1 51.7 19.5 19.6 29.1 35.8 50.8 40.1 37.1 37.3 13.4 49.9 13.7 30.5 27.8 21.7 39.3 16.6 19.9 19.6 35.6 18.6 11.1 15.8 4.9 5.6 2.5 9.7 3.5 7.4 5.2 6.0 7.5 4.9 10.3 7.5 5.2 4.6 7.0 5.7 12.9 7.2 6.6 23.6 28.1 38.4 31.8 21.6 19.4 37.6 24.8 28.3 39.5 38.7 32.9 12.4 27.2 23.0 61.9 5.2 35.7 32.1 30.7 50.6 68.7 24.3 14.9 24.4 28.1 29.2 50.4 0.0 27.8 11.2 25.5 31.2 30.1 20.3 24.6 49.3 45.5 31.3 31.9 14.3 63.9 23.2 18.6 20.8 58.2 49.2 27.3 31.6 47.7 22.6 57.0 38.8 21.7 11.9 20.4 24.6 37.6 28.4 48.3 21.6 NUSAP1 "ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41332694-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 38.3;lymphoid tissue: 123.4" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 350.4;Extravillous trophoblasts: 100.9;Spermatocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 16.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042904, HPA074847" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Yes Yes Nucleoplasm "Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 3.2 12.9 0.7 20.3 1.3 38.3 3.8 0.7 0.9 2.9 5.4 1.1 4.4 5.8 1.5 2.8 16.1 0.9 2.5 2.7 0.7 0.7 2.5 4.2 5.7 16.5 0.9 0.5 4.2 3.0 0.0 0.6 9.2 0.9 1.8 6.5 0.8 3.6 5.6 4.4 6.0 6.3 2.2 1.2 7.4 4.1 8.6 0.6 123.4 0.8 9.7 19.4 2.9 5.3 2.7 3.1 6.4 1.4 1.7 16.3 3.1 37.4 12.6 41.8 19.9 2.2 3.6 13.9 30.0 17.7 33.1 32.1 17.0 19.6 19.4 16.7 11.3 26.6 36.2 32.2 14.7 31.8 34.9 15.8 49.4 31.3 16.0 0.6 31.4 22.2 1.1 1.7 17.6 13.6 6.5 19.8 30.1 27.0 66.3 25.6 10.0 38.8 21.1 21.5 38.5 15.6 41.9 44.6 21.0 11.8 11.7 30.3 20.8 41.3 24.3 8.6 15.9 36.6 23.3 12.0 25.7 32.3 29.0 52.7 24.7 47.7 62.1 13.5 47.2 44.1 6.4 1.4 4.4 0.7 0.9 0.4 2.7 3.5 2.6 3.1 2.1 0.2 1.9 0.8 1.7 1.2 2.9 16.3 3.1 0.7 1.3 0.7 0.9 0.7 0.7 0.9 0.5 0.9 0.6 0.0 1.0 6.7 5.9 34.2 0.8 0.8 22.9 0.0 4.5 0.0 0.0 10.7 3.3 2.1 20.6 0.7 1.8 350.4 0.4 100.9 8.5 4.1 6.9 3.8 30.5 0.0 2.9 9.2 13.2 8.5 0.3 16.4 3.3 6.4 3.4 1.5 1.6 0.0 1.8 3.9 0.9 0.0 4.1 103.5 65.4 21.8 16.1 13.4 10.2 4.7 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138670772-138780348 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "brain: 23.0;kidney: 8.0;ovary: 19.3" "Cell type enriched" "Detected in single" 7 "Distal tubular cells: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 4 "pons and medulla: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" NA Yes "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.4 0.5 3.1 0.6 3.7 0.2 0.4 0.8 6.0 0.6 0.3 0.0 0.0 0.2 1.1 0.5 0.2 0.6 0.2 0.2 1.9 1.5 8.0 0.3 0.3 0.2 2.4 2.0 19.3 0.2 0.4 0.4 0.4 23.0 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 0.3 0.7 0.2 0.2 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 1.6 6.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.7 0.8 5.6 1.9 1.5 2.4 2.0 23.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309268-41332621 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.7;testis: 41.7" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 19.9;Spermatocytes: 82.8;Spermatogonia: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 1.3 2.1 0.5 3.8 0.8 7.5 0.7 1.5 1.1 1.1 3.4 0.7 2.3 3.0 0.6 0.6 4.6 0.6 1.3 1.9 0.9 0.4 1.1 1.1 1.0 4.3 0.6 0.4 1.2 0.6 0.0 0.3 1.6 0.5 0.5 3.1 0.2 1.2 1.3 8.3 2.5 3.1 0.6 0.8 2.7 1.4 41.7 0.7 16.7 0.5 6.3 4.0 0.7 1.5 2.5 7.7 1.1 1.3 1.9 5.9 1.7 13.3 7.1 14.1 10.3 0.7 0.9 13.4 8.3 3.8 9.9 10.7 12.7 6.6 8.0 7.3 3.0 15.6 20.9 14.3 6.4 7.9 17.2 16.5 16.9 20.8 13.1 0.1 18.4 9.5 0.3 1.3 5.6 5.9 2.1 8.4 16.8 23.1 15.4 6.6 6.4 10.8 13.7 12.8 19.9 15.5 13.3 11.8 12.0 4.4 6.2 22.4 7.5 13.7 14.0 3.8 5.9 13.9 10.5 4.1 10.2 15.8 10.2 14.7 7.4 32.4 28.3 3.0 22.5 14.7 0.0 0.8 1.1 0.6 1.3 1.5 2.1 1.8 1.6 1.4 2.5 2.6 1.7 0.0 1.9 0.8 7.7 5.9 1.7 0.5 0.8 1.5 1.1 0.9 0.4 0.6 0.4 0.5 0.7 0.0 0.3 0.0 0.6 3.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 7.1 0.0 0.5 5.5 0.1 0.9 0.0 0.3 19.9 1.5 0.3 1.1 0.8 6.5 0.0 0.0 0.0 0.6 9.2 0.9 1.6 0.0 1.0 1.7 0.6 0.1 0.0 1.1 0.2 0.2 6.5 0.9 82.8 66.8 2.0 3.2 0.7 3.0 0.1 ORC1 "HSORC1, ORC1L, PARC1" ENSG00000085840 "Origin recognition complex subunit 1" Q13415 1 52372829-52404459 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.9;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.6;Extravillous trophoblasts: 8.3;Spermatogonia: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027439, HPA027450" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA027439: , HPA027450: AB_10602041" "unprognostic (3.28e-1)" "unprognostic (4.42e-3)" "prognostic favorable (1.74e-5)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (3.77e-3)" "prognostic unfavorable (3.69e-4)" "unprognostic (3.86e-2)" "unprognostic (2.70e-3)" "unprognostic (8.39e-2)" "unprognostic (1.25e-10)" "unprognostic (4.56e-3)" "unprognostic (1.05e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" 0.9 1.2 0.2 9.9 0.4 22.9 0.8 1.4 1.1 1.1 3.4 0.4 0.1 1.4 0.6 1.5 5.3 0.5 0.8 0.9 0.3 0.4 1.0 1.1 1.4 5.7 0.3 0.4 1.0 0.7 0.2 0.9 1.6 0.9 0.8 3.8 0.5 1.4 0.8 0.9 2.0 3.0 0.7 0.4 4.2 1.2 8.7 0.5 29.1 0.5 8.0 11.3 1.0 1.7 1.0 1.3 0.7 0.4 7.5 2.3 0.7 7.4 8.2 13.3 8.7 0.3 1.1 12.8 5.3 4.9 15.8 16.4 10.1 4.2 17.2 4.7 3.3 7.2 10.3 19.5 6.7 13.8 7.3 11.2 20.6 12.2 10.0 0.0 27.6 11.8 0.6 0.3 15.4 1.7 1.1 4.6 10.9 23.9 8.4 5.1 5.5 21.6 13.1 29.4 4.5 11.8 23.3 20.7 16.8 2.7 9.8 7.5 6.3 12.3 7.5 4.2 13.0 4.1 11.1 2.1 6.4 9.3 10.0 13.2 4.4 11.7 21.3 6.3 20.6 7.8 0.1 0.2 0.0 0.5 0.3 0.6 0.4 0.8 0.8 1.3 1.0 0.3 0.7 0.7 7.5 0.4 0.1 2.3 0.7 0.2 0.4 1.4 1.1 0.3 0.4 0.3 0.4 0.9 0.5 0.0 0.0 0.8 0.2 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 4.6 0.1 0.0 0.0 0.2 8.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.8 0.6 0.2 0.0 0.0 0.7 0.2 0.1 0.0 0.4 3.3 0.9 0.0 0.1 3.2 7.3 1.0 1.5 0.5 1.9 0.1 OSER1 "C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1" ENSG00000132823 "Oxidative stress responsive serine rich 1" Q9NX31 20 44196496-44210791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 722.5;Late spermatids: 1504.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045125 Approved Approved "Nucleoli,Nucleoli rim,Nuclear speckles" NA Yes "Nucleoli, Nucleoli rim, Nuclear speckles" "HPA045125: AB_10961629" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.18e-1)" "unprognostic (6.07e-2)" "unprognostic (8.44e-3)" "unprognostic (3.31e-1)" "unprognostic (1.14e-1)" "unprognostic (8.78e-2)" "unprognostic (8.01e-3)" "unprognostic (9.87e-2)" "unprognostic (3.96e-1)" "unprognostic (2.14e-1)" "unprognostic (2.45e-1)" "unprognostic (8.39e-2)" "unprognostic (1.06e-1)" 18.7 11.8 11.9 18.4 13.3 62.5 20.0 17.8 13.3 19.1 17.2 13.0 13.0 15.1 17.5 17.6 23.5 14.2 13.7 16.9 12.4 10.0 15.0 16.3 17.7 16.9 16.3 10.9 21.4 10.9 19.3 12.5 31.7 13.1 22.6 14.1 12.4 17.0 13.2 46.3 22.3 18.9 23.5 16.9 18.2 14.7 47.4 13.3 15.1 19.0 15.4 17.4 29.6 16.7 28.4 14.6 74.3 21.9 15.1 17.6 19.8 20.4 16.0 11.6 9.1 31.1 22.2 13.5 18.9 28.5 29.8 27.4 38.3 21.2 20.5 18.7 17.2 38.8 27.9 13.2 17.4 25.1 6.9 8.6 6.6 34.5 25.9 18.0 11.3 11.0 26.3 29.3 19.5 35.8 15.5 13.5 12.5 9.7 25.3 16.3 30.6 9.1 13.8 10.6 18.7 16.4 12.7 19.7 14.1 14.8 14.0 11.7 11.8 26.9 35.8 23.9 14.3 18.2 10.2 11.8 24.6 18.9 14.6 16.2 17.2 18.4 19.9 17.4 8.5 12.7 50.2 16.8 27.7 12.7 15.7 13.7 28.4 14.8 12.5 14.6 26.9 17.6 15.9 74.3 15.1 21.9 9.5 17.1 19.8 11.9 13.3 17.8 13.3 12.4 10.0 16.3 10.9 13.1 13.3 17.9 28.4 24.4 119.5 230.4 9.6 33.9 17.8 24.1 22.7 12.2 3.9 33.6 31.5 38.1 722.5 31.5 56.3 0.0 32.0 30.4 33.9 80.1 33.4 26.0 38.1 11.1 47.4 17.2 27.0 1504.1 37.7 43.4 72.6 117.2 30.0 23.4 42.0 45.6 33.2 26.2 14.1 19.4 49.5 76.2 55.8 173.4 145.2 35.9 35.3 99.2 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910062-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 17.4;Club cells: 25.0;Collecting duct cells: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066650 Approved "Nuclear bodies,Cytosol" NA Yes Cytosol "Nuclear bodies" "HPA066650: AB_2685698" "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavorable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favorable (8.84e-4)" 4.7 8.1 9.8 29.3 20.4 14.0 16.0 3.4 6.0 8.4 5.7 6.2 20.4 6.9 8.3 26.1 7.6 9.1 13.0 3.7 8.6 4.2 21.7 29.2 14.6 16.3 5.6 9.3 16.9 29.3 7.7 23.7 5.1 7.1 15.2 6.4 7.6 10.2 14.7 0.9 10.3 10.0 6.2 10.9 12.5 10.0 9.2 6.5 20.3 28.1 6.3 12.9 9.0 12.1 3.3 0.4 3.9 0.5 0.3 1.9 0.1 6.6 8.7 11.7 16.9 4.4 9.4 26.8 14.7 3.0 5.7 7.6 23.7 12.2 8.7 24.8 5.8 9.2 15.5 5.2 13.5 4.7 5.2 10.6 7.0 23.8 21.9 10.1 6.0 2.9 9.9 23.8 12.1 21.5 6.5 1.4 13.5 7.8 12.6 6.8 19.0 7.4 14.3 4.6 6.9 15.3 9.6 2.5 4.6 8.0 8.3 7.3 7.3 5.8 18.3 19.9 15.4 35.8 4.8 4.7 25.5 17.2 11.1 7.0 16.6 16.5 4.4 8.2 2.5 8.4 0.1 0.5 0.1 0.9 0.1 1.9 1.4 0.2 0.7 0.2 3.3 0.3 0.5 3.9 0.3 0.2 0.4 0.5 0.1 9.8 20.4 3.4 6.0 8.6 4.2 5.6 9.3 7.1 6.5 6.0 17.4 0.5 2.5 1.6 0.3 1.4 7.6 12.0 25.0 19.2 0.0 4.5 0.0 2.9 0.4 0.7 1.6 0.0 0.4 3.8 2.3 3.2 3.5 5.0 2.5 0.0 4.1 0.6 0.6 0.0 1.7 2.2 0.0 1.8 2.3 2.4 2.2 3.1 1.8 0.8 1.1 0.0 0.9 0.7 2.1 1.5 3.2 4.4 3.1 2.4 PAK4 ENSG00000130669 "P21 (RAC1) activated kinase 4" O96013 19 39125770-39182816 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 45.4;MCF7: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025747, CAB044670, HPA070175, HPA072220" Uncertain Supported "Plasma membrane,Cell Junctions" NA Yes "Plasma membrane, Cell Junctions" "CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (5.86e-2)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (8.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.13e-3)" "unprognostic (3.90e-2)" "unprognostic (4.04e-2)" "unprognostic (7.29e-2)" "prognostic unfavorable (9.85e-4)" "prognostic favorable (5.29e-5)" "unprognostic (2.39e-1)" "unprognostic (7.05e-2)" "unprognostic (2.02e-1)" "unprognostic (4.85e-2)" 6.8 11.1 11.0 12.7 12.3 4.8 11.9 13.7 12.4 17.3 19.6 13.7 19.9 26.0 12.2 17.3 20.1 15.3 16.5 8.1 10.9 8.1 19.4 17.0 18.7 5.4 13.7 7.7 13.8 29.6 11.2 17.0 23.0 10.3 29.6 8.1 19.7 40.9 18.5 10.3 18.6 25.1 9.0 8.3 7.9 18.6 22.3 12.5 8.8 15.2 10.1 14.7 11.5 15.0 2.8 3.4 4.2 2.5 3.6 4.5 1.9 17.9 45.4 6.8 10.3 2.1 2.3 20.5 8.6 3.5 5.8 5.9 29.7 15.3 4.1 13.1 5.4 7.6 6.6 3.7 6.8 2.2 10.9 10.4 4.8 8.3 14.4 3.4 4.9 7.1 2.7 3.0 5.4 3.9 3.8 7.5 6.3 9.7 3.2 3.4 50.0 5.2 5.4 12.3 15.9 10.9 5.3 5.3 3.1 5.6 19.8 21.7 15.0 8.7 39.0 9.7 3.7 17.3 8.2 12.5 9.9 17.0 11.3 15.3 3.7 3.5 3.4 12.1 2.9 11.8 1.0 2.5 4.2 2.6 1.4 3.6 2.2 2.9 4.5 3.4 2.8 2.2 2.2 2.1 3.6 2.1 2.9 3.0 1.9 11.0 12.3 13.7 12.4 10.9 8.1 13.7 7.7 10.3 12.5 0.0 1.0 0.5 15.0 12.8 14.8 1.2 20.4 6.7 0.0 17.4 23.6 35.6 26.6 18.7 2.7 15.8 35.5 0.0 17.2 46.7 10.8 17.8 5.7 10.5 8.3 20.6 43.0 12.3 5.6 4.9 10.9 2.5 6.8 14.4 30.6 14.1 16.5 40.3 9.9 10.6 13.1 0.0 7.2 5.7 17.7 16.4 54.7 8.7 29.9 20.6 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles NA Yes Vesicles "HPA068394: AB_2685980" "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.01e-6)" "prognostic favorable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.9 11.0 12.5 18.0 2.0 3.7 4.2 4.9 5.9 9.1 8.6 6.6 13.8 12.9 6.7 5.6 6.4 18.2 12.9 7.7 3.8 13.7 5.6 3.9 21.6 8.9 0.2 8.4 14.4 0.9 4.1 4.9 1.3 4.6 5.9 11.0 7.7 35.1 7.7 25.9 12.1 9.0 10.5 19.4 7.5 24.1 16.4 41.6 6.2 4.5 28.6 13.3 18.2 17.6 13.2 1.7 18.9 13.1 3.6 16.0 9.8 7.3 6.9 15.3 10.6 17.2 7.0 11.4 17.5 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 0.0 0.0 2.9 1.4 2.7 14.6 0.8 12.7 10.7 6.8 0.0 55.0 0.7 0.0 4.4 0.5 1.0 2.0 0.0 9.9 7.2 0.8 7.5 2.3 0.0 11.5 6.4 4.1 3.7 9.5 3.0 0.6 4.5 5.0 1.0 5.3 15.7 6.5 2.9 0.0 0.3 145.7 0.0 1.2 1.6 5.2 4.4 0.5 0.0 9.3 0.8 PBK "CT84, FLJ14385, Nori-3, SPK, TOPK" ENSG00000168078 "PDZ binding kinase" Q96KB5 8 27809620-27838095 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 19.4;testis: 67.9" "Group enriched" "Detected in many" 4 "Early spermatids: 218.2;Spermatocytes: 187.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 1.6" "Group enriched" "Detected in many" 10 "NK-cells: 2.1;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 61.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005753, HPA050656" Enhanced Supported Approved Cytosol NA Yes Cytosol "HPA005753: AB_1855018, HPA050656: AB_2681205" "unprognostic (7.17e-2)" "unprognostic (7.21e-3)" "unprognostic (1.04e-3)" "unprognostic (2.77e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.29e-5)" "unprognostic (3.65e-3)" "unprognostic (7.38e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.18e-12)" "unprognostic (9.61e-2)" "unprognostic (1.86e-1)" "unprognostic (8.30e-2)" "unprognostic (8.68e-2)" 0.6 0.8 0.2 7.7 0.3 3.3 1.3 0.3 0.4 1.1 3.8 0.3 0.2 3.7 0.4 0.6 6.2 0.3 0.8 3.3 0.3 0.2 0.7 0.9 1.2 5.4 0.3 0.2 0.4 0.4 0.0 0.2 2.2 0.3 0.4 4.6 0.2 1.1 0.2 0.4 1.9 3.6 0.9 0.6 1.7 1.7 67.9 0.2 19.4 0.3 4.7 5.3 0.7 1.9 0.1 0.0 0.0 0.0 2.1 1.6 0.5 61.3 20.0 19.7 12.5 1.9 3.5 8.3 28.2 13.4 29.0 24.5 6.9 11.4 32.7 10.0 10.8 32.3 16.3 18.9 9.5 31.9 8.0 10.2 7.8 14.2 10.1 0.1 5.1 11.7 0.9 7.8 13.4 7.2 5.2 14.6 16.2 11.5 22.0 34.2 6.9 19.3 6.0 3.5 16.6 17.4 12.1 27.4 8.8 10.9 9.5 7.8 12.2 10.5 12.4 15.8 5.7 13.0 7.8 8.5 19.1 46.0 24.2 29.9 3.1 8.7 15.1 11.6 9.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 1.6 0.5 0.2 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.9 7.9 0.0 0.3 5.1 0.0 2.3 0.0 0.0 3.1 0.0 0.5 218.2 0.0 1.3 46.7 0.0 40.6 2.9 0.7 0.0 1.0 4.2 0.0 0.0 7.4 1.9 37.5 7.8 0.6 0.0 0.0 4.3 0.0 0.2 0.0 2.8 0.0 0.0 6.5 0.5 187.0 31.0 2.0 5.6 0.0 5.3 0.7 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177539-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA069107: AB_2686088, HPA073074: AB_2686568" "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 17.6 22.6 13.7 14.6 16.0 11.3 21.0 33.5 15.9 20.9 18.2 14.6 20.4 10.3 24.0 20.7 15.6 22.5 14.7 31.3 12.8 10.8 15.4 18.1 14.8 19.6 16.9 13.0 30.6 28.6 12.1 37.6 13.4 14.9 20.0 16.3 14.4 21.4 19.3 21.6 15.0 15.2 19.7 13.4 20.1 19.2 43.4 16.5 19.4 25.4 11.6 20.6 18.0 21.2 15.1 9.7 8.1 12.5 7.6 32.4 19.0 21.9 9.3 14.3 12.6 26.3 19.8 10.0 16.9 25.5 23.6 21.9 18.3 20.8 17.6 11.3 22.9 30.0 14.0 22.6 15.3 26.3 15.3 22.3 22.7 24.3 16.1 26.2 38.4 9.3 16.2 17.1 14.8 26.3 19.0 18.6 24.6 17.3 7.2 26.7 10.6 20.4 27.2 14.1 40.6 11.9 18.7 15.9 16.8 21.4 11.1 19.1 11.8 10.5 26.3 19.3 15.1 14.5 47.0 12.0 7.0 25.2 10.1 12.7 11.1 10.3 24.6 24.2 26.2 15.9 8.1 9.6 7.1 27.6 12.5 32.4 15.1 23.6 28.7 9.7 14.2 21.5 22.3 1.5 7.6 11.5 9.2 23.5 19.0 13.7 16.0 33.5 15.9 12.8 10.8 16.9 13.0 14.9 16.5 17.9 11.8 26.0 26.1 19.2 21.0 26.8 15.3 30.8 14.8 14.0 15.7 25.3 23.2 19.0 26.4 26.3 7.9 23.3 12.0 20.4 25.7 26.0 10.4 17.8 18.1 35.0 7.5 15.4 20.8 8.0 38.3 13.8 15.1 26.2 14.1 19.5 17.0 19.5 38.2 18.4 24.9 19.4 28.9 129.6 82.8 21.7 26.0 34.8 19.9 21.4 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364311-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.1;lymphoid tissue: 78.3" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 32.4;Extravillous trophoblasts: 120.0;Hofbauer cells: 92.8;Syncytiotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "T-reg: 24.2" "Lineage enriched" "Detected in many" 5 "T-cells: 24.2" "Low cell line specificity" "Detected in many" HPA047929 Supported Centrosome NA Yes Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.8 0.7 24.5 0.8 42.1 2.6 0.4 0.8 1.8 7.7 0.6 1.0 4.6 1.6 2.8 18.8 0.6 4.0 2.2 0.8 1.0 2.5 3.0 4.0 21.8 1.4 0.4 0.9 1.4 0.1 0.6 5.1 0.7 1.6 10.1 0.5 3.1 0.4 0.9 2.8 8.1 1.6 1.9 10.9 4.9 3.0 0.5 78.3 1.2 18.0 20.7 4.3 5.7 2.2 3.2 2.0 0.4 5.2 24.2 2.7 30.8 35.7 30.4 19.4 3.2 11.5 22.2 23.9 21.2 46.0 66.7 40.1 29.4 59.3 8.5 12.1 12.5 23.2 75.7 18.4 52.0 37.6 27.2 58.1 37.6 34.5 0.3 38.2 21.5 3.9 1.9 36.3 7.4 9.9 34.9 36.3 35.7 21.8 52.8 35.6 46.3 85.8 11.3 38.9 15.5 60.5 57.6 38.9 21.8 31.9 3.0 15.7 18.9 15.0 11.0 15.8 21.2 53.2 4.9 22.8 47.9 27.6 63.6 11.9 41.1 37.1 9.5 84.4 15.3 2.0 0.2 1.2 1.6 0.1 0.2 2.2 4.8 4.5 3.2 0.5 0.4 0.8 1.6 5.2 0.4 0.2 24.2 2.7 0.7 0.8 0.4 0.8 0.8 1.0 1.4 0.4 0.7 0.5 8.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 9.1 1.8 0.0 32.4 1.7 5.8 0.0 0.0 0.0 0.0 2.7 120.0 0.0 0.0 3.5 0.0 92.8 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 3.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 115.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 13.9 21.4 11.1 31.8 15.8 87.2 13.7 17.2 14.6 13.7 23.1 15.6 13.7 18.9 15.7 13.7 36.0 12.7 17.5 13.6 11.6 9.8 21.7 14.9 17.8 41.6 18.8 10.8 14.4 14.3 14.0 13.9 24.0 14.3 10.8 26.1 18.7 17.7 15.6 11.0 16.5 20.5 12.8 16.1 24.5 15.7 40.5 17.4 115.8 18.1 40.7 38.7 17.3 17.2 16.9 16.0 8.7 11.6 19.6 24.4 16.9 74.2 58.5 59.3 25.5 14.1 13.2 41.6 48.9 28.8 46.1 65.6 45.6 59.4 75.5 15.9 17.4 40.4 55.8 35.0 58.9 42.3 22.4 38.7 53.0 22.5 106.2 6.0 72.5 23.8 9.6 14.0 39.2 9.3 9.7 26.3 50.4 47.2 63.8 44.9 26.8 138.7 80.3 44.4 58.0 32.4 76.6 52.2 60.9 20.8 43.4 51.0 34.6 34.3 53.0 33.6 22.8 37.4 37.0 17.5 33.3 38.3 46.8 55.8 32.4 92.5 127.9 15.0 69.1 42.6 2.4 11.6 8.7 19.2 10.9 23.8 16.9 24.4 19.3 16.0 13.6 22.4 20.1 3.8 19.6 11.4 14.7 23.3 16.9 11.1 15.8 17.2 14.6 11.6 9.8 18.8 10.8 14.3 17.4 41.7 27.0 42.4 43.7 60.1 36.0 11.2 17.8 34.8 43.3 55.8 25.5 92.8 51.4 37.7 137.5 25.2 25.5 46.7 34.8 161.2 34.6 21.0 20.9 24.7 83.0 30.2 19.1 35.6 27.3 83.6 33.4 41.7 35.4 67.7 35.2 57.6 24.8 21.0 37.8 36.6 74.2 51.8 33.9 133.4 89.3 43.4 55.5 43.6 63.4 25.0 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 24.4 28.1 26.0 26.1 30.1 28.2 29.6 19.0 31.8 19.7 21.9 27.2 18.1 20.4 28.0 21.3 31.2 28.0 22.7 18.1 26.3 18.5 24.2 34.9 19.8 30.0 27.2 26.6 30.5 49.0 31.3 17.0 20.2 23.6 24.2 19.2 18.6 22.2 22.1 34.1 32.3 19.8 22.9 24.3 26.4 25.2 34.5 27.2 21.2 25.3 23.1 24.9 21.8 22.6 14.4 17.8 3.9 19.4 12.4 16.2 16.3 34.3 39.2 14.5 30.8 16.7 16.4 22.3 22.9 18.8 39.1 30.5 45.4 14.8 46.6 20.5 26.0 30.2 24.0 44.5 40.8 28.8 19.9 42.8 22.6 22.5 39.1 41.7 54.5 23.8 23.1 25.7 40.6 40.9 18.7 25.1 16.7 37.2 19.0 23.6 43.3 26.4 55.3 28.1 33.8 28.8 33.8 25.3 45.6 21.4 23.8 25.1 26.0 22.6 25.8 30.3 12.1 18.1 28.0 19.8 45.9 34.8 23.3 38.2 24.2 20.7 47.6 32.2 25.1 29.3 3.9 15.8 3.9 13.3 19.4 16.2 14.4 12.4 12.7 17.8 13.8 14.2 12.7 0.6 12.4 13.9 15.4 9.5 16.3 26.0 30.1 19.0 31.8 26.3 18.5 27.2 26.6 23.6 27.2 3.0 17.6 13.7 18.1 20.0 6.4 3.4 25.5 26.8 19.4 24.4 7.9 30.6 21.6 36.3 38.4 21.1 24.6 0.0 38.0 33.3 14.9 13.1 17.4 20.7 33.9 3.2 22.5 28.8 29.7 10.4 18.4 20.8 20.3 31.5 19.9 13.1 33.1 14.0 19.1 39.6 8.1 19.4 18.4 23.5 19.3 19.9 23.8 15.0 24.7 12.2 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289135-296107 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 148.7" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 54.5;U-266/70: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol NA Yes Cytosol "HPA039383: AB_10796225, HPA058829: AB_2683830" "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.12e-4)" 5.6 1.8 6.0 16.7 9.3 6.3 10.5 2.9 7.7 12.7 5.6 3.3 10.4 21.1 6.9 14.9 5.6 8.4 8.3 4.4 6.3 1.7 14.8 17.0 15.7 24.6 7.6 2.5 3.5 148.7 2.6 3.6 3.4 8.0 8.5 3.0 7.1 8.9 21.8 5.6 2.4 23.2 5.2 10.1 24.2 4.7 2.3 7.5 6.3 18.0 6.4 15.4 7.3 8.7 2.3 2.5 4.9 4.2 6.9 8.5 2.7 2.1 2.3 4.4 4.8 1.8 1.6 3.3 1.7 1.4 1.0 0.8 2.0 6.1 0.0 2.2 2.0 2.1 1.3 0.3 0.7 0.1 5.2 1.6 1.0 1.5 2.6 2.2 0.1 9.4 5.9 0.6 0.3 0.3 3.7 3.3 54.5 4.0 6.5 0.5 3.1 8.9 4.7 3.4 0.7 0.3 8.5 0.8 3.0 2.3 0.7 0.0 1.0 0.6 3.2 2.9 2.0 2.3 1.1 3.0 2.1 2.9 0.6 0.2 14.3 0.4 2.3 0.3 1.7 2.4 1.5 0.9 1.2 8.5 4.2 7.2 2.1 1.3 4.7 0.6 2.3 3.1 6.1 4.9 6.9 3.2 2.5 0.2 2.7 6.0 9.3 2.9 7.7 6.3 1.7 7.6 2.5 8.0 7.5 148.9 104.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 58.0 31.4 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 7.1 2.9 0.0 0.0 5.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 14.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500369 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" NA Yes "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favorable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 11.0 12.3 10.0 17.2 17.4 11.5 11.6 18.7 15.2 17.2 14.2 16.5 11.7 9.9 22.7 12.1 37.0 15.1 12.6 10.7 11.4 7.9 16.4 18.7 13.8 10.4 15.3 8.9 15.3 15.4 22.3 18.1 11.6 12.1 13.7 15.8 15.4 18.1 10.3 14.9 19.1 15.4 15.7 13.6 14.4 12.1 15.7 18.5 17.8 15.2 18.1 30.0 12.1 20.6 5.3 5.6 4.0 6.3 4.8 7.7 3.4 12.4 8.6 19.3 13.9 4.9 5.5 2.9 9.0 9.2 19.7 20.5 8.2 14.2 12.0 8.2 10.7 12.4 8.9 13.3 9.0 17.7 9.0 7.4 25.0 14.7 12.7 7.4 14.9 28.9 4.9 8.4 12.6 22.3 7.3 25.9 9.3 12.6 8.3 12.5 3.9 10.5 3.7 14.6 6.8 5.9 11.1 18.4 8.9 10.2 11.3 10.2 12.8 20.1 8.3 10.4 8.0 11.2 5.5 16.8 9.6 18.0 6.7 17.3 6.4 9.1 10.1 9.3 12.6 10.1 3.4 4.6 4.0 7.7 4.1 6.8 3.3 5.9 7.2 4.5 5.3 4.0 5.4 3.5 4.8 6.3 5.6 2.7 3.4 10.0 17.4 18.7 15.2 11.4 7.9 15.3 8.9 12.1 18.5 65.5 49.1 30.2 22.5 34.3 33.3 35.0 28.1 81.7 67.1 22.7 19.6 15.0 14.9 29.8 4.7 40.9 48.1 23.3 31.5 14.3 20.1 21.0 45.2 50.0 20.2 22.3 47.4 41.1 23.6 5.9 17.8 29.3 16.9 19.0 49.8 18.4 39.7 31.6 28.0 40.8 37.3 38.8 26.8 48.3 31.1 47.3 12.7 29.4 44.9 29.8 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.9" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 23.0;Spermatogonia: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 21.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB012647, HPA055473, HPA066948" Supported Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: AB_2682827, HPA066948: " "unprognostic (1.38e-1)" "prognostic favorable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favorable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.4 3.0 3.3 6.7 3.7 15.0 3.9 7.7 10.0 4.4 4.3 2.2 0.4 7.1 3.2 4.1 6.8 3.3 3.0 2.2 4.7 2.9 2.9 5.6 3.1 7.0 4.4 10.9 2.9 5.6 3.0 2.8 10.1 3.2 5.2 2.0 2.7 6.1 3.5 7.1 7.9 6.5 2.0 5.9 5.3 5.9 5.0 1.9 21.9 3.9 4.3 9.2 3.3 2.8 1.9 3.1 0.1 1.8 0.4 3.3 1.2 4.2 4.9 2.3 4.9 0.5 1.9 21.5 5.9 1.6 2.2 2.9 4.4 8.1 3.5 1.9 0.8 2.0 6.2 1.7 2.4 0.4 6.9 9.9 2.9 3.4 9.1 5.7 3.3 7.5 7.0 4.3 1.1 0.3 0.4 4.0 8.2 3.4 2.6 0.9 1.9 9.2 5.5 3.2 4.5 3.5 15.0 3.4 6.7 0.8 1.5 4.1 5.5 2.5 6.6 1.6 1.4 4.8 5.6 2.2 2.8 6.2 2.0 3.8 8.5 4.8 6.6 3.6 2.7 4.4 0.0 1.7 0.1 1.9 1.8 1.8 1.5 1.4 1.5 3.1 1.9 1.7 1.7 0.0 0.4 1.6 0.8 3.3 1.2 3.3 3.7 7.7 10.0 4.7 2.9 4.4 10.9 3.2 1.9 3.0 9.1 8.1 3.4 0.0 13.1 2.8 7.6 0.0 10.3 3.5 9.8 23.0 1.7 2.5 1.1 2.2 8.6 0.0 4.0 5.2 1.3 3.4 1.1 8.9 4.7 1.6 8.6 1.8 1.9 0.7 6.6 2.8 0.0 1.8 7.9 5.7 3.4 8.0 3.9 3.1 16.2 0.0 1.7 9.2 24.7 0.0 8.1 5.3 8.6 2.6 PIF1 "C15orf20, FLJ22692" ENSG00000140451 "PIF1 5'-to-3' DNA helicase" Q9H611 15 64815632-64825668 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.3" "Group enriched" "Detected in many" 5 "Early spermatids: 22.3;Erythroid cells: 70.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.2" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB018701 Supported Supported Nucleoplasm NA Yes Nucleoplasm "CAB018701: AB_2164654" "unprognostic (1.99e-1)" "unprognostic (6.11e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.62e-1)" "unprognostic (8.33e-3)" "unprognostic (8.66e-4)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (6.68e-2)" "unprognostic (2.38e-2)" "unprognostic (3.27e-2)" "unprognostic (0.00e+0)" "unprognostic (2.96e-3)" "unprognostic (1.78e-1)" "unprognostic (9.61e-2)" "unprognostic (5.95e-2)" 1.8 1.1 0.6 12.9 0.6 6.0 0.6 0.6 1.2 1.2 5.2 0.6 0.6 3.3 2.0 1.3 4.6 0.8 1.4 0.9 0.6 1.8 0.7 0.6 1.9 7.5 0.9 0.6 0.6 0.6 0.0 0.6 1.4 1.0 2.5 1.8 0.9 0.8 1.2 0.6 1.6 3.7 2.1 0.6 7.0 2.7 3.3 0.6 14.3 0.6 5.1 6.0 1.8 1.9 0.7 0.3 0.0 0.0 0.0 3.2 0.4 5.2 6.1 15.0 6.0 2.7 3.2 5.5 5.1 2.8 5.2 4.0 9.6 8.8 6.3 2.1 2.5 4.8 14.5 15.3 4.3 1.9 10.0 5.6 7.3 17.1 6.9 1.4 2.9 6.0 1.8 0.0 2.3 1.9 1.3 5.3 9.5 4.8 12.7 4.9 4.6 3.1 12.2 12.2 6.6 4.2 6.5 5.0 8.9 2.9 2.9 6.2 4.0 3.9 4.4 2.3 6.9 4.9 3.2 3.6 3.1 16.4 5.0 9.4 10.2 9.4 6.0 3.0 12.9 4.4 0.0 0.0 0.0 1.5 0.0 0.5 0.7 0.1 1.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.3 3.2 0.4 0.6 0.6 0.6 1.2 0.6 1.8 0.9 0.6 1.0 0.6 0.0 1.4 0.8 0.6 1.6 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 22.3 1.5 0.3 70.0 0.0 5.6 2.6 0.9 0.0 0.0 4.8 0.0 0.0 7.4 2.2 1.3 1.4 3.1 0.0 0.0 0.8 0.6 0.2 0.0 2.1 0.0 0.8 6.5 2.7 0.1 1.9 0.9 0.9 8.9 0.9 1.1 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36535020-36539310 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" No Yes "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 3.0 2.4 2.5 4.9 2.9 3.0 4.5 1.8 6.4 2.5 3.8 2.4 0.4 3.3 3.2 4.4 5.7 2.0 2.7 3.5 2.3 6.7 12.0 2.9 4.7 3.6 2.2 4.3 4.8 3.3 6.0 2.6 6.3 2.1 4.8 3.7 3.7 2.8 6.5 5.0 3.9 3.1 3.2 4.3 3.3 3.4 2.2 4.0 4.1 8.1 5.5 2.4 1.2 4.4 6.2 1.1 4.9 4.8 5.8 3.3 7.3 9.7 6.8 6.2 2.9 2.6 8.9 8.9 3.9 8.1 6.7 8.5 7.7 11.0 2.7 4.9 8.9 10.4 11.9 5.0 11.1 6.1 12.6 9.5 6.1 6.8 2.3 19.5 10.5 3.0 5.8 8.9 4.0 1.8 4.5 3.6 16.0 7.0 5.6 5.4 9.6 5.8 9.7 4.3 6.6 8.6 16.0 10.8 4.3 9.7 13.5 10.2 12.7 4.7 6.3 6.4 17.0 3.0 6.1 13.9 16.9 13.4 15.7 5.9 18.6 13.2 3.7 9.9 12.5 1.1 2.8 0.5 3.6 4.2 5.6 2.5 4.7 3.6 6.2 4.4 5.8 5.2 0.9 4.8 4.9 2.9 2.4 3.3 3.0 1.9 1.5 7.4 3.1 2.0 1.2 10.2 2.7 3.4 0.0 0.0 5.2 6.6 4.6 0.1 2.8 1.4 0.0 5.5 5.1 3.7 4.9 0.0 5.3 4.0 3.2 1.2 1.3 2.1 0.2 2.6 2.7 0.0 2.8 3.5 5.6 4.7 3.1 2.1 3.8 2.7 0.0 3.1 2.6 7.3 5.9 3.4 4.3 5.0 4.8 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin-like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 51.1;neutrophil: 34.8" "Group enriched" "Detected in many" 8 "granulocytes: 51.1;monocytes: 16.8" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.3" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" NA Yes Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 10.6 11.3 8.2 11.2 8.2 11.2 10.2 25.2 10.3 9.9 8.2 8.2 8.2 11.4 10.3 12.6 8.2 10.0 8.8 8.2 8.2 5.0 18.6 17.6 8.2 13.2 8.2 8.2 12.1 12.9 19.0 27.6 9.8 8.2 13.6 10.2 8.2 12.0 10.7 12.3 15.8 10.1 8.2 10.5 16.7 9.2 80.1 8.2 8.2 18.3 8.2 11.0 9.9 8.2 0.3 4.3 51.1 16.8 4.0 2.9 4.7 14.0 11.9 13.7 23.7 15.2 3.5 13.3 8.5 3.8 6.1 6.0 8.4 16.4 11.5 16.3 4.4 10.9 15.1 7.5 9.0 4.2 9.4 11.1 10.6 39.9 7.2 3.4 10.6 27.6 4.4 10.6 8.2 16.8 7.6 5.1 17.2 11.3 28.0 4.2 19.0 16.7 55.3 5.9 11.8 6.3 9.8 4.0 11.7 27.5 23.1 12.8 9.2 7.2 81.3 10.1 15.3 14.2 16.5 12.2 21.8 13.9 13.9 11.0 16.9 21.5 13.9 6.1 15.9 12.8 4.1 8.5 51.1 2.9 14.0 1.7 0.1 0.3 1.8 4.3 0.3 0.3 0.7 34.8 4.0 16.8 0.1 0.1 4.7 8.2 8.2 25.2 10.3 8.2 5.0 8.2 8.2 8.2 8.2 35.7 41.6 25.1 19.4 14.0 37.1 1.1 63.7 37.5 42.1 14.0 64.8 10.8 1.7 5.8 13.5 16.4 15.8 0.0 4.9 9.6 8.9 14.5 23.3 62.2 8.5 71.5 28.3 17.8 14.3 9.1 68.4 12.3 18.6 10.0 23.8 26.5 6.4 17.3 48.1 3.4 60.9 25.8 12.0 43.6 9.8 11.8 13.2 66.0 24.8 10.8 PIM3 ENSG00000198355 "Pim-3 proto-oncogene, serine/threonine kinase" Q86V86 22 49960513-49964080 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.5;SK-BR-3: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068758 Supported Cytosol NA Yes Cytosol "HPA068758: AB_2686026" "unprognostic (3.67e-2)" "unprognostic (7.69e-3)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-2)" "unprognostic (5.83e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.09e-4)" "unprognostic (5.59e-3)" "unprognostic (1.71e-1)" "unprognostic (3.92e-3)" "unprognostic (7.27e-3)" 32.5 15.5 6.8 19.9 16.7 62.4 50.5 7.6 11.9 16.4 22.6 11.3 20.9 15.9 14.4 17.6 25.0 15.9 37.8 23.6 7.5 7.9 29.1 25.7 38.3 29.4 21.1 4.9 13.9 36.4 4.8 14.9 31.4 15.1 28.4 7.6 9.7 27.6 22.7 39.9 31.3 20.9 12.2 10.1 25.4 33.6 13.0 13.5 9.7 19.1 19.9 19.0 25.6 18.3 6.1 5.7 16.9 4.0 1.2 4.5 1.9 7.3 4.9 3.3 6.2 2.6 1.9 18.9 4.6 7.5 5.6 4.0 8.1 6.3 13.2 5.9 1.2 11.3 6.3 6.3 3.5 2.0 9.9 26.2 5.4 11.7 9.8 12.2 11.7 10.5 3.7 11.7 3.4 5.8 3.0 18.0 9.0 7.4 46.5 1.6 16.5 5.9 20.9 6.9 7.7 7.9 27.7 5.5 15.6 2.9 5.6 11.8 8.2 9.0 41.3 28.9 3.2 5.4 15.6 4.7 3.5 15.0 5.7 7.5 23.9 15.2 11.2 8.7 6.6 9.4 0.0 3.1 0.1 1.9 3.2 2.3 3.4 4.4 3.8 2.5 6.1 4.1 1.7 16.9 1.2 4.0 5.7 4.5 1.9 6.8 16.7 7.6 11.9 7.5 7.9 21.1 4.9 15.1 13.5 59.6 91.3 64.7 240.2 201.8 30.4 27.9 68.8 20.1 45.5 76.8 2.0 51.0 71.3 44.7 2.1 87.2 56.5 0.0 46.7 226.7 51.4 225.9 70.2 37.5 64.3 58.8 93.7 59.5 30.8 4.1 30.0 74.6 102.9 46.9 56.5 11.1 57.1 46.3 10.6 48.8 15.3 25.8 117.4 19.9 37.3 178.9 326.1 26.6 49.6 261.0 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 50.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.6 17.1 50.8 22.8 0.4 1.5 3.9 14.9 9.2 24.5 16.6 10.1 5.5 0.0 6.0 12.1 12.1 9.3 25.6 6.6 13.2 19.5 10.2 0.0 10.2 12.2 0.0 0.5 15.5 0.8 0.4 10.1 3.9 2.3 7.7 11.3 3.0 7.2 15.3 9.1 2.7 0.1 22.2 10.2 11.2 22.7 20.4 8.9 4.0 1.9 11.6 16.3 12.9 13.4 12.6 6.4 6.2 1.2 3.6 19.2 15.6 11.3 24.3 2.6 9.2 0.0 7.5 6.2 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 25.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 53.8" "Low region specificity" "Detected in many" HPA007721 Approved Approved Cytosol NA Yes Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 7.4 1.5 6.5 5.3 42.3 18.8 8.7 24.6 19.1 8.9 3.7 2.1 2.1 5.3 9.1 2.1 11.4 3.5 5.3 2.8 7.1 4.2 3.1 5.4 3.5 10.0 4.8 3.6 19.3 4.3 2.3 5.5 12.5 29.2 3.5 3.5 2.1 7.0 2.4 4.5 11.6 5.9 2.1 22.2 10.5 17.3 3.6 6.7 2.1 5.1 2.1 5.4 4.7 7.9 5.8 2.9 6.3 11.9 1.8 4.1 2.7 8.8 33.9 8.2 12.3 1.7 1.3 6.5 8.0 0.9 4.3 4.2 13.7 9.6 11.4 5.6 3.5 6.4 2.8 2.0 5.3 2.3 6.8 15.1 53.8 11.0 18.2 5.3 5.5 21.2 7.0 0.7 15.8 1.6 2.9 3.3 18.6 14.0 6.2 3.1 2.8 16.6 8.1 17.4 2.3 6.6 9.4 4.4 16.6 1.3 4.1 8.8 4.7 8.1 4.8 7.4 5.9 9.2 7.7 2.3 5.7 9.1 6.2 8.8 2.1 5.6 26.3 3.7 14.6 6.1 4.3 3.8 6.3 2.8 8.1 3.9 2.3 2.2 3.4 2.9 5.8 2.8 2.7 4.9 1.8 11.9 2.7 4.1 2.7 6.5 42.3 24.6 19.1 7.1 4.2 4.8 3.6 29.2 6.7 8.9 25.9 6.1 8.4 6.2 8.1 2.2 7.6 0.0 2.3 0.0 2.0 8.4 0.0 5.1 0.6 3.9 11.5 0.0 1.6 9.0 3.4 4.9 3.5 6.4 4.8 7.9 2.9 6.2 6.5 0.6 2.3 6.4 0.0 1.0 7.5 2.8 12.0 8.7 3.5 1.4 6.1 12.9 4.1 7.9 18.3 7.5 22.5 4.4 7.4 7.1 PLIN3 "M6PRBP1, PP17, TIP47" ENSG00000105355 "Perilipin 3" O60664 19 4838341-4867768 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Transport "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006427, HPA066538" Uncertain Enhanced "Lipid droplets" NA Yes 9300000 "Lipid droplets" "HPA006427: AB_1079289, HPA066538: AB_2685687" "unprognostic (1.18e-1)" "unprognostic (4.86e-2)" "unprognostic (1.55e-2)" "prognostic favorable (2.62e-4)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.27e-5)" "prognostic unfavorable (7.67e-6)" "unprognostic (2.27e-1)" "unprognostic (1.28e-1)" "unprognostic (4.34e-2)" "unprognostic (8.24e-2)" "prognostic unfavorable (9.15e-7)" "unprognostic (2.62e-1)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (2.39e-2)" 13.2 28.9 7.4 16.9 16.3 25.5 12.7 2.8 10.8 17.8 17.5 37.9 4.2 29.1 9.3 12.6 46.9 9.5 14.8 12.4 9.2 7.0 10.4 19.6 9.9 13.6 32.4 8.3 23.4 8.1 3.1 3.9 28.3 17.8 11.0 8.9 6.7 18.1 9.7 40.0 31.8 38.6 11.1 26.7 13.1 11.1 13.6 25.1 20.0 13.1 35.8 29.1 14.1 19.7 12.5 28.9 45.9 37.5 9.4 8.4 19.0 28.2 16.7 11.7 10.6 12.9 42.1 5.1 41.2 38.4 33.3 30.8 10.9 25.8 14.6 9.4 51.7 17.6 13.0 5.3 23.2 19.6 16.7 7.6 15.9 9.5 19.9 9.3 11.3 24.2 32.9 9.7 23.5 5.1 19.0 17.3 4.7 24.1 6.5 40.2 11.6 16.1 15.3 8.8 12.9 27.1 27.7 15.7 8.2 28.3 6.5 0.5 5.5 12.8 11.6 10.1 9.9 14.9 25.7 25.7 17.7 17.5 70.7 21.2 9.2 11.7 10.1 53.3 16.1 20.4 28.3 37.5 16.1 3.8 26.2 3.8 12.5 6.7 4.3 28.9 9.3 5.4 3.4 45.9 9.4 18.0 21.4 8.4 19.0 7.4 16.3 2.8 10.8 9.2 7.0 32.4 8.3 17.8 25.1 17.9 24.6 17.5 48.4 126.4 0.2 2.5 10.2 64.3 42.1 10.4 2.0 124.8 31.5 90.9 8.1 25.3 190.9 0.0 74.9 62.3 89.7 37.6 54.3 14.4 92.9 0.0 39.0 29.4 63.2 9.8 33.1 85.3 52.3 65.9 60.5 22.6 161.7 98.2 49.8 32.3 0.6 51.8 50.5 46.1 15.6 200.5 162.9 17.5 40.8 62.6 PLK1 PLK ENSG00000166851 "Polo like kinase 1" P53350 16 23677656-23690367 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 83.9;testis: 32.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 86.9;Erythroid cells: 23.3;Extravillous trophoblasts: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "T-reg: 9.0" "Lineage enriched" "Detected in many" 5 "T-cells: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA051638, HPA053229" Approved NA Yes "HPA051638: AB_2681561, HPA053229: AB_2682084" "unprognostic (7.21e-3)" "unprognostic (1.77e-1)" "unprognostic (1.98e-3)" "unprognostic (4.97e-3)" "unprognostic (9.56e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (2.70e-7)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.55e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.33e-1)" "unprognostic (8.10e-2)" "unprognostic (1.19e-1)" "unprognostic (1.26e-2)" 2.9 1.1 1.1 14.2 1.5 15.9 1.7 2.1 1.1 1.5 7.1 0.7 0.5 6.0 1.1 0.9 10.4 0.7 1.5 1.0 1.0 0.8 1.3 1.2 2.6 15.2 0.8 0.6 1.2 0.7 0.0 0.8 6.8 0.7 0.9 5.9 0.5 1.7 0.8 0.8 2.9 5.9 2.0 0.7 8.3 3.6 32.4 0.5 83.9 0.6 6.6 20.4 2.1 2.6 1.9 0.5 0.7 0.1 1.3 9.0 2.3 43.5 45.5 37.6 20.4 1.1 2.6 21.1 24.9 16.5 39.1 29.1 39.7 28.8 21.8 13.0 16.8 20.6 25.1 51.2 20.5 47.1 31.0 28.9 27.7 35.9 54.2 0.3 31.9 30.4 1.0 1.1 27.7 28.6 4.9 28.5 28.6 43.0 30.1 30.1 39.8 30.1 31.9 42.9 17.9 23.2 46.9 25.5 34.6 11.1 9.5 21.2 14.7 28.5 20.0 12.9 22.4 25.4 19.7 14.4 18.6 23.8 18.2 42.5 21.5 33.3 37.8 15.8 27.8 30.4 0.0 0.1 0.0 0.0 0.0 0.0 1.9 1.4 0.5 0.5 0.0 0.0 0.0 0.7 1.3 0.0 0.0 9.0 2.3 1.1 1.5 2.1 1.1 1.0 0.8 0.8 0.6 0.7 0.5 3.0 0.0 0.8 1.0 1.1 1.3 0.6 0.0 0.0 0.0 0.0 3.9 4.5 0.0 0.6 86.9 0.5 1.5 23.3 0.7 48.0 0.7 1.0 1.1 0.9 17.0 0.0 0.0 3.1 3.7 4.8 1.1 2.6 0.0 0.0 2.9 1.1 0.8 0.0 0.7 0.0 1.1 0.0 0.3 3.2 5.0 1.6 3.2 1.3 3.9 1.8 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494747-56645301 "Enzymes, Plasma proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 5.4;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 7 "B-cells: 5.4" "Cell line enhanced" "Detected in many" "ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5" "HPA028892, HPA072751" Uncertain Supported "Golgi apparatus" NA Yes "Golgi apparatus" "HPA028892: AB_10602149, HPA072751: AB_2686555" "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 46.4 17.2 29.0 10.8 30.7 4.2 39.1 13.5 27.5 102.7 15.5 33.8 22.1 8.1 32.7 36.9 20.8 36.7 24.0 23.3 39.9 13.5 30.2 57.7 24.3 6.7 19.2 30.1 27.9 12.2 30.7 7.2 70.9 20.0 37.7 14.4 34.7 22.4 58.7 16.6 24.4 12.5 32.9 16.5 7.9 18.7 23.4 29.7 5.2 107.1 19.4 6.7 35.8 44.0 5.4 0.0 0.8 0.3 0.0 0.0 0.2 0.4 1.5 2.0 0.2 105.3 52.6 5.0 5.5 5.6 5.1 2.5 4.4 0.8 0.7 0.6 8.3 5.7 0.8 0.3 0.1 1.0 0.0 1.3 0.1 0.6 6.1 2.5 0.0 0.0 65.0 0.4 4.9 4.1 3.6 4.8 0.0 0.4 0.0 5.5 0.4 0.0 0.0 6.2 1.2 6.1 0.0 0.0 0.2 0.8 4.6 0.0 4.1 1.7 2.3 0.5 6.4 0.7 0.0 3.0 25.8 2.1 95.5 0.2 0.0 0.0 0.0 4.5 0.2 1.8 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 29.0 30.7 13.5 27.5 39.9 13.5 19.2 30.1 20.0 29.7 23.8 20.5 11.5 20.0 0.0 3.2 0.0 56.0 8.1 23.9 21.0 0.0 102.0 18.3 16.0 5.7 50.7 10.7 23.3 7.9 10.3 54.5 13.7 3.5 84.4 36.2 0.0 2.4 854.4 45.1 12.0 1011.7 10.2 0.0 1.0 10.3 146.0 8.7 7.0 374.8 18.2 2.5 135.8 0.0 4.3 2.5 0.0 179.8 4.3 7.8 16.5 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544864 "Predicted intracellular proteins, Transporters" "Antiviral defense" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.9 14.9 11.9 39.7 21.4 27.0 31.1 5.7 19.0 20.9 29.6 7.2 22.1 18.4 19.6 25.7 25.4 19.5 30.8 22.7 16.1 12.7 32.0 36.5 33.8 38.6 17.6 4.9 40.0 26.1 10.3 18.4 25.7 22.1 25.0 28.0 12.6 32.3 34.2 16.4 9.9 24.6 19.4 29.8 46.0 20.5 15.4 14.8 16.4 27.5 14.9 19.5 27.5 48.0 6.5 27.5 26.2 41.2 14.3 8.1 17.6 17.2 6.9 4.4 2.0 6.6 11.2 6.8 5.4 14.8 55.1 73.3 5.5 14.4 1.3 12.9 3.4 43.1 14.2 3.5 5.1 9.3 5.3 3.5 11.1 2.2 4.1 50.5 6.3 5.8 17.8 8.7 6.1 31.1 8.8 8.0 3.2 7.1 17.2 11.2 6.7 4.9 2.4 4.2 11.7 6.2 4.4 4.9 0.4 15.5 4.7 2.7 0.0 6.9 3.4 91.2 6.3 3.4 7.7 4.8 4.4 3.8 9.9 9.0 13.2 2.4 0.0 4.5 4.6 3.8 8.2 41.2 11.0 5.6 40.4 8.1 6.5 3.7 5.0 27.5 4.9 2.6 3.8 26.2 14.3 22.7 7.3 2.1 17.6 11.9 21.4 5.7 19.0 16.1 12.7 17.6 4.9 22.1 14.8 32.8 47.9 22.6 70.0 32.7 0.4 4.0 86.6 81.7 60.3 90.7 0.0 46.8 63.0 225.1 1.5 110.1 67.7 0.0 192.6 100.1 54.5 74.2 26.7 25.9 121.5 0.0 31.9 91.4 84.8 2.2 106.4 157.8 45.5 24.4 60.9 52.6 150.7 102.1 43.2 33.8 1.3 38.8 58.7 0.3 2.2 25.0 37.2 21.3 51.4 160.1 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 1093.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 54.1;hTCEpi: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: AB_2685684" "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavorable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 70.5 58.1 21.3 46.1 28.3 105.4 48.1 30.8 31.8 55.9 51.5 30.3 27.0 23.6 60.3 30.9 45.4 73.6 45.0 48.5 20.8 17.9 32.9 97.9 59.5 87.1 23.1 22.3 83.4 41.3 31.3 29.5 38.8 20.4 56.6 26.0 46.5 35.5 40.8 154.1 49.0 32.4 63.6 31.1 46.9 38.2 35.5 20.8 91.2 38.4 30.8 45.4 113.2 41.0 9.6 7.3 37.5 7.1 6.9 10.4 3.8 2.9 2.8 6.1 10.3 24.8 41.8 4.2 3.8 26.8 7.2 16.9 2.4 8.2 6.4 18.7 4.6 29.6 10.1 3.2 5.8 11.0 8.0 10.0 1.1 16.5 7.7 54.1 5.9 14.8 30.0 57.5 4.8 22.2 27.2 11.8 7.6 0.9 19.7 7.9 2.9 1.5 31.3 1.7 3.3 6.1 7.0 7.4 5.1 16.9 5.2 3.9 11.0 9.9 13.6 10.0 19.0 6.7 29.9 11.2 5.7 3.4 4.0 1.4 31.0 15.1 2.1 11.5 5.1 3.5 10.3 6.6 36.7 7.5 7.1 7.8 8.3 8.9 7.8 4.2 9.6 10.4 10.4 37.5 6.9 6.3 7.3 7.1 3.8 21.3 28.3 30.8 31.8 20.8 17.9 23.1 22.3 20.4 20.8 131.0 125.0 333.4 716.3 860.7 129.0 174.7 124.9 45.5 52.4 85.5 47.1 189.8 198.9 158.1 59.9 195.6 165.4 23.3 206.9 57.7 278.7 681.2 165.7 181.5 204.0 68.3 237.9 148.0 328.8 20.9 446.1 557.5 416.7 926.1 131.7 222.1 145.2 115.8 354.7 216.2 99.3 413.9 840.5 47.0 44.3 1093.4 229.5 380.5 99.7 411.4 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261762-65305589 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 7.5 6.6 4.9 11.9 8.8 9.8 7.5 14.1 8.8 12.0 9.6 9.8 6.4 6.7 10.1 5.5 10.4 9.3 5.9 6.1 5.2 4.5 7.9 7.0 7.5 14.7 10.3 5.5 10.3 7.9 8.0 4.8 9.3 6.5 7.1 9.6 6.7 8.9 7.5 6.5 8.0 9.2 10.7 10.2 13.6 8.8 15.0 8.4 35.7 7.9 10.3 19.7 8.6 7.3 6.0 13.3 8.0 10.1 4.9 7.3 7.7 14.4 13.3 22.0 10.2 3.3 3.9 7.5 9.9 15.8 32.0 23.7 5.3 12.7 17.4 11.4 8.6 15.5 9.1 17.9 14.8 27.4 9.4 6.7 13.1 20.2 6.0 1.9 12.1 10.8 2.7 2.1 27.7 5.8 5.8 11.9 8.9 12.6 11.8 21.6 20.0 26.0 5.4 16.4 10.7 8.5 14.1 12.8 16.8 9.6 10.0 14.4 8.6 9.5 10.4 3.3 14.4 13.0 6.2 4.3 11.8 9.5 15.6 7.2 5.5 6.6 17.9 8.5 7.7 15.8 8.0 10.1 3.9 6.5 9.5 7.3 6.0 6.9 7.1 13.3 5.6 5.6 5.1 5.0 4.9 7.6 10.4 7.1 7.7 4.9 8.8 14.1 8.8 5.2 4.5 10.3 5.5 6.5 8.4 0.0 4.3 0.8 3.8 1.4 2.5 2.7 5.1 2.7 3.4 5.2 2.0 8.3 3.3 5.7 2.1 3.5 1.0 0.0 3.0 14.9 4.4 2.2 0.0 1.6 8.4 3.2 2.9 3.7 2.1 2.9 6.9 4.3 0.0 10.8 2.2 2.3 3.6 2.6 7.1 1.4 4.9 6.5 3.6 12.0 14.5 1.3 6.1 5.1 5.3 3.2 POLD3 "KIAA0039, P66, P68, PPP1R128" ENSG00000077514 "DNA polymerase delta 3, accessory subunit" Q15054 11 74493851-74669117 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058846 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA058846: AB_2683833" "unprognostic (3.68e-1)" "unprognostic (3.22e-2)" "unprognostic (2.05e-3)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.99e-3)" "unprognostic (1.54e-3)" "unprognostic (9.21e-3)" "prognostic unfavorable (7.90e-6)" "unprognostic (7.92e-3)" "unprognostic (2.65e-1)" "unprognostic (9.11e-2)" "unprognostic (1.23e-1)" 12.6 8.2 11.3 12.8 17.5 8.3 12.7 10.3 16.4 13.8 15.6 12.5 10.3 14.5 18.1 11.7 14.1 15.6 14.1 9.6 10.2 7.8 40.3 10.0 12.7 14.0 12.1 13.1 15.9 17.5 9.3 16.0 12.4 12.3 13.2 17.2 9.9 13.0 11.8 10.4 10.8 17.1 18.2 9.1 13.9 14.5 19.8 13.9 15.2 14.2 8.0 13.5 15.9 13.7 8.1 14.7 16.5 19.0 8.7 11.0 9.6 12.0 11.0 17.0 11.6 5.3 9.1 12.1 16.4 9.2 17.2 14.6 14.4 15.7 17.2 12.2 7.8 10.0 15.8 14.1 10.7 21.7 12.9 9.0 11.0 17.1 4.8 3.8 20.9 10.0 4.0 6.8 20.0 10.8 5.4 6.6 15.3 9.9 13.9 9.8 9.5 23.5 9.4 10.2 36.0 11.3 22.6 42.9 14.3 7.8 11.7 11.4 7.7 19.5 9.8 19.0 10.8 11.5 13.4 6.3 17.0 12.3 19.1 12.9 9.8 20.5 38.6 9.7 13.3 12.8 6.0 19.0 12.5 8.2 15.1 8.1 8.1 10.4 7.2 14.7 6.7 10.4 8.5 16.5 8.7 14.8 4.3 11.0 9.6 11.3 17.5 10.3 16.4 10.2 7.8 12.1 13.1 12.3 13.9 11.9 18.3 8.2 6.3 5.3 11.8 5.6 7.6 53.5 23.9 8.7 7.9 13.0 5.0 14.6 22.4 11.1 10.3 23.3 28.4 23.6 8.2 7.5 18.5 3.4 13.9 22.3 5.2 6.2 8.5 19.4 11.5 15.5 3.3 22.6 9.2 14.6 17.7 8.5 8.1 23.8 17.1 6.5 4.7 34.3 31.1 4.6 10.9 8.2 16.6 10.5 POLH "RAD30A, XP-V" ENSG00000170734 "DNA polymerase eta" Q9Y253 6 43576150-43615660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006721, HPA026762" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA006721: AB_1847785, HPA026762: AB_10601248" "unprognostic (1.79e-1)" "unprognostic (7.29e-2)" "unprognostic (2.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.61e-1)" "unprognostic (5.11e-3)" "unprognostic (9.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (7.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.24e-1)" "unprognostic (9.50e-2)" "unprognostic (6.73e-2)" "unprognostic (8.77e-2)" "unprognostic (7.91e-2)" "unprognostic (6.02e-2)" 7.4 9.4 7.5 9.7 10.4 4.6 7.2 10.5 10.5 8.5 8.4 12.7 8.0 5.7 9.6 7.1 11.4 7.8 6.2 6.7 5.3 4.4 7.2 7.5 9.8 16.3 8.9 8.1 7.4 13.0 7.1 9.7 5.1 7.9 6.9 10.1 8.9 8.6 5.6 9.5 11.7 7.9 11.8 6.9 9.2 7.6 24.7 6.8 22.1 9.9 6.2 18.3 8.6 8.4 8.6 4.3 4.5 2.6 6.8 7.2 3.2 20.5 4.7 6.4 9.3 9.1 15.1 15.2 22.0 6.9 12.9 14.8 5.4 3.6 22.8 5.5 8.9 3.7 5.2 6.4 13.8 16.1 11.5 4.9 6.7 13.3 15.6 6.8 11.4 9.0 10.1 17.0 10.5 5.7 5.2 12.1 7.0 10.5 13.7 16.2 6.8 10.3 3.0 1.9 15.7 3.6 11.3 6.6 5.7 4.9 15.4 7.2 2.5 7.0 5.8 3.5 7.4 8.3 5.1 16.4 11.9 11.6 5.6 11.1 12.9 8.9 41.2 5.7 6.7 12.9 4.5 2.6 4.1 7.2 2.5 6.4 7.8 6.0 5.2 2.1 8.6 5.0 5.2 2.0 6.8 1.9 4.3 7.0 3.2 7.5 10.4 10.5 10.5 5.3 4.4 8.9 8.1 7.9 6.8 11.9 5.1 4.9 2.6 4.1 6.3 2.4 2.5 5.3 7.9 3.5 9.8 1.7 5.0 2.0 7.6 2.1 2.6 23.3 0.7 2.4 2.6 2.1 0.0 2.1 1.5 0.0 5.2 0.6 1.5 6.0 3.1 1.7 1.7 2.8 2.2 2.3 1.6 2.9 2.8 1.4 8.5 0.0 3.1 17.9 5.9 2.6 1.6 2.9 3.1 2.5 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 10 "Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.5 9.2 7.9 5.6 0.7 0.9 7.2 6.4 2.5 7.6 10.2 7.3 5.0 16.1 2.9 3.5 9.2 10.7 9.3 4.1 12.9 4.7 5.1 10.3 5.7 4.5 0.0 11.1 9.5 0.1 0.3 6.9 4.3 1.3 3.7 6.0 6.8 12.3 7.9 5.2 10.0 6.5 7.5 4.1 4.5 8.5 9.5 5.7 2.4 7.8 4.3 3.9 7.4 4.0 2.6 7.2 3.7 11.1 2.9 6.7 8.8 2.6 8.3 6.2 5.0 16.7 3.2 8.3 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 0.0 0.3 0.0 0.4 0.8 0.3 1.4 0.0 1.4 3.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.2 0.3 1.5 0.0 1.0 0.4 0.5 0.3 0.3 0.0 0.1 0.1 0.0 0.5 7.0 3.3 0.1 0.2 0.9 0.9 0.9 PPARGC1B "PERC, PGC1B" ENSG00000155846 "PPARG coactivator 1 beta" Q86YN6 5 149730298-149855022 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050543 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA050543: AB_2681165" "unprognostic (2.86e-1)" "unprognostic (1.07e-2)" "unprognostic (5.09e-3)" "unprognostic (1.13e-3)" "unprognostic (2.63e-1)" "unprognostic (2.00e-3)" "unprognostic (4.51e-3)" "unprognostic (6.55e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (9.01e-6)" "unprognostic (8.45e-2)" "unprognostic (5.09e-2)" "unprognostic (1.51e-1)" "unprognostic (2.77e-3)" 4.5 2.4 3.9 9.5 7.1 4.3 3.5 16.3 8.7 3.9 15.6 1.6 16.3 13.1 5.4 2.6 9.0 5.5 6.2 10.0 3.3 4.1 2.3 3.7 7.4 3.0 3.3 4.8 3.2 3.4 17.7 2.0 3.2 7.2 6.4 11.6 7.6 4.0 19.7 10.3 6.6 16.6 18.6 2.7 4.2 7.9 2.0 1.3 2.2 1.7 8.4 5.8 11.5 5.6 1.9 2.4 2.2 6.2 0.8 0.7 0.5 0.5 1.9 0.8 4.6 1.8 0.6 7.4 0.3 0.0 0.5 0.7 8.3 1.9 9.0 1.3 0.0 2.1 5.6 6.8 3.4 0.6 0.5 5.9 8.4 3.2 1.7 0.5 11.5 3.4 0.9 4.6 1.8 3.1 0.3 1.0 4.0 5.7 3.0 0.4 2.2 4.2 5.4 3.0 2.5 4.9 8.0 5.0 5.0 1.4 11.0 2.5 0.6 1.3 9.8 1.5 1.4 2.6 3.8 1.3 1.1 1.7 3.7 1.8 3.7 2.7 5.3 2.3 7.3 0.9 1.0 2.0 0.7 0.4 3.8 0.7 1.9 0.4 0.3 2.4 0.9 0.6 0.6 2.2 0.8 6.2 0.3 0.3 0.5 3.9 7.1 16.3 8.7 3.3 4.1 3.3 4.8 7.2 1.3 0.0 0.6 1.5 3.2 4.5 105.6 18.8 2.5 0.0 1.2 1.8 127.6 1.5 1.7 0.2 0.2 3.5 17.2 0.0 0.7 1.2 1.8 1.7 1.1 3.4 6.9 7.9 5.2 5.5 9.5 0.0 1.4 8.3 3.3 1.0 8.5 3.6 0.5 3.5 0.4 1.9 72.0 6.5 6.1 0.2 3.2 9.4 4.1 0.0 19.0 3.4 PPP1R13L "IASPP, RAI" ENSG00000104881 "Protein phosphatase 1 regulatory subunit 13 like" Q8WUF5 19 45379634-45406349 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 78.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 77.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.6;hTCEpi: 52.2;hTERT-HME1: 36.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB005016, HPA041231, HPA059883" Approved Enhanced Cytosol NA Yes Cytosol "CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151" "unprognostic (1.87e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (2.92e-1)" "unprognostic (3.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.31e-3)" "prognostic unfavorable (3.39e-5)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.40e-4)" "unprognostic (2.52e-3)" "unprognostic (1.92e-2)" "unprognostic (1.55e-3)" "unprognostic (1.34e-1)" "unprognostic (7.69e-2)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" 6.7 6.6 2.5 3.6 4.1 0.6 14.5 3.5 3.4 13.2 6.2 2.4 8.5 2.9 5.8 8.2 51.6 3.6 4.7 37.2 4.0 1.2 8.0 5.7 8.5 1.6 3.9 2.5 4.4 12.4 6.6 6.6 38.7 3.9 11.5 3.8 5.1 17.8 15.7 3.8 78.3 7.1 3.8 3.3 2.5 4.4 1.6 6.1 2.7 10.6 24.4 25.6 13.2 22.9 0.6 0.7 0.0 1.5 0.0 2.3 0.2 21.2 3.0 1.2 1.0 1.3 0.8 18.5 3.8 0.6 4.8 6.7 6.0 19.8 2.5 1.7 3.0 9.9 28.4 1.0 35.6 4.4 6.5 1.5 0.3 9.8 2.2 2.8 0.2 0.9 1.1 52.2 7.6 36.2 21.7 8.9 2.1 2.1 0.9 0.3 17.4 0.4 0.4 1.4 9.7 5.0 1.9 1.5 0.4 6.2 25.5 0.6 2.2 19.7 18.9 0.4 8.5 16.5 0.5 13.6 6.1 18.7 0.4 18.7 10.6 10.9 1.6 0.9 0.7 1.5 0.0 0.0 0.0 1.5 0.4 0.7 0.6 2.3 0.4 0.2 0.2 0.1 0.7 0.0 0.0 1.5 0.7 1.3 0.2 2.5 4.1 3.5 3.4 4.0 1.2 3.9 2.5 3.9 6.1 32.8 8.8 0.5 77.1 61.0 2.0 34.3 20.4 8.1 22.7 19.2 9.8 69.5 5.0 28.4 0.5 11.2 15.4 0.0 13.4 33.0 6.1 31.1 4.6 2.1 6.7 0.0 6.9 8.0 2.6 0.2 5.5 2.7 11.8 1.8 6.2 2.2 35.6 14.0 11.7 2.7 25.6 6.5 10.4 2.9 1.9 62.0 107.4 0.7 7.1 62.2 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Group enriched" "Detected in many" 4 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.9 40.2 33.7 22.8 3.5 6.0 18.1 47.4 28.0 52.5 40.3 26.8 32.1 12.5 18.9 30.2 32.5 44.9 38.3 20.3 49.8 23.2 42.5 26.0 52.6 24.6 0.9 12.8 22.5 1.5 2.6 29.8 30.6 11.7 29.4 20.3 21.6 26.9 48.8 28.6 13.1 19.5 13.2 43.1 17.3 13.8 42.0 16.8 23.4 25.0 30.7 24.3 45.1 25.1 16.3 24.3 30.1 25.3 17.6 34.7 30.7 28.6 68.2 8.7 23.1 15.5 15.2 31.8 53.0 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 0.0 1.9 12.3 5.2 14.7 6.8 2.4 0.0 4.0 10.3 3.5 0.0 9.5 0.0 2.9 17.7 3.2 2.0 70.0 2.5 59.0 7.4 5.1 9.2 1.6 17.6 3.2 5.2 9.8 8.6 12.3 3.4 7.0 3.3 9.0 4.5 4.5 1.7 2.6 1.8 0.0 3.5 6.5 10.3 129.3 60.0 12.4 12.2 6.9 7.4 5.4 PRIM1 ENSG00000198056 "DNA primase subunit 1" P49642 12 56731596-56752373 "Predicted intracellular proteins" "DNA replication, Transcription" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040010 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes "Nucleoplasm, Golgi apparatus, Vesicles" "HPA040010: AB_10805599" "unprognostic (3.04e-3)" "unprognostic (1.67e-2)" "unprognostic (2.12e-2)" "unprognostic (1.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (2.40e-8)" "unprognostic (4.68e-2)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (1.82e-1)" "unprognostic (1.98e-3)" "unprognostic (3.94e-1)" "unprognostic (2.16e-1)" "unprognostic (5.35e-2)" "unprognostic (6.53e-2)" 5.7 5.2 6.7 9.8 9.3 26.0 10.1 16.0 10.6 6.0 8.2 6.7 5.5 4.5 6.2 4.9 9.6 6.2 3.1 4.0 7.6 4.6 4.5 8.2 5.4 11.1 9.2 4.6 9.7 10.7 7.9 12.3 5.0 7.9 5.2 11.1 5.3 7.0 4.3 6.3 7.9 8.3 6.1 11.8 10.2 6.3 17.0 10.8 28.3 5.1 6.8 13.2 5.6 6.9 8.6 6.3 3.5 6.2 5.3 12.7 4.6 12.2 10.6 14.7 9.0 1.7 2.6 17.3 10.4 8.5 18.5 17.3 11.4 15.8 24.1 8.7 4.8 7.4 12.4 17.7 11.3 20.4 12.0 11.0 31.8 6.8 10.9 0.5 38.9 13.5 1.1 2.1 16.4 7.1 2.8 6.6 28.1 29.9 38.1 10.7 9.1 22.2 14.8 16.3 8.8 13.3 25.0 25.8 20.8 4.4 9.3 15.0 13.3 12.4 6.0 5.6 11.2 19.4 14.9 3.0 9.6 22.8 10.0 13.1 13.9 27.7 13.6 6.0 16.5 12.7 1.4 1.4 3.5 7.8 3.4 9.0 8.6 10.5 7.5 3.4 8.2 12.7 10.0 0.0 5.3 6.2 6.3 9.1 4.6 6.7 9.3 16.0 10.6 7.6 4.6 9.2 4.6 7.9 10.8 6.0 5.0 11.5 11.9 3.4 4.2 2.4 2.5 8.1 6.8 7.0 5.9 7.0 0.0 4.4 5.0 5.8 1.3 70.0 6.4 22.0 3.3 2.7 3.5 4.3 10.3 19.1 1.2 3.7 7.3 2.5 6.6 7.2 3.3 9.0 2.9 5.6 3.4 0.0 4.6 1.6 11.8 12.9 3.9 38.6 82.6 3.4 3.8 10.5 8.5 2.0 PRR11 FLJ11029 ENSG00000068489 "Proline rich 11" Q96HE9 17 59155499-59204705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 10.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023923, HPA052376" Uncertain Approved "Endoplasmic reticulum" Yes Yes "Endoplasmic reticulum" "HPA023923: AB_1855783, HPA052376: AB_2681803" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.15e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.22e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.80e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.84e-1)" "unprognostic (1.55e-3)" 3.2 1.4 2.8 13.8 4.2 14.9 2.0 0.9 2.8 3.1 4.2 2.2 0.7 6.9 2.0 2.1 10.3 1.7 2.1 1.4 3.1 2.3 1.7 1.1 3.4 9.6 3.2 1.6 1.7 1.0 0.2 0.6 4.8 2.0 1.2 5.5 1.2 2.2 0.5 1.3 2.9 4.8 3.2 5.1 7.3 2.5 2.5 2.1 40.8 1.3 7.7 11.7 2.8 3.2 1.4 3.0 2.5 10.6 0.7 2.0 0.8 27.6 13.3 21.0 6.1 0.6 4.9 8.6 17.2 10.8 17.9 14.3 16.4 18.7 17.9 17.6 12.6 14.6 10.2 16.1 17.7 39.3 24.8 10.3 19.7 14.7 11.0 0.2 20.8 8.3 1.1 1.3 19.7 26.2 4.4 20.2 15.0 10.7 19.5 19.1 21.5 20.4 3.7 8.7 13.0 22.5 16.4 31.5 11.5 4.8 7.5 9.1 12.6 14.2 5.2 7.5 10.6 14.0 8.0 13.7 36.8 43.0 18.5 30.6 12.6 24.2 18.0 8.2 11.6 35.9 1.0 2.3 2.5 0.8 5.1 0.3 1.4 0.6 1.0 3.0 0.9 0.6 0.8 2.3 0.7 10.6 1.6 2.0 0.8 2.8 4.2 0.9 2.8 3.1 2.3 3.2 1.6 2.0 2.1 0.0 1.7 7.0 1.9 1.6 2.0 0.8 0.0 0.0 2.3 0.0 0.0 1.8 0.0 0.3 0.5 1.1 0.4 46.7 0.4 19.2 1.6 1.0 2.3 0.0 6.5 1.6 4.7 3.7 13.3 0.2 0.9 5.1 1.7 6.4 2.2 0.8 0.6 0.0 2.1 0.3 2.8 0.0 2.1 3.0 5.1 1.1 1.7 2.5 4.3 1.4 PRR13 "DKFZP564J157, FLJ23818" ENSG00000205352 "Proline rich 13" Q9NZ81 12 53441605-53446645 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 190.5" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 1157.2;Enterocytes: 1047.2;Proximal tubular cells: 808.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039396, HPA046219" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA039396: AB_2676484, HPA046219: AB_10963936" "unprognostic (1.09e-1)" "prognostic favorable (9.08e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-1)" "unprognostic (8.97e-3)" "unprognostic (4.88e-3)" "unprognostic (1.86e-3)" "unprognostic (7.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.41e-2)" "unprognostic (6.81e-3)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "prognostic favorable (7.55e-4)" 31.9 48.0 29.7 38.3 36.4 64.0 29.3 19.5 38.3 23.8 81.1 27.0 26.6 117.5 24.2 34.4 31.2 35.0 40.1 31.1 30.9 30.1 88.2 51.4 35.5 49.3 34.3 39.2 30.2 29.3 16.1 26.5 32.5 31.3 30.0 70.6 27.1 26.1 44.9 33.3 22.9 110.7 24.5 32.5 53.6 51.9 15.7 28.7 41.6 34.3 21.6 45.6 35.8 25.3 79.6 60.1 190.5 86.5 50.8 72.9 117.1 25.3 51.2 12.7 14.1 21.8 27.9 27.8 21.2 31.0 27.3 26.7 92.6 59.7 39.9 72.5 30.7 33.6 22.9 25.8 33.5 33.5 38.5 19.2 58.1 28.2 43.4 53.8 86.6 80.1 36.9 34.0 51.0 35.1 29.5 29.1 24.1 49.9 40.1 42.8 68.7 48.5 85.1 20.9 32.4 34.7 43.0 10.8 42.4 60.7 44.0 11.4 8.4 31.5 45.1 38.0 27.4 63.6 67.2 29.9 18.5 18.2 33.0 20.8 29.8 36.2 58.5 24.8 52.5 34.8 63.6 75.8 142.7 50.7 84.6 49.4 79.6 56.9 53.8 60.1 70.8 53.5 57.5 190.5 50.8 86.5 49.7 72.9 117.1 29.7 36.4 19.5 38.3 30.9 30.1 34.3 39.2 31.3 28.7 77.4 108.7 131.7 128.0 42.2 6.7 20.7 178.3 136.5 72.8 177.9 27.5 204.3 1157.2 205.4 8.6 70.6 1047.2 0.0 224.1 275.8 70.2 205.1 179.3 136.2 316.3 17.5 163.2 59.5 331.1 4.2 53.8 241.9 102.9 348.1 279.4 63.8 250.2 733.0 43.2 808.7 20.6 77.6 60.4 33.7 20.1 48.9 243.4 192.8 262.9 167.7 PSMC3IP "GT198, Hop2, HUMGT198A, TBPIP" ENSG00000131470 "PSMC3 interacting protein" Q9P2W1 17 42572315-42577831 "Disease related genes, Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.8" "Cell type enhanced" "Detected in many" 14 "Spermatocytes: 109.9;Spermatogonia: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044439 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA044439: AB_10964210" "unprognostic (2.98e-1)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (2.87e-1)" "unprognostic (6.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-7)" "unprognostic (6.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.47e-1)" "unprognostic (7.26e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (9.41e-4)" "unprognostic (6.03e-2)" "unprognostic (3.68e-1)" "unprognostic (1.39e-2)" "unprognostic (1.82e-1)" 4.0 2.0 6.6 4.2 12.1 9.2 5.2 5.0 7.7 3.4 4.3 7.0 4.1 1.7 5.2 5.5 3.9 8.6 2.4 2.1 7.4 6.3 2.8 1.2 3.1 4.7 9.7 4.1 4.8 2.7 8.5 2.1 5.4 8.7 5.5 4.3 2.4 2.5 5.7 1.9 4.1 1.9 6.9 12.7 2.3 2.8 29.8 9.9 3.1 2.5 1.5 7.1 4.2 3.3 2.4 6.2 2.2 0.5 0.2 1.9 0.3 6.4 9.7 16.2 11.8 3.8 5.4 3.6 25.2 8.0 22.1 27.4 9.6 4.2 6.9 5.6 7.4 8.8 9.8 12.5 9.6 25.5 9.5 10.5 4.1 21.8 11.4 0.5 14.6 4.7 1.8 2.2 34.9 11.7 3.0 6.4 9.1 14.0 12.6 19.2 7.5 9.8 9.1 9.9 7.2 9.2 10.4 16.5 6.2 5.0 5.3 21.6 13.7 10.1 3.7 10.2 8.4 9.0 6.4 3.0 24.0 13.7 17.9 41.6 9.9 16.8 9.9 11.2 6.9 25.9 0.0 0.2 1.8 1.9 0.3 1.9 2.4 0.9 1.7 0.2 0.8 0.3 0.9 2.2 0.2 0.5 6.2 1.2 0.3 6.6 12.1 5.0 7.7 7.4 6.3 9.7 4.1 8.7 9.9 3.0 3.0 3.0 2.5 4.7 5.8 0.8 2.5 22.7 3.4 3.5 9.8 7.6 0.0 3.4 9.2 3.2 0.0 23.3 2.8 16.4 4.3 1.3 1.1 0.9 6.3 0.0 0.0 2.5 3.8 9.4 4.9 2.4 5.0 9.0 0.7 4.6 1.6 0.0 8.1 1.9 13.3 19.4 9.2 109.9 37.9 3.6 4.3 1.9 2.6 0.7 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" HPA056561 Approved Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "HPA056561: AB_2683175" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.8 9.8 40.0 19.3 1.6 3.2 11.0 15.0 12.2 20.5 19.7 15.0 7.9 9.6 5.5 7.4 9.6 13.6 21.5 12.3 17.2 3.7 10.4 6.0 13.1 12.2 1.8 6.4 6.9 3.6 1.1 8.1 5.8 7.7 10.0 11.5 13.6 4.4 16.4 17.1 9.7 4.3 16.5 8.7 11.2 15.1 38.5 3.2 6.9 5.0 16.8 9.7 8.4 12.9 15.4 15.2 7.8 6.1 5.1 12.7 21.0 8.9 24.6 3.4 2.2 3.3 10.2 15.3 35.3 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 0.0 3.8 0.0 2.3 1.8 6.5 0.9 2.5 1.4 0.0 1.8 23.6 3.4 0.0 0.9 0.5 0.4 0.5 0.0 0.7 28.6 2.3 0.6 1.1 0.9 9.2 3.2 0.0 1.3 4.0 1.9 5.5 1.6 1.7 0.0 3.2 7.7 0.4 0.0 42.1 2.3 70.6 0.0 2.3 2.7 1.2 1.0 2.4 0.0 2.0 0.7 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713541 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047183 Approved Enhanced Nucleoplasm,Cytosol No Yes 610000 Nucleoplasm Cytosol "HPA047183: AB_2679972" "unprognostic (1.49e-3)" "prognostic favorable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 72.8 37.7 60.0 78.4 65.2 161.4 76.1 38.2 64.2 75.0 80.9 53.9 33.9 56.3 84.8 59.9 83.7 66.7 47.2 38.7 66.3 48.3 67.3 73.5 63.5 104.0 68.7 59.6 80.5 79.5 31.3 97.9 59.1 54.2 50.0 82.7 42.2 55.5 53.4 60.6 92.5 62.8 58.4 86.6 90.1 69.2 113.9 67.2 127.5 73.4 50.4 118.6 70.0 69.9 189.1 134.7 114.4 126.9 117.0 167.3 255.0 99.6 59.9 85.5 76.2 26.0 34.7 87.8 68.1 57.2 59.5 62.5 58.0 116.9 157.9 78.1 53.1 41.2 52.8 120.2 83.9 75.7 125.1 94.5 203.5 49.5 93.6 32.3 230.8 87.1 50.3 31.5 52.7 43.6 56.8 97.0 129.0 118.2 67.2 51.9 142.5 324.2 314.8 128.7 99.1 50.0 223.4 60.9 107.3 72.8 89.1 174.5 107.4 78.2 78.3 59.4 70.5 59.0 183.6 72.0 50.2 89.1 61.3 73.1 81.5 40.1 316.2 34.3 141.6 80.4 114.4 113.6 75.3 99.1 114.0 143.5 189.1 143.8 120.6 126.3 160.4 160.6 134.8 23.1 117.0 126.9 134.7 167.3 255.0 60.0 65.2 38.2 64.2 66.3 48.3 68.7 59.6 54.2 67.2 902.2 1420.8 3111.4 3331.5 6879.8 692.5 258.3 1666.3 1917.9 1803.9 2156.5 276.9 2179.3 3208.0 2815.5 89.5 3767.9 1421.2 1752.0 3609.4 4317.6 3273.0 2682.0 2759.5 1209.1 2876.6 767.5 1629.9 1539.5 3031.9 138.7 1209.6 4164.5 3499.0 2458.1 2866.2 2213.1 3219.9 1988.5 1320.3 2161.4 753.7 1895.0 6501.7 798.6 2809.8 6944.4 2286.6 2724.1 3072.9 3503.3 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "Pituitary tumor-transforming 1" O95997 5 160421822-160428744 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.5;testis: 100.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 54.5" "Lineage enriched" "Detected in all" 7 "T-cells: 54.5" "Low cell line specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 1.5 1.7 2.1 16.2 5.5 34.1 2.9 1.4 4.6 3.8 8.2 1.0 0.7 5.8 1.3 2.6 24.1 1.0 1.9 2.3 5.1 2.7 1.7 1.4 3.8 19.2 1.5 2.2 1.1 1.2 0.2 2.0 5.0 2.2 1.6 11.3 1.5 4.5 1.1 1.2 8.7 5.8 4.5 1.4 7.5 3.4 100.1 1.0 29.8 23.9 23.2 35.1 3.3 7.2 8.1 6.1 2.4 2.1 3.3 54.5 4.7 45.7 23.8 53.8 38.5 9.1 9.0 16.8 24.3 55.7 64.6 70.8 46.0 40.3 50.0 21.7 27.6 74.3 24.0 33.4 67.6 92.7 57.1 30.3 26.4 32.2 27.7 1.8 23.9 23.2 4.2 11.3 43.8 26.6 19.8 45.5 33.5 21.1 39.0 66.3 21.5 28.6 58.8 27.1 37.7 34.6 26.7 63.3 42.9 32.9 9.3 33.5 21.3 35.1 21.4 72.2 45.5 43.7 26.2 19.4 29.2 39.1 22.8 70.9 33.6 29.9 57.2 31.5 41.4 51.7 1.9 0.7 2.4 7.0 2.1 2.5 8.1 14.4 16.2 6.1 5.5 3.6 8.9 0.8 3.3 1.4 5.8 54.5 4.7 2.1 5.5 1.4 4.6 5.1 2.7 1.5 2.2 2.2 1.0 6.0 15.5 20.5 54.1 220.3 1.3 4.9 7.6 1.4 11.4 5.2 0.0 50.4 3.3 4.0 470.4 10.3 6.3 654.1 4.5 163.8 37.7 15.3 38.0 2.9 72.7 0.0 5.8 17.8 20.0 39.3 10.3 35.9 82.7 39.7 15.4 2.7 3.5 9.1 7.4 1.2 0.7 6.5 35.3 278.1 72.8 136.5 26.7 44.5 34.5 30.7 PYURF PreY ENSG00000145337 "PIGY upstream reading frame" Q96I23 4 88520985-88523813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036455 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA036455: AB_10673388" "unprognostic (8.25e-2)" "unprognostic (9.14e-2)" "unprognostic (6.61e-2)" "unprognostic (2.03e-1)" "unprognostic (5.03e-2)" "unprognostic (7.23e-2)" "unprognostic (1.10e-2)" "unprognostic (8.84e-3)" "unprognostic (3.64e-1)" "unprognostic (1.48e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-2)" "unprognostic (9.04e-3)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" 40.4 48.3 47.3 29.2 43.9 44.2 63.2 28.2 43.4 40.6 38.4 31.2 35.2 35.8 47.4 56.4 40.9 41.0 36.4 62.5 45.4 45.1 48.7 59.1 33.5 43.1 47.6 35.3 44.9 61.8 40.7 42.6 39.0 43.2 42.7 37.7 31.6 48.6 42.9 54.0 37.1 37.5 44.7 51.4 36.9 33.8 28.5 38.4 28.3 47.7 40.5 33.0 41.7 51.4 45.3 50.8 35.0 43.3 47.3 54.1 74.3 29.4 9.9 19.9 23.6 40.3 41.5 13.5 21.8 30.7 27.4 23.2 7.7 23.5 0.1 24.6 30.8 18.6 12.7 18.0 27.4 34.6 36.0 31.3 32.7 13.2 29.3 30.6 54.0 21.1 28.6 41.5 17.6 36.1 26.0 44.7 10.2 36.7 33.2 39.5 22.3 32.8 33.1 16.7 34.5 19.1 33.5 18.6 34.3 22.5 16.7 24.1 23.6 27.6 25.3 57.4 20.6 11.7 27.2 30.4 29.2 26.9 28.4 20.0 23.6 19.1 3.6 25.6 27.5 32.0 30.9 43.3 35.0 45.0 42.0 50.2 45.3 52.0 48.5 50.8 35.5 54.1 51.6 8.6 47.3 41.0 31.9 51.8 74.3 47.3 43.9 28.2 43.4 45.4 45.1 47.6 35.3 43.2 38.4 47.6 58.8 74.6 136.8 204.7 28.0 4.5 68.8 84.3 85.3 82.0 9.8 205.8 243.7 96.5 35.0 121.7 71.5 23.3 113.5 97.9 127.4 138.8 102.8 109.9 125.1 25.4 110.1 92.7 113.8 79.3 116.5 112.4 330.7 100.0 88.2 79.4 90.7 113.1 112.8 171.4 25.3 58.2 140.4 100.3 65.3 252.6 137.1 99.2 113.0 120.5 RAB10 ENSG00000084733 "RAB10, member RAS oncogene family" P61026 2 26034107-26137454 "Predicted intracellular proteins" "Protein transport, Transport" Hydrolase Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 426.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045611 Approved NA Yes 14000000 "HPA045611: AB_10961124" "unprognostic (7.73e-3)" "unprognostic (2.45e-2)" "unprognostic (8.21e-3)" "prognostic unfavorable (7.40e-4)" "unprognostic (8.22e-3)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (9.22e-3)" "unprognostic (6.14e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.06e-2)" "unprognostic (8.69e-3)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.99e-2)" 17.8 21.8 24.1 15.9 21.0 6.0 20.4 16.0 23.2 23.0 22.2 22.6 11.9 15.6 16.9 16.4 82.0 15.8 17.4 18.6 22.8 22.3 22.2 18.4 15.9 22.7 28.7 15.6 16.4 20.9 20.2 13.5 15.6 22.0 17.1 22.9 10.6 24.6 17.4 72.8 26.9 20.2 18.7 34.7 28.0 21.9 13.2 23.9 19.7 21.3 62.6 41.8 21.4 32.7 11.1 22.0 16.8 44.5 15.2 13.7 21.8 36.1 43.2 21.0 17.4 44.4 37.0 20.1 28.4 25.0 23.1 20.6 25.2 27.2 24.7 27.4 31.0 25.4 19.9 25.1 27.3 24.8 25.3 17.3 42.5 18.9 42.1 41.4 34.9 24.3 30.1 45.1 28.1 33.5 36.3 29.0 15.4 34.9 25.2 31.1 16.0 21.2 27.4 21.3 43.9 25.3 20.6 44.0 41.5 46.6 35.3 29.6 27.5 24.0 44.4 29.3 24.4 19.5 25.4 35.1 35.8 18.6 24.7 30.4 16.4 25.6 39.7 36.0 42.2 27.3 13.9 23.7 10.5 10.7 42.4 12.9 11.1 12.7 11.4 22.0 9.8 11.0 12.1 16.8 15.2 44.5 7.6 13.7 21.8 24.1 21.0 16.0 23.2 22.8 22.3 28.7 15.6 22.0 23.9 74.5 42.5 50.8 151.1 303.7 24.2 71.1 79.0 80.3 95.5 87.2 7.9 107.8 97.8 172.1 25.9 86.3 114.1 70.0 83.7 161.5 85.0 175.1 49.7 56.7 141.2 25.4 62.6 51.0 147.7 25.4 58.1 132.5 84.4 310.2 76.0 99.5 118.1 90.2 65.7 112.3 29.8 84.1 116.4 51.6 71.4 426.6 107.3 53.2 80.4 307.2 RAC2 EN-7 ENSG00000128340 "Rac family small GTPase 2" P15153 22 37225261-37244448 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 166.3;bone marrow: 66.3;lymphoid tissue: 169.1" "Cell type enhanced" "Detected in many" 14 "B-cells: 269.8;granulocytes: 502.9;T-cells: 411.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 55.3;HL-60: 77.3;HMC-1: 158.6;Karpas-707: 75.3;U-87 MG: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022946, HPA047820" Enhanced NA Yes 34000000 "CAB022946: , HPA047820: AB_2680167" "prognostic favorable (1.03e-5)" "unprognostic (2.91e-1)" "unprognostic (3.21e-2)" "unprognostic (1.82e-3)" "unprognostic (6.74e-2)" "unprognostic (7.78e-2)" "unprognostic (3.47e-1)" "unprognostic (5.00e-2)" "unprognostic (8.52e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (3.81e-1)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.45e-1)" "unprognostic (1.75e-1)" "unprognostic (6.21e-2)" "unprognostic (1.50e-2)" 17.4 2.6 2.0 79.2 4.1 66.3 8.3 0.9 2.0 3.3 7.5 1.5 1.2 6.0 3.2 3.5 7.8 4.7 11.2 5.6 1.7 1.9 4.8 5.3 29.6 89.3 3.0 0.2 4.9 2.3 0.0 1.8 3.5 2.2 6.2 5.9 3.3 16.9 2.2 1.4 2.9 29.4 3.2 4.1 102.8 7.0 2.5 2.0 169.1 3.6 3.6 74.2 11.2 4.0 85.3 79.1 166.3 88.3 98.4 121.7 130.9 14.3 0.0 0.0 0.0 1.6 14.8 0.0 1.9 4.5 1.5 3.2 0.0 4.8 17.8 2.2 5.6 0.0 3.6 0.1 25.0 1.7 55.3 0.0 22.2 0.4 0.0 4.0 77.3 158.6 10.8 3.5 2.7 9.4 0.1 26.2 17.3 5.2 75.3 0.2 0.0 22.8 30.7 0.3 1.4 9.5 7.6 0.0 20.3 2.4 0.0 0.2 0.0 0.0 2.5 0.3 0.1 1.0 41.7 28.1 0.0 2.6 0.1 0.2 34.1 17.5 18.8 69.1 33.7 3.8 115.0 53.8 166.3 111.5 73.2 84.4 85.3 89.3 97.9 53.4 70.9 69.5 88.6 146.6 98.4 88.3 79.1 121.7 130.9 2.0 4.1 0.9 2.0 1.7 1.9 3.0 0.2 2.2 2.0 14.9 73.5 269.8 1.9 4.7 0.0 0.8 2.5 6.7 15.9 1.8 0.0 0.6 0.0 10.2 0.1 6.8 1.3 0.0 1.8 1.5 4.6 0.3 502.9 1.3 136.6 0.0 4.1 13.5 121.0 0.4 0.3 135.5 28.7 2.8 3.2 0.0 13.1 11.5 0.0 1.0 0.0 12.9 3.8 0.0 0.9 3.4 2.4 411.2 10.7 2.8 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 3.7 2.6 4.9 10.0 11.3 21.0 4.2 6.3 7.8 4.2 10.1 4.7 1.5 6.5 3.3 1.9 17.7 2.7 4.0 2.7 4.8 4.5 5.9 2.8 5.6 13.7 7.8 5.0 2.5 2.0 3.3 1.4 8.4 5.4 2.4 11.9 2.0 4.7 2.1 3.8 8.7 7.5 7.6 5.9 5.9 6.8 29.4 6.6 40.9 2.4 8.7 17.8 6.0 6.5 6.3 2.2 16.5 3.5 8.8 14.8 4.8 44.6 40.8 32.5 20.8 6.0 7.2 27.8 47.4 22.8 49.7 34.0 40.7 34.2 24.8 21.2 25.1 24.3 30.3 32.4 22.0 53.0 47.5 20.4 31.9 40.4 13.3 2.2 33.6 26.4 3.9 4.1 33.7 26.9 14.6 16.8 22.7 23.0 38.1 46.4 31.3 27.7 16.8 23.2 25.3 27.0 26.4 39.8 18.2 13.2 22.3 27.4 23.7 38.7 24.6 13.1 17.3 47.8 15.2 15.3 32.9 29.7 21.0 34.1 20.2 49.9 29.4 16.6 23.0 19.2 16.5 2.6 3.9 5.7 3.5 4.9 6.3 6.9 7.8 2.2 3.9 4.2 5.5 0.5 8.8 1.9 1.5 14.8 4.8 4.9 11.3 6.3 7.8 4.8 4.5 7.8 5.0 5.4 6.6 6.0 5.4 8.5 2.4 11.4 1.6 1.2 2.5 2.7 3.4 5.2 3.9 6.2 16.6 1.5 9.3 1.7 1.5 46.7 1.8 40.9 4.1 2.1 2.3 1.8 11.4 1.6 0.0 6.2 11.7 11.4 1.4 8.0 1.7 3.6 2.6 1.7 1.6 0.0 3.5 1.9 0.7 12.9 2.8 65.3 40.1 11.3 7.2 4.4 4.1 1.1 RAD21 "hHR21, KIAA0078, SCC1" ENSG00000164754 "RAD21 cohesin complex component" O60216 8 116845935-116874866 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020044, CAB022065" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB022065: , HPA020044: AB_1856035" "unprognostic (7.85e-2)" "unprognostic (4.92e-1)" "unprognostic (3.05e-1)" "unprognostic (5.43e-3)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.86e-3)" "unprognostic (8.99e-2)" "unprognostic (8.80e-2)" "unprognostic (5.58e-3)" "unprognostic (3.56e-2)" "unprognostic (4.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" 31.6 40.9 48.2 30.5 52.2 78.5 37.7 58.8 55.3 24.2 36.3 37.5 21.5 24.8 30.5 25.3 32.1 23.1 22.0 37.8 45.6 44.1 30.5 27.9 29.6 49.2 54.3 35.4 33.5 18.2 29.1 30.0 38.9 45.5 26.5 37.3 19.0 25.3 31.0 37.8 24.0 26.0 33.4 49.7 31.2 31.5 37.6 56.2 58.3 41.9 20.9 50.4 37.1 36.0 8.7 5.4 17.9 7.1 8.0 25.4 6.2 41.6 20.5 40.2 22.5 20.2 17.5 18.0 29.0 27.5 32.2 29.8 16.8 39.3 61.6 16.0 20.6 17.2 23.3 34.2 18.7 37.8 81.7 21.9 62.8 25.2 21.3 12.7 20.1 37.0 14.9 15.4 18.8 22.8 21.3 25.1 89.9 25.2 86.3 27.7 25.1 92.1 11.9 23.6 53.8 25.9 33.8 29.2 30.9 19.2 24.5 50.8 26.2 30.4 82.1 19.6 22.0 34.4 24.9 18.4 22.8 33.4 23.8 30.3 45.7 52.5 55.5 19.5 29.0 27.2 17.2 4.5 15.5 11.0 5.3 11.2 8.7 12.9 13.0 5.4 8.3 13.5 13.0 17.9 8.0 7.1 4.5 25.4 6.2 48.2 52.2 58.8 55.3 45.6 44.1 54.3 35.4 45.5 56.2 238.2 123.7 70.9 67.0 84.9 73.4 149.3 48.4 87.0 138.8 52.4 29.5 106.6 36.5 47.5 247.8 88.8 56.4 70.0 38.8 119.7 73.7 80.6 143.9 61.8 58.9 63.5 81.0 64.4 91.5 303.2 107.9 82.3 65.8 97.4 62.9 99.6 49.1 57.5 100.0 50.1 60.7 71.1 54.7 31.6 81.6 87.8 95.1 93.8 69.2 65.3 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.9;testis: 24.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Extravillous trophoblasts: 57.9;Spermatocytes: 52.6;Spermatogonia: 26.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB010381, HPA039310" Enhanced Supported "Nucleoli rim,Cytosol" NA Yes "Nucleoli rim" Cytosol "CAB010381: AB_2253533, HPA039310: AB_2676434" "prognostic unfavorable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 1.0 0.9 0.4 6.6 0.9 5.3 1.0 0.7 0.9 1.1 5.7 0.4 0.3 1.7 0.8 2.0 4.9 0.5 1.7 1.8 0.5 0.5 1.0 1.0 1.9 7.4 0.5 0.3 0.9 0.7 0.0 0.4 6.2 0.7 0.8 7.6 0.4 1.4 0.3 1.3 2.1 2.6 1.2 1.1 5.0 1.5 24.0 0.5 27.9 0.6 3.7 9.7 1.0 1.9 3.1 1.7 2.7 2.2 2.2 8.8 1.7 12.4 5.5 13.2 5.0 1.3 3.6 12.0 22.0 6.1 19.5 19.7 13.0 8.5 7.0 10.9 7.8 7.5 26.4 24.9 10.3 19.1 14.6 8.5 17.6 10.8 9.9 0.1 14.2 12.1 0.5 1.7 13.1 5.8 3.0 10.6 19.9 23.1 19.7 16.9 10.9 20.3 13.1 15.1 29.3 6.9 23.2 18.7 11.8 7.1 16.8 5.9 11.1 9.7 17.1 3.5 16.7 10.3 11.8 4.4 14.1 9.0 19.8 11.3 5.0 24.6 23.4 6.1 29.7 12.4 2.0 0.9 2.7 4.1 2.0 0.8 3.1 4.3 5.5 1.7 1.6 1.2 2.1 1.3 2.2 2.2 1.2 8.8 1.7 0.4 0.9 0.7 0.9 0.5 0.5 0.5 0.3 0.7 0.5 0.0 0.0 0.8 1.2 3.2 0.4 0.8 0.0 0.0 1.2 0.0 0.0 16.0 0.0 0.0 2.6 0.1 0.9 46.7 0.0 57.9 0.6 0.7 0.0 0.0 10.9 0.0 0.0 1.8 2.4 4.0 0.6 0.5 0.0 0.0 3.2 0.2 0.1 3.7 0.7 0.0 0.0 0.0 0.2 52.6 26.0 1.4 21.2 1.5 5.2 1.3 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560048 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 3.0 2.0 1.7 9.2 3.6 15.4 2.7 4.5 2.6 1.8 5.4 1.4 3.8 5.4 1.5 3.2 7.6 1.1 2.2 1.9 1.5 1.2 1.7 1.7 2.6 8.8 2.1 1.7 1.5 1.2 0.5 1.2 4.2 1.8 1.7 7.1 1.5 2.8 1.0 1.2 3.2 6.2 1.9 2.9 5.8 2.9 9.2 2.5 29.8 1.4 4.7 8.2 2.1 3.1 4.5 9.7 0.9 3.1 1.9 1.5 0.9 13.0 4.6 16.5 8.2 1.0 2.1 19.3 17.2 7.6 19.2 25.4 12.5 12.7 17.1 2.5 3.7 9.0 8.3 11.4 5.1 29.5 13.4 9.7 21.5 8.0 8.6 0.2 19.5 10.9 0.4 0.5 11.5 11.2 2.7 7.7 11.8 13.4 19.7 12.1 4.7 15.9 7.1 40.1 12.7 5.2 16.0 19.8 6.7 5.8 6.5 5.5 6.1 12.8 10.0 4.1 17.4 4.0 11.4 3.4 13.1 13.4 14.1 18.3 3.0 3.4 32.7 4.9 14.1 10.5 0.0 0.8 0.9 0.2 3.1 0.8 4.2 0.6 1.5 0.6 4.5 0.2 0.4 0.0 1.9 2.7 9.7 1.4 0.9 1.7 3.6 4.5 2.6 1.5 1.2 2.1 1.7 1.8 2.5 0.0 0.3 7.5 1.7 4.6 3.0 1.2 2.5 0.0 5.7 0.0 3.9 6.8 0.0 2.0 33.7 0.7 1.3 46.7 2.3 30.1 2.9 1.1 1.1 1.0 34.3 0.0 2.4 1.8 4.7 50.0 1.1 6.6 0.0 10.8 2.8 2.6 1.1 0.0 1.4 1.2 4.9 0.0 1.9 35.8 29.9 2.3 3.9 3.8 7.7 0.9 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46247688-46278473 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 41.9;testis: 56.6" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 4 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 1.9 0.6 1.5 12.9 4.7 9.4 1.3 3.0 1.9 1.1 4.8 0.7 0.5 2.8 1.2 2.1 5.2 0.3 1.2 1.5 1.8 1.5 1.4 0.5 1.5 6.0 1.9 0.7 0.8 1.4 0.6 0.5 4.2 0.9 1.1 5.8 0.6 1.4 1.0 1.4 3.0 3.6 1.8 3.2 4.1 1.7 56.6 0.6 41.9 1.7 3.8 9.6 1.0 1.7 0.5 0.3 0.0 0.1 0.9 4.1 0.7 9.0 6.8 20.5 12.5 1.5 1.0 19.1 10.7 4.7 18.1 18.6 14.5 6.0 17.8 8.2 4.5 16.5 9.4 18.9 6.0 16.0 9.7 19.1 21.8 18.2 14.4 0.0 21.8 12.8 0.6 0.5 18.0 5.3 3.0 5.6 20.7 15.6 18.2 9.9 8.6 27.1 24.2 18.3 8.0 11.2 21.7 11.4 7.8 4.4 7.8 9.8 7.0 7.8 10.8 2.6 17.4 3.8 15.9 2.4 19.5 11.6 10.0 18.0 7.7 4.4 19.2 5.2 14.5 7.8 0.0 0.1 0.0 1.2 0.1 0.2 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.9 0.1 0.0 4.1 0.7 1.5 4.7 3.0 1.9 1.8 1.5 1.9 0.7 0.9 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 1.8 0.1 0.2 0.0 0.0 7.8 0.4 0.3 4.6 0.0 2.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.0 4.2 0.3 1.4 0.0 1.2 0.4 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41245611-41286251 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 12.2 30.7 23.5 16.9 28.4 28.5 16.1 17.6 41.1 8.5 11.8 23.1 7.3 12.7 9.5 9.4 26.1 11.5 13.7 11.5 26.9 30.4 12.0 25.1 11.5 19.5 31.7 28.6 10.6 20.2 11.0 17.7 16.1 28.1 11.4 9.6 7.1 16.3 13.3 12.5 51.6 12.8 12.3 22.0 14.2 16.0 64.3 28.3 22.1 12.7 14.4 21.7 13.3 29.2 8.7 7.6 8.2 14.8 7.1 13.1 9.7 58.2 30.6 20.0 20.9 10.8 8.9 24.3 50.5 27.6 51.0 26.7 37.1 19.2 31.4 40.8 37.0 24.6 54.3 36.3 39.8 30.8 25.4 56.3 26.6 29.9 28.9 13.5 42.9 20.0 8.6 19.0 36.3 32.2 16.8 26.7 11.8 34.1 22.4 29.0 49.9 25.0 34.9 21.8 53.1 36.4 30.7 19.7 33.1 19.9 33.4 18.2 12.1 35.9 31.8 18.5 19.2 18.7 17.3 41.2 39.1 37.5 21.5 41.5 16.7 22.2 29.9 27.3 30.5 22.5 2.8 9.5 8.2 11.2 11.2 13.1 7.9 11.3 10.3 7.1 8.7 10.5 8.0 2.7 7.1 14.8 7.6 11.6 9.7 23.5 28.4 17.6 41.1 26.9 30.4 31.7 28.6 28.1 28.3 3.0 24.7 28.1 17.5 20.5 15.2 17.4 22.9 9.4 9.1 8.7 13.7 15.1 3.3 34.2 259.8 12.7 10.1 0.0 17.4 28.1 9.3 32.2 5.8 17.9 14.0 14.3 24.0 11.6 13.4 1320.8 13.8 17.1 11.8 10.0 13.9 7.8 29.0 6.5 11.3 11.2 24.4 0.0 9.0 18.0 19.2 27.0 19.8 23.8 10.9 19.2 RASSF1 "123F2, NORE2A, RDA32, REH3P21" ENSG00000068028 "Ras association domain family member 1" Q9NS23 3 50329782-50340980 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 56.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040735 Approved NA Yes "HPA040735: AB_10671692" "unprognostic (5.02e-2)" "prognostic favorable (2.64e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.00e-3)" "prognostic favorable (2.60e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (3.80e-2)" "unprognostic (2.11e-1)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (4.27e-2)" "unprognostic (2.29e-1)" "unprognostic (1.11e-1)" "unprognostic (9.71e-2)" 21.5 9.9 8.5 21.3 13.0 50.3 23.3 12.4 13.8 17.9 17.1 12.3 15.7 11.2 15.7 13.7 13.6 13.4 25.2 17.7 10.4 7.5 12.2 10.6 25.9 24.5 17.6 8.6 14.7 23.2 5.2 10.3 18.4 12.9 13.5 8.7 15.0 23.7 12.8 18.8 17.8 17.2 16.0 12.5 32.3 13.3 24.6 12.9 9.7 13.6 15.2 21.4 19.7 16.9 12.7 6.9 56.8 15.1 16.7 23.1 10.0 14.2 5.9 4.4 7.3 10.2 14.0 6.5 24.6 16.3 21.2 17.0 13.5 10.8 6.9 3.8 26.3 9.5 7.7 9.3 10.2 11.5 17.1 6.0 23.8 18.4 7.0 11.8 23.3 26.3 10.7 7.3 20.9 7.5 6.2 9.4 8.6 9.9 16.2 9.5 5.0 8.8 31.4 5.9 12.0 17.8 7.3 4.6 15.9 6.2 4.2 5.2 9.6 21.9 14.8 16.4 4.7 8.9 23.0 8.9 14.7 11.0 20.8 12.1 6.6 4.3 15.0 8.2 29.2 26.2 56.8 6.6 21.2 23.1 11.1 14.5 12.7 7.5 16.3 6.9 9.7 4.8 11.4 5.1 16.7 15.1 5.2 7.5 10.0 8.5 13.0 12.4 13.8 10.4 7.5 17.6 8.6 12.9 12.9 14.9 7.2 27.0 30.7 65.6 12.0 9.5 10.2 5.3 13.6 1.8 13.7 23.5 5.0 21.6 1.7 46.0 9.2 0.0 22.9 22.0 28.3 20.6 56.5 4.2 32.7 3.2 16.0 26.4 22.3 7.2 17.5 21.8 86.0 16.2 14.1 7.8 29.1 14.4 13.8 6.3 9.1 25.8 58.7 31.7 9.3 43.8 13.8 61.7 12.0 18.2 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 5.2 9.9 6.1 12.5 8.1 6.1 17.3 14.3 7.0 5.3 9.2 3.3 5.8 8.0 6.4 5.9 9.2 6.2 8.7 6.2 5.5 6.7 8.5 11.3 6.6 5.7 8.4 1.5 8.2 12.1 9.3 3.2 9.4 6.0 5.6 7.4 3.1 8.2 6.2 5.2 11.8 9.7 8.6 5.6 10.1 6.5 18.9 7.2 21.9 11.0 8.3 14.5 6.4 5.7 3.1 2.3 0.1 2.0 1.7 2.9 0.8 4.9 7.3 1.7 3.6 4.3 5.1 12.9 5.7 1.0 1.6 1.7 3.5 9.4 17.3 9.2 3.5 0.1 10.6 5.6 1.5 2.8 14.5 11.5 12.5 12.3 5.0 3.6 5.9 4.9 3.8 5.1 1.7 2.3 6.6 2.7 10.2 9.4 11.4 4.9 1.6 7.1 6.2 6.6 5.9 3.0 8.5 8.7 18.4 7.7 2.3 5.6 6.4 9.9 6.3 6.7 9.5 7.3 11.5 4.3 1.0 7.2 4.2 0.2 20.5 8.4 10.3 1.9 13.2 4.8 0.1 0.7 0.1 0.8 2.0 2.1 3.1 1.7 2.7 1.6 2.1 2.9 1.0 0.1 1.7 1.1 2.3 2.1 0.8 6.1 8.1 14.3 7.0 5.5 6.7 8.4 1.5 6.0 7.2 0.0 2.1 13.7 10.1 6.5 6.0 8.1 0.0 1.4 1.2 7.0 3.9 12.3 3.3 7.2 1.8 4.5 11.8 70.0 4.2 16.3 7.1 7.3 0.0 7.4 10.2 0.0 21.2 3.1 7.5 3.9 8.1 5.4 5.0 4.6 16.7 10.6 4.9 14.0 7.4 10.4 2.7 25.8 6.4 20.6 18.3 7.9 7.6 3.2 21.5 7.4 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" 8 144511288-144517845 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 7.1;Spermatocytes: 12.6;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 14 "B-cells: 1.9;monocytes: 1.0;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 2.0 1.6 2.6 12.3 5.6 21.0 2.8 11.5 3.7 1.8 4.3 1.5 1.6 5.6 2.5 4.9 9.4 1.5 1.9 1.9 2.3 1.7 1.6 1.9 1.6 5.9 1.5 2.2 1.9 3.5 0.3 2.4 2.7 2.2 7.7 1.5 1.4 5.4 0.9 2.1 9.4 4.8 1.1 1.7 4.7 3.0 18.1 1.8 18.9 2.5 5.3 8.0 1.6 1.8 1.9 0.1 0.0 1.0 0.0 1.6 0.2 10.4 18.7 8.7 18.4 0.5 0.9 15.3 10.6 1.9 7.9 6.6 18.4 15.5 7.1 7.1 1.7 4.6 12.7 5.8 4.5 2.2 12.5 22.0 25.7 32.0 13.7 0.1 6.5 21.5 1.1 0.6 8.8 1.8 1.1 2.2 14.6 25.5 9.3 2.7 32.4 23.7 17.7 6.1 8.7 22.4 24.9 6.9 11.9 2.1 11.3 17.3 10.4 14.4 12.1 3.7 2.5 14.7 14.4 2.9 12.8 38.7 15.3 19.5 5.2 5.4 12.1 7.3 20.2 12.8 0.0 0.1 0.0 1.1 1.0 0.0 1.9 0.5 1.1 0.1 0.0 0.9 1.6 0.0 0.0 0.0 0.1 0.0 0.2 2.6 5.6 11.5 3.7 2.3 1.7 1.5 2.2 2.2 1.8 0.0 0.0 2.2 0.4 1.3 2.5 1.6 2.5 0.0 0.0 0.0 3.9 1.2 0.0 0.4 3.1 0.0 0.4 0.0 0.4 7.1 0.8 0.5 0.0 0.6 3.0 0.0 0.0 0.0 0.3 6.2 1.1 0.6 0.0 0.0 1.4 0.2 0.3 0.0 1.4 0.3 1.6 0.0 0.4 12.6 21.1 0.9 1.3 0.0 3.1 0.4 REEP4 "C8orf20, FLJ22246, FLJ22277, PP432, Yip2c" ENSG00000168476 "Receptor accessory protein 4" Q9H6H4 8 22138020-22141951 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 93.5;Syncytiotrophoblasts: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042683 Approved Approved Cytosol No Yes Cytosol "HPA042683: AB_2571730" "unprognostic (2.38e-1)" "unprognostic (9.96e-3)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (3.41e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.88e-5)" "unprognostic (5.72e-2)" "unprognostic (1.06e-1)" "unprognostic (2.25e-1)" "unprognostic (6.65e-2)" 6.3 4.3 3.9 9.2 6.2 18.1 22.9 2.3 4.3 12.8 11.9 6.9 4.0 8.4 5.6 5.4 39.8 5.5 11.1 4.5 3.4 2.9 5.2 6.4 18.0 16.5 7.2 2.5 4.9 11.0 3.2 5.6 35.8 5.7 9.2 8.8 4.5 11.0 6.0 3.0 43.1 8.6 5.2 7.5 19.9 12.3 19.1 6.8 14.5 10.8 20.4 24.9 12.4 20.8 4.4 17.7 25.9 23.6 9.8 10.9 10.2 12.3 25.7 8.3 13.0 3.6 3.6 14.7 11.1 6.3 14.6 13.3 14.8 12.6 15.1 14.6 6.1 12.9 32.0 9.9 19.2 7.5 8.4 11.3 16.2 13.6 15.1 3.9 7.4 25.1 3.3 37.1 11.1 9.4 4.7 8.9 18.4 12.7 52.8 7.5 19.0 19.1 26.9 12.0 18.9 16.1 10.8 6.9 30.9 6.6 13.3 6.7 12.3 9.0 10.5 16.0 5.8 20.8 11.3 9.1 9.7 15.8 21.6 15.6 12.1 9.1 9.9 10.9 16.8 19.2 17.7 23.6 25.9 10.9 23.0 8.5 4.4 9.6 9.1 17.7 2.2 4.5 5.9 6.8 9.8 15.3 6.9 6.1 10.2 3.9 6.2 2.3 4.3 3.4 2.9 7.2 2.5 5.7 6.8 3.0 8.6 6.7 15.8 24.8 5.4 1.4 7.6 2.7 5.7 12.2 2.0 42.2 0.0 21.3 7.0 6.7 17.0 93.5 13.4 42.8 9.8 4.1 10.3 4.9 49.9 0.0 16.7 13.5 40.7 7.4 8.3 23.4 3.3 11.8 28.1 2.1 18.6 28.6 7.8 1.8 1.6 12.9 10.3 28.2 16.8 34.4 78.7 13.1 29.0 18.3 RFC2 "A1, RFC40" ENSG00000049541 "Replication factor C subunit 2" P35250 7 74231499-74254458 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029493 Approved Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "HPA029493: AB_10603991" "unprognostic (1.25e-1)" "prognostic favorable (9.91e-4)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (2.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.09e-7)" "unprognostic (2.22e-1)" "unprognostic (6.65e-2)" "unprognostic (3.61e-2)" "unprognostic (2.59e-1)" 11.0 9.5 16.1 15.8 15.4 23.0 15.3 13.9 16.6 10.1 12.8 10.0 5.0 8.6 10.0 9.4 17.9 10.1 9.0 9.1 12.1 9.1 10.1 23.0 10.6 20.4 12.3 14.0 11.7 15.1 10.9 8.6 17.5 15.1 11.0 15.0 8.9 12.2 8.1 16.5 18.8 10.0 12.7 14.8 14.2 12.2 13.5 14.0 22.1 10.4 14.7 28.5 9.9 11.6 22.4 18.7 27.5 24.2 24.8 13.6 15.8 22.9 17.9 20.9 20.7 4.3 5.1 9.6 13.5 14.9 27.5 33.2 19.8 21.4 21.7 3.8 9.5 26.1 15.8 17.0 22.6 28.6 15.5 29.5 13.2 24.9 14.7 3.4 19.8 8.2 5.1 5.1 25.9 17.9 6.0 14.7 20.9 27.4 13.4 21.1 27.1 19.7 38.6 23.8 36.5 15.1 29.5 23.2 27.1 14.7 18.6 17.0 21.6 16.0 30.3 11.0 26.9 21.9 18.3 5.7 27.3 18.1 21.0 30.1 8.2 10.6 37.7 13.8 30.7 28.3 19.5 22.0 15.6 11.4 24.2 11.7 19.0 9.9 10.4 18.7 22.4 12.6 9.5 27.5 24.8 22.4 10.0 13.6 15.8 16.1 15.4 13.9 16.6 12.1 9.1 12.3 14.0 15.1 14.0 11.9 12.0 15.3 19.1 21.2 14.1 5.0 10.2 9.4 15.9 5.2 2.0 51.5 5.0 14.8 2.2 11.7 9.9 0.0 16.7 50.3 12.7 9.4 22.0 13.1 32.8 3.2 4.6 11.6 12.7 1.8 8.1 24.0 20.3 34.3 7.8 12.8 12.3 5.8 10.3 7.8 8.7 6.5 15.1 23.6 52.6 14.9 38.6 23.6 15.6 12.4 RFC4 "A1, RFC37" ENSG00000163918 "Replication factor C subunit 4" P35249 3 186789880-186807058 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 48.3;Spermatocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004557, HPA049123, HPA058507" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736" "unprognostic (2.45e-1)" "prognostic favorable (7.41e-5)" "unprognostic (2.84e-1)" "unprognostic (1.81e-3)" "unprognostic (1.03e-1)" "unprognostic (6.69e-3)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.29e-3)" "unprognostic (1.15e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.80e-2)" "unprognostic (4.98e-1)" "unprognostic (6.15e-2)" "unprognostic (2.16e-1)" 7.1 6.9 11.5 14.1 16.0 26.8 10.5 28.0 13.9 8.8 11.6 5.3 5.8 8.2 11.8 7.3 13.0 10.2 7.6 8.0 8.6 6.2 8.2 9.3 6.6 22.1 14.5 9.8 12.7 11.9 6.5 9.0 11.0 12.5 7.3 16.1 5.9 8.1 5.8 8.1 8.7 11.8 13.6 8.4 15.6 9.8 20.3 12.8 28.6 6.4 11.0 25.2 8.3 8.5 11.2 7.7 7.4 10.3 7.0 16.5 6.2 34.8 12.0 28.5 18.2 4.1 4.5 22.5 16.9 10.7 27.0 29.9 17.9 16.7 25.2 39.3 8.1 25.9 18.4 25.1 16.5 33.3 38.0 22.1 25.9 18.4 18.2 3.2 27.3 17.4 3.8 6.0 18.5 14.5 6.0 9.0 39.5 20.1 35.9 18.4 16.6 34.3 25.6 25.2 31.2 16.4 27.2 24.5 34.6 9.7 13.0 27.9 13.9 21.1 23.3 19.1 22.4 39.6 26.2 4.1 16.4 20.7 27.4 50.4 20.1 44.4 83.9 14.4 30.1 21.5 0.0 2.2 7.4 9.8 3.3 9.4 10.6 9.7 10.1 3.9 11.2 9.8 8.9 0.4 7.0 10.3 7.7 16.5 6.2 11.5 16.0 28.0 13.9 8.6 6.2 14.5 9.8 12.5 12.8 0.0 2.1 20.1 13.1 5.4 17.0 6.9 10.2 9.4 7.9 10.4 0.0 26.7 5.0 9.4 18.6 4.5 2.0 23.3 14.4 48.3 5.1 4.1 8.1 2.9 20.0 7.9 1.2 6.7 2.1 7.9 9.8 5.2 1.7 15.4 4.2 12.4 7.9 3.5 7.4 6.7 14.0 6.5 10.3 67.9 38.7 2.6 9.4 8.6 11.5 3.1 RHNO1 "C12orf32, HKMT1188, MGC13204, RHINO" ENSG00000171792 "RAD9-HUS1-RAD1 interacting nuclear orphan 1" Q9BSD3 12 2876258-2889523 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes "unprognostic (3.90e-2)" "unprognostic (4.86e-2)" "unprognostic (6.48e-3)" "unprognostic (1.86e-1)" "unprognostic (5.15e-2)" "unprognostic (3.59e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.15e-2)" "unprognostic (1.19e-2)" "unprognostic (1.12e-3)" "unprognostic (4.83e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (5.74e-13)" "unprognostic (1.97e-1)" "unprognostic (1.64e-1)" "unprognostic (2.54e-2)" "unprognostic (4.53e-2)" 7.8 13.7 16.5 18.9 22.4 16.7 14.1 9.8 22.1 16.4 15.6 14.9 12.8 12.5 14.0 26.7 24.7 14.6 13.5 15.0 20.9 15.2 12.4 6.3 10.4 22.6 13.6 17.5 19.4 25.0 16.2 18.7 15.0 13.0 16.1 17.1 13.8 15.3 16.8 8.9 18.3 13.0 13.8 14.1 16.1 12.1 23.4 6.7 36.5 19.3 13.0 23.1 16.2 14.7 19.6 14.8 18.5 13.0 13.7 29.3 13.6 12.9 16.7 20.9 10.4 4.9 6.4 21.7 12.7 14.2 16.7 16.9 20.6 28.9 10.5 7.3 13.4 21.3 10.4 14.3 16.5 21.0 42.4 8.9 13.9 7.8 12.4 7.0 15.5 10.8 6.2 10.9 16.3 35.3 12.5 17.2 22.5 12.3 25.8 20.3 18.6 27.8 9.0 48.1 17.2 10.4 18.8 25.0 8.3 14.1 16.1 7.1 10.6 18.1 11.3 9.5 41.1 21.9 14.9 11.4 17.8 27.7 20.0 26.4 5.9 11.2 27.7 8.2 12.9 16.3 12.7 13.0 18.5 14.2 12.1 18.4 16.4 21.8 18.8 14.8 19.6 22.4 14.9 2.9 13.7 12.2 8.9 29.3 13.6 16.5 22.4 9.8 22.1 20.9 15.2 13.6 17.5 13.0 6.7 0.0 5.1 20.7 8.6 6.9 6.2 6.4 5.1 4.0 1.2 10.4 7.9 29.0 19.9 11.4 5.0 7.1 8.4 23.3 7.5 28.9 7.3 14.5 13.9 3.4 27.2 9.5 9.9 11.6 13.7 11.1 11.2 11.1 3.3 45.9 18.1 11.6 7.3 10.5 8.1 12.0 9.4 0.0 5.5 39.5 43.7 6.1 18.2 17.0 16.0 12.2 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11351762 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.7;testis: 29.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.0 1.8 4.2 18.0 5.1 4.8 2.8 0.7 4.1 2.8 7.3 1.0 0.4 4.3 2.5 3.2 11.8 1.0 2.6 1.9 2.5 1.5 3.1 2.3 2.9 17.9 1.6 5.6 3.6 1.6 0.7 1.1 13.2 1.2 2.6 9.0 0.8 2.9 1.7 1.1 8.7 5.6 1.1 1.4 4.2 4.0 29.6 1.2 31.7 1.4 2.8 20.4 3.6 4.5 6.5 0.6 0.9 0.0 0.3 3.0 0.3 19.2 12.9 25.4 10.8 1.1 5.5 10.6 11.2 8.9 10.6 17.7 4.9 22.9 26.7 9.7 5.2 12.0 11.3 10.8 10.7 17.3 5.2 10.1 14.6 7.6 32.6 0.4 5.6 6.6 1.2 2.1 4.6 4.4 4.2 5.8 11.8 20.1 21.3 5.5 22.2 19.3 26.2 21.3 26.9 5.1 23.5 27.4 28.5 6.3 12.5 14.6 11.6 9.5 15.9 8.3 15.3 27.0 8.4 1.8 8.5 8.0 16.3 1.6 5.8 9.6 31.7 7.9 18.5 15.7 0.0 0.0 0.9 0.6 0.0 0.0 6.5 0.2 0.0 0.4 2.5 1.8 0.7 0.2 0.3 0.0 0.6 3.0 0.3 4.2 5.1 0.7 4.1 2.5 1.5 1.6 5.6 1.2 1.2 0.0 0.3 4.9 6.4 6.1 0.1 0.8 5.1 0.0 2.3 7.0 0.0 100.7 5.0 2.3 2.2 0.7 1.1 23.3 0.4 27.0 2.6 1.6 0.0 0.8 15.8 0.0 2.4 1.3 1.0 4.3 14.7 3.4 3.3 1.8 5.9 0.0 1.1 3.5 40.0 0.0 0.5 32.3 0.9 31.4 42.9 4.6 39.9 0.0 7.0 2.8 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.7 17.5 16.4 19.3 16.2 12.8 17.4 17.2 18.6 20.1 15.9 29.5 33.2 14.0 23.8 20.4 30.5 28.8 23.2 25.9 12.6 16.6 12.8 36.8 8.2 24.3 12.4 15.4 15.3 13.3 13.3 25.0 22.6 13.2 15.2 21.7 17.8 22.0 13.8 34.5 14.1 16.0 16.4 18.3 22.4 14.7 16.8 11.1 12.3 11.5 11.7 11.3 13.9 17.6 4.6 16.5 39.9 12.9 10.0 24.3 16.2 12.7 15.6 5.3 8.6 0.1 8.1 26.1 18.9 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 3.0 6.5 9.0 12.0 6.2 9.1 0.5 28.1 2.7 7.9 10.4 2.0 31.3 5.0 17.7 3.4 7.5 10.0 0.0 15.0 54.3 13.5 11.2 7.0 19.8 18.0 4.8 13.2 8.6 9.9 4.9 13.0 8.8 1.7 12.6 10.2 9.7 11.8 10.2 16.6 10.3 7.6 6.5 10.3 12.2 8.3 7.4 20.4 9.6 14.5 8.6 RPL36AL RPL36A ENSG00000165502 "Ribosomal protein L36a like" Q969Q0 14 49618519-49620685 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA Yes "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (1.55e-2)" "unprognostic (2.44e-2)" "unprognostic (8.73e-2)" "unprognostic (3.15e-3)" "unprognostic (1.52e-1)" "unprognostic (2.55e-2)" "unprognostic (1.31e-1)" "unprognostic (6.37e-2)" "unprognostic (4.18e-2)" "unprognostic (1.38e-3)" "unprognostic (2.29e-1)" "unprognostic (4.72e-1)" "unprognostic (1.16e-3)" "unprognostic (8.32e-2)" "unprognostic (2.80e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.00e-1)" 60.3 55.8 45.9 46.5 40.9 68.2 66.5 35.9 37.7 69.3 74.3 29.2 56.6 52.1 54.9 102.1 61.8 45.9 31.5 48.2 38.0 34.4 69.9 139.2 54.8 63.6 45.3 34.1 105.3 131.9 35.7 62.0 56.9 40.3 62.9 50.5 30.8 85.2 68.6 82.4 40.8 99.8 71.1 48.0 78.8 61.8 36.7 41.8 65.4 72.5 67.6 71.0 87.6 63.9 105.8 112.7 119.5 66.7 84.5 132.0 139.8 73.4 55.4 40.1 23.2 57.7 79.8 23.5 60.7 67.1 56.9 64.5 57.6 50.9 96.9 57.9 50.2 40.1 53.0 34.0 51.8 66.6 33.2 39.2 60.7 58.5 74.3 73.1 96.9 52.2 81.6 79.4 43.5 58.8 67.6 72.0 43.8 38.5 86.3 43.7 94.8 57.0 87.0 22.5 52.9 57.0 36.1 63.1 51.9 86.3 111.8 35.1 21.7 53.4 42.4 60.8 39.8 91.8 53.9 55.4 35.7 56.8 46.4 46.7 52.6 53.7 97.8 25.8 43.9 33.9 119.5 66.7 99.6 98.6 63.2 132.0 105.8 129.3 123.0 68.7 79.9 120.7 112.6 74.0 84.5 55.9 112.7 118.2 139.8 45.9 40.9 35.9 37.7 38.0 34.4 45.3 34.1 40.3 41.8 285.9 358.6 508.2 1190.5 840.1 106.5 561.0 550.3 325.2 378.7 296.6 23.6 568.2 843.9 636.4 440.5 541.3 862.9 397.1 1188.0 608.8 559.0 968.4 688.3 743.7 689.7 76.3 351.4 449.9 649.0 160.8 672.0 707.1 799.7 1234.5 570.5 159.8 1112.3 813.6 502.0 790.1 95.2 478.6 799.2 285.3 135.9 733.7 431.8 698.8 483.1 1226.2 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS7 S7 ENSG00000171863 "Ribosomal protein S7" P62081 2 3575205-3580919 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056586 Approved Approved "Endoplasmic reticulum,Cytosol" NA Yes 1000000 "Endoplasmic reticulum, Cytosol" "HPA056586: AB_2683179" "unprognostic (3.28e-3)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.00e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.27e-4)" "unprognostic (6.41e-2)" "unprognostic (6.02e-3)" "unprognostic (7.08e-2)" "unprognostic (5.60e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.34e-8)" "unprognostic (3.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" 54.0 42.1 41.7 57.4 47.8 91.9 112.1 35.1 52.6 57.9 54.4 22.5 35.3 38.3 49.4 70.5 75.2 60.6 80.9 42.7 35.6 28.9 88.1 184.7 40.5 73.8 35.4 49.9 128.7 94.3 19.0 42.3 56.0 46.5 49.6 61.0 27.5 61.1 46.8 96.7 74.9 53.8 46.2 35.2 74.2 55.7 120.7 30.3 59.0 49.0 129.1 89.6 54.8 62.3 124.7 91.6 22.4 53.7 83.8 117.9 145.9 62.6 61.4 94.7 101.7 94.2 206.7 155.5 76.2 133.1 126.8 74.0 106.1 99.2 209.9 127.4 88.0 88.2 69.2 107.0 123.7 112.2 65.7 144.3 76.6 45.1 152.7 227.3 132.6 79.8 173.5 186.7 78.6 171.0 137.4 148.1 194.4 118.2 106.7 128.2 84.5 146.9 296.0 139.7 189.1 95.4 117.4 96.6 186.7 143.2 77.2 108.0 162.4 40.3 155.3 231.8 83.4 85.4 192.4 69.1 76.4 50.2 52.5 122.0 119.8 218.3 205.7 80.3 159.9 85.0 22.4 53.7 19.9 74.4 47.3 109.5 124.7 107.1 94.6 91.6 107.1 117.9 103.2 11.4 83.8 44.3 87.8 90.6 145.9 41.7 47.8 35.1 52.6 35.6 28.9 35.4 49.9 46.5 30.3 461.6 611.6 3582.6 3530.2 3485.1 365.6 144.4 1480.3 812.4 1235.2 614.1 306.3 3079.2 2208.3 1634.1 1148.8 1674.5 681.7 724.2 2971.3 4852.3 1818.6 2622.1 1119.4 1214.5 2053.4 133.5 1202.6 1662.2 2169.7 372.0 2710.8 2469.9 1898.0 2610.5 1831.6 516.1 2628.7 1420.3 1643.8 3007.3 556.0 1429.3 2159.8 1061.8 775.2 4415.0 3108.3 2545.2 2502.1 3299.7 RPS9 S9 ENSG00000170889 "Ribosomal protein S9" P46781 19 54200742-54249003 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 90.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 90.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048746 Approved NA Yes 1100000 "HPA048746: AB_2680510" "prognostic favorable (9.23e-4)" "unprognostic (1.11e-1)" "unprognostic (4.84e-2)" "unprognostic (1.15e-3)" "unprognostic (1.22e-2)" "unprognostic (2.82e-1)" "unprognostic (4.61e-2)" "unprognostic (3.12e-1)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (2.22e-1)" "unprognostic (9.45e-2)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" 51.9 40.6 32.5 68.3 25.6 74.8 80.3 18.2 28.1 52.1 63.8 29.5 48.3 42.3 89.9 51.1 80.4 38.9 80.4 47.4 27.5 22.2 40.4 60.5 48.3 114.8 31.8 22.9 98.2 188.8 15.2 27.1 33.1 22.4 58.7 30.2 34.0 106.3 47.5 74.5 65.1 41.6 59.4 35.5 65.5 67.0 41.5 19.4 67.3 71.4 85.0 62.9 59.5 79.4 13.1 15.7 90.3 20.0 7.4 13.9 23.9 22.1 8.6 14.2 23.1 28.5 47.0 16.9 30.4 26.9 21.8 17.4 10.5 21.6 72.3 23.7 20.4 11.8 25.1 34.3 22.8 17.4 25.7 42.2 32.5 7.9 11.4 20.2 42.3 18.0 43.1 35.8 17.7 31.2 27.5 33.0 26.9 36.7 26.8 17.2 5.1 37.5 25.1 29.2 20.3 10.0 27.2 24.1 37.8 23.8 17.3 16.7 29.0 17.8 33.7 29.4 11.4 30.2 47.7 38.2 12.1 22.6 19.7 40.5 25.4 49.1 43.7 17.8 36.5 19.6 6.2 20.0 17.1 8.8 9.3 11.7 11.9 11.7 9.2 13.1 13.1 13.9 11.1 90.3 7.4 4.6 15.7 7.5 23.9 32.5 25.6 18.2 28.1 27.5 22.2 31.8 22.9 22.4 19.4 425.8 944.9 3342.8 5052.7 5748.7 340.7 179.8 1582.2 559.4 998.6 840.9 164.9 2056.8 2108.8 1563.5 629.7 2076.8 1653.9 630.8 4888.9 3968.8 2619.1 3740.7 816.5 1809.4 2393.9 165.3 1899.5 1766.6 3230.1 1190.7 2659.9 3505.9 3114.3 2539.2 2869.7 472.8 2898.8 2433.8 1427.1 2466.8 447.6 1034.8 3377.6 475.1 482.9 6556.0 2066.0 2439.9 4056.1 4586.3 RRM1 ENSG00000167325 "Ribonucleotide reductase catalytic subunit M1" P23921 11 4094707-4138876 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Allosteric enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022093, HPA057265, HPA064297" Enhanced Supported Cytosol NA Yes 13000 Cytosol "CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236" "unprognostic (4.47e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-3)" "unprognostic (3.65e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.31e-2)" "unprognostic (3.43e-2)" "unprognostic (6.90e-2)" "unprognostic (1.06e-3)" "unprognostic (4.21e-2)" "unprognostic (6.88e-3)" "unprognostic (9.20e-3)" "unprognostic (6.16e-2)" "unprognostic (8.41e-2)" "unprognostic (9.93e-3)" 13.9 25.3 8.0 15.2 12.2 18.5 14.4 18.0 12.6 15.7 15.9 11.1 11.5 11.9 13.0 9.8 25.4 10.7 8.7 11.9 7.9 9.0 9.2 13.1 11.0 20.2 9.0 10.3 13.6 10.7 24.2 11.2 22.7 18.4 14.0 18.9 12.0 15.4 10.7 28.3 26.8 12.5 17.5 10.7 12.4 13.8 10.5 9.1 78.6 9.8 28.0 27.1 17.5 18.5 5.6 4.3 3.3 8.3 5.7 24.3 6.0 46.1 25.1 41.1 23.9 6.3 12.6 16.0 42.5 21.1 48.4 50.0 22.5 35.1 50.0 10.3 21.2 21.0 37.1 38.1 30.6 57.3 24.5 40.4 25.4 37.6 17.5 2.5 43.4 18.6 5.9 8.3 26.5 19.1 10.6 23.2 30.2 33.1 23.6 40.3 20.9 51.1 9.4 26.0 32.1 25.5 41.4 32.1 17.8 13.3 13.1 35.2 19.3 37.4 22.6 6.8 17.3 22.3 15.2 13.2 45.5 23.8 45.1 31.2 15.5 21.4 54.6 25.3 29.1 28.2 3.3 2.5 2.6 7.7 6.5 13.3 5.6 14.2 10.7 4.3 3.5 11.3 9.2 0.0 5.7 8.3 2.7 24.3 6.0 8.0 12.2 18.0 12.6 7.9 9.0 9.0 10.3 18.4 9.1 17.9 11.8 16.4 16.8 29.8 14.7 30.7 17.8 17.4 21.6 17.4 5.9 33.4 6.6 22.3 59.0 10.8 9.7 70.0 19.4 48.6 21.4 12.0 6.9 14.8 24.3 17.5 17.3 11.6 8.6 43.8 12.0 10.6 10.1 9.0 17.5 21.8 14.0 11.8 15.6 6.3 20.0 12.9 21.5 60.8 31.3 25.3 33.2 15.8 24.7 13.6 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" "Low cell line specificity" "Detected in many" HPA056994 Enhanced Supported Cytosol Yes Yes Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.5 17.9 25.4 17.4 2.2 4.1 25.1 48.3 24.0 34.5 37.6 29.9 14.1 27.1 6.7 15.1 35.0 14.5 41.0 24.9 42.3 60.8 15.8 52.3 17.2 26.3 0.1 38.7 25.1 1.5 0.5 42.2 3.6 5.7 27.9 21.0 21.9 80.5 42.9 22.3 42.7 20.8 20.5 30.4 21.0 32.2 55.4 18.6 17.0 22.5 25.1 20.7 39.7 28.2 4.9 11.0 15.2 6.9 9.7 26.5 38.5 19.8 67.7 52.3 41.0 55.4 18.8 32.9 38.0 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 3.0 1.0 2.2 1.0 9.3 0.0 1.2 2.5 5.3 1.2 0.0 0.0 5.4 1.7 0.5 3.0 0.3 2.6 93.5 0.0 192.1 3.6 1.1 5.7 1.7 40.1 0.0 0.0 5.5 5.9 5.7 0.3 3.5 0.0 0.0 7.9 0.0 0.5 0.0 0.4 1.6 0.0 0.0 0.3 5.2 44.5 1.4 40.7 7.2 13.0 2.0 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347124-100364834 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 300.1;Hepatocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 204.0;CAPAN-2: 141.3" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" No Yes "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: AB_2685154" "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (7.79e-5)" 245.0 21.3 59.8 11.4 32.7 5.5 94.0 12.7 83.9 5.3 10.8 63.6 0.1 21.4 3.7 7.0 13.4 1.7 18.3 109.2 61.5 43.4 5.0 130.8 32.2 23.1 65.1 23.6 12.7 6.1 7.7 1.5 5.3 34.5 24.4 10.1 4.5 24.9 3.7 2.4 3.4 6.1 4.6 130.0 4.2 5.9 12.2 35.4 1.4 2.0 6.9 5.4 3.7 5.0 2.0 5.3 0.2 3.3 2.9 5.1 2.1 31.0 28.6 61.1 41.9 204.0 117.7 12.5 3.3 73.7 8.0 42.8 24.6 141.3 13.1 2.6 7.8 36.6 55.6 33.6 119.4 7.0 4.4 13.9 7.3 18.2 49.2 39.4 10.2 8.0 64.0 36.2 31.1 54.8 21.6 15.2 29.1 20.4 40.1 3.2 48.6 11.6 12.2 21.2 9.1 8.2 5.4 22.6 41.1 34.9 34.9 3.8 14.7 6.6 31.2 64.1 18.5 35.0 22.0 6.0 0.8 9.5 0.7 6.8 11.2 6.0 20.2 14.6 32.0 5.1 0.0 1.5 0.0 3.0 3.3 5.1 1.3 1.2 1.6 5.3 2.0 1.0 2.9 0.2 2.9 0.0 3.0 0.0 2.1 59.8 32.7 12.7 27.9 61.5 43.4 65.1 23.6 34.5 35.4 50.6 300.1 34.7 3.9 3.3 4.0 2.9 35.7 9.4 23.9 0.0 5.9 2.0 0.0 12.5 52.9 9.3 13.7 0.0 59.1 53.1 9.3 26.0 5.8 153.5 29.3 25.4 24.8 41.7 97.6 68.6 3.4 8.2 55.6 17.2 15.7 11.8 21.6 2.9 1.4 3.8 4.7 0.0 4.4 0.9 1.1 1.9 14.5 5.2 16.8 3.5 SCLT1 "FLJ30655, hCAP-1A" ENSG00000151466 "Sodium channel and clathrin linker 1" Q96NL6 4 128864921-129093607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.0" "Group enriched" "Detected in all" 4 "granulocytes: 31.0;monocytes: 13.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036560, HPA036561" Approved NA Yes "HPA036560: AB_2675190, HPA036561: AB_10673658" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (5.05e-2)" "unprognostic (9.18e-2)" "unprognostic (1.33e-3)" "unprognostic (1.64e-2)" "unprognostic (1.94e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-1)" "unprognostic (3.09e-2)" "unprognostic (5.34e-4)" "unprognostic (6.54e-2)" "unprognostic (2.70e-1)" "unprognostic (6.05e-2)" "unprognostic (8.92e-2)" 7.4 6.5 8.5 16.5 10.5 25.0 7.1 11.8 10.6 6.9 7.1 9.7 9.8 7.8 9.5 7.2 8.3 6.8 9.1 8.1 8.9 8.0 5.5 6.7 11.6 14.9 7.8 5.2 10.8 7.5 7.6 10.3 8.9 9.3 5.5 8.6 9.7 6.0 8.8 3.6 6.5 8.3 8.4 8.9 14.5 6.8 8.9 7.9 24.3 6.8 6.0 11.9 9.2 7.6 2.0 4.5 31.0 13.3 5.0 2.2 3.1 11.7 3.4 11.9 8.4 4.1 6.7 6.6 10.2 9.0 11.1 10.1 3.5 11.0 10.4 6.6 5.7 7.8 4.7 7.7 7.4 11.6 23.2 6.2 13.7 7.0 3.9 5.7 16.0 11.0 4.2 2.8 8.8 8.9 5.5 8.6 5.7 15.1 26.1 9.5 5.5 13.0 8.0 5.4 8.7 6.4 7.5 11.9 6.5 7.0 3.4 17.8 5.3 8.0 7.2 6.7 5.6 4.2 6.7 7.9 9.4 11.5 12.2 13.5 12.5 9.3 17.8 5.1 18.0 14.3 6.5 8.1 16.1 2.2 11.2 1.4 2.0 1.4 1.7 4.5 2.0 1.5 1.8 31.0 5.0 13.3 2.3 2.1 3.1 8.5 10.5 11.8 10.6 8.9 8.0 7.8 5.2 9.3 7.9 11.9 9.8 11.7 7.9 9.8 14.3 18.9 15.3 21.4 12.5 1.8 27.5 10.1 3.3 4.8 43.1 9.5 6.4 0.0 5.5 17.2 10.6 3.1 11.5 1.5 11.6 15.9 5.2 7.4 14.9 34.6 10.0 14.5 8.5 8.2 6.2 7.7 6.6 7.2 8.5 2.7 22.2 12.9 13.1 16.6 11.1 12.2 7.8 21.5 8.3 4.8 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43802589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 78.4 109.1 61.4 103.2 58.1 110.6 115.0 33.0 45.9 71.2 107.6 45.1 99.7 59.2 65.1 121.7 109.6 60.0 128.9 166.4 56.1 48.2 97.5 153.1 79.7 81.4 72.9 42.6 51.8 125.4 23.5 62.5 102.9 89.4 84.7 87.6 63.0 134.3 106.7 98.7 59.9 86.4 68.5 66.7 79.5 79.5 65.5 45.8 77.0 122.5 116.7 82.9 84.8 116.3 146.1 259.3 225.7 218.7 91.4 142.8 413.5 34.8 58.0 43.3 59.0 150.7 111.1 33.4 62.2 78.0 40.5 51.9 74.4 35.1 18.1 51.6 106.7 53.7 46.4 33.8 46.7 20.3 49.5 40.1 43.7 84.4 142.7 73.9 40.7 94.4 104.9 60.6 32.8 35.2 63.3 59.0 51.4 45.0 119.6 79.4 106.8 52.0 96.5 36.9 136.5 67.6 53.4 28.7 83.0 110.5 127.6 32.5 35.0 33.3 140.1 31.8 39.2 117.3 174.4 49.9 69.4 35.4 104.1 45.4 44.2 59.2 125.6 74.8 74.1 71.8 127.3 218.7 225.7 113.6 194.5 103.1 142.2 125.7 116.0 185.9 146.1 116.7 118.3 129.1 91.4 166.0 259.3 142.8 413.5 61.4 58.1 33.0 45.9 56.1 48.2 72.9 42.6 89.4 45.8 470.5 717.5 1171.8 1145.4 1022.8 54.4 1942.2 1490.4 1019.8 757.5 1647.0 51.1 2342.3 3302.5 1581.0 331.8 1228.3 2242.3 817.7 1967.3 2747.0 1831.7 2360.8 754.3 2534.0 3171.2 44.5 1122.7 1502.0 1926.7 193.3 1134.5 1999.7 1724.2 2939.6 2776.8 318.1 1792.5 2080.9 932.7 3520.7 108.9 595.0 1152.9 641.0 342.8 1360.5 2739.6 1068.3 1696.1 2044.0 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200583782 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.6;lymphoid tissue: 25.7;testis: 27.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: AB_2677149" "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 5.3 1.7 1.5 8.6 2.3 5.3 3.5 4.0 3.1 1.6 2.7 0.7 0.3 2.1 1.6 1.0 3.7 1.6 1.3 1.4 1.9 1.5 1.8 1.0 1.9 6.5 2.7 3.7 2.2 1.2 1.1 0.9 2.2 3.2 1.4 2.9 0.1 1.7 1.5 1.0 2.0 2.8 1.7 3.5 3.9 1.7 27.9 2.3 25.7 1.5 4.1 7.0 2.0 1.8 3.8 2.1 12.6 1.9 2.4 4.2 1.4 15.7 7.4 17.9 8.0 2.4 3.9 11.1 18.1 7.6 15.6 15.7 11.4 10.7 10.3 8.5 8.6 16.5 11.8 15.7 9.4 26.7 20.6 7.8 19.4 10.7 8.1 0.7 20.2 15.7 1.5 1.1 15.7 8.1 3.8 13.8 14.7 14.9 15.2 29.5 7.0 16.2 8.3 12.7 11.2 18.5 12.8 23.6 9.4 6.5 6.2 10.5 7.2 13.3 6.5 7.9 15.1 6.9 11.9 8.3 16.4 16.3 15.0 15.8 6.9 14.4 22.4 10.3 13.6 23.4 12.6 1.8 5.1 2.8 1.7 1.9 3.0 3.2 2.8 1.0 3.8 2.4 3.0 1.3 2.4 1.9 2.1 4.2 1.4 1.5 2.3 4.0 3.1 1.9 1.5 2.7 3.7 3.2 2.3 3.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 14.7 11.4 0.0 0.0 3.2 3.3 3.1 0.0 0.0 0.0 0.0 2.3 24.6 0.0 0.0 10.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 2.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 SH3RF2 "FLJ23654, Hepp1, POSHER, PPP1R39, RNF158" ENSG00000156463 "SH3 domain containing ring finger 2" Q8TEC5 5 145936579-146081791 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 7204.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basal ganglia: 11.5;cerebral cortex: 2.9" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "dendritic cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2" "Region enriched" "Detected in single" 14 "basal ganglia: 23.9" "Region enhanced" "Detected in some" "basal ganglia: 14.5" "HPA035903, HPA058119" Uncertain Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA035903: AB_10696515, HPA058119: AB_2683611" "unprognostic (8.90e-3)" "unprognostic (2.00e-3)" "unprognostic (5.11e-3)" "unprognostic (1.66e-2)" "unprognostic (1.45e-3)" "unprognostic (1.47e-2)" "unprognostic (9.96e-3)" "unprognostic (8.22e-2)" "unprognostic (3.92e-1)" "unprognostic (7.37e-3)" "unprognostic (2.44e-3)" "unprognostic (1.66e-1)" "unprognostic (2.98e-2)" "unprognostic (5.21e-2)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.13e-3)" 2.6 0.6 1.2 6.2 11.5 0.0 2.9 0.2 2.9 6.4 19.1 0.4 0.4 9.2 2.9 2.2 22.2 3.6 40.8 23.5 0.8 0.3 0.8 4.6 1.9 0.0 0.3 1.1 1.0 14.3 0.0 3.3 0.3 0.1 2.2 8.5 0.9 16.9 1.0 21.7 33.1 21.4 1.2 0.5 0.2 11.9 6.4 0.6 0.6 3.8 19.6 16.1 0.9 10.0 0.0 1.4 0.3 0.1 0.0 1.6 0.3 10.2 2.8 0.1 0.6 0.0 0.0 0.0 0.1 0.8 2.1 0.8 34.6 9.5 0.0 5.4 0.4 15.3 9.5 0.0 11.2 2.0 0.1 0.1 0.0 4.1 4.6 0.6 0.0 0.0 0.1 6.0 3.2 7.6 17.2 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.8 8.5 0.7 0.0 0.1 0.0 4.4 1.0 0.0 0.0 0.6 0.2 0.2 0.5 3.3 0.0 4.9 0.4 8.9 0.7 3.3 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.7 1.4 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.8 0.3 1.2 11.5 0.2 2.9 0.8 0.3 0.3 1.1 0.1 0.6 14.9 2.9 0.0 4.5 48.9 0.6 414.9 2.5 2.7 2.3 1.8 0.0 0.0 0.0 6.5 1412.5 1.5 27.7 0.0 7.6 0.0 0.5 1.3 1.1 8.3 0.2 0.0 1.2 0.6 0.0 7204.3 23.9 0.0 8.5 1.0 12.2 1.9 13.6 17.5 32.5 0.6 0.0 12.9 1.4 32.0 16.2 43.7 0.0 0.0 27.1 6.4 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46580554-46621626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 1.5 0.8 1.0 17.3 3.0 18.9 0.9 2.4 1.3 0.8 2.2 0.6 0.3 1.3 1.5 2.0 5.7 0.4 1.1 1.5 1.0 0.7 5.0 0.3 1.7 11.2 0.7 0.7 1.2 0.3 0.2 0.8 2.8 0.7 0.9 2.5 0.3 2.6 0.3 1.4 3.8 2.3 1.9 1.1 9.9 1.4 14.1 0.9 22.9 0.6 3.0 12.9 2.0 1.6 4.6 2.0 1.8 5.4 0.3 3.4 2.1 15.3 16.4 6.2 7.5 1.3 3.2 8.6 31.4 12.4 30.7 14.3 7.8 10.1 13.5 14.2 14.3 12.4 10.2 13.6 10.2 38.0 8.6 9.1 14.8 12.4 13.2 0.0 13.0 18.9 0.6 0.6 22.5 9.2 3.0 16.0 7.1 6.1 14.3 33.3 10.2 11.6 10.8 4.8 7.2 17.5 21.2 41.6 21.6 6.3 4.8 2.6 3.4 21.7 11.5 4.9 5.6 6.3 10.7 9.2 22.5 14.6 21.7 24.9 11.3 14.9 21.6 10.3 14.0 22.6 0.3 0.8 1.8 0.5 1.3 0.1 4.6 0.8 0.4 1.2 1.9 0.1 0.3 0.8 0.3 5.4 2.0 3.4 2.1 1.0 3.0 2.4 1.3 1.0 0.7 0.7 0.7 0.7 0.9 0.0 1.4 0.0 0.5 1.4 0.2 1.4 2.5 0.0 2.3 0.0 0.0 3.1 0.0 0.3 6.4 0.3 0.4 0.0 0.0 24.1 1.0 0.4 0.0 0.0 10.7 0.0 0.0 2.5 2.9 1.5 0.6 3.9 1.7 2.8 0.2 1.0 0.1 0.0 0.4 0.0 0.3 0.0 0.5 27.0 30.1 0.5 3.1 0.7 0.6 0.9 SKA1 "C18orf24, MGC10200" ENSG00000154839 "Spindle and kinetochore associated complex subunit 1" Q96BD8 18 50374995-50394173 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.5;testis: 28.0" "Cell type enhanced" "Detected in some" 14 "Erythroid cells: 23.3;Extravillous trophoblasts: 8.2;Spermatocytes: 15.8;Spermatogonia: 8.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 31.2" "Not detected" "Not detected" HPA045495 Approved Supported Microtubules NA Yes Microtubules "HPA045495: AB_10960405" "unprognostic (2.18e-2)" "unprognostic (7.85e-3)" "unprognostic (7.66e-3)" "unprognostic (5.93e-3)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (9.60e-8)" "unprognostic (1.03e-3)" "unprognostic (1.16e-2)" "unprognostic (1.20e-2)" "unprognostic (1.18e-4)" "unprognostic (3.91e-3)" "unprognostic (0.00e+0)" "unprognostic (4.50e-3)" "unprognostic (4.66e-2)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" 1.3 1.5 0.3 6.3 0.3 12.1 1.5 2.2 0.5 1.2 1.9 0.1 0.0 1.7 0.5 0.8 6.1 0.3 1.1 0.4 0.5 0.4 0.6 0.8 1.3 5.2 0.5 0.4 0.4 2.8 0.1 0.3 3.3 0.4 0.4 2.8 0.2 1.2 0.0 0.6 1.5 2.0 1.4 1.0 4.4 1.5 28.0 0.0 27.5 0.4 5.9 8.7 0.9 1.6 2.1 0.6 2.5 0.9 1.7 1.9 1.1 9.9 3.9 6.4 6.2 0.5 0.9 3.8 11.1 4.7 13.0 12.9 6.5 3.6 8.9 2.9 3.4 9.1 8.9 9.1 4.5 12.3 12.5 3.1 10.7 3.1 6.8 1.1 17.0 10.7 0.5 0.4 11.2 6.6 1.0 7.3 10.8 13.6 31.2 10.6 3.5 12.0 3.8 4.7 2.7 3.1 5.9 8.2 8.7 2.5 1.1 5.5 3.5 6.7 3.5 5.1 5.2 5.0 5.9 3.9 13.0 7.1 4.5 11.8 13.5 21.7 15.2 5.7 13.9 11.0 1.9 0.9 0.5 0.9 0.4 0.6 1.7 1.2 1.9 0.5 2.1 0.7 0.8 2.5 1.7 0.5 0.6 1.5 1.1 0.3 0.3 2.2 0.5 0.5 0.4 0.5 0.4 0.4 0.0 0.0 2.1 0.8 0.1 0.9 0.3 0.3 0.0 0.0 1.2 0.0 2.0 0.9 0.0 0.1 2.7 0.3 0.0 23.3 0.0 8.2 0.4 0.3 0.0 0.0 4.4 0.0 1.2 1.3 0.3 1.5 0.3 0.3 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.6 0.0 0.0 15.8 8.6 0.3 1.3 1.3 1.0 0.7 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle, Centrosome" Cytosol "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.3 6.0 10.8 9.1 0.0 2.3 8.5 15.3 6.5 19.4 13.2 9.8 12.2 15.5 4.6 8.4 8.3 10.7 14.4 6.2 21.2 13.3 7.4 20.6 3.9 5.6 0.0 16.0 8.0 0.4 0.4 15.5 5.2 1.8 9.4 13.2 10.7 6.6 12.8 8.8 24.3 14.4 12.5 17.2 11.2 16.0 23.2 7.2 4.3 4.4 13.8 5.1 5.1 8.0 3.2 7.5 7.1 12.3 3.8 7.7 11.1 7.1 18.4 4.0 8.5 15.6 1.9 12.5 22.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 0.0 0.0 2.2 0.5 1.8 0.0 0.6 0.0 2.7 2.3 0.0 0.0 1.3 0.0 0.9 5.1 0.8 0.2 0.0 1.2 19.6 0.8 0.4 0.0 0.2 4.6 0.0 0.0 2.5 1.9 6.0 1.4 2.2 0.0 1.0 0.3 0.2 0.6 0.9 1.1 0.3 0.0 0.0 0.9 18.7 13.5 2.5 1.8 1.0 2.7 0.1 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SLC9A3R1 "EBP50, NHERF, NHERF1" ENSG00000109062 "SLC9A3 regulator 1" O14745 17 74748652-74769353 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Wnt signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 372.3;Proximal tubular cells: 352.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 78.7;SK-BR-3: 64.2;T-47d: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001962, HPA009672, HPA027247" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" NA Yes 9600000 "Plasma membrane" "Vesicles, Centriolar satellite" "CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162" "unprognostic (1.29e-1)" "unprognostic (4.58e-2)" "unprognostic (1.73e-2)" "unprognostic (5.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (7.41e-2)" "unprognostic (5.61e-2)" "unprognostic (5.38e-2)" "unprognostic (7.53e-2)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (7.81e-3)" "unprognostic (5.53e-2)" "unprognostic (3.84e-2)" "unprognostic (2.08e-2)" 5.4 33.3 19.8 9.9 23.3 22.6 15.2 21.9 15.1 12.5 30.6 15.2 35.9 57.6 5.4 12.0 74.3 20.5 30.8 5.6 14.2 8.8 36.1 64.9 8.6 13.5 14.3 14.0 5.0 26.5 12.5 4.9 8.3 12.8 10.1 13.4 22.9 41.8 23.3 1.5 11.2 73.3 3.1 12.1 13.8 14.8 5.4 14.1 18.4 5.6 24.3 30.3 7.1 20.3 9.8 14.3 72.7 24.8 45.1 70.4 44.3 13.9 11.5 5.7 5.9 3.5 2.5 25.9 3.3 3.1 8.6 8.4 36.0 8.4 3.0 3.4 7.1 4.6 20.1 9.8 6.5 4.1 3.7 9.4 23.0 31.1 47.9 7.1 15.0 15.6 2.1 3.6 6.8 2.9 18.0 7.1 9.2 7.3 16.5 13.2 78.7 35.3 33.7 5.1 39.5 6.8 3.8 6.5 13.9 11.9 10.0 4.9 6.5 3.5 64.2 7.2 16.6 124.2 12.0 2.3 2.7 7.8 6.3 5.5 28.6 12.9 5.6 4.3 20.0 1.5 72.7 14.1 65.3 70.4 20.6 46.6 9.8 43.2 59.3 13.7 8.6 25.5 45.2 50.3 45.1 24.8 14.3 47.0 44.3 19.8 23.3 21.9 15.1 14.2 8.8 14.3 14.0 12.8 14.1 6.0 18.8 36.3 18.8 41.0 1.9 14.9 206.4 41.5 14.8 29.6 3.9 67.4 56.3 154.8 9.9 11.7 372.3 0.0 86.0 43.0 16.6 31.5 24.3 159.6 66.7 4.8 18.0 4.9 23.7 8.2 8.1 24.4 27.0 7.2 41.8 82.0 78.1 101.7 39.3 352.2 4.7 6.5 14.4 6.0 20.7 50.2 93.3 101.5 27.5 31.5 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434962 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 332.4;Spermatogonia: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (4.20e-5)" "prognostic unfavorable (9.00e-4)" "prognostic unfavorable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 4.8 5.5 3.0 25.4 4.4 15.1 4.0 3.1 3.2 5.3 10.1 1.7 5.3 6.5 5.2 4.9 19.3 4.6 7.0 5.7 2.4 1.7 4.4 6.3 7.9 16.5 3.1 1.3 4.7 4.2 1.7 10.8 7.4 2.6 4.4 6.9 2.7 5.7 6.9 5.9 4.6 7.0 6.2 3.1 13.1 5.7 20.7 3.2 70.2 5.1 7.6 14.3 7.8 6.3 8.8 6.1 30.5 7.6 7.8 15.8 4.8 63.3 11.7 26.7 12.3 5.1 5.2 12.3 31.6 14.9 36.6 31.7 14.8 36.5 40.1 18.5 13.0 24.3 36.6 30.3 15.3 58.8 53.1 21.1 38.8 20.1 4.7 2.8 25.7 31.8 2.6 2.2 19.3 15.8 13.3 15.5 17.1 22.3 46.7 21.8 11.4 31.5 6.4 15.7 15.7 27.6 32.0 41.9 29.1 6.8 7.9 16.1 16.7 24.1 22.3 11.0 13.1 26.8 19.2 14.6 23.4 19.6 21.3 57.6 31.2 31.8 73.2 16.8 26.4 25.9 30.5 3.2 12.1 6.7 4.7 6.5 8.8 10.5 8.0 3.5 7.2 6.7 6.0 5.7 7.8 7.6 6.1 15.8 4.8 3.0 4.4 3.1 3.2 2.4 1.7 3.1 1.3 2.6 3.2 98.3 146.6 24.2 16.6 36.2 14.2 31.9 22.9 32.1 44.3 33.2 7.9 29.7 3.3 18.2 26.7 45.6 21.1 116.8 12.6 126.9 41.4 11.7 76.3 15.6 51.1 0.0 28.9 39.3 26.0 21.5 23.3 45.4 16.9 37.9 24.6 9.8 11.3 20.1 45.3 6.2 24.1 129.4 30.3 332.4 238.9 31.1 28.5 48.4 46.6 17.6 SMCO4 "C11orf75, FN5" ENSG00000166002 "Single-pass membrane protein with coiled-coil domains 4" Q9NRQ5 11 93478472-93543508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 124.3" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041120 Uncertain NA Yes "HPA041120: AB_2677309" "unprognostic (7.45e-2)" "unprognostic (1.70e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-1)" "unprognostic (6.47e-2)" "unprognostic (8.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.43e-1)" "unprognostic (5.51e-1)" "unprognostic (4.23e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (5.81e-7)" "unprognostic (1.61e-1)" "unprognostic (3.05e-1)" "unprognostic (1.55e-2)" "unprognostic (5.01e-2)" 6.1 19.0 4.3 10.0 7.3 1.6 6.2 2.5 4.5 5.0 10.6 4.5 11.5 16.1 5.4 4.6 5.5 9.4 9.3 13.4 4.5 7.9 10.9 33.5 9.0 9.1 6.2 4.0 6.4 17.9 1.1 15.7 3.5 5.7 13.1 8.0 6.0 124.3 10.3 6.2 5.5 21.2 4.8 5.0 16.7 12.2 9.9 4.5 5.4 34.3 3.1 8.6 3.7 5.1 4.2 29.7 11.4 57.3 5.6 5.4 15.7 3.3 6.3 9.3 2.7 3.5 5.5 6.2 9.1 2.6 4.3 7.8 11.2 14.6 9.1 11.3 8.4 6.4 1.9 8.5 1.1 2.5 25.6 7.7 2.2 11.8 25.7 3.6 8.8 11.3 5.4 5.1 2.0 1.6 4.9 7.0 32.0 5.3 49.1 1.4 7.0 8.9 17.4 9.9 25.4 9.3 17.2 5.9 4.6 7.9 8.3 1.5 7.9 7.5 11.0 0.7 11.7 4.3 12.2 3.9 4.5 16.8 15.0 8.2 1.9 0.2 7.1 3.3 17.2 1.7 6.8 51.3 1.2 0.8 57.3 3.5 4.2 5.4 1.5 28.8 3.0 0.7 0.6 11.4 5.6 52.1 29.7 2.0 15.7 4.3 7.3 2.5 4.5 4.5 7.9 6.2 4.0 5.7 4.5 23.8 20.2 13.7 30.3 29.1 1.9 27.1 56.0 8.1 15.9 47.1 0.0 3.7 179.1 29.8 88.0 22.2 95.7 0.0 61.8 8.5 23.4 137.8 2.3 84.7 133.0 3.2 43.1 12.9 81.9 100.6 11.8 67.0 28.7 35.1 107.8 4.5 39.2 115.8 9.9 48.8 1.4 6.5 11.8 5.9 41.5 18.6 4.0 10.2 59.6 20.7 SMTN ENSG00000183963 Smoothelin P53814 22 31064105-31104757 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 99.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 267.0;Ito cells: 149.1;Sertoli cells: 181.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001721, HPA051778, HPA058590" Enhanced Supported "Nucleoplasm,Actin filaments" No Yes 11000 Nucleoplasm "Actin filaments" "CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765" "unprognostic (1.36e-2)" "unprognostic (4.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (1.08e-3)" "unprognostic (2.05e-2)" "unprognostic (4.56e-1)" "unprognostic (2.15e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (2.75e-2)" "unprognostic (1.84e-1)" "unprognostic (8.41e-3)" "unprognostic (6.34e-2)" 17.4 3.3 5.0 8.3 3.8 1.5 13.2 12.7 4.7 34.3 99.3 2.0 7.5 10.3 72.4 12.5 26.4 23.5 32.5 27.6 4.3 1.3 7.0 4.7 9.1 1.7 3.6 2.2 18.2 6.8 1.3 2.0 6.0 5.3 34.5 10.6 14.9 4.6 66.7 28.8 6.4 20.3 91.7 1.7 16.9 36.7 6.2 4.0 1.8 5.1 16.8 2.2 61.3 21.4 4.1 1.3 0.3 2.8 0.3 3.1 1.9 19.9 6.0 2.0 7.7 3.2 5.0 16.6 30.0 14.0 24.7 16.9 8.4 6.4 8.9 2.7 16.5 5.0 2.9 2.0 17.7 11.7 2.9 16.5 9.5 4.8 9.9 2.8 14.0 16.6 4.1 1.6 32.7 5.4 8.4 21.2 3.4 10.1 7.4 16.9 17.9 1.6 3.1 2.3 10.0 25.5 5.5 5.9 9.4 9.9 6.5 3.2 3.6 9.4 4.5 4.4 2.2 5.3 2.2 33.4 18.2 17.2 17.0 22.2 7.1 8.6 5.2 26.4 5.5 56.8 0.0 2.8 0.0 0.5 0.7 0.2 4.1 0.5 1.2 1.3 0.2 3.1 1.7 0.3 0.3 0.7 0.7 0.1 1.9 5.0 3.8 12.7 4.7 4.3 1.3 3.6 2.2 5.3 4.0 6.0 3.5 0.8 24.1 57.9 30.5 32.0 5.1 1.4 2.3 8.7 267.0 9.1 8.3 12.2 0.7 45.4 5.1 0.0 17.0 57.4 41.7 20.3 0.0 2.0 5.1 4.8 28.0 149.1 9.2 1.3 20.8 4.5 13.5 1.0 23.0 35.7 47.3 10.5 45.6 18.6 46.9 181.1 111.4 6.5 5.1 60.6 18.3 3.1 23.8 13.4 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.5 10.3 12.5 13.5 7.3 6.7 3.3 6.6 7.2 9.5 5.6 4.1 1.2 3.3 2.5 11.6 8.2 10.2 10.0 6.2 10.0 0.5 2.0 5.4 9.6 5.4 3.8 1.2 5.3 3.8 7.6 9.0 6.4 4.1 6.1 3.7 3.8 0.7 10.3 7.3 3.8 2.8 3.2 0.8 8.0 9.0 11.7 1.3 5.5 2.3 15.0 9.4 13.8 15.2 4.4 5.8 19.3 8.1 9.3 23.8 4.6 11.6 14.4 1.4 0.3 3.4 10.1 1.6 15.0 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 0.0 2.6 1.4 4.8 11.2 18.8 12.1 0.0 2.7 7.9 19.2 35.3 12.5 1.7 3.4 0.4 10.5 1.7 0.0 1.3 8.6 11.0 5.2 10.4 0.2 8.5 22.3 5.8 9.8 5.3 1.5 11.2 6.0 5.0 1.0 1.3 19.4 1.8 0.0 17.7 1.2 3.7 12.9 11.3 0.7 1.0 14.1 2.7 1.0 2.5 2.5 SOX4 ENSG00000124766 "SRY-box 4" Q06945 6 21592768-21598619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.8" "Group enriched" "Detected in all" 4 "dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2" "Region enriched" "Detected in many" 4 "olfactory region: 66.5" "Low region specificity" "Detected in many" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 4.2 0.7 2.0 1.9 0.9 6.0 6.3 3.0 6.3 6.7 2.8 3.0 18.0 4.1 2.3 4.2 5.5 2.0 1.1 1.8 4.3 1.3 5.1 0.8 0.6 18.1 5.3 0.0 1.8 1.0 4.1 3.7 9.6 1.4 0.3 4.1 2.7 4.9 0.3 1.0 4.4 2.5 3.4 1.4 6.2 3.6 3.1 21.8 12.8 10.0 3.3 1.1 2.0 1.8 5.2 13.3 55.4 4.9 1.2 21.7 0.8 1.7 1.0 0.9 3.5 3.5 0.6 22.2 1.3 0.7 5.4 6.9 3.8 0.7 7.6 14.5 0.5 2.4 2.3 0.8 1.8 0.4 2.1 3.9 0.4 1.6 14.2 15.6 30.0 0.1 0.0 1.1 4.3 47.6 4.5 9.9 2.6 5.0 21.0 1.1 0.0 9.6 16.7 17.4 31.2 7.7 9.0 2.9 17.3 4.4 6.5 11.9 1.5 5.2 0.3 3.9 0.3 0.0 15.4 0.5 6.5 6.1 12.8 9.8 0.9 0.2 5.5 0.0 2.8 0.1 0.1 4.1 3.1 1.1 0.8 0.4 3.3 10.0 21.8 0.9 2.0 184.6 59.8 33.5 82.0 99.9 88.8 228.6 341.4 161.9 235.4 146.5 11.8 61.5 56.3 757.4 3.9 238.0 78.0 0.0 523.0 358.6 243.9 126.1 56.8 5.8 33.0 46.1 327.2 70.6 85.2 8.3 11.2 56.1 231.2 80.2 156.9 228.7 1059.7 155.6 10.6 77.4 25.8 6.5 198.6 3.7 175.2 81.3 25.3 23.5 265.6 178.0 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599279 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3;testis: 94.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 101.5;Spermatocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 10.1;T-reg: 6.2" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" NA Yes "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.1 1.1 2.3 7.6 3.8 16.5 1.7 2.7 3.4 1.7 5.1 0.8 0.5 3.9 2.0 1.9 3.8 0.5 1.8 1.7 1.8 3.7 12.7 9.5 2.6 6.5 1.5 0.7 1.4 1.9 0.4 1.9 3.3 1.3 1.3 5.3 1.3 1.4 0.9 0.8 2.5 7.1 1.5 1.9 5.8 1.7 94.2 1.0 27.3 3.9 5.5 11.2 1.8 1.3 1.2 0.4 10.1 0.7 1.0 6.2 1.2 23.8 25.3 30.3 23.5 1.5 2.5 12.4 19.3 12.2 28.7 23.2 19.7 7.3 16.8 10.5 13.4 27.0 20.8 32.9 12.2 30.7 30.2 21.1 17.8 25.2 23.9 0.2 23.1 22.5 0.8 1.1 23.1 12.0 4.2 15.0 26.2 19.2 29.7 23.3 15.7 30.4 27.5 16.3 19.2 12.8 20.3 42.2 20.0 8.6 12.7 23.0 13.5 27.7 33.4 9.6 26.1 23.8 21.2 7.4 16.6 27.9 13.7 32.9 13.8 21.1 25.9 11.2 17.7 26.4 10.1 0.0 0.3 0.6 0.7 1.1 0.9 1.8 1.3 0.1 1.2 1.5 1.4 0.6 1.0 0.4 0.4 6.2 1.2 2.3 3.8 2.7 3.4 1.8 3.7 1.5 0.7 1.3 1.0 3.0 1.7 2.2 1.1 1.8 4.7 0.4 0.0 10.7 2.3 0.0 0.0 1.7 1.7 0.5 101.5 1.0 6.2 23.3 0.3 10.6 1.1 0.6 1.1 3.9 5.3 3.2 12.5 4.3 1.8 14.4 0.9 3.6 0.0 1.0 2.3 0.6 0.3 0.8 0.0 10.9 3.3 6.5 1.7 43.6 23.0 0.9 3.2 2.5 2.7 0.5 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24, NDC80 kinetochore complex component" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.0" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 2.8 3.2 1.1 9.0 1.0 19.4 3.8 0.4 1.9 2.8 4.0 0.8 0.9 3.5 2.2 2.8 8.4 1.4 2.4 8.2 1.0 0.4 1.8 2.6 4.2 4.9 0.6 1.0 1.1 1.0 0.1 1.0 5.9 0.6 1.4 3.5 0.8 2.4 1.5 2.7 3.2 4.4 6.7 0.7 5.5 4.0 13.3 0.7 58.0 0.9 12.8 12.2 2.3 3.2 1.9 1.3 7.2 1.4 4.2 3.7 0.7 26.2 9.9 13.7 11.1 1.9 3.6 6.2 15.4 5.7 14.6 16.6 10.4 9.0 20.8 17.6 6.8 8.5 14.3 10.6 11.0 10.8 11.0 9.1 28.0 23.0 15.4 0.4 19.6 12.5 0.7 0.4 10.4 4.8 3.8 12.8 23.0 14.9 43.9 10.1 17.3 26.7 11.9 9.6 7.3 16.0 21.4 21.0 6.7 4.3 8.7 14.3 10.3 13.5 8.4 3.6 6.8 8.3 7.1 12.1 13.8 14.7 18.5 18.4 26.8 13.8 20.0 10.2 19.4 11.2 4.1 1.4 1.5 1.4 1.2 1.2 1.9 2.3 3.4 0.5 1.9 2.7 1.7 7.2 4.2 1.3 1.3 3.7 0.7 1.1 1.0 0.4 1.9 1.0 0.4 0.6 1.0 0.6 0.7 0.0 0.3 0.0 0.8 1.0 0.0 7.0 2.5 0.0 1.2 5.2 5.9 3.0 0.0 0.2 0.1 0.1 0.7 70.0 0.0 13.5 4.0 0.3 5.7 0.0 11.2 0.0 2.4 2.5 2.8 1.7 0.6 1.3 0.0 0.0 1.1 0.9 0.2 0.0 0.4 0.4 0.3 0.0 0.3 6.5 10.1 0.3 1.7 2.2 2.9 0.4 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25, NDC80 kinetochore complex component" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 31.3;Hofbauer cells: 12.6;Muller glia cells: 13.2;Spermatocytes: 21.2;Spermatogonia: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 4 "B-cells: 1.1;T-cells: 2.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA047144: AB_2679952, HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.74e-6)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.9 1.6 3.6 7.2 2.2 6.7 2.1 0.4 3.5 1.3 4.0 0.9 0.0 6.8 1.3 1.5 8.5 0.6 1.0 1.1 2.7 1.6 1.5 1.6 1.9 7.5 1.2 2.5 1.2 2.6 0.7 0.2 3.3 1.1 0.8 3.1 1.3 2.1 0.0 0.7 2.1 3.8 1.8 0.7 4.1 3.0 5.9 1.1 38.0 0.6 5.6 8.0 1.5 2.7 1.1 0.0 0.4 0.1 0.0 2.5 0.4 1.0 8.4 19.6 10.9 0.9 0.9 7.1 11.3 4.3 11.4 9.1 4.3 7.9 7.0 5.0 1.8 15.0 10.4 7.5 0.0 10.1 4.7 11.5 14.0 5.3 2.0 0.0 10.4 4.2 0.0 0.5 7.3 0.1 2.3 5.7 14.8 1.1 7.9 3.2 5.2 7.5 12.6 0.6 5.0 11.2 13.6 19.5 3.1 4.6 6.6 14.7 0.9 10.1 6.9 1.9 6.6 0.5 7.3 1.7 1.7 20.7 6.7 9.5 15.3 26.6 6.9 2.2 1.6 6.7 0.0 0.1 0.2 0.0 0.1 0.0 0.9 0.4 0.0 0.0 1.1 0.2 0.5 0.4 0.0 0.0 0.0 2.5 0.4 3.6 2.2 0.4 3.5 2.7 1.6 1.2 2.5 1.1 1.1 0.0 0.6 1.5 1.1 4.7 0.0 0.4 0.0 0.0 3.4 0.0 0.0 2.8 0.0 0.0 1.2 0.4 1.0 0.0 0.0 31.3 0.8 0.2 0.0 0.8 12.6 0.0 0.0 4.3 1.6 0.6 0.6 1.6 0.0 0.0 1.4 13.2 0.8 0.0 1.1 0.0 0.3 0.0 0.3 21.2 17.6 1.3 4.8 1.7 3.0 0.9 SPDL1 "CCDC99, FLJ20364, hSpindly" ENSG00000040275 "Spindle apparatus coiled-coil protein 1" Q96EA4 5 169583634-169604778 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 97.4;Spermatogonia: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044700, HPA048146" Enhanced Approved Cytosol NA Yes Cytosol "HPA044700: AB_2679052, HPA048146: AB_2680284" "unprognostic (2.61e-2)" "unprognostic (1.94e-1)" "unprognostic (8.59e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.24e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.48e-6)" "unprognostic (2.63e-3)" "unprognostic (5.70e-3)" "unprognostic (8.27e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.93e-1)" 5.5 4.7 6.5 9.0 11.5 9.9 8.0 14.5 11.0 5.5 5.6 6.6 3.4 5.9 6.4 4.4 9.7 4.9 4.9 4.0 7.8 5.8 5.1 3.6 4.7 13.9 8.3 7.1 7.2 4.1 5.6 8.0 8.4 11.6 4.1 6.0 2.0 5.1 3.6 5.0 5.3 5.9 7.7 16.7 8.2 5.3 33.7 10.4 23.9 4.5 8.5 13.6 5.4 5.8 10.7 16.5 3.2 4.6 6.4 9.3 3.0 14.6 17.6 18.0 12.6 4.8 4.5 15.9 46.6 6.2 34.9 31.7 23.1 9.9 13.8 30.9 38.1 24.0 10.3 14.6 20.0 38.3 14.2 16.3 16.1 31.7 9.0 2.2 16.9 13.9 2.1 1.7 14.6 9.2 7.4 15.8 14.3 10.1 10.2 37.1 14.2 13.8 7.2 13.1 7.3 17.1 16.2 17.7 10.2 22.8 5.2 11.6 8.5 21.7 6.2 9.1 13.3 7.0 11.3 11.2 39.8 12.6 11.3 36.1 8.1 17.0 18.6 9.6 15.6 13.3 3.2 2.2 2.9 7.3 3.0 7.7 8.8 6.6 7.7 2.2 10.7 9.3 7.4 0.4 6.4 4.6 16.5 6.4 3.0 6.5 11.5 14.5 11.0 7.8 5.8 8.3 7.1 11.6 10.4 3.0 7.5 6.7 1.7 3.5 7.1 7.2 0.0 4.0 7.9 1.8 0.0 7.9 5.0 4.9 7.6 3.9 0.5 23.3 4.2 21.7 7.5 1.1 8.1 2.9 10.0 3.2 1.7 11.6 4.0 8.7 4.0 6.1 3.3 6.4 1.9 6.1 5.4 1.7 6.0 5.1 3.9 6.5 9.2 97.4 70.9 3.9 4.1 4.4 5.1 2.1 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 27.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA044559 Uncertain Approved Nucleoli,Cytosol NA Yes Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavorable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 3.9 3.2 4.2 5.1 4.4 13.8 13.7 2.3 5.4 5.1 5.9 6.7 2.0 3.5 6.7 4.7 16.8 3.9 3.5 3.2 4.7 6.1 3.3 2.4 16.8 7.6 4.5 2.3 6.6 4.2 4.8 4.7 12.3 5.2 7.2 6.9 4.8 27.4 2.9 1.2 3.5 4.9 5.8 5.2 5.9 3.9 3.4 3.5 11.2 5.6 6.4 11.8 4.3 8.2 1.2 1.4 3.7 2.1 6.0 1.5 0.8 16.0 4.1 9.6 7.8 2.1 3.0 6.9 8.0 3.4 4.7 5.7 2.7 16.0 0.0 3.5 3.7 5.4 5.4 12.3 5.8 8.6 6.9 3.9 20.6 5.5 2.5 0.9 17.8 16.1 1.4 2.0 7.8 4.2 2.3 5.1 3.6 6.2 20.1 10.7 5.4 5.9 9.6 9.9 2.6 6.0 8.3 20.7 4.4 3.4 4.3 0.0 5.3 14.4 4.2 1.5 20.8 9.1 8.5 2.2 9.5 10.7 15.7 5.0 4.4 5.1 10.6 5.0 14.7 5.6 1.7 1.8 3.7 1.5 2.1 0.7 1.2 0.8 0.9 1.4 1.1 0.5 1.0 0.0 6.0 1.7 0.0 0.5 0.8 4.2 4.4 2.3 5.4 4.7 6.1 4.5 2.3 5.2 3.5 0.0 1.3 0.5 1.3 3.0 5.2 1.2 0.0 4.0 2.3 3.5 2.0 5.5 1.7 0.6 0.0 2.7 1.7 0.0 1.2 5.8 3.1 2.6 9.2 0.8 2.2 1.6 6.4 8.6 1.3 0.0 2.8 1.7 5.0 0.0 7.2 1.2 1.3 7.0 3.2 1.0 2.4 0.0 1.6 0.0 0.2 5.5 2.7 3.2 6.0 4.7 SRSF10 "FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2" ENSG00000188529 "Serine and arginine rich splicing factor 10" O75494 1 23964804-23980927 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053805, HPA053831" Uncertain Supported Nucleoplasm NA Yes 28000 Nucleoplasm "HPA053805: AB_2682269, HPA053831: AB_2682275" "unprognostic (2.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.34e-2)" "unprognostic (1.77e-1)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.05e-2)" "unprognostic (1.68e-3)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.74e-4)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.69e-2)" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (2.40e-2)" 34.1 41.8 23.7 34.3 27.1 69.0 34.5 35.5 28.7 35.0 29.2 24.6 35.0 26.8 44.1 34.4 30.6 36.2 24.8 27.1 25.3 21.7 33.0 41.0 32.0 41.6 24.0 22.3 42.8 33.6 29.5 47.9 33.7 24.9 32.5 34.3 23.1 31.1 32.9 30.0 27.1 32.5 30.7 29.8 40.0 31.2 32.4 29.2 73.8 42.9 22.0 41.2 31.4 33.1 51.9 44.1 53.3 50.1 47.7 47.1 41.6 32.1 25.8 44.4 28.1 25.1 21.2 27.8 37.6 16.2 34.9 30.9 26.2 32.2 70.1 24.4 18.0 22.1 28.1 50.5 26.5 44.8 38.2 36.1 42.2 44.6 34.1 19.1 46.2 30.5 13.3 20.5 22.7 22.5 19.7 27.3 25.8 53.9 26.8 29.3 22.8 50.4 33.7 56.7 38.2 25.6 46.3 32.5 35.2 29.2 26.0 32.4 25.3 28.6 25.4 27.6 29.6 27.3 37.3 26.1 29.0 28.3 26.5 36.2 27.1 37.0 56.6 25.0 51.8 31.9 53.3 43.0 44.3 36.4 50.1 45.8 51.9 41.9 42.3 36.4 42.9 47.1 41.6 27.4 47.7 48.9 44.1 46.9 41.6 23.7 27.1 35.5 28.7 25.3 21.7 24.0 22.3 24.9 29.2 104.2 84.9 121.8 101.4 37.8 151.3 50.9 63.7 155.2 142.1 75.0 151.2 94.2 66.3 76.4 85.5 99.4 62.3 23.3 77.4 141.6 73.7 80.8 89.2 54.2 71.8 93.8 117.0 76.1 48.7 91.5 118.2 72.5 25.3 92.0 73.8 132.6 67.9 81.6 104.0 60.5 285.3 103.5 89.5 166.6 159.0 39.6 53.0 96.9 93.0 74.0 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 5.2 12.4 9.7 11.2 27.3 12.6 3.2 20.7 17.5 8.5 11.0 6.8 5.5 30.0 6.4 12.9 8.4 4.6 7.6 11.0 12.5 12.5 8.2 25.3 22.0 8.8 10.5 7.3 6.6 4.7 17.2 10.8 27.8 25.5 16.5 13.1 7.1 5.9 8.0 1.6 2.6 29.9 5.4 17.0 8.8 13.2 5.1 16.3 5.1 7.7 5.7 7.4 5.2 8.8 2.8 2.8 11.0 3.1 2.9 4.2 2.1 6.8 3.4 16.7 10.0 15.0 30.1 5.7 7.0 16.0 10.6 31.6 12.6 20.5 8.2 2.9 4.5 31.0 3.0 8.4 24.4 10.1 7.8 3.6 6.3 10.9 7.6 16.7 3.1 4.0 16.0 16.8 22.4 16.7 12.4 19.4 8.0 3.5 15.9 7.1 1.3 7.7 5.7 5.7 0.2 1.8 1.8 18.6 7.5 15.4 2.2 9.5 37.1 0.0 4.2 6.3 11.6 5.5 10.1 28.7 8.9 8.1 5.9 2.9 5.5 5.0 7.3 8.5 11.8 4.5 11.0 2.1 1.5 4.2 3.1 2.2 2.8 2.0 3.0 2.8 2.7 2.1 3.1 0.0 2.9 2.2 1.9 1.2 2.1 9.7 27.3 20.7 17.5 12.5 12.5 10.5 7.3 25.5 16.3 23.8 33.3 11.0 1.2 0.9 9.5 17.7 12.7 1.4 4.5 8.7 7.9 13.3 1.7 6.8 6.1 14.6 33.7 0.0 8.1 5.1 5.1 3.1 31.2 16.4 16.3 6.4 20.5 4.9 18.3 7.0 6.6 18.3 3.3 6.4 21.7 6.0 7.4 17.5 7.4 5.3 7.3 19.4 8.7 7.7 9.7 2.3 11.8 8.6 15.5 2.8 STIL "MCPH7, SIL" ENSG00000123473 "STIL, centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.0;testis: 23.8" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 18.6;Spermatogonia: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.2 1.4 1.3 10.8 2.4 11.0 2.9 1.4 2.2 1.2 4.1 0.9 2.5 3.6 1.5 2.2 5.8 0.9 1.7 2.0 1.4 1.2 1.5 1.6 1.7 5.0 1.3 1.5 1.2 1.5 0.9 0.9 5.5 1.1 1.7 6.4 0.8 3.6 0.5 0.8 4.2 4.0 1.3 1.2 3.4 2.2 23.8 1.0 36.0 1.1 3.5 7.1 1.3 2.1 1.9 1.6 5.4 0.7 3.3 1.2 0.5 16.9 9.1 13.1 11.7 0.9 2.3 8.4 15.0 7.2 16.8 17.7 9.8 8.4 20.0 7.1 7.5 17.3 11.3 15.3 7.9 18.1 14.9 6.9 22.5 11.3 8.6 0.5 18.2 11.5 0.8 1.3 14.4 9.4 2.1 11.1 15.3 15.9 19.1 12.6 7.7 17.6 5.7 15.9 9.4 7.5 11.5 21.4 9.6 4.7 10.2 11.7 7.0 16.1 11.9 7.8 16.3 7.7 10.4 6.5 15.9 16.1 11.4 20.3 6.3 13.1 19.7 7.4 13.9 14.7 4.3 0.7 1.1 1.1 0.4 0.5 1.7 1.2 1.0 0.5 1.9 0.8 0.8 5.4 3.3 0.3 1.6 1.1 0.5 1.3 2.4 1.4 2.2 1.4 1.2 1.3 1.5 1.1 1.0 3.0 0.3 2.2 0.5 0.8 1.2 0.5 0.0 6.7 2.3 0.0 3.9 1.2 0.0 1.2 0.7 0.9 1.8 0.0 0.4 3.8 0.8 1.2 2.3 0.5 2.3 0.0 1.7 1.8 1.9 1.3 0.3 1.2 0.0 4.6 4.3 0.8 1.8 1.5 0.7 0.3 0.7 0.0 0.0 18.6 17.8 2.0 0.7 0.8 3.4 1.4 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell type enhanced" "Detected in many" 5 "B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.2 2.2 3.4 1.2 15.0 5.7 3.8 7.7 11.6 8.5 8.9 6.8 1.1 36.3 7.1 4.4 2.2 2.2 1.4 3.3 10.4 6.4 3.8 3.4 2.9 0.6 4.5 13.7 36.8 7.2 3.3 10.5 5.5 12.1 3.5 8.6 2.6 34.1 21.1 1.7 17.8 31.0 1.9 5.9 5.2 2.9 20.7 11.0 5.0 7.6 1.3 1.3 1.9 1.9 1.6 5.5 1.3 7.2 4.2 8.3 4.1 5.9 4.3 14.0 22.6 39.5 6.2 4.7 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 83.4 80.3 158.6 22.9 53.1 0.3 2.2 10.2 34.8 52.4 10.4 0.0 5.9 3.3 5.2 4.6 11.6 59.1 46.7 2.5 20.9 21.2 28.7 189.5 2.4 23.5 0.0 2.9 7.4 142.8 2.0 5.2 145.8 55.6 40.5 11.0 0.9 7.9 38.6 4.2 1.4 0.2 6.5 20.5 28.6 24.9 55.5 4.2 178.5 10.5 39.9 SUN2 UNC84B ENSG00000100242 "Sad1 and UNC84 domain containing 2" Q9UH99 22 38734725-38794143 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001209 Supported Supported "Nuclear membrane" NA Yes "Nuclear membrane" "HPA001209: AB_1080465" "unprognostic (9.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" "unprognostic (5.09e-2)" "unprognostic (1.36e-1)" "unprognostic (5.57e-2)" "unprognostic (1.94e-2)" "unprognostic (2.37e-2)" "unprognostic (3.14e-2)" "unprognostic (1.25e-3)" "unprognostic (8.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (8.10e-2)" "unprognostic (2.33e-2)" 59.3 22.9 28.7 41.7 58.7 84.6 66.9 17.6 43.8 33.7 33.6 57.5 24.2 29.0 47.3 23.3 41.4 42.5 25.3 32.3 37.8 19.3 24.4 47.1 37.7 56.8 73.6 25.4 44.8 44.1 10.5 14.8 22.7 42.5 31.2 16.3 14.9 39.1 35.0 48.6 31.0 31.6 35.3 37.1 46.3 35.2 30.2 68.0 42.6 26.9 20.1 36.0 47.0 35.9 6.4 6.0 14.0 13.9 13.3 25.5 11.8 25.1 11.7 11.7 13.0 35.7 8.9 15.3 17.3 20.3 20.6 17.5 10.5 28.5 7.9 21.2 24.5 12.7 18.8 3.9 12.8 8.5 27.5 15.8 5.1 12.6 9.4 21.7 17.4 54.3 7.5 10.9 9.8 9.2 13.9 16.3 16.0 6.5 45.0 11.1 8.0 9.6 15.1 1.1 17.8 7.6 16.1 16.4 23.8 5.1 12.3 10.4 3.8 19.3 21.5 10.1 5.7 14.4 32.7 27.3 15.0 13.1 13.1 22.4 33.3 10.4 8.4 27.8 21.0 25.0 14.0 7.4 9.7 25.5 8.8 16.5 6.3 16.2 20.6 6.0 6.4 17.1 20.1 8.0 13.3 13.9 3.7 11.0 11.8 28.7 58.7 17.6 43.8 37.8 19.3 73.6 25.4 42.5 68.0 20.8 22.2 33.6 23.8 16.1 8.4 2.2 35.7 2.7 17.0 31.4 7.9 11.6 3.3 30.6 1.7 29.2 45.1 23.3 41.2 49.9 28.2 22.7 25.3 93.6 23.5 20.6 17.9 30.1 39.8 2.0 56.7 37.5 16.9 3.6 25.6 21.7 45.2 31.3 61.5 16.3 12.4 51.8 34.0 0.9 0.7 15.1 12.4 112.3 17.8 18.0 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63852983-64226433 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.4" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 579.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 15.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in many" "eosinophil: 30.3" "Group enriched" "Detected in many" 10 "granulocytes: 30.3;T-cells: 16.3" "Cell line enhanced" "Detected in many" "Daudi: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.8 4.5 2.3 18.0 2.8 5.5 29.7 15.8 3.3 16.1 13.4 1.9 7.7 3.6 18.8 13.6 17.2 7.1 8.6 27.3 2.3 2.4 35.6 13.0 15.2 11.0 2.7 2.1 22.8 22.4 60.1 17.6 14.1 16.3 13.7 4.8 13.0 9.8 9.2 111.4 24.1 10.6 10.2 2.3 16.0 6.9 14.3 1.9 16.9 30.9 29.7 15.8 11.1 26.4 2.3 1.1 30.3 0.1 1.5 16.3 1.3 17.7 6.0 8.9 2.8 8.9 2.6 11.8 1.2 1.2 2.0 3.6 2.0 3.7 44.5 1.9 1.2 2.2 8.6 5.8 2.3 2.5 6.7 2.3 0.2 4.4 0.5 1.7 0.7 0.2 3.7 8.4 2.6 2.4 2.0 4.6 5.7 0.2 3.6 1.5 9.9 4.7 0.2 4.0 5.7 1.8 5.6 8.4 1.4 13.5 8.5 8.2 6.1 14.1 3.3 3.8 3.8 3.9 0.1 4.0 3.3 5.3 1.1 3.7 4.9 2.1 16.9 0.9 0.0 4.7 0.2 0.0 30.3 16.3 0.1 11.0 2.1 10.0 10.8 0.0 2.3 4.9 7.4 13.3 1.5 0.1 1.1 11.1 1.3 2.3 2.8 15.8 2.6 2.3 2.4 2.7 2.1 16.3 1.9 285.9 119.8 37.9 110.7 98.9 26.4 222.5 107.0 271.7 293.5 191.9 172.8 136.2 16.6 78.5 6.5 155.5 34.5 0.0 48.5 56.0 55.6 45.4 24.4 28.8 14.9 6.4 44.4 68.7 4.7 8.1 93.5 7.9 45.5 4.6 57.4 99.5 65.8 10.5 50.2 64.2 579.2 109.9 65.5 13.6 7.8 76.5 187.3 96.2 67.0 63.0 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 58.9;granulocytes: 129.6;T-cells: 171.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "basophil: 55.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 55.6" "Cell line enhanced" "Detected in many" "HMC-1: 16.8;SCLC-21H: 11.2;U-138 MG: 12.8;U-2 OS: 13.9;U-266/70: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favorable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 8.3 1.5 2.3 9.0 3.7 9.4 3.8 0.8 2.4 5.1 7.4 7.1 0.6 2.9 4.6 5.5 3.6 11.6 7.3 5.3 3.4 2.0 4.7 2.2 20.2 26.7 3.5 1.3 2.5 2.3 0.9 2.1 1.3 5.5 5.3 1.8 4.8 12.4 4.8 11.4 3.0 12.0 3.5 10.4 21.9 5.8 3.2 3.9 2.3 21.7 1.2 24.5 18.8 3.6 0.2 1.3 55.6 4.5 10.9 10.2 4.4 4.9 0.7 0.0 0.3 0.7 0.7 0.2 2.0 1.3 0.5 1.4 0.4 3.9 0.0 0.4 3.4 1.8 0.5 0.1 0.6 2.0 9.7 0.3 3.8 0.1 0.0 1.2 1.0 16.8 2.2 1.5 4.2 0.7 1.8 1.0 0.7 0.2 3.8 5.0 0.2 0.1 1.3 0.1 0.9 0.7 0.0 4.1 0.5 1.9 0.2 11.2 0.8 0.7 7.1 0.5 0.2 1.3 0.2 5.8 12.8 13.9 0.3 0.4 19.6 4.4 0.4 8.2 5.4 0.4 55.6 4.5 0.2 10.2 0.8 6.0 0.2 4.1 6.8 1.3 0.0 4.5 5.5 9.2 10.9 0.3 0.3 4.1 4.4 2.3 3.7 0.8 2.4 3.4 2.0 3.5 1.3 5.5 3.9 14.9 12.5 12.8 3.1 4.0 0.0 4.0 2.5 58.9 20.5 14.0 2.0 1.1 5.0 0.6 6.2 2.4 1.4 0.0 0.5 0.4 2.4 2.4 129.6 0.9 4.2 0.0 0.0 4.3 8.9 9.9 0.0 9.1 10.1 14.4 1.3 0.1 0.4 0.0 0.7 1.4 0.4 0.0 2.5 2.2 6.6 3.9 1.6 171.2 0.4 2.6 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 67.3;Peritubular cells: 39.3;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.1" "Cell line enhanced" "Detected in many" "HAP1: 15.1;HMC-1: 31.3;RT4: 20.6;TIME: 17.7" "Region enriched" "Detected in single" 5 "hypothalamus: 35.1" "Low region specificity" "Detected in some" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles NA Yes 6100000 Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 3.8 3.1 9.1 2.8 9.5 1.6 4.4 4.3 8.4 18.1 5.3 6.6 4.8 1.7 36.2 5.4 2.6 10.0 2.9 2.1 11.9 6.0 4.2 7.1 3.0 0.7 9.8 2.7 47.3 8.8 1.3 41.9 2.6 9.4 9.2 6.8 1.3 3.8 6.0 4.5 1.4 3.0 22.5 7.8 2.3 5.3 7.8 9.5 0.0 6.2 1.1 1.4 4.3 9.4 0.5 0.3 5.1 0.3 0.5 0.4 2.3 0.1 3.0 0.8 0.0 4.5 2.5 0.0 3.9 2.5 4.2 7.5 0.3 3.9 0.0 1.0 2.7 3.6 3.5 15.1 1.3 4.4 0.0 1.3 0.0 5.1 0.2 1.1 0.0 31.3 0.9 0.3 3.8 0.2 1.6 10.5 0.0 1.4 0.0 1.9 1.0 0.0 0.0 0.6 10.6 0.0 0.0 1.2 0.0 3.7 20.6 7.6 0.3 1.5 5.9 0.8 1.6 3.7 0.3 17.7 2.2 4.7 10.8 0.9 0.0 0.0 0.0 2.7 0.0 2.4 1.1 0.3 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.5 0.4 0.2 5.1 0.5 0.2 0.3 0.1 2.3 9.1 9.5 4.3 8.4 11.9 6.0 9.8 2.7 9.4 9.5 26.8 1.7 0.0 6.9 0.1 0.1 3.6 22.9 6.7 6.8 3.5 0.0 0.2 3.3 5.5 1.6 9.5 15.8 0.0 2.0 0.2 6.3 15.5 3.5 32.1 1.0 0.0 0.0 12.3 1.6 2.0 67.3 0.9 3.3 0.0 18.0 4.6 5.4 25.4 39.3 1.6 0.4 51.8 6.2 1.4 4.6 0.6 0.0 0.7 8.1 7.6 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes Yes "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.4 21.2 32.5 18.6 1.7 3.6 18.3 28.9 15.5 33.2 22.0 23.5 30.8 32.5 12.3 15.7 38.6 17.2 34.3 21.0 33.8 14.3 18.6 27.5 17.6 21.6 1.6 37.2 23.4 1.5 1.4 20.9 12.1 7.3 25.2 26.8 24.8 25.7 31.4 20.8 49.0 53.3 35.1 21.8 27.9 34.8 23.0 13.0 18.8 38.6 25.3 15.9 17.4 11.0 8.1 25.5 21.6 21.6 14.7 19.4 23.2 17.5 43.5 18.0 23.9 52.1 11.2 36.0 27.4 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 0.0 7.9 16.0 0.5 1.9 1.0 2.2 0.0 0.0 4.5 8.7 7.9 3.3 0.0 2.1 43.8 2.5 2.0 23.3 0.6 16.5 2.6 1.0 4.7 4.3 35.7 4.8 1.2 4.9 20.5 49.1 2.6 21.9 0.0 12.6 3.1 1.4 1.9 3.5 2.5 1.8 3.2 6.5 1.0 69.6 47.8 1.3 3.3 15.3 5.7 1.3 TARDBP "ALS10, TDP-43" ENSG00000120948 "TAR DNA binding protein" Q13148 1 11012344-11026420 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003703, HPA017284" Supported Enhanced Nucleoplasm NA Yes 13000 Nucleoplasm "CAB003703: AB_425904, HPA017284: AB_1857775" "unprognostic (3.72e-3)" "prognostic favorable (1.15e-5)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (8.52e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (4.75e-3)" "unprognostic (2.24e-1)" "unprognostic (2.54e-2)" "unprognostic (2.27e-3)" "unprognostic (2.27e-1)" "unprognostic (1.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.71e-2)" 36.1 38.1 52.3 43.3 62.9 31.7 42.8 86.2 61.8 38.7 39.8 47.6 37.5 39.8 45.8 47.2 47.8 37.9 32.4 40.8 49.5 36.7 39.3 48.3 40.2 52.8 59.0 45.2 53.0 39.1 60.2 68.1 44.2 46.5 43.3 52.9 38.4 41.7 45.3 57.1 43.0 43.4 50.5 44.7 46.1 38.1 34.5 62.6 52.2 46.7 38.0 63.5 38.1 47.9 29.4 31.7 16.5 24.8 33.6 31.1 17.0 52.6 36.2 62.1 31.8 33.7 28.4 36.7 36.2 32.0 59.6 44.6 42.7 38.9 70.2 26.6 40.2 35.0 37.8 75.2 42.1 78.6 37.6 36.3 53.2 60.1 56.7 27.6 63.7 35.4 23.1 47.9 41.8 34.3 33.5 42.2 27.7 68.3 39.6 50.4 42.5 46.6 51.7 49.5 50.5 32.4 55.3 49.8 44.6 42.9 39.0 42.4 35.0 49.3 39.1 27.9 47.4 39.1 45.0 38.5 40.0 47.0 32.9 52.0 29.6 36.5 74.3 26.2 64.1 42.4 16.3 19.6 16.5 25.4 24.8 31.1 29.4 26.0 24.6 31.7 21.2 25.9 27.7 7.9 33.6 23.6 22.2 26.8 17.0 52.3 62.9 86.2 61.8 49.5 36.7 59.0 45.2 46.5 62.6 29.8 67.3 58.2 67.5 101.8 36.2 65.0 33.1 64.3 60.3 27.9 27.5 55.0 28.2 39.9 5.6 56.1 37.9 46.7 47.0 69.3 45.5 61.8 39.5 45.1 43.8 35.0 63.7 35.6 47.5 7.8 43.7 40.0 33.7 38.7 45.1 35.8 42.4 31.6 48.4 33.2 37.8 32.3 50.6 50.2 31.1 100.1 61.4 41.7 47.8 60.0 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Hofbauer cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 27.5;HaCaT: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.5 4.0 0.2 0.9 3.1 6.1 9.1 12.2 6.8 8.9 7.4 2.6 12.1 0.4 9.3 7.1 1.9 36.4 0.2 13.6 3.1 0.9 0.5 0.2 14.1 2.0 14.6 0.6 1.1 8.4 22.5 8.9 22.3 15.8 3.1 0.7 0.8 0.3 7.0 3.5 0.1 1.6 0.6 2.7 2.3 0.4 1.8 0.0 13.6 17.2 0.3 0.5 4.1 9.1 1.2 0.6 3.0 0.9 19.0 10.9 3.3 1.8 4.9 0.6 0.5 0.2 11.1 1.0 1.2 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 53.6 12.2 1.9 11.4 7.3 2.4 0.6 7.6 5.3 20.5 3.5 0.0 18.5 3.3 3.7 1.5 3.1 15.0 0.0 2.8 9.4 2.1 3.8 0.0 4.7 31.3 1.6 7.5 0.6 19.8 1.0 1.7 9.3 3.3 3.6 11.1 2.9 8.7 7.0 0.7 2.5 2.2 0.0 2.0 1.6 2.8 9.5 14.5 1.9 4.2 11.1 TBKBP1 "KIAA0775, ProSAPiP2" ENSG00000198933 "TBK1 binding protein 1" A7MCY6 17 47694081-47712050 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.0;Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8" "Cell line enhanced" "Detected in many" "CACO-2: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062347, HPA064856" Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA062347: AB_2684744, HPA064856: AB_2685371" "unprognostic (2.14e-3)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.92e-2)" "unprognostic (2.39e-1)" "unprognostic (3.09e-2)" "unprognostic (3.72e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "prognostic favorable (8.14e-6)" "unprognostic (5.83e-2)" "unprognostic (1.14e-1)" "unprognostic (3.03e-1)" "unprognostic (4.22e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.59e-5)" 12.6 7.8 16.1 8.7 8.4 5.6 6.0 13.5 20.1 11.2 7.3 3.9 5.4 3.1 9.7 5.9 10.9 6.7 7.8 12.2 16.3 14.6 6.3 3.2 7.8 5.3 11.2 15.2 17.9 15.0 9.2 6.4 9.2 8.0 7.4 2.4 12.2 18.2 9.8 30.1 4.6 3.6 12.1 4.2 11.0 5.4 8.5 2.8 2.8 9.1 6.5 6.7 8.0 9.6 0.6 0.5 5.7 0.5 2.2 2.8 0.3 0.2 5.2 9.7 10.3 5.0 5.1 6.3 5.3 5.5 2.6 3.1 32.5 0.8 0.1 5.3 6.5 4.7 0.6 7.6 1.3 1.5 6.3 17.1 13.7 4.6 5.4 11.6 2.6 3.0 10.2 3.5 0.6 0.9 8.2 9.1 3.8 11.8 0.0 1.4 1.4 1.6 12.8 13.5 0.2 3.7 6.1 3.0 5.4 3.3 0.4 8.5 15.8 2.5 0.6 2.7 9.6 5.8 5.9 10.5 8.1 9.6 9.7 0.6 3.6 0.3 6.4 4.7 4.9 2.0 0.0 0.5 0.9 2.8 0.2 1.5 0.0 0.7 2.0 0.5 0.6 0.3 1.0 5.7 2.2 0.0 0.5 0.5 0.3 16.1 8.4 13.5 17.9 16.3 14.6 11.2 15.2 8.0 2.8 0.0 1.4 0.5 3.3 3.5 13.0 2.8 0.0 0.0 1.2 3.5 2.0 0.1 1.7 0.9 5.9 5.2 0.0 0.0 1.5 0.1 3.7 4.7 0.0 1.1 2.7 27.0 5.1 9.8 3.3 4.1 8.1 1.7 1.7 1.0 0.1 4.1 1.1 0.0 8.1 3.7 3.5 0.0 4.2 4.4 5.1 2.6 0.2 1.5 0.0 1.7 TCF19 SC1 ENSG00000137310 "Transcription factor 19" Q9Y242 6 31158542-31167159 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA065994 Approved Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA065994: " "unprognostic (1.41e-2)" "unprognostic (4.92e-2)" "unprognostic (4.00e-2)" "unprognostic (5.16e-3)" "unprognostic (1.99e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (7.04e-2)" "unprognostic (1.35e-2)" "unprognostic (5.92e-2)" "unprognostic (1.74e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (3.54e-10)" "unprognostic (3.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.36e-2)" "unprognostic (1.21e-1)" 4.3 1.5 1.3 12.4 4.1 2.3 5.2 8.2 3.9 7.0 5.6 2.3 3.7 9.2 4.2 6.2 11.2 3.2 3.8 3.4 1.7 1.1 4.3 1.6 4.8 18.0 3.0 1.0 4.6 3.6 0.4 0.9 1.5 2.0 5.5 4.0 2.3 4.1 6.7 2.5 11.5 6.0 3.9 1.8 8.6 5.9 3.1 1.8 31.3 2.8 14.4 13.8 4.8 6.7 2.0 0.9 0.2 0.3 1.2 3.8 1.2 33.2 0.3 0.3 0.0 2.3 3.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.0 7.5 8.2 19.8 0.0 0.0 12.4 0.0 0.2 18.7 2.9 1.9 0.8 0.0 0.1 8.8 1.2 0.0 0.9 0.0 1.8 7.4 17.0 0.0 16.2 3.2 0.1 0.4 5.3 0.0 0.0 0.0 0.4 2.0 0.2 2.9 0.1 20.6 0.2 0.2 0.0 0.2 2.7 0.0 2.4 0.0 20.6 0.1 0.1 0.1 5.3 6.0 10.2 0.0 0.1 0.1 0.0 0.3 0.0 0.7 0.0 3.8 1.6 1.9 3.4 0.9 2.0 2.4 0.9 0.2 1.2 0.1 0.0 2.6 1.2 1.3 4.1 8.2 3.9 1.7 1.1 3.0 1.0 2.0 1.8 3.0 1.1 6.0 2.1 4.5 2.6 1.2 0.0 0.0 3.4 3.5 0.0 0.6 6.6 1.6 0.3 3.3 1.1 0.0 1.6 7.2 2.7 1.0 1.1 0.2 7.5 1.6 1.2 1.3 1.9 0.4 4.6 4.3 11.8 10.0 3.3 3.3 0.8 0.0 6.0 0.3 0.5 0.0 6.8 0.5 12.8 3.3 0.3 5.1 7.7 0.9 TCP11L1 FLJ11336 ENSG00000176148 "T-complex 11 like 1" Q9NUJ3 11 33039417-33105943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005769 Approved Approved Cytosol NA Yes Cytosol "HPA005769: AB_2202398" "unprognostic (5.22e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (3.73e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "unprognostic (6.99e-2)" "unprognostic (9.10e-2)" "unprognostic (1.42e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.50e-3)" 12.0 10.1 13.0 10.2 19.2 12.8 14.1 15.0 25.3 10.4 15.1 14.7 9.3 11.7 11.1 6.9 9.8 8.2 15.5 10.6 13.9 14.9 11.6 8.1 9.4 8.8 16.8 16.1 11.1 12.6 9.9 12.5 13.3 21.2 10.3 14.4 7.4 8.7 14.4 6.6 10.4 22.9 16.8 16.2 9.8 10.0 10.3 11.1 8.1 7.4 5.0 10.7 10.6 10.9 2.6 11.1 13.1 6.1 4.5 5.7 3.1 6.8 12.5 6.3 6.0 11.0 12.4 4.3 10.0 8.4 7.7 10.4 6.4 3.3 6.9 2.8 19.2 11.5 11.0 8.4 7.7 10.9 8.9 6.7 4.5 13.8 4.6 7.2 4.3 6.4 10.0 9.7 7.9 15.1 8.8 7.5 10.1 2.9 8.4 19.2 9.9 4.6 1.8 4.7 5.1 4.6 5.4 13.1 1.2 7.0 2.6 5.2 10.7 25.2 16.4 4.6 8.5 4.0 1.9 11.4 13.6 19.8 15.2 10.4 10.5 10.3 8.0 9.8 2.3 10.6 13.1 6.1 8.3 3.6 3.7 3.5 2.2 2.0 4.0 5.9 2.6 2.0 2.6 3.6 4.5 0.9 11.1 5.7 3.1 13.0 19.2 15.0 22.9 13.9 14.9 16.8 16.1 21.2 11.1 8.9 0.6 3.0 8.6 2.1 7.2 2.8 5.1 0.0 1.2 0.0 3.9 2.7 1.7 3.6 8.4 3.5 4.2 0.0 3.5 17.4 3.2 3.9 4.6 1.3 5.8 7.9 1.7 4.9 5.3 4.5 1.7 3.7 0.0 31.5 1.0 1.5 5.1 1.5 2.5 4.4 4.9 0.0 7.3 7.6 5.5 2.3 3.9 5.0 1.2 3.3 TGIF1 "HPE4, TGIF" ENSG00000177426 "TGFB induced factor homeobox 1" Q15583 18 3411608-3459978 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 533.4;Basal keratinocytes: 319.4;Urothelial cells: 322.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062160 Supported Nucleoplasm NA Yes Nucleoplasm "HPA062160: AB_2684701" "unprognostic (1.11e-2)" "unprognostic (5.20e-2)" "unprognostic (2.40e-1)" "unprognostic (1.97e-1)" "unprognostic (3.57e-3)" "unprognostic (3.10e-2)" "unprognostic (2.75e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (9.60e-2)" "unprognostic (1.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.60e-1)" "unprognostic (7.07e-2)" "unprognostic (2.48e-3)" 31.9 16.6 6.9 17.2 9.3 11.2 22.0 2.7 6.2 26.8 23.8 15.5 48.4 9.6 32.7 47.3 27.1 24.8 31.4 12.9 6.5 7.2 24.7 33.6 27.9 10.6 8.1 5.9 23.0 20.2 5.3 10.2 49.6 9.9 33.2 22.4 15.3 25.1 29.8 21.2 22.9 16.6 18.5 8.6 23.1 19.8 23.1 9.2 18.1 60.2 11.2 21.0 40.5 29.0 18.2 14.0 20.4 17.3 7.4 27.5 12.7 6.2 28.5 18.7 6.0 19.1 25.8 45.7 12.0 46.0 9.8 12.6 11.2 28.6 0.3 4.0 9.8 33.0 6.4 7.1 13.4 13.0 2.5 3.0 0.8 13.6 21.2 35.9 9.0 7.5 17.9 57.8 17.8 47.5 27.0 20.9 4.3 6.4 0.1 19.2 12.2 5.8 11.0 47.6 22.6 6.3 6.2 8.4 2.0 40.3 30.7 5.2 5.2 31.6 24.8 17.5 32.7 5.7 8.1 8.9 15.4 13.4 18.1 7.5 1.0 0.1 2.8 15.8 3.4 19.3 20.4 17.3 2.9 25.9 6.5 27.5 18.2 21.6 25.2 14.0 12.8 15.5 18.0 7.8 7.4 6.1 1.4 11.4 12.7 6.9 9.3 2.7 6.2 6.5 7.2 8.1 5.9 9.9 9.2 32.8 38.1 22.9 533.4 319.4 0.0 4.8 61.1 58.9 46.6 116.9 0.0 126.0 41.4 90.1 18.0 35.0 23.5 23.3 65.8 139.4 114.7 314.8 67.9 27.2 66.3 1.6 44.5 17.2 38.3 5.0 26.4 53.4 72.6 105.6 69.3 6.0 95.9 60.4 14.5 79.5 0.0 32.3 126.7 5.0 13.2 224.7 125.7 55.4 72.7 322.0 TICRR "C15orf42, FLJ41618, MGC45866, SLD3, Treslin" ENSG00000140534 "TOPBP1 interacting checkpoint and replication regulator" Q7Z2Z1 15 89575482-89631056 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 1.6;Extravillous trophoblasts: 4.8;Spermatogonia: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046746, HPA049454" Supported Nucleoplasm NA Yes Nucleoplasm "HPA046746: AB_2732533, HPA049454: AB_2680773" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (3.41e-1)" "unprognostic (1.10e-1)" "unprognostic (6.22e-5)" "unprognostic (7.73e-3)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.64e-1)" "unprognostic (1.31e-4)" "unprognostic (5.87e-2)" "unprognostic (0.00e+0)" "unprognostic (3.54e-2)" "unprognostic (7.38e-2)" "unprognostic (4.53e-2)" "unprognostic (3.59e-2)" 0.9 0.4 0.3 3.5 0.4 6.9 0.6 0.1 0.4 1.0 2.5 0.1 0.1 2.2 1.0 0.1 9.0 0.7 0.5 0.3 0.2 0.3 0.3 0.2 0.7 2.9 0.4 0.1 0.9 0.1 0.0 0.3 3.9 0.1 0.5 2.6 0.2 1.2 0.1 0.1 1.0 3.2 0.4 0.2 2.9 0.9 7.7 0.1 21.7 0.4 9.5 12.2 0.8 2.3 0.0 0.0 0.0 0.4 0.0 0.7 0.0 7.1 9.8 12.8 7.3 0.5 1.0 7.2 5.2 2.4 7.4 7.8 10.7 5.5 9.5 2.8 1.7 6.2 14.3 17.5 4.6 6.8 4.8 16.9 14.2 9.5 5.6 0.0 10.1 5.2 0.3 0.3 6.0 4.5 1.1 3.6 8.5 13.5 11.1 4.3 6.7 8.8 8.6 8.5 7.1 5.1 12.7 11.5 7.7 1.7 10.2 5.5 5.4 12.5 7.1 2.1 9.8 5.3 6.8 2.2 8.1 10.2 16.4 10.7 2.6 5.0 8.2 2.8 8.6 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.4 0.1 0.3 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.7 0.1 0.8 0.0 0.3 0.1 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 7.0 1.8 2.6 4.4 3.2 2.6 5.3 5.6 10.6 3.6 6.1 0.9 6.3 21.5 4.6 2.2 5.3 2.1 3.6 4.3 7.5 17.4 2.1 2.1 4.3 2.0 2.2 6.7 2.9 3.5 2.4 3.8 4.2 6.1 5.6 6.0 2.1 46.1 4.7 3.5 11.8 3.7 0.5 4.3 2.3 20.6 6.7 14.3 7.9 4.8 6.1 6.3 4.5 9.5 2.2 1.2 4.0 9.7 4.2 5.7 6.7 4.7 4.4 28.9 26.5 39.8 5.3 4.5 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 17.9 20.6 34.4 9.9 18.9 1.0 14.1 10.2 6.7 11.4 12.2 0.0 42.8 16.6 12.7 0.0 14.5 5.8 0.0 21.2 17.8 22.6 27.2 3.5 8.5 16.0 0.0 8.6 4.9 10.7 0.0 8.3 11.2 32.1 6.4 7.0 11.3 12.9 3.6 10.3 6.3 0.6 6.5 13.4 0.9 3.0 22.7 66.4 27.3 6.5 10.7 TIPIN FLJ20516 ENSG00000075131 "TIMELESS interacting protein" Q9BVW5 15 66336206-66386746 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039704, HPA058799" Enhanced NA Yes "HPA039704: AB_10795258, HPA058799: AB_2683824" "unprognostic (3.47e-1)" "prognostic favorable (4.15e-4)" "unprognostic (3.49e-3)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (2.47e-4)" "unprognostic (3.75e-1)" "unprognostic (1.32e-3)" "unprognostic (1.42e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.18e-3)" "unprognostic (9.47e-2)" "unprognostic (1.09e-1)" "unprognostic (4.91e-1)" "unprognostic (2.89e-3)" 6.0 7.8 11.0 9.2 8.9 15.1 8.3 14.2 9.4 6.2 6.6 11.2 6.2 3.9 6.9 6.0 8.9 7.9 3.7 5.4 8.2 8.2 5.7 7.0 5.0 12.0 7.9 7.8 9.2 6.5 11.2 8.7 5.3 8.3 5.2 7.6 9.1 6.1 7.0 6.8 5.4 4.9 6.3 8.4 6.6 5.4 25.7 8.9 12.8 6.3 6.9 14.0 4.7 5.7 6.5 6.8 2.4 7.2 7.7 6.2 3.2 10.4 12.6 14.1 6.7 2.6 5.3 11.6 14.8 6.0 20.9 18.5 18.4 12.0 21.4 10.8 5.5 12.2 16.7 35.3 12.7 19.9 14.2 19.6 18.8 12.7 10.2 5.0 19.7 6.9 6.7 4.2 19.4 15.8 3.0 8.6 17.9 15.6 10.4 17.9 11.9 18.0 12.7 14.3 24.5 10.0 18.1 21.0 21.3 7.1 12.0 13.3 8.4 10.3 6.6 9.5 10.7 10.0 12.0 5.7 14.9 16.3 12.8 26.9 6.3 32.2 34.0 10.0 36.2 15.1 0.7 3.6 2.4 4.9 7.2 5.8 4.0 3.8 4.2 6.8 6.5 5.5 6.2 1.0 7.7 4.3 5.1 3.4 3.2 11.0 8.9 14.2 9.4 8.2 8.2 7.9 7.8 8.3 8.9 6.0 6.5 44.9 39.5 87.0 11.3 2.2 28.1 5.3 5.7 8.7 9.8 27.1 72.9 7.4 44.0 18.0 3.5 23.3 7.3 32.4 21.8 32.9 8.1 12.9 18.5 7.9 4.6 17.8 28.6 22.7 17.5 23.6 54.0 5.4 7.3 8.4 6.0 7.0 17.0 8.4 13.3 32.3 27.6 93.7 64.3 95.1 16.2 34.9 10.7 25.3 TK1 ENSG00000167900 "Thymidine kinase 1" P04183 17 78174075-78187233 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA synthesis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0" "Cell type enhanced" "Detected in many" 14 "Extravillous trophoblasts: 178.8;Hofbauer cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 21.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" CAB004683 Enhanced NA Yes "CAB004683: AB_437067" "unprognostic (7.09e-2)" "unprognostic (1.17e-3)" "unprognostic (1.82e-1)" "unprognostic (2.14e-3)" "unprognostic (3.22e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.87e-4)" "prognostic unfavorable (3.03e-5)" "unprognostic (4.05e-2)" "unprognostic (3.18e-3)" "unprognostic (6.64e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (6.50e-11)" "unprognostic (5.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (4.94e-2)" 5.3 2.0 2.1 21.4 4.5 32.8 4.8 1.1 1.9 3.7 11.4 2.2 1.9 8.5 2.4 4.8 18.9 2.2 7.0 4.3 1.6 0.7 7.9 6.2 9.3 15.7 3.1 1.6 2.1 3.6 0.1 1.3 8.6 2.1 2.3 7.9 0.5 4.6 2.0 2.0 6.2 8.5 4.4 1.7 9.0 9.4 3.6 1.6 41.8 1.3 33.0 20.5 3.1 5.8 4.0 2.1 1.1 1.2 6.2 21.2 3.5 65.8 54.7 10.9 13.8 1.0 4.3 7.1 32.7 17.2 48.7 67.6 48.3 27.8 21.4 11.5 19.6 20.3 30.0 9.9 29.2 25.2 7.4 36.5 37.8 19.6 31.6 0.3 16.0 24.4 2.1 1.0 25.4 3.5 3.4 19.8 7.5 23.2 47.5 18.6 49.1 8.0 9.0 5.6 38.5 38.1 21.7 44.2 47.8 12.9 21.4 4.9 14.5 25.1 68.9 9.2 10.0 46.5 21.5 9.1 47.9 47.0 34.1 42.0 20.0 10.4 27.5 23.5 10.8 21.5 0.0 0.7 0.0 1.1 1.2 0.5 4.0 5.3 2.7 2.1 1.2 0.3 1.4 1.1 6.2 1.0 0.7 21.2 3.5 2.1 4.5 1.1 1.9 1.6 0.7 3.1 1.6 2.1 1.6 0.0 2.4 8.2 6.8 25.2 0.0 0.6 2.5 4.0 7.9 12.2 0.0 46.0 6.6 6.3 2.6 3.2 3.9 46.7 9.8 178.8 7.2 3.3 0.0 8.6 55.5 0.0 5.2 9.8 10.8 4.2 0.6 11.3 3.3 8.2 12.4 0.0 11.2 8.6 0.7 14.7 0.0 0.0 2.2 1.1 18.4 9.8 42.7 7.2 25.1 12.3 TMEM106C MGC5576 ENSG00000134291 "Transmembrane protein 106C" Q9BVX2 12 47963569-47968878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Enterocytes: 249.4;Undifferentiated cells: 213.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 136.0" "Low region specificity" "Detected in all" HPA047204 Enhanced NA Yes "HPA047204: AB_2679982" "unprognostic (1.63e-2)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.13e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.27e-8)" "unprognostic (1.05e-1)" "unprognostic (1.90e-2)" "unprognostic (1.52e-3)" "unprognostic (3.60e-1)" "unprognostic (7.29e-2)" "prognostic favorable (4.62e-4)" "unprognostic (1.12e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-2)" "unprognostic (1.83e-1)" 10.6 19.1 12.6 18.5 17.3 12.2 20.4 17.5 16.3 16.6 41.2 6.5 29.0 33.9 19.7 43.6 17.5 15.1 23.1 25.8 17.7 14.4 26.4 13.6 16.5 10.4 8.5 14.6 21.4 39.1 33.7 27.4 23.6 12.8 15.9 45.3 30.4 59.0 16.6 8.0 11.3 58.1 16.9 7.1 31.0 21.9 28.3 5.8 23.1 20.5 16.1 15.2 12.1 16.6 14.9 5.1 10.7 4.1 7.3 26.2 16.5 37.2 26.1 24.2 26.7 11.2 8.2 23.0 21.0 30.3 38.4 33.1 39.1 38.6 32.8 29.6 23.0 35.9 25.6 37.9 23.0 36.7 31.3 36.4 25.5 37.5 15.8 8.6 26.0 18.9 5.6 15.7 35.0 18.5 26.4 24.4 35.5 17.1 37.6 26.8 27.0 37.6 11.6 4.3 40.0 36.1 33.3 31.4 27.9 20.3 28.6 16.3 19.4 32.6 22.0 21.9 13.2 80.5 21.2 6.0 16.2 27.8 23.3 37.1 20.9 34.1 36.5 20.6 136.0 15.5 10.7 3.7 9.5 19.5 3.3 23.8 14.9 19.1 20.2 5.1 12.1 17.9 19.6 3.2 7.3 4.1 0.8 26.2 16.5 12.6 17.3 17.5 16.3 17.7 14.4 8.5 14.6 12.8 5.8 29.8 20.2 17.1 26.7 42.6 28.5 32.9 50.9 2.7 12.5 33.2 17.7 49.4 72.9 57.2 2.1 15.7 249.4 23.3 39.1 24.8 34.3 27.1 10.4 15.1 45.2 28.6 34.5 44.8 13.8 3.1 30.2 11.1 20.3 11.8 121.6 146.7 38.5 151.1 38.9 64.1 40.9 12.9 37.6 21.3 32.1 35.8 12.5 24.5 213.7 24.2 TMEM138 "HSPC196, JBTS16" ENSG00000149483 "Transmembrane protein 138" Q9NPI0 11 61362001-61369509 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042373 Approved Approved Microtubules NA Yes Microtubules "HPA042373: AB_10793880" "unprognostic (1.30e-1)" "unprognostic (4.69e-3)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.15e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (2.28e-1)" "unprognostic (4.42e-2)" "unprognostic (3.49e-1)" "unprognostic (4.46e-1)" 12.4 38.3 7.5 13.5 11.3 15.4 13.0 8.2 11.4 13.5 11.6 15.0 7.9 9.2 17.3 22.5 10.2 15.2 11.4 8.6 7.7 7.1 18.7 46.3 14.1 13.8 12.2 10.4 29.4 12.8 16.5 13.0 19.7 9.5 16.1 15.4 28.4 14.8 10.8 6.3 16.2 16.7 15.0 11.2 17.6 11.9 10.7 11.4 13.7 14.5 11.4 17.8 12.9 12.4 15.5 17.0 22.6 15.9 14.9 16.4 13.1 6.8 14.0 6.7 8.3 20.4 9.4 7.3 8.8 13.7 14.2 12.9 7.1 9.8 6.2 7.9 11.5 20.1 12.8 10.9 14.1 17.1 7.5 7.1 4.6 12.4 8.9 15.3 8.7 13.9 13.5 20.0 24.2 16.6 5.4 13.1 7.4 11.6 10.9 23.7 19.7 7.2 10.2 9.2 9.7 15.2 5.9 3.5 12.4 14.0 16.9 6.9 5.4 10.2 11.5 12.1 5.1 17.7 6.7 6.9 19.2 7.4 12.2 9.6 10.0 8.9 6.0 9.5 10.6 9.1 22.6 15.9 15.0 14.8 15.4 15.9 15.5 14.1 13.9 10.1 14.1 15.3 13.7 3.9 14.9 10.0 17.0 16.4 13.1 7.5 11.3 8.2 11.4 7.7 7.1 12.2 10.4 9.5 11.4 14.9 27.5 19.9 14.7 17.6 26.4 3.5 2.5 40.2 19.4 19.2 76.6 48.7 13.3 14.9 22.4 17.5 14.7 0.0 13.8 34.8 19.7 13.2 35.9 13.9 42.9 14.3 9.2 11.6 17.3 5.3 29.4 21.1 35.4 22.6 9.2 25.4 14.7 14.0 26.9 16.5 164.4 0.0 12.2 18.4 17.1 17.9 23.0 27.4 12.1 10.3 TMEM243 "C7orf23, MGC4175, MM-TRAG" ENSG00000135185 "Transmembrane protein 243" Q9BU79 7 87196160-87220587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014918 Uncertain NA Yes "HPA014918: AB_2067447" "unprognostic (5.14e-3)" "unprognostic (7.27e-2)" "unprognostic (1.36e-1)" "unprognostic (3.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.50e-1)" "unprognostic (3.39e-2)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (4.58e-2)" "unprognostic (2.69e-1)" "unprognostic (6.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.32e-2)" "prognostic favorable (9.13e-4)" 14.3 8.6 7.9 26.0 7.9 11.3 15.9 6.2 9.0 15.1 13.4 5.5 18.8 11.5 15.6 19.3 12.0 13.0 10.7 8.3 7.1 7.1 23.6 3.8 26.6 29.5 7.2 6.9 19.5 33.8 11.2 12.3 15.2 8.4 14.0 8.4 10.3 27.5 18.3 4.4 10.8 19.3 9.8 10.1 26.8 12.5 6.7 6.1 23.8 42.5 6.4 36.6 11.7 22.3 45.4 32.8 10.3 9.4 16.1 37.8 9.9 11.8 7.2 7.2 9.0 17.3 19.5 17.4 9.7 14.8 7.3 13.5 10.0 14.5 25.6 21.5 9.7 13.3 11.4 6.8 9.8 9.8 10.8 18.2 0.4 12.5 21.1 13.6 9.2 2.0 12.8 9.9 5.6 11.3 14.1 10.9 13.5 1.2 13.8 9.9 19.5 11.4 1.5 8.1 1.3 10.0 22.7 21.7 35.0 21.1 9.3 7.9 7.2 7.2 15.1 10.7 13.1 5.6 1.6 5.8 12.4 10.9 31.5 8.4 19.7 16.9 49.6 11.4 8.5 7.2 10.3 9.2 5.8 12.4 9.4 17.8 45.4 22.3 15.5 15.6 44.1 37.8 26.2 4.0 16.1 6.2 32.8 19.7 9.9 7.9 7.9 6.2 9.0 7.1 7.1 7.2 6.9 8.4 6.1 23.8 79.5 136.8 39.7 37.9 5.5 0.8 33.1 33.5 27.3 21.0 37.3 97.6 44.7 21.0 31.6 29.3 9.2 23.3 37.3 35.0 55.2 32.9 2.3 2.9 44.2 11.1 7.0 24.5 49.1 9.8 76.8 45.9 49.0 19.8 23.5 7.7 23.2 28.1 55.5 54.9 11.9 45.3 24.9 16.1 37.2 33.2 28.0 61.8 35.9 37.9 TMPO "LAP2, LEMD4, TP" ENSG00000120802 Thymopoietin "P42166, P42167" 12 98515512-98550379 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" DNA-binding Cardiomyopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 130.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008150, CAB009847, HPA070805" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: " "unprognostic (2.36e-1)" "unprognostic (4.46e-3)" "unprognostic (5.90e-2)" "unprognostic (2.80e-2)" "unprognostic (1.35e-1)" "unprognostic (2.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-2)" "unprognostic (3.69e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-3)" "prognostic unfavorable (9.34e-4)" "unprognostic (6.01e-3)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (3.26e-2)" 10.8 9.5 8.1 25.0 9.5 36.8 12.7 19.1 11.0 16.9 22.9 10.7 8.7 15.9 18.4 17.1 23.0 15.4 10.3 9.6 8.5 8.3 15.8 20.5 13.8 34.0 9.0 11.2 34.7 21.6 9.9 9.9 13.6 7.6 15.6 17.6 12.5 14.0 9.7 9.4 11.7 22.6 10.7 9.4 29.1 16.8 11.4 10.3 130.9 13.2 12.2 35.4 13.0 17.9 14.1 10.9 18.1 33.1 9.7 15.6 13.3 30.8 20.4 50.3 25.5 4.2 5.6 29.8 25.4 13.5 34.5 25.1 22.2 15.5 53.9 15.6 14.7 12.6 19.8 42.1 19.1 31.7 37.7 26.1 46.1 18.6 14.6 3.8 53.2 30.8 3.1 6.3 20.3 10.9 12.0 19.6 33.6 38.9 20.9 21.4 19.4 86.8 42.0 30.2 28.6 19.1 72.9 33.3 37.3 12.2 28.8 39.8 23.8 43.5 27.3 13.7 20.6 30.8 25.6 10.5 20.0 17.5 13.6 25.9 22.8 38.8 60.3 5.7 30.9 26.5 18.1 14.4 6.1 9.5 25.0 10.2 10.9 11.1 10.8 10.9 14.1 15.6 11.7 1.1 9.7 33.1 6.1 13.3 13.3 8.1 9.5 19.1 11.0 8.5 8.3 9.0 11.2 7.6 10.3 29.8 18.0 45.4 21.4 24.6 20.8 7.1 25.5 36.1 48.9 29.6 11.8 16.5 26.6 16.3 26.8 36.0 27.6 70.0 27.6 75.5 19.0 17.7 27.8 45.0 32.2 9.5 27.5 32.5 64.7 21.9 26.4 40.1 16.9 34.3 51.4 24.2 21.6 31.5 38.2 27.8 47.9 19.4 15.6 38.6 53.5 20.5 9.8 33.1 42.9 16.3 TNFAIP8 "GG2-1, MDC-3.13, SCC-S2" ENSG00000145779 "TNF alpha induced protein 8" O95379 5 119268692-119399688 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 73.4;lymphoid tissue: 83.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054434, HPA057089" Uncertain Enhanced Nucleoplasm No Yes 270000 Nucleoplasm "HPA054434: AB_2682487, HPA057089: AB_2683331" "prognostic favorable (2.45e-4)" "unprognostic (6.06e-2)" "unprognostic (9.81e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.86e-3)" "unprognostic (4.92e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-2)" "unprognostic (5.81e-3)" "unprognostic (4.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.88e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-2)" 21.1 2.1 1.6 49.9 3.0 17.8 18.9 1.5 1.7 11.3 8.0 1.6 4.7 4.3 9.7 9.2 15.0 4.6 9.7 8.5 1.8 1.7 8.7 8.4 22.0 71.3 2.9 1.8 4.2 12.5 5.2 1.7 36.1 12.2 11.8 5.5 4.2 13.7 5.8 2.2 14.4 21.4 6.9 3.6 37.5 13.1 4.7 2.2 83.1 9.3 8.6 41.1 12.7 12.8 50.3 25.2 73.4 19.7 19.7 54.4 36.5 7.5 5.3 2.8 4.6 6.1 5.1 26.0 4.2 11.4 3.2 6.6 2.9 8.8 14.2 1.3 4.7 5.1 10.8 2.3 12.8 4.5 15.5 4.9 22.5 11.9 4.9 2.9 27.1 25.0 5.7 12.1 9.6 4.6 6.2 4.3 28.3 8.7 44.5 4.4 2.9 23.0 35.4 4.3 4.4 2.5 7.0 12.6 20.6 12.8 15.2 1.5 2.2 15.8 3.1 1.5 9.7 2.7 31.0 2.1 5.8 2.2 4.0 4.9 21.9 24.0 28.6 6.7 29.0 3.4 73.4 18.6 55.3 22.6 19.7 43.9 50.3 45.5 33.2 25.2 44.2 54.4 34.9 10.6 19.7 14.8 12.1 34.8 36.5 1.6 3.0 1.5 1.7 1.8 1.7 2.9 1.8 12.2 2.2 8.9 16.0 115.2 57.1 142.5 0.1 8.9 15.3 48.2 25.0 17.4 0.0 133.6 14.9 46.4 1.9 18.9 1.3 0.0 87.0 135.2 42.9 45.5 208.8 0.5 45.7 0.0 1.2 6.2 52.3 1.1 2.0 76.8 35.4 266.9 7.6 3.9 105.8 2.9 1.8 11.0 0.5 45.3 34.0 0.4 14.9 104.3 244.7 119.6 3.8 58.5 TNFAIP8L1 MGC17791 ENSG00000185361 "TNF alpha induced protein 8 like 1" Q8WVP5 19 4639518-4655568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 302.9;Late spermatids: 681.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 23.0;HUVEC TERT2: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA Yes "unprognostic (1.39e-1)" "unprognostic (1.14e-2)" "unprognostic (3.70e-1)" "unprognostic (9.03e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (8.39e-2)" "unprognostic (3.88e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (7.65e-2)" "unprognostic (8.99e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" 8.5 2.1 6.2 8.9 4.6 2.2 6.2 6.3 9.9 3.4 19.3 2.2 1.4 8.8 3.4 3.6 7.6 23.5 7.5 5.3 6.2 4.3 6.9 26.1 6.0 11.0 2.6 3.1 4.2 1.8 1.0 3.1 12.8 3.7 6.0 4.7 3.0 2.3 1.7 4.3 6.7 13.4 5.5 1.6 12.6 8.9 8.5 2.8 6.4 5.2 6.7 5.5 6.7 4.7 6.2 3.1 10.6 7.7 4.9 5.5 3.0 11.0 3.5 4.9 7.8 1.5 2.4 2.5 2.1 3.8 4.3 3.9 6.3 4.2 5.3 1.0 3.1 4.6 5.6 3.0 3.6 4.0 8.7 1.4 12.2 2.0 11.3 2.2 1.8 23.0 3.1 1.1 3.8 2.5 5.3 22.1 6.6 6.3 7.9 4.8 3.5 2.1 8.8 2.5 7.8 4.8 6.1 3.2 2.5 4.2 1.0 2.0 4.4 1.0 2.9 4.3 3.8 2.1 4.9 15.9 2.2 9.0 3.3 8.0 4.3 5.3 4.8 4.2 5.6 6.2 4.5 3.8 10.6 2.5 5.2 4.4 6.2 4.4 2.7 3.1 5.1 5.5 4.6 1.8 4.9 7.7 2.7 5.1 3.0 6.2 4.6 6.3 9.9 6.2 4.3 2.6 3.1 3.7 2.8 0.0 13.0 13.7 2.5 10.3 3.4 2.0 12.7 99.0 10.3 3.5 0.0 2.0 1.7 2.5 302.9 26.9 3.2 23.3 1.1 6.5 6.6 2.6 49.5 37.2 6.9 3.2 7.5 58.9 10.4 681.4 7.8 12.4 5.0 13.6 2.3 1.5 2.1 0.0 6.7 17.4 5.3 19.4 5.2 8.6 5.7 9.8 7.8 10.2 6.6 2.6 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNS2 "C1-TEN, KIAA1075, TENC1" ENSG00000111077 "Tensin 2" Q63HR2 12 53046969-53064372 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Ito cells: 80.4;Leydig cells: 131.2;Peritubular cells: 107.1;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 41.2;ASC TERT1: 28.1;HHSteC: 21.7;HSkMC: 30.8;hTERT-RPE1: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034659 Approved NA Yes "HPA034659: AB_10603349" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (5.21e-3)" "unprognostic (1.86e-1)" "unprognostic (3.59e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-2)" "unprognostic (8.97e-3)" "prognostic favorable (1.72e-4)" "prognostic favorable (9.32e-4)" "unprognostic (4.46e-2)" "unprognostic (1.09e-2)" "unprognostic (8.46e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-2)" 69.5 26.5 13.2 12.8 17.4 0.8 43.9 8.1 14.7 37.4 22.1 17.5 22.0 9.7 35.3 23.6 20.1 30.4 32.9 34.2 13.3 9.8 21.1 18.7 25.8 16.5 15.8 10.5 48.6 18.0 14.8 13.0 22.0 14.6 23.7 8.4 33.7 21.4 29.6 38.7 11.2 14.8 25.0 13.4 27.9 16.7 16.6 16.0 0.6 23.2 26.5 7.2 24.1 47.6 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.7 7.2 0.9 0.7 41.2 28.1 0.2 4.0 9.5 2.1 1.1 0.5 1.9 0.0 8.9 11.0 0.9 0.5 0.0 2.6 0.8 0.1 0.2 0.1 7.8 3.8 21.7 0.1 0.1 30.8 0.1 2.8 1.6 21.9 12.6 0.1 0.2 0.1 8.7 1.7 0.0 0.0 0.6 0.5 2.0 0.2 2.3 0.1 2.9 0.1 0.4 0.9 1.5 0.8 3.1 0.6 9.1 0.2 17.9 4.5 5.4 1.6 0.7 0.2 0.0 0.0 7.2 0.1 7.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.2 17.4 8.1 14.7 13.3 9.8 15.8 10.5 14.6 16.0 3.0 18.8 0.0 7.4 0.0 19.6 7.3 7.6 2.7 4.5 5.2 0.0 0.4 3.3 3.6 1.9 56.1 0.0 0.0 3.7 0.3 14.3 3.4 0.0 28.2 1.9 28.6 1.2 80.4 7.1 2.9 131.2 1.3 0.0 0.0 4.2 37.3 2.5 4.2 107.1 2.2 12.0 148.8 8.8 2.3 3.6 0.0 0.7 0.0 2.4 2.2 TONSL "IKBR, NFKBIL2" ENSG00000160949 "Tonsoku like, DNA repair protein" Q96HA7 8 144428775-144444444 "Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 31.4;Enterocytes: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024679, HPA046494" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA024679: AB_1854441, HPA046494: AB_2679673" "unprognostic (6.68e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.88e-2)" "unprognostic (7.35e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.04e-3)" "unprognostic (7.81e-2)" "unprognostic (4.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.62e-7)" "unprognostic (3.24e-2)" "unprognostic (1.78e-1)" "unprognostic (9.11e-3)" "unprognostic (7.96e-2)" 1.4 2.8 1.4 11.0 1.8 11.7 1.9 6.1 2.7 1.9 5.5 1.4 3.2 5.5 2.2 1.8 5.6 1.7 1.3 1.6 1.2 1.1 2.0 2.3 2.6 3.7 1.9 1.2 2.4 2.3 1.1 1.1 2.6 2.9 2.1 1.7 0.8 3.1 2.2 1.0 4.0 6.8 1.4 1.9 5.6 3.5 4.8 2.1 10.3 3.3 3.6 5.3 3.9 5.1 0.6 0.1 0.0 0.2 1.9 0.6 0.1 6.9 6.2 4.7 7.4 0.3 0.6 11.4 5.9 1.1 3.6 2.8 5.0 6.1 6.5 6.1 0.9 1.7 4.8 4.6 3.6 0.8 6.7 9.1 15.4 8.0 5.2 0.2 4.7 9.7 0.6 0.5 3.7 0.7 0.9 1.7 9.0 17.3 4.9 1.4 14.4 11.6 8.0 6.7 6.8 9.2 14.1 3.1 6.7 2.0 7.6 7.9 4.5 6.2 4.2 2.6 1.9 6.0 4.4 2.0 4.4 18.4 5.0 7.2 1.7 3.2 3.9 4.3 10.0 5.1 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.2 0.6 0.1 0.6 0.5 0.4 0.0 1.9 0.0 0.0 0.2 0.1 1.4 1.8 6.1 2.7 1.2 1.1 1.9 1.2 2.9 2.1 6.0 31.4 5.2 3.3 7.9 2.4 2.1 10.2 6.7 5.7 1.8 2.0 2.5 0.0 1.0 0.2 2.3 32.9 0.0 0.9 4.4 4.1 3.1 2.3 8.6 3.7 1.6 2.4 4.3 1.6 0.2 0.3 5.8 13.5 1.0 8.4 0.8 0.8 5.7 1.1 3.7 2.5 6.5 3.3 2.8 8.1 9.8 1.0 3.9 9.6 3.1 TOP1 ENSG00000198900 "DNA topoisomerase I" P11387 20 41028818-41124487 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Syncytiotrophoblasts: 670.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009058, HPA019039" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No Yes "Nucleoplasm, Nucleoli fibrillar center" "CAB009058: AB_2303554, HPA019039: AB_1858187" "unprognostic (1.46e-1)" "unprognostic (8.65e-2)" "unprognostic (1.33e-2)" "unprognostic (1.92e-3)" "unprognostic (5.05e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.86e-2)" "unprognostic (1.51e-1)" "unprognostic (4.60e-2)" "unprognostic (3.74e-3)" "unprognostic (6.51e-2)" "unprognostic (8.65e-2)" "unprognostic (4.70e-2)" "unprognostic (5.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" 26.6 31.0 24.6 46.3 25.3 55.3 37.4 39.6 31.1 21.3 30.0 11.1 26.7 29.7 22.9 22.5 36.0 20.5 29.2 21.0 23.0 18.3 31.8 32.7 37.9 38.6 21.9 20.9 25.5 22.5 22.2 39.9 43.9 25.2 23.3 27.2 13.6 25.3 34.3 26.2 24.6 48.4 23.1 27.4 36.9 26.7 14.2 24.2 54.2 31.5 25.1 40.6 25.2 41.7 9.0 17.2 18.4 11.1 5.8 8.2 4.6 22.0 15.4 28.9 23.7 11.7 14.0 28.7 20.0 17.6 23.2 21.2 40.5 27.8 62.9 21.4 10.3 24.8 21.5 34.7 31.9 34.1 13.6 17.7 80.2 12.4 28.7 30.6 34.5 27.6 15.8 17.0 22.6 37.2 20.8 24.2 23.0 34.7 21.9 26.2 49.0 48.8 21.9 23.3 22.1 28.8 41.7 27.2 33.4 24.8 20.5 24.1 16.7 31.3 19.4 20.3 21.8 21.6 30.9 23.7 18.8 16.0 17.4 21.4 13.9 15.6 73.3 25.3 19.4 17.8 9.1 9.2 14.3 6.5 9.2 8.2 9.0 7.2 6.8 8.6 8.7 7.7 6.9 18.4 5.8 11.1 17.2 7.9 4.6 24.6 25.3 39.6 31.1 23.0 18.3 21.9 20.9 25.2 24.2 110.2 181.3 71.6 274.4 218.4 93.3 38.9 84.1 73.6 228.6 94.2 56.9 139.0 63.0 78.8 6.3 78.8 108.1 210.2 57.1 149.4 129.3 136.7 76.2 114.3 86.4 68.3 88.0 63.8 84.7 6.5 55.3 93.8 69.2 72.1 73.8 94.4 93.7 112.2 65.4 91.4 80.4 84.1 77.1 95.2 57.3 187.2 670.2 61.2 78.0 206.2 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Group enriched" "Detected in many" 4 "Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 34.3 45.6 58.1 26.6 2.9 5.9 12.9 47.1 25.4 43.4 38.5 21.4 26.3 55.4 24.0 15.9 26.0 54.7 44.6 18.8 58.3 29.5 29.8 36.6 29.2 35.6 0.2 51.2 39.0 1.3 1.5 30.5 31.1 9.4 22.8 36.1 39.5 38.0 46.8 11.9 59.3 34.4 24.1 24.9 18.2 50.4 90.2 23.0 10.4 22.0 34.3 24.7 38.0 47.5 15.0 35.3 39.8 23.6 14.9 28.6 40.4 33.0 45.2 21.8 24.6 48.3 16.1 35.3 47.7 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 0.0 1.3 28.7 1.4 10.4 0.0 1.1 2.5 0.0 6.8 0.0 0.0 8.4 0.0 0.9 12.5 0.7 2.1 280.4 0.0 81.4 9.7 1.2 0.0 3.9 64.5 0.0 0.0 27.6 30.0 15.2 4.4 13.1 1.7 2.8 5.9 0.0 0.2 3.6 1.8 0.0 0.0 71.1 1.4 527.8 241.9 5.4 7.4 7.7 24.2 2.6 TOR3A "ADIR, ADIR2, FLJ22345" ENSG00000186283 "Torsin family 3 member A" Q9H497 1 179081377-179098023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 59.3;U-266/84: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028766 Approved "Intracellular and membrane" NA Yes "HPA028766: AB_10602251" "unprognostic (5.55e-2)" "unprognostic (6.52e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (3.90e-1)" "unprognostic (8.82e-3)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (4.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "prognostic unfavorable (4.78e-8)" "unprognostic (4.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" 12.3 13.5 8.0 22.9 11.4 20.6 14.9 4.5 15.5 11.0 15.9 12.5 9.5 13.8 14.3 13.2 12.9 13.3 21.3 9.9 7.4 8.4 12.4 17.3 13.5 28.1 8.2 11.8 13.4 26.8 14.2 14.9 10.7 8.7 13.3 15.5 11.0 22.2 14.6 20.4 12.0 18.0 13.3 8.3 31.3 16.0 6.5 6.2 18.1 17.7 13.6 25.0 14.8 11.1 31.3 29.3 6.4 23.0 9.7 13.6 16.5 11.0 13.6 3.9 10.8 7.9 6.2 12.1 8.3 9.9 9.7 7.0 5.8 17.5 17.8 14.9 8.0 5.9 14.4 10.7 6.9 5.1 13.7 10.0 19.4 8.1 8.8 12.8 21.1 16.9 6.9 6.3 7.6 6.5 4.0 7.0 7.0 23.4 34.1 6.6 23.6 13.0 11.8 7.9 13.2 7.6 10.0 6.8 17.3 6.1 15.5 7.8 10.4 12.3 19.5 5.1 6.9 14.6 15.5 4.4 7.7 5.4 12.6 10.8 59.3 64.0 15.1 5.4 15.0 5.5 1.7 23.0 6.4 10.9 17.9 13.6 31.3 10.1 12.2 26.4 21.8 7.9 9.3 4.7 9.7 17.2 29.3 13.5 16.5 8.0 11.4 4.5 15.5 7.4 8.4 8.2 11.8 8.7 6.2 3.0 9.4 42.4 12.5 15.0 3.2 9.3 15.3 10.7 3.4 10.4 9.8 27.3 3.3 27.9 0.8 16.4 11.8 0.0 39.1 50.7 19.2 15.1 10.4 8.6 51.9 0.0 13.8 11.1 22.5 0.0 15.8 26.1 15.1 72.1 16.3 15.7 18.6 14.0 17.7 7.7 9.0 6.5 14.4 0.9 5.1 13.8 9.2 23.6 24.3 10.7 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652520-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 25.7" "Cell type enhanced" "Detected in some" "eosinophil: 1.2;memory B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.5 0.3 1.1 3.4 2.3 1.0 1.1 25.7 0.4 1.5 0.7 2.4 1.3 0.3 0.4 6.2 4.8 12.8 1.4 0.3 1.9 1.2 0.2 2.1 3.8 2.0 0.5 0.0 2.6 1.5 0.3 0.7 1.7 3.2 3.6 0.4 0.4 5.5 1.4 0.4 11.9 0.5 0.3 0.9 4.2 0.8 9.8 0.3 2.5 0.4 0.8 7.1 0.6 3.9 1.4 0.1 1.2 0.1 0.0 0.6 0.1 2.0 0.1 0.2 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.5 3.2 2.0 1.6 0.0 0.7 3.4 2.1 0.7 0.0 0.6 6.9 0.1 3.2 2.0 0.0 0.0 2.3 0.0 1.4 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.6 1.5 11.4 1.5 0.4 0.0 0.1 0.0 9.3 0.1 0.2 3.0 14.6 6.8 0.3 0.0 0.6 0.0 8.7 7.1 0.0 2.3 6.2 0.0 4.5 2.7 0.5 14.6 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 1.4 0.4 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 2.3 25.7 0.3 1.9 1.2 0.5 0.0 3.2 0.3 0.0 1.0 0.0 3.9 2.7 0.5 1.2 0.0 17.4 7.9 0.0 0.0 0.2 0.0 0.0 18.5 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 2.4 0.0 0.0 10.0 0.6 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 0.1 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 70.8 23.8 28.8 22.5 2.3 4.2 27.8 29.8 16.9 43.3 32.7 50.5 30.7 33.4 17.6 16.6 32.4 37.5 32.8 27.0 49.5 14.4 12.7 65.4 22.8 34.4 0.7 25.1 16.8 1.4 1.5 27.1 19.8 6.2 23.3 25.3 48.3 30.5 33.9 29.1 41.9 19.5 32.1 27.4 25.8 23.9 77.8 20.2 11.6 11.6 20.9 14.1 45.6 17.3 13.5 20.7 30.0 15.3 15.7 48.6 29.9 22.2 45.7 12.2 21.1 29.9 15.2 89.5 31.6 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 0.0 6.2 16.2 0.8 6.2 0.8 0.8 7.6 0.0 5.7 0.0 0.0 4.4 0.0 1.0 6.4 0.3 0.6 70.0 0.4 57.2 2.9 0.6 0.0 2.5 15.9 1.6 1.2 9.8 5.3 10.6 0.9 5.1 0.0 3.6 2.6 0.3 1.2 0.6 0.0 0.0 0.3 0.0 2.1 121.8 68.8 5.4 3.9 6.9 7.3 1.4 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;lymphoid tissue: 24.6" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" NA Yes "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favorable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 1.3 1.4 8.0 6.0 19.3 18.6 2.7 2.1 14.5 1.8 3.5 30.6 0.3 3.6 4.1 1.3 6.6 2.8 3.6 1.2 13.4 6.4 2.0 1.6 2.6 13.8 28.3 6.3 2.1 2.4 2.7 2.5 2.6 14.3 2.9 3.5 0.1 2.6 1.6 1.6 6.8 4.0 3.8 14.5 6.3 3.3 10.4 28.4 24.6 2.8 0.3 14.5 6.1 3.1 7.8 4.7 16.1 2.2 8.8 15.2 2.6 8.9 7.1 9.1 0.6 3.6 5.0 12.0 14.2 12.3 17.8 17.1 0.7 15.6 23.9 10.6 10.6 5.6 15.3 0.0 5.8 23.5 21.7 8.6 0.8 2.1 1.0 5.1 10.5 1.4 4.2 1.7 8.6 6.1 10.8 12.4 3.6 11.2 10.2 16.6 9.4 6.4 0.7 23.9 5.8 11.9 9.0 7.9 10.7 6.2 2.9 5.9 1.3 4.0 11.9 0.3 12.8 14.1 9.8 9.4 1.3 4.2 2.1 1.3 17.0 6.1 6.0 1.5 13.8 1.4 16.1 2.2 3.7 8.3 2.2 9.4 7.8 13.6 11.2 3.2 6.9 9.4 11.1 2.7 8.8 1.0 4.7 15.2 2.6 8.0 19.3 2.1 11.8 13.4 6.4 28.3 6.3 14.3 28.4 0.0 6.2 12.3 4.2 4.2 0.4 0.7 2.5 1.4 1.2 1.8 5.9 4.1 0.0 1.7 23.4 1.8 1.1 0.0 1.7 9.8 1.8 1.8 1.1 0.0 2.5 0.0 10.4 2.5 3.0 10.7 0.3 2.1 3.3 1.0 2.2 0.5 1.4 3.5 0.7 1.4 1.3 0.0 0.5 12.5 13.9 3.9 2.1 12.8 4.4 2.7 TROAP TASTIN ENSG00000135451 "Trophinin associated protein" Q12815 12 49323236-49331731 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.3;lymphoid tissue: 45.6;testis: 29.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 58.4;Extravillous trophoblasts: 19.1;Late spermatids: 57.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA044102 Uncertain NA Yes "HPA044102: AB_10963691" "unprognostic (1.47e-1)" "unprognostic (2.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.92e-3)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.43e-3)" "unprognostic (2.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.08e-3)" "unprognostic (3.51e-2)" "unprognostic (0.00e+0)" "unprognostic (1.80e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (5.17e-2)" 0.7 1.3 0.3 17.3 0.4 26.3 2.6 0.4 0.9 2.1 6.5 0.5 0.3 5.1 0.8 2.5 11.2 0.5 3.2 1.9 0.4 0.2 1.2 1.3 2.0 6.2 0.3 0.5 0.8 0.8 0.0 0.5 4.3 0.7 0.9 5.5 0.6 2.2 0.8 0.7 4.3 5.2 1.4 0.4 5.9 4.0 29.1 0.3 45.6 0.7 7.0 10.8 1.1 4.1 2.0 0.4 0.2 0.1 2.3 10.9 0.9 23.9 19.0 24.8 18.1 0.7 1.8 18.6 11.7 11.6 35.2 20.2 42.0 19.0 16.4 5.8 8.9 18.9 19.2 19.3 11.4 20.5 13.2 26.4 22.8 30.1 13.6 0.5 16.6 24.7 0.4 1.6 23.4 16.0 5.8 19.9 18.4 14.1 28.3 14.1 31.0 30.5 25.5 11.4 70.2 28.7 15.7 20.7 21.3 8.4 9.0 15.8 10.8 14.4 27.8 8.7 15.1 22.8 12.6 6.3 8.9 24.5 18.1 31.5 15.3 16.6 20.5 8.5 18.7 9.9 0.2 0.0 0.1 0.2 0.0 0.4 2.0 2.9 3.0 0.4 1.5 0.1 0.7 0.0 2.3 0.1 0.0 10.9 0.9 0.3 0.4 0.4 0.9 0.4 0.2 0.3 0.5 0.7 0.3 0.0 0.0 0.8 1.1 3.4 0.2 0.3 0.0 0.0 2.3 0.0 0.0 6.1 0.0 0.7 58.4 0.2 0.4 0.0 0.6 19.1 1.6 0.5 0.0 0.4 12.7 0.0 1.2 5.5 2.9 57.0 1.7 1.6 1.7 1.0 2.3 0.0 0.8 1.9 0.4 0.0 0.3 0.0 0.0 15.4 7.8 1.8 3.3 2.5 4.7 2.3 TTC9C MGC29649 ENSG00000162222 "Tetratricopeptide repeat domain 9C" Q8N5M4 11 62728069-62740293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055169 Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA055169: AB_2682724" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (2.71e-2)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (6.56e-3)" "unprognostic (1.86e-3)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" "unprognostic (6.90e-3)" "unprognostic (1.33e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.67e-7)" "prognostic favorable (4.15e-5)" "unprognostic (7.49e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-2)" 17.1 19.0 23.4 20.9 24.2 6.5 18.4 26.2 29.3 19.1 19.3 15.8 21.2 25.0 22.9 21.6 18.0 22.6 18.7 13.2 21.5 22.6 20.9 17.2 16.4 28.2 20.4 20.0 32.9 22.3 12.3 18.3 23.1 22.3 18.5 18.8 16.7 21.6 20.0 21.1 24.4 18.2 19.0 17.0 23.2 18.4 17.0 17.5 31.1 24.3 13.3 27.9 21.3 18.0 25.2 20.2 31.0 23.9 16.8 22.7 14.0 20.2 17.5 14.6 14.3 20.1 24.4 10.8 20.8 21.4 25.7 21.2 15.5 20.2 15.4 39.8 14.6 22.3 18.4 21.6 6.5 20.0 40.1 10.8 17.0 25.6 18.6 23.1 11.4 19.0 16.1 13.9 20.8 21.1 18.6 18.8 18.6 12.3 15.6 24.4 14.8 18.1 24.3 12.4 16.5 13.9 14.4 18.6 23.3 16.2 8.0 12.8 10.5 18.0 16.0 25.2 13.5 21.0 11.0 16.2 26.3 15.3 29.0 14.9 16.4 24.6 17.1 14.3 8.8 13.6 31.0 23.9 23.1 14.4 21.3 11.0 25.2 15.4 14.2 20.2 22.6 15.4 13.9 15.3 16.8 13.8 20.2 22.7 14.0 23.4 24.2 26.2 29.3 21.5 22.6 20.4 20.0 22.3 17.5 14.9 10.4 25.9 12.6 26.3 17.1 7.0 7.6 13.4 15.9 17.4 7.9 29.1 23.2 20.0 18.9 21.4 16.9 0.0 13.1 36.2 23.8 13.9 8.1 7.8 33.4 27.0 5.8 13.5 24.8 15.9 26.2 19.0 15.1 42.3 12.6 13.2 18.1 18.2 25.8 20.6 16.8 32.3 18.4 27.7 26.6 29.1 19.9 20.8 15.3 17.6 TTF2 "HuF2, ZGRF6" ENSG00000116830 "Transcription termination factor 2" Q9UNY4 1 117060303-117107453 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005776, HPA070762" Approved Supported Cytosol NA Yes Cytosol "HPA005776: AB_1080416, HPA070762: AB_2686307" "unprognostic (1.82e-1)" "unprognostic (2.18e-1)" "unprognostic (3.29e-3)" "unprognostic (2.01e-3)" "unprognostic (4.90e-2)" "unprognostic (3.41e-3)" "unprognostic (5.27e-4)" "unprognostic (7.96e-2)" "unprognostic (1.92e-2)" "unprognostic (3.33e-1)" "unprognostic (4.64e-2)" "unprognostic (9.52e-3)" "unprognostic (7.34e-3)" "unprognostic (1.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.65e-2)" 5.7 9.4 5.4 8.5 8.4 6.6 6.0 0.9 5.2 5.9 7.0 8.4 2.6 6.0 5.9 2.3 9.8 4.5 3.9 5.8 4.6 3.8 3.9 3.1 4.7 11.5 12.0 2.1 5.5 5.5 6.7 10.7 4.9 7.2 5.0 8.1 4.2 6.5 3.6 8.4 6.9 5.7 6.8 7.7 6.8 5.4 6.3 8.0 25.1 5.2 7.8 17.8 6.4 6.5 3.7 5.9 3.2 6.3 5.3 6.1 2.5 12.7 4.7 9.5 13.4 3.8 3.3 11.9 6.8 3.2 10.1 9.0 6.6 2.2 15.5 10.6 4.5 11.3 13.3 16.8 8.8 15.6 11.9 11.8 13.2 9.1 8.3 2.7 19.3 15.3 3.8 3.4 7.4 13.9 2.5 6.8 12.3 10.1 14.2 7.6 19.5 12.8 12.0 14.9 12.2 9.5 18.5 35.1 6.8 6.1 5.8 8.2 3.4 10.3 10.3 3.8 7.6 5.6 7.9 6.9 6.4 13.6 15.0 14.8 6.5 5.6 19.1 4.3 14.7 25.6 1.8 5.2 3.2 3.0 6.3 2.9 3.7 3.5 4.7 5.9 3.5 3.6 4.1 0.9 5.3 3.6 3.3 6.1 2.5 5.4 8.4 0.9 5.2 4.6 3.8 12.0 2.1 7.2 8.0 6.0 5.4 18.8 8.6 11.7 5.7 5.6 5.1 4.0 6.8 12.2 7.9 5.8 5.0 5.8 5.9 7.2 5.9 0.0 6.9 7.2 5.2 10.8 9.2 2.5 9.7 11.1 4.7 4.9 5.6 5.4 6.1 12.0 6.8 24.4 7.5 5.3 6.7 2.9 3.9 2.7 6.4 0.0 10.3 6.6 9.3 12.5 3.2 8.7 11.0 15.2 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.3;testis: 31.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 1.1 1.4 0.3 3.2 0.4 13.9 1.0 0.3 0.4 1.0 2.7 0.2 0.2 2.2 0.5 1.0 6.5 0.3 0.4 1.5 0.4 0.3 0.9 0.6 1.2 4.6 0.4 0.2 0.4 0.5 0.0 0.3 3.0 0.6 0.6 3.6 0.3 1.2 0.6 0.3 2.0 2.8 0.7 0.8 2.1 1.8 31.7 0.2 58.3 0.5 2.6 5.4 0.8 1.8 1.7 0.0 1.1 0.0 1.1 4.0 0.8 13.3 8.0 24.0 19.6 1.1 3.5 13.6 15.5 9.5 22.7 27.8 10.9 10.2 19.8 12.1 6.6 23.8 17.3 21.1 9.5 31.6 18.0 17.0 18.3 10.6 8.9 0.0 21.5 11.9 0.4 1.0 15.8 10.1 3.3 12.8 27.9 19.9 20.4 19.2 9.9 12.2 15.5 14.1 12.0 9.7 11.0 43.8 8.2 5.7 8.6 16.5 9.7 9.1 9.9 5.6 13.5 9.3 16.3 5.3 10.2 10.2 6.6 24.7 4.6 15.5 11.0 3.6 20.0 8.7 0.0 0.0 1.1 0.6 0.0 0.6 0.9 1.0 1.6 0.0 1.7 0.3 0.5 0.3 1.1 0.0 0.0 4.0 0.8 0.3 0.4 0.3 0.4 0.4 0.3 0.4 0.2 0.6 0.2 3.0 0.6 0.0 0.5 1.1 0.0 0.7 0.0 4.0 3.4 0.0 2.0 4.1 3.3 0.4 19.9 0.1 0.2 23.3 0.2 13.1 0.8 0.2 1.1 0.0 5.2 0.0 1.7 0.0 2.4 12.8 0.9 1.2 0.0 9.0 1.0 0.3 0.4 0.0 0.7 0.0 1.2 6.5 0.2 63.4 28.5 0.3 3.1 0.0 1.2 0.7 TUBA1B K-ALPHA-1 ENSG00000123416 "Tubulin alpha 1b" P68363 12 49127782-49131397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 2055.8;Extravillous trophoblasts: 2123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011513, HPA039247, HPA043684, HPA063394" Enhanced Supported Microtubules NA Yes Microtubules "CAB011513: AB_2210057, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic unfavorable (5.49e-4)" "unprognostic (4.19e-2)" "unprognostic (3.84e-3)" "unprognostic (5.84e-2)" "unprognostic (2.91e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (2.98e-3)" "unprognostic (9.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.69e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.85e-12)" "unprognostic (1.60e-1)" "unprognostic (3.52e-1)" "unprognostic (4.67e-2)" "unprognostic (3.55e-3)" 78.4 41.5 152.9 86.2 126.0 171.1 64.0 83.7 233.1 47.4 82.7 82.8 13.9 38.7 58.2 59.6 66.2 53.3 43.5 60.6 132.2 162.1 48.3 52.4 66.3 95.4 139.6 107.1 48.7 25.1 33.3 41.0 81.1 210.6 31.9 95.9 52.2 37.8 59.1 28.0 55.8 47.6 138.9 171.2 71.1 45.0 43.9 42.4 177.1 32.9 32.6 117.8 62.3 39.7 31.5 70.8 43.9 116.1 24.2 32.4 63.0 141.8 160.8 174.9 99.0 45.3 66.4 94.6 125.9 127.4 245.3 199.0 202.6 150.9 160.8 91.0 176.8 100.2 89.3 191.9 172.1 226.3 90.1 101.0 114.4 95.6 103.2 12.5 171.2 91.1 39.5 26.3 191.5 63.9 83.4 209.1 149.6 127.9 105.6 199.3 156.6 228.5 136.7 121.3 355.4 190.1 185.6 147.3 101.0 114.9 95.2 110.2 94.3 105.5 82.1 37.5 92.3 116.1 170.3 110.7 117.9 136.3 116.7 161.9 58.5 84.9 173.9 82.1 137.6 110.7 17.0 24.6 43.9 28.7 111.4 31.7 31.5 27.7 26.6 70.8 28.1 29.6 23.1 31.0 24.2 116.1 70.4 32.4 63.0 152.9 126.0 83.7 233.1 132.2 162.1 139.6 107.1 210.6 42.4 184.6 250.6 325.6 528.1 518.7 347.0 0.8 73.9 235.5 208.1 177.9 463.4 679.2 306.7 770.6 221.0 428.2 272.6 2055.8 547.5 2123.2 693.9 267.9 526.9 93.8 1800.6 470.4 291.6 371.4 295.8 163.0 302.6 786.9 448.7 1928.8 280.9 329.6 529.9 232.8 222.4 178.4 860.1 258.7 672.6 106.1 598.5 393.2 254.6 340.9 286.4 353.4 TUBA1C "bcm948, MGC10851, MGC14580, TUBA6" ENSG00000167553 "Tubulin alpha 1c" Q9BQE3 12 49188736-49274603 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 900.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 35.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 279.1" "Low region specificity" "Detected in all" "HPA039247, HPA043684, HPA063394" Supported Supported Microtubules NA Yes Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-2)" "prognostic favorable (7.37e-5)" "unprognostic (3.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.88e-2)" "prognostic unfavorable (8.48e-8)" "prognostic unfavorable (6.85e-4)" "unprognostic (2.11e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (5.64e-6)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.26e-7)" "unprognostic (2.95e-1)" "unprognostic (1.26e-1)" "unprognostic (2.49e-1)" "unprognostic (5.45e-3)" 40.4 17.0 4.6 22.2 6.7 25.4 22.5 3.5 5.2 39.1 40.8 7.3 20.0 22.2 21.9 27.9 125.5 15.0 40.3 17.6 5.4 4.4 73.2 74.8 24.9 38.9 8.4 1.2 25.2 19.4 5.1 9.4 62.1 22.8 15.1 34.2 28.6 40.9 26.3 18.6 37.5 77.1 27.1 9.3 24.6 25.7 16.7 5.2 52.6 32.7 129.7 82.9 26.7 41.9 4.6 12.1 35.4 7.7 5.4 8.8 7.9 86.6 67.8 14.8 25.4 15.9 26.8 57.6 69.7 78.5 123.1 66.1 65.9 65.7 39.2 74.6 81.8 73.9 40.1 86.5 97.5 82.1 37.9 31.0 47.6 29.5 63.4 11.9 36.7 35.2 19.4 46.7 104.6 44.1 39.1 79.1 22.0 68.1 21.4 105.9 54.6 20.1 35.9 44.7 279.1 134.7 23.1 29.1 21.7 54.1 41.3 11.8 0.6 60.5 40.1 26.2 61.3 39.1 28.9 57.5 58.4 64.7 57.7 115.8 7.1 19.9 38.0 30.7 36.3 50.4 35.4 6.1 13.2 5.8 7.7 8.8 4.6 6.1 5.3 12.1 3.2 3.0 3.4 5.6 5.4 5.7 9.4 7.6 7.9 4.6 6.7 3.5 5.2 5.4 4.4 8.4 1.2 22.8 5.2 110.2 146.6 47.0 283.9 172.8 0.6 0.6 30.6 41.5 103.5 55.8 0.0 214.4 59.7 229.8 7.4 44.2 249.9 163.5 483.8 900.6 110.0 150.7 65.8 47.8 250.7 0.0 74.3 47.3 60.7 6.3 63.0 86.0 43.9 432.8 111.1 2.9 339.7 108.7 38.2 109.4 0.4 38.8 152.7 6.9 57.4 160.1 135.1 67.5 106.5 297.1 TUBA3C "bA408E5.3, TUBA2" ENSG00000198033 "Tubulin alpha 3c" Q13748 13 19173770-19181852 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 415 "testis: 161.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 509.9;Late spermatids: 171.1;Spermatocytes: 798.7;Spermatogonia: 313.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 50 "HDLM-2: 28.0;U-2 OS: 71.3;U-266/70: 23.1;U-266/84: 28.0" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA Yes Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.76e-3)" "unprognostic (1.33e-1)" "unprognostic (3.00e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 161.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 71.3 0.0 0.0 23.1 28.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 509.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.1 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 12.9 0.0 798.7 313.9 0.3 0.0 0.0 0.0 0.0 TUBB "M40, MGC16435, OK/SW-cl.56, Tubb5" ENSG00000196230 "Tubulin beta class I" P07437 6 30720201-30725426 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.7" "Cell type enhanced" "Detected in all" 6 "Extravillous trophoblasts: 1893.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005417, CAB012406, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes 510000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (1.01e-1)" "unprognostic (2.33e-1)" "unprognostic (2.17e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (2.18e-3)" "unprognostic (1.27e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.62e-8)" "unprognostic (8.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" 51.6 27.7 30.0 31.8 33.2 78.8 30.0 30.9 57.2 43.3 37.0 24.3 18.7 10.8 58.5 39.7 39.9 41.0 29.6 33.1 23.7 48.2 31.4 74.1 32.7 62.1 27.8 24.0 81.5 27.0 15.3 16.3 41.1 39.9 32.2 34.2 30.6 27.9 24.3 29.6 37.6 24.3 37.6 27.4 47.7 29.1 19.7 14.4 198.7 26.9 36.8 91.5 39.7 34.3 15.4 17.5 8.6 15.4 12.3 18.2 19.8 42.4 15.7 61.3 26.6 17.4 30.0 0.5 0.0 0.0 0.0 0.0 29.9 16.2 21.2 26.3 19.6 16.4 14.7 49.5 44.5 0.0 11.9 31.3 0.5 0.0 17.2 8.3 57.8 28.5 22.3 10.4 0.0 0.5 13.5 21.6 46.9 16.7 0.0 27.0 30.7 41.8 0.2 0.0 13.5 18.5 0.0 0.6 12.5 35.8 24.2 10.7 35.9 23.1 10.2 0.4 39.9 26.7 5.3 13.3 64.5 28.7 0.0 0.2 19.8 38.1 49.2 12.7 57.5 81.6 4.9 7.7 8.6 15.5 12.2 18.2 15.4 12.1 17.6 6.2 10.0 12.3 12.2 4.3 12.3 15.4 17.5 14.2 19.8 30.0 33.2 30.9 57.2 23.7 48.2 27.8 24.0 39.9 14.4 122.1 48.4 184.6 261.7 511.8 64.2 96.8 186.0 50.9 100.1 162.3 37.3 493.5 263.6 1083.5 6.9 247.2 97.2 700.8 929.9 1893.7 657.3 117.4 203.1 240.5 829.2 103.3 156.9 268.2 310.8 15.4 372.8 361.3 305.4 1224.5 123.1 172.7 843.8 91.2 223.1 178.3 51.0 116.4 444.0 46.2 42.8 376.4 184.3 200.5 178.2 168.9 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241213-137243707 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 207.7" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 1754.5;Late spermatids: 2132.3;Spermatocytes: 1761.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 31.1 22.1 33.0 22.1 32.7 87.5 24.4 22.3 67.2 23.0 44.0 35.9 25.2 33.4 22.7 52.7 65.7 122.5 32.1 66.4 35.2 55.5 46.6 49.7 28.4 21.0 33.8 46.6 33.7 33.0 13.4 25.3 31.9 48.4 29.8 27.3 40.9 41.8 31.8 37.1 55.9 38.9 28.4 21.5 21.0 30.5 207.7 12.2 61.1 40.1 56.7 40.1 21.8 25.7 17.2 18.3 37.0 14.6 11.2 21.7 14.4 59.3 89.0 38.1 27.4 19.2 20.3 53.1 55.8 47.0 77.2 53.4 94.0 73.1 36.4 42.7 54.1 75.3 113.0 47.1 89.8 29.4 25.9 39.8 26.4 70.9 73.8 12.1 31.0 29.4 13.0 25.5 58.9 16.2 19.2 55.1 26.1 36.8 21.0 63.6 163.2 28.1 42.3 40.2 105.3 155.3 35.8 72.7 33.7 58.0 55.6 26.7 28.7 73.9 42.6 14.8 22.6 61.3 33.8 42.7 55.2 61.5 62.5 73.3 8.1 22.5 40.2 45.0 24.3 47.8 37.0 14.1 20.5 21.4 14.6 20.6 17.2 16.7 18.2 17.5 14.1 10.7 14.3 28.6 11.2 14.6 18.3 21.7 14.4 33.0 32.7 22.3 67.2 35.2 55.5 33.8 46.6 48.4 12.2 205.4 139.7 150.7 842.9 289.7 457.2 82.3 132.5 1026.5 175.1 136.1 282.7 235.6 187.3 348.8 1754.5 152.3 547.1 490.6 391.5 458.3 161.8 365.4 188.9 114.3 228.8 230.4 375.8 129.5 67.2 2132.3 235.3 111.2 131.6 359.7 292.5 271.2 343.5 375.2 143.9 259.6 647.3 109.9 245.2 1761.9 564.6 260.1 268.5 97.8 359.3 575.4 TUBB6 "HsT1601, MGC4083" ENSG00000176014 "Tubulin beta 6 class V" Q9BUF5 18 12307669-12344320 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 423.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.7" "Group enriched" "Detected in many" 5 "B-cells: 14.8;dendritic cells: 46.7" "Cell line enhanced" "Detected in many" "TIME: 94.1" "Region enriched" "Detected in single" 10 "olfactory region: 24.5" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes 150000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.40e-2)" "unprognostic (8.28e-3)" "unprognostic (1.22e-2)" "unprognostic (5.20e-3)" "unprognostic (8.42e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-2)" "unprognostic (4.95e-2)" "unprognostic (4.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (5.83e-3)" "unprognostic (1.99e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (9.69e-4)" 63.0 7.2 4.2 24.0 7.6 7.9 46.6 3.2 3.9 47.4 38.7 5.6 14.7 8.9 62.8 36.3 83.3 28.6 35.9 39.5 5.1 5.5 13.6 8.2 23.6 28.4 6.1 2.5 42.3 18.0 0.9 7.3 27.3 11.9 34.7 8.3 15.6 14.9 27.1 17.4 21.6 16.2 84.4 7.1 15.3 22.0 15.0 4.7 4.2 14.5 47.4 32.8 62.1 26.1 14.8 46.7 0.5 5.8 0.3 0.1 3.5 23.2 16.0 17.1 8.8 17.6 24.5 12.2 72.5 48.3 56.0 52.3 12.0 7.6 0.1 33.7 48.2 17.2 11.3 9.2 71.6 43.0 0.2 5.0 3.7 18.4 8.0 17.8 0.3 6.9 25.5 16.6 47.9 25.9 17.5 40.6 1.4 17.4 0.3 47.6 23.6 0.1 17.6 9.1 0.4 7.7 0.1 29.7 0.2 10.9 0.6 2.3 3.1 42.1 4.1 12.4 18.1 8.9 23.3 94.1 71.8 59.0 66.2 67.2 1.3 0.4 0.4 55.2 5.2 25.5 0.5 5.8 0.0 0.1 2.2 0.1 11.7 0.0 0.0 7.6 14.8 0.0 0.1 0.1 0.3 2.0 46.7 0.0 3.5 4.2 7.6 3.2 3.9 5.1 5.5 6.1 2.5 11.9 4.7 77.4 9.3 11.5 34.7 61.8 1.0 45.2 10.2 13.4 23.9 7.0 0.0 49.8 1.7 133.5 171.4 65.5 0.0 0.0 92.9 423.0 106.7 14.4 43.9 0.4 67.7 0.0 0.0 79.2 11.7 98.9 65.0 55.0 32.1 111.0 0.1 0.0 147.5 0.0 85.9 0.6 1.6 25.8 106.6 5.0 4.3 58.5 18.5 2.5 0.2 49.6 TUBG1 "TUBG, TUBGCP1" ENSG00000131462 "Tubulin gamma 1" P23258 17 42609676-42615234 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 102.4" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 583.2;Late spermatids: 391.6;Spermatocytes: 311.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004608 Enhanced NA Yes "CAB004608: AB_628417" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (1.79e-2)" "prognostic favorable (8.99e-4)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.08e-8)" "unprognostic (2.62e-3)" "unprognostic (5.67e-2)" "unprognostic (1.83e-1)" "unprognostic (3.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.48e-5)" "unprognostic (2.64e-1)" "unprognostic (3.52e-1)" "unprognostic (2.61e-3)" "unprognostic (1.97e-2)" 11.7 14.1 8.8 10.7 11.2 23.9 13.0 12.4 19.3 7.5 9.8 6.9 7.8 9.6 9.7 7.8 15.4 7.7 10.4 18.3 13.2 12.6 16.2 20.5 8.6 9.2 8.7 12.0 8.8 30.1 13.1 9.5 14.2 12.2 9.6 8.6 8.3 9.2 11.1 24.3 15.9 7.7 14.1 6.8 10.3 12.8 102.4 5.2 14.6 9.7 11.8 10.8 10.8 9.5 9.7 26.2 1.8 15.4 6.8 8.3 6.3 23.6 62.6 24.3 26.5 15.8 10.9 21.9 27.2 18.8 44.6 34.7 37.9 16.5 17.0 20.1 22.3 38.4 38.0 26.1 38.1 32.5 44.7 33.4 13.7 41.6 62.9 7.7 14.9 19.5 8.5 11.9 54.8 16.6 11.1 28.1 26.1 25.0 17.3 32.9 69.6 36.5 15.8 12.6 36.0 31.3 17.6 36.0 27.2 19.2 29.3 34.7 16.8 17.0 16.1 13.2 25.6 50.2 14.6 17.9 44.7 28.7 36.6 42.2 25.2 30.9 25.4 23.5 14.8 31.1 1.3 8.4 1.8 7.3 15.4 7.6 9.7 6.7 7.5 9.7 8.3 7.1 7.3 0.4 6.8 15.2 26.2 8.3 6.3 8.8 11.2 12.4 19.3 13.2 12.6 8.7 12.0 12.2 5.2 14.9 3.4 8.9 12.1 15.7 12.2 15.7 10.2 13.4 6.8 7.0 3.9 32.5 33.2 32.7 583.2 15.0 10.5 140.2 48.1 68.4 11.3 12.1 2.3 13.0 34.6 19.1 9.2 14.7 7.0 391.6 21.0 9.9 16.9 43.3 10.6 15.2 33.2 8.0 20.5 45.9 10.6 58.2 13.0 311.8 108.4 25.0 16.8 4.9 9.8 11.9 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles NA Yes Vesicles Nucleoplasm "HPA051426: AB_2681481" "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 19.8 13.1 10.9 6.2 12.2 3.6 13.8 9.9 17.4 15.3 13.2 10.7 9.7 11.3 17.6 14.0 9.3 15.0 11.0 11.0 10.4 10.5 13.8 12.2 9.3 4.3 12.3 11.3 16.5 10.3 9.6 9.1 17.9 10.4 15.8 8.4 10.2 14.9 14.2 15.6 14.8 11.9 12.1 8.6 7.5 11.8 32.0 11.9 2.9 20.0 11.4 6.7 11.0 14.9 0.6 1.8 0.0 0.8 0.0 0.1 0.0 6.6 1.4 1.5 0.0 4.9 4.1 0.0 5.1 0.0 2.0 2.4 0.1 2.4 0.0 1.6 6.0 5.3 0.0 3.6 6.4 1.2 0.0 7.1 25.9 7.7 0.0 2.4 0.0 0.0 5.0 9.0 2.2 5.1 0.0 2.1 0.0 0.0 0.0 2.3 3.3 0.0 0.1 1.3 5.3 6.6 0.0 1.0 0.1 2.7 3.1 0.5 11.7 6.3 5.3 5.2 3.0 4.6 7.3 4.5 0.0 9.5 0.1 0.0 0.0 0.0 0.0 6.2 1.7 6.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.8 1.8 0.0 0.0 10.9 12.2 9.9 17.4 10.4 10.5 12.3 11.3 10.4 11.9 11.9 5.4 0.0 35.5 54.0 25.2 9.7 17.8 2.7 5.7 15.7 3.9 24.7 56.3 6.4 50.7 21.8 8.0 0.0 10.7 12.0 22.0 30.2 0.0 16.4 8.1 20.6 12.6 15.4 2.2 5.0 28.4 5.3 27.0 1.0 12.7 29.9 6.4 10.5 20.5 18.1 13.4 32.3 39.6 89.6 11.5 33.1 24.3 0.0 12.8 15.6 TXNL1 "TRP32, Txl, TXNL" ENSG00000091164 "Thioredoxin like 1" O43396 18 56597208-56651600 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002828, HPA002829, CAB016446" Supported Supported Enhanced Cytosol NA Yes 1500000 Cytosol "CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359" "unprognostic (2.05e-1)" "unprognostic (2.97e-1)" "unprognostic (3.38e-3)" "unprognostic (4.54e-2)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (9.62e-6)" "unprognostic (1.83e-1)" "unprognostic (1.03e-2)" "prognostic favorable (6.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-3)" "unprognostic (1.24e-1)" "unprognostic (1.26e-1)" "unprognostic (2.62e-1)" "unprognostic (1.51e-1)" 20.5 31.9 27.9 17.8 30.0 34.0 24.4 20.6 34.5 22.5 20.1 21.5 17.3 20.1 22.1 33.8 29.6 18.0 19.8 37.2 27.7 28.5 28.0 38.5 16.4 21.7 27.7 22.8 26.1 34.3 21.5 23.3 26.8 32.1 23.1 21.6 17.6 22.4 20.9 64.4 17.6 21.1 26.5 23.4 20.4 24.0 19.3 21.1 22.3 96.0 27.7 23.3 27.7 18.9 22.2 29.9 39.0 35.3 23.4 23.0 30.9 24.8 24.6 33.3 34.3 29.0 42.5 23.7 29.7 30.6 38.4 32.6 21.8 24.6 27.1 26.5 32.3 27.8 31.0 31.5 26.9 39.8 27.6 14.4 37.1 20.6 40.8 34.0 54.0 24.2 32.2 27.9 36.1 33.2 40.6 30.8 20.8 27.1 45.5 38.8 23.9 31.2 35.3 24.1 17.3 26.5 25.5 22.5 47.0 44.8 38.9 27.7 25.3 16.9 23.7 28.1 27.7 25.9 29.0 24.4 40.4 21.3 14.0 28.9 44.2 47.3 42.3 26.3 41.4 29.5 39.0 35.3 25.3 15.9 29.6 21.7 22.2 19.7 20.8 29.9 19.3 19.4 19.6 26.5 23.4 27.9 25.5 23.0 30.9 27.9 30.0 20.6 34.5 27.7 28.5 27.7 22.8 32.1 21.1 53.6 38.7 77.2 102.3 119.4 77.4 92.0 48.4 57.6 61.4 27.9 131.6 212.5 92.9 122.4 165.3 62.6 79.4 46.7 112.7 104.6 91.2 91.6 51.9 68.4 133.8 54.0 72.8 56.4 76.0 218.7 71.9 78.2 62.4 131.7 97.3 59.0 117.2 83.1 78.8 104.9 82.7 64.7 97.8 196.1 99.4 110.2 299.9 68.2 101.2 105.2 TYMS "HsT422, TMS, TS, Tsase" ENSG00000176890 "Thymidylate synthetase" P04818 18 657604-673578 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.9;lymphoid tissue: 75.5" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 109.0;Spermatocytes: 197.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.8" "Group enriched" "Detected in many" 6 "NK-cells: 6.8;T-cells: 13.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebellum: 6.7;olfactory region: 8.8" "CAB002784, HPA074922" Enhanced NA Yes "CAB002784: , HPA074922: " "unprognostic (7.58e-2)" "unprognostic (2.06e-3)" "unprognostic (9.31e-2)" "unprognostic (2.34e-2)" "unprognostic (7.35e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.10e-6)" "unprognostic (1.62e-3)" "unprognostic (1.68e-2)" "unprognostic (9.82e-2)" "unprognostic (1.07e-3)" "unprognostic (3.28e-2)" "unprognostic (1.23e-2)" "unprognostic (6.34e-2)" "unprognostic (1.66e-1)" "unprognostic (5.65e-3)" "unprognostic (2.47e-1)" 3.0 2.6 4.6 15.5 5.8 34.9 2.8 1.2 6.3 3.4 10.1 10.2 1.5 4.8 2.5 3.6 12.3 2.4 4.6 2.0 5.8 2.9 4.8 5.1 4.2 15.4 3.4 4.5 2.0 3.1 1.1 1.3 14.3 3.4 3.0 12.9 1.1 3.4 0.8 0.7 3.6 6.9 5.5 4.6 8.9 4.2 21.5 5.3 75.5 1.7 10.9 19.3 4.8 4.3 1.2 1.8 1.0 0.1 6.8 13.8 2.5 13.9 21.5 44.9 21.7 5.0 8.4 22.8 32.9 19.7 35.6 42.7 18.1 11.2 21.7 12.9 17.7 20.2 6.3 31.3 12.4 30.8 20.4 34.8 36.8 20.2 31.1 1.1 75.6 40.4 7.4 2.9 22.4 7.0 6.8 29.7 46.2 29.5 34.9 44.8 16.0 91.0 41.9 16.2 17.0 16.1 60.2 40.4 26.1 13.3 12.4 15.3 24.9 27.8 12.9 8.3 29.1 8.8 34.5 11.7 41.2 81.4 37.7 64.2 43.3 53.3 49.6 10.9 32.7 47.0 0.0 0.0 1.0 1.1 0.1 0.0 1.2 2.9 2.2 1.8 0.0 0.0 0.7 0.6 6.8 0.1 0.3 13.8 2.5 4.6 5.8 1.2 6.3 5.8 2.9 3.4 4.5 3.4 5.3 0.0 2.9 3.0 11.2 12.8 0.4 2.1 5.1 0.0 7.9 0.0 0.0 36.1 1.7 2.4 18.3 1.5 8.4 23.3 0.7 109.0 7.2 4.0 6.9 1.7 57.9 0.0 1.2 6.2 15.9 22.3 5.8 9.2 10.1 6.4 13.0 42.9 1.4 3.5 3.5 19.4 1.9 12.9 4.1 197.1 30.9 6.4 22.5 7.5 39.0 3.5 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 107.8;U-251 MG: 70.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 30.5 2.2 6.1 4.9 29.8 23.9 4.2 44.9 16.6 34.7 28.3 5.8 14.4 1.2 10.1 34.4 12.5 5.3 6.9 13.1 57.2 4.8 10.3 5.4 7.0 11.4 14.0 9.2 3.7 11.0 6.2 38.0 107.8 15.9 21.2 9.6 30.5 12.6 46.4 5.6 5.3 5.9 4.5 31.4 10.0 4.8 11.9 14.9 5.4 3.6 6.6 6.8 19.6 12.2 10.4 7.5 6.0 10.5 36.0 17.5 16.1 44.0 70.2 21.2 7.4 10.1 10.0 4.3 11.0 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 6.0 30.4 17.9 120.0 119.7 10.0 26.6 17.8 53.5 38.7 15.7 7.9 22.4 61.3 24.8 36.3 23.3 84.7 0.0 56.9 52.1 141.3 91.8 33.4 88.9 14.0 6.4 52.6 21.5 7.0 11.8 46.9 15.2 81.0 27.9 124.5 14.0 55.8 69.1 38.9 20.2 12.3 19.4 160.3 182.9 121.8 71.5 81.7 20.1 59.9 111.6 UBC ENSG00000150991 "Ubiquitin C" P0CG48 12 124911604-124917368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000362, CAB005419, HPA041344, HPA049132" Supported NA Yes "CAB000362: AB_2301097, CAB005419: AB_2180553, HPA041344: AB_2677422, HPA049132: AB_2680646" "unprognostic (7.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (8.64e-3)" "unprognostic (2.41e-2)" "unprognostic (7.38e-2)" "unprognostic (6.35e-3)" "unprognostic (7.60e-3)" "unprognostic (1.48e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (7.90e-7)" "unprognostic (6.69e-2)" "unprognostic (2.74e-1)" "unprognostic (5.64e-2)" "unprognostic (8.81e-2)" 152.8 89.5 73.0 58.1 88.5 196.2 96.9 78.2 125.0 95.6 106.9 105.6 70.0 48.4 109.9 83.9 175.8 90.5 108.1 132.5 75.1 85.7 94.3 132.0 108.6 60.2 85.0 57.3 86.5 73.7 60.5 58.4 128.0 93.1 104.2 86.4 94.0 121.7 94.8 419.0 91.9 103.6 103.3 105.3 70.9 84.6 97.5 52.3 73.7 80.1 89.8 101.3 150.5 206.7 45.7 60.3 139.1 84.3 54.6 68.1 100.4 99.2 85.5 71.1 58.4 186.6 115.9 49.4 117.2 133.1 80.0 78.7 78.9 117.7 82.6 106.5 131.8 141.2 72.9 129.2 207.7 68.9 101.1 54.0 63.5 62.3 139.8 143.5 94.2 59.2 133.0 160.0 95.1 146.3 111.6 101.1 34.2 54.4 88.7 91.8 85.3 88.3 106.3 68.0 54.6 105.2 52.9 68.5 77.4 109.5 154.8 82.3 62.5 114.4 133.3 112.5 43.0 114.3 65.9 131.6 185.3 58.8 102.8 82.1 109.2 124.7 112.6 100.7 51.0 120.7 35.3 60.5 78.2 62.3 71.5 61.0 45.7 55.1 65.4 42.7 43.3 44.2 51.0 139.1 54.6 84.3 60.3 68.1 100.4 73.0 88.5 78.2 125.0 75.1 85.7 85.0 57.3 93.1 52.3 1348.9 1307.1 575.7 2017.4 1083.6 579.5 832.9 583.4 961.0 878.1 626.4 314.2 702.0 756.0 1214.5 3691.3 1026.8 1382.4 210.2 987.5 942.2 882.2 2124.1 868.5 392.8 1127.1 489.4 717.4 556.8 579.9 3011.0 728.6 1481.6 1157.3 2650.2 712.8 1596.5 1112.5 1297.5 780.3 726.7 905.9 601.5 1117.9 598.0 404.4 916.7 1467.0 984.5 558.6 1627.8 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Group enriched" "Detected in many" 5 "Erythroid cells: 397.1;Extravillous trophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" Yes Yes "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.3 28.9 52.2 25.0 1.4 3.2 30.0 31.3 15.9 51.6 37.1 94.9 45.6 41.8 30.7 14.9 64.3 38.9 0.2 33.5 52.7 17.8 27.5 12.9 22.2 24.9 0.4 18.4 32.3 1.0 3.6 34.9 34.2 7.8 25.1 26.7 0.2 35.6 42.4 64.9 30.3 5.2 31.3 44.8 69.3 32.2 47.3 0.2 17.4 13.7 30.1 25.1 49.3 36.1 19.8 27.4 36.5 27.1 9.1 46.3 40.5 31.4 60.5 11.3 0.3 46.5 28.1 13.1 43.8 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 0.0 5.9 29.5 3.6 15.3 0.0 0.0 2.5 0.0 7.9 0.0 0.0 15.5 0.0 0.8 5.8 0.2 5.5 397.1 0.4 368.9 5.1 2.7 5.7 3.9 75.1 0.0 1.2 22.7 19.9 5.4 0.9 9.3 0.0 1.8 12.8 0.0 1.0 6.2 0.0 0.0 0.0 0.0 1.9 6.1 18.0 10.2 26.1 10.1 15.1 8.2 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 226.9;Spermatocytes: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 60.3 32.7 28.8 22.9 1.8 2.6 5.1 49.2 14.9 30.4 27.7 22.1 21.6 58.8 20.4 12.3 36.6 17.8 28.8 12.8 13.5 46.0 95.7 35.1 18.8 7.1 5.5 42.0 34.2 2.9 3.6 22.3 21.6 6.6 11.9 32.1 34.9 41.2 19.0 16.0 56.8 21.8 72.2 16.9 55.5 50.1 22.2 21.1 8.1 12.9 73.1 39.6 62.7 15.6 27.9 9.1 11.1 22.8 18.2 18.3 52.1 15.6 116.9 33.2 79.7 69.0 19.2 29.7 66.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 0.0 4.3 37.3 136.4 144.5 56.5 2.4 7.6 0.0 0.0 19.2 51.1 34.3 13.3 44.4 86.7 31.2 25.8 70.0 26.4 226.9 94.9 63.2 18.4 9.6 55.5 30.2 88.9 22.7 24.7 27.7 16.1 39.9 70.9 55.1 28.4 76.7 57.6 28.1 11.7 14.8 59.0 12.9 96.6 216.2 140.8 101.4 50.0 44.7 30.4 121.0 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.8" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 1.9 4.2 9.6 8.5 12.2 20.8 3.9 4.4 13.5 3.5 11.2 0.7 17.2 7.5 4.3 4.1 10.3 2.9 3.0 8.8 8.8 11.2 4.5 2.8 3.1 15.2 8.7 8.2 1.3 0.9 2.4 3.1 8.7 8.2 2.2 13.9 1.9 2.8 7.0 13.1 4.5 6.9 8.1 3.4 6.7 4.0 16.0 1.8 46.8 2.6 12.8 15.3 6.3 4.5 9.0 3.6 1.7 8.6 1.1 11.1 2.9 30.4 29.1 43.3 20.4 4.0 7.4 24.8 33.3 18.6 38.1 26.9 20.7 37.4 35.5 13.2 12.1 28.4 24.9 40.0 19.5 34.4 32.2 22.9 21.7 15.8 23.6 1.8 25.9 26.4 2.6 4.7 29.9 12.5 9.1 22.1 40.1 27.3 29.3 29.8 28.3 46.4 33.1 16.8 31.7 14.8 36.0 46.1 30.8 14.6 14.6 34.1 34.8 23.3 28.7 11.1 13.5 30.2 16.4 10.8 17.2 27.5 30.0 39.5 14.9 29.1 45.2 17.0 27.0 35.6 0.0 0.8 1.7 3.7 2.4 2.8 9.0 5.0 3.9 1.7 6.3 7.3 8.0 0.0 1.1 8.6 3.6 11.1 2.9 9.6 12.2 4.4 13.5 8.8 11.2 8.7 8.2 8.2 1.8 0.0 2.1 10.4 11.0 12.7 5.2 12.2 0.0 6.7 7.9 5.2 0.0 33.9 5.0 11.2 13.0 1.9 2.7 186.9 6.6 82.9 4.8 2.2 8.1 1.7 23.5 9.5 1.2 4.3 1.8 6.6 2.8 5.2 3.3 3.6 9.0 1.3 7.8 0.0 3.9 7.9 0.9 6.5 1.9 115.5 96.9 9.5 18.8 9.5 19.6 4.1 UBQLN2 "Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157" ENSG00000188021 "Ubiquilin 2" Q9UHD9 X 56563639-56567868 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Autophagy "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006431, CAB013481" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 200000 Cytosol "Plasma membrane" "CAB013481: AB_2533341, HPA006431: AB_1078707" "unprognostic (1.23e-2)" "unprognostic (2.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.66e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-3)" 13.4 20.8 27.0 13.9 40.7 9.4 16.2 34.9 35.3 17.3 13.6 17.8 15.0 11.1 17.0 16.7 18.1 18.2 14.5 20.8 26.2 28.6 13.9 18.9 14.0 16.4 21.2 26.6 27.0 10.6 25.5 18.3 15.6 20.8 21.1 12.5 13.3 13.7 21.5 24.6 13.5 11.6 18.7 18.8 13.9 12.9 5.4 16.7 18.0 20.9 10.9 17.7 16.4 14.1 5.5 10.9 25.0 19.4 12.1 20.4 10.9 18.6 13.9 14.0 16.3 32.2 20.6 8.8 15.1 18.0 11.4 12.6 7.8 8.8 14.3 16.6 17.8 17.8 11.0 26.6 16.9 13.8 22.1 16.0 5.8 19.2 8.2 16.9 11.3 12.8 19.1 21.4 15.3 13.4 16.5 9.9 9.3 6.7 15.8 17.9 8.7 14.5 9.9 11.6 6.0 16.6 13.0 18.1 13.5 23.0 14.6 17.3 16.2 21.8 9.7 8.8 25.6 16.2 8.4 11.1 12.1 12.4 17.4 9.1 6.0 7.4 9.9 13.6 12.0 10.2 25.0 14.1 14.1 9.9 19.3 11.1 5.1 15.1 11.5 10.9 5.5 20.4 12.2 12.4 12.1 19.4 3.9 14.1 10.9 27.0 40.7 34.9 35.3 26.2 28.6 21.2 26.6 20.8 16.7 20.8 12.1 13.7 34.3 27.7 41.9 31.1 12.7 13.4 9.1 17.4 17.7 23.0 14.9 17.9 0.0 17.1 14.4 0.0 14.5 22.2 23.5 24.0 12.7 19.2 21.1 39.7 32.8 18.4 34.3 0.4 23.0 18.9 16.9 27.9 18.1 22.1 15.8 14.0 34.3 10.9 31.2 12.9 32.5 0.3 0.2 26.6 33.4 17.5 18.8 32.1 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498868-97571209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5;neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 16.0 5.6 7.7 7.3 7.1 10.2 20.5 5.1 9.0 11.5 4.6 5.8 9.7 2.9 6.6 13.9 8.1 8.3 9.0 23.8 6.8 6.5 15.6 11.2 26.0 8.3 9.1 4.8 8.9 12.9 3.1 7.8 5.3 6.4 6.5 1.5 8.9 10.7 10.8 24.2 22.7 2.5 7.0 6.7 5.3 4.1 30.3 5.7 1.0 12.9 10.9 4.4 10.3 8.6 0.3 1.7 8.5 3.4 0.0 0.4 0.5 9.0 9.0 2.4 11.9 10.1 9.5 2.8 10.4 15.3 11.2 8.6 6.0 7.9 1.1 12.7 7.0 7.0 10.9 2.4 13.9 1.5 2.7 4.7 1.1 2.8 7.5 14.6 1.0 3.1 13.1 4.7 12.1 3.0 17.2 17.8 2.4 0.6 1.7 7.1 4.3 0.4 9.2 3.9 1.7 16.6 0.9 4.2 1.0 8.6 3.4 0.8 2.5 4.7 2.9 13.4 2.2 10.8 6.8 19.1 14.2 8.7 14.8 13.5 2.2 2.5 0.4 11.9 6.1 7.3 1.3 3.4 7.5 0.2 0.8 0.2 0.3 0.1 0.0 1.7 0.0 0.1 0.0 8.5 0.0 0.9 1.2 0.4 0.5 7.7 7.1 5.1 8.1 6.8 6.5 9.1 4.8 6.4 5.7 38.7 19.9 0.0 7.7 23.1 2.2 14.1 7.6 9.4 13.6 7.0 3.9 2.8 10.0 16.1 52.6 20.4 0.3 0.0 11.2 9.4 17.5 12.5 0.0 5.8 24.5 6.4 0.0 4.9 7.3 20.2 11.8 8.5 10.1 9.0 0.1 10.1 16.8 0.0 8.9 8.1 15.9 12.9 9.0 5.9 5.7 26.0 2.4 0.9 0.2 6.2 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 75.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Group enriched" "Detected in many" 4 "dendritic cells: 8.2;T-cells: 4.2" "Cell line enhanced" "Detected in many" "MOLT-4: 63.9;REH: 145.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 0.7 0.0 0.7 8.2 3.7 16.5 0.7 0.3 4.2 0.3 1.5 1.6 0.0 2.1 0.3 0.2 2.0 0.0 1.0 0.9 1.2 0.1 0.1 0.3 10.0 4.3 0.7 0.3 0.6 0.0 0.0 1.0 1.4 0.0 1.4 0.0 0.0 0.0 0.3 1.9 2.2 0.8 0.7 2.2 1.9 3.1 4.0 75.6 0.0 4.0 6.6 1.1 0.0 0.4 8.2 1.5 0.4 0.9 4.2 0.9 15.9 11.6 17.5 12.4 0.5 2.0 2.8 13.0 6.2 13.6 13.2 13.8 8.1 9.1 3.2 5.7 4.9 8.0 12.0 7.0 9.6 14.7 13.7 7.8 10.8 14.7 0.2 19.3 11.9 1.0 0.5 7.3 1.9 2.1 4.0 14.4 11.2 10.5 8.1 12.5 63.9 11.8 7.8 5.8 12.5 145.0 39.1 6.6 3.7 11.7 13.0 10.3 10.2 5.6 1.8 2.9 10.1 18.4 5.0 14.4 11.7 18.6 15.7 4.5 4.6 26.8 8.3 18.8 18.3 0.6 0.4 0.2 1.1 0.1 0.1 0.3 1.5 1.9 2.2 0.4 0.4 1.5 1.5 0.9 0.3 8.2 4.2 0.9 0.0 0.0 1.5 0.6 0.0 2.6 1.6 2.5 1.4 1.2 0.0 0.0 1.7 0.0 1.7 2.5 0.0 0.9 0.0 0.3 5.8 0.5 0.5 0.0 0.6 7.5 3.2 0.0 0.0 2.1 0.9 0.6 0.7 0.0 2.8 1.5 0.5 2.6 1.9 0.4 0.0 0.8 0.0 1.5 4.2 6.9 0.0 1.1 0.0 4.7 0.7 UNG "DGU, HIGM4, UDG, UNG1, UNG2" ENSG00000076248 "Uracil DNA glycosylase" P13051 12 109097574-109110992 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB011605 Uncertain Approved Cytosol NA Yes Cytosol "CAB011605: AB_778737" "unprognostic (4.38e-2)" "unprognostic (3.82e-3)" "unprognostic (1.03e-2)" "unprognostic (1.33e-2)" "unprognostic (4.64e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.68e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.66e-2)" "unprognostic (8.78e-3)" "unprognostic (1.91e-1)" "unprognostic (1.35e-3)" "unprognostic (2.57e-2)" "unprognostic (4.50e-1)" "unprognostic (1.40e-2)" "unprognostic (6.89e-2)" 16.3 44.1 17.0 19.4 17.0 10.0 22.8 10.5 14.4 13.5 20.3 10.2 21.4 12.6 11.8 10.8 22.5 11.8 11.0 15.4 13.5 13.1 20.4 23.3 7.1 12.1 19.6 12.2 12.3 12.7 17.3 8.9 18.6 12.0 12.9 22.1 10.7 16.6 19.7 29.1 22.5 13.5 11.0 19.7 13.2 12.3 35.6 9.8 35.1 25.1 19.8 19.0 11.5 14.4 9.8 3.9 5.8 3.0 8.7 19.5 7.9 20.1 20.7 20.0 18.1 33.3 9.6 19.1 11.9 8.2 18.9 14.5 16.4 13.9 26.5 18.0 10.7 9.9 12.8 22.0 12.4 18.4 22.4 40.9 25.9 12.0 27.7 5.0 38.4 16.0 8.6 11.4 9.0 5.0 15.1 13.6 31.9 20.9 8.9 12.7 25.2 35.3 45.4 35.5 32.9 32.0 32.6 30.1 22.6 11.8 25.5 28.5 15.8 21.5 18.5 10.4 27.2 34.5 18.0 7.0 16.4 14.7 10.8 16.5 17.3 37.2 50.3 12.5 25.9 20.0 5.8 1.5 2.7 13.4 3.0 19.5 9.8 15.9 15.5 3.9 9.2 10.3 11.5 0.0 8.7 3.0 2.8 14.0 7.9 17.0 17.0 10.5 14.4 13.5 13.1 19.6 12.2 12.0 9.8 0.0 4.5 6.7 10.0 16.0 2.6 10.6 7.6 2.7 2.3 40.1 3.9 41.8 16.6 11.9 3.2 11.6 7.3 0.0 5.5 24.6 10.3 5.9 7.0 20.3 15.7 4.8 8.1 14.7 2.9 3.4 13.0 4.5 13.5 5.4 18.2 11.8 5.9 7.0 13.8 14.6 3.0 6.5 9.0 18.6 64.3 18.2 17.0 17.8 34.2 7.6 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VPS25 "DERP9, EAP20, MGC10540" ENSG00000131475 "Vacuolar protein sorting 25 homolog" Q9BRG1 17 42773436-42779599 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004978, HPA052217, HPA057284" Uncertain Approved Centrosome NA Yes Centrosome "CAB004978: AB_426095, HPA052217: AB_2681765, HPA057284: AB_2683397" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-4)" "unprognostic (7.37e-2)" "unprognostic (7.57e-2)" "unprognostic (9.83e-3)" "unprognostic (2.76e-3)" "unprognostic (5.84e-2)" "unprognostic (1.25e-1)" "unprognostic (2.90e-1)" "unprognostic (8.10e-3)" "unprognostic (3.88e-1)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" 18.5 22.8 14.0 16.9 17.4 17.9 26.2 11.0 28.2 21.0 28.8 20.9 23.9 25.3 21.5 32.8 45.9 28.7 22.6 18.0 15.5 12.2 48.7 48.0 17.4 22.0 12.7 15.3 21.7 41.3 28.5 15.7 36.7 17.3 21.3 33.3 27.4 32.6 18.7 24.7 26.0 37.9 20.5 11.3 21.2 25.1 26.6 11.5 32.1 29.2 31.9 37.4 18.7 22.8 19.8 33.2 42.4 35.4 31.0 20.2 22.3 17.4 36.3 27.7 16.7 35.3 24.2 25.7 22.2 31.4 45.7 32.0 31.1 20.6 17.5 37.2 32.3 24.2 18.3 38.1 48.4 29.7 15.9 47.9 13.2 24.0 46.0 36.5 24.7 17.7 32.8 31.3 40.5 43.5 27.2 28.6 21.1 45.0 17.7 27.4 25.1 35.5 27.3 21.3 39.9 25.6 13.3 33.5 28.3 54.8 20.0 23.6 18.2 12.5 16.2 33.6 44.6 37.3 26.3 15.4 29.1 18.7 16.3 23.6 17.5 9.9 25.4 25.5 16.9 21.3 28.8 32.2 42.4 17.1 35.4 17.4 19.8 18.7 20.2 33.2 17.0 19.1 18.1 18.7 31.0 31.2 22.4 17.1 22.3 14.0 17.4 11.0 28.2 15.5 12.2 12.7 15.3 17.3 11.5 23.8 27.6 21.6 37.4 12.4 22.7 23.4 50.9 58.9 38.7 59.3 13.7 121.4 112.7 124.9 2.0 24.1 66.4 46.7 133.4 153.4 26.3 34.8 28.8 40.4 88.0 22.3 39.4 25.2 36.7 4.2 25.6 28.4 40.5 55.1 64.5 42.1 108.5 61.4 28.7 82.0 23.0 32.3 21.5 37.9 47.3 19.9 101.7 28.4 58.3 47.7 WDR34 "bA216B9.3, DIC5, FAP133, MGC20486" ENSG00000119333 "WD repeat domain 34" Q96EX3 9 128633661-128656787 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 19.1;naive B-cell: 25.3" "Lineage enriched" "Detected in many" 4 "B-cells: 25.3" "Cell line enhanced" "Detected in all" "MCF7: 89.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040764, HPA041091" Approved Approved Cytosol NA Yes Cytosol "HPA040764: AB_10795625, HPA041091: AB_10796237" "unprognostic (1.45e-1)" "prognostic favorable (1.63e-4)" "unprognostic (2.55e-1)" "prognostic favorable (7.01e-5)" "unprognostic (2.27e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (8.79e-4)" "unprognostic (6.04e-2)" "unprognostic (4.39e-1)" "unprognostic (3.65e-1)" "unprognostic (8.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-3)" "unprognostic (2.06e-2)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 6.3 23.0 8.2 16.9 9.0 23.4 21.3 4.2 12.3 12.6 13.6 7.4 24.1 17.3 11.4 19.9 17.3 24.4 24.2 13.6 8.0 9.1 23.6 16.0 14.4 9.1 5.6 8.0 13.1 23.9 14.8 18.2 15.1 14.2 14.5 8.3 11.2 21.6 24.1 7.3 12.3 14.3 9.2 6.2 11.6 16.1 51.0 7.1 42.1 33.1 17.8 13.7 8.6 11.2 25.3 5.6 0.9 2.5 2.0 2.8 1.9 23.2 42.1 11.4 16.6 2.5 3.7 33.5 10.3 6.8 14.1 9.0 20.7 42.3 8.8 7.1 6.2 13.3 38.9 9.9 10.7 3.5 20.0 8.9 5.6 29.9 10.5 3.1 8.8 9.0 1.7 5.4 14.1 4.0 5.2 9.6 24.2 17.3 7.4 7.4 89.2 31.9 22.6 14.0 19.7 26.2 34.5 14.4 28.8 8.8 7.7 27.5 22.3 31.2 28.7 7.5 3.1 49.2 8.6 6.2 17.2 25.6 20.6 19.2 8.6 21.0 8.2 15.4 8.8 15.6 0.9 0.5 0.2 0.8 0.8 1.2 19.1 1.5 2.1 1.4 25.3 0.6 0.9 0.4 2.0 2.5 5.6 2.8 1.9 8.2 9.0 4.2 12.3 8.0 9.1 5.6 8.0 14.2 7.1 44.7 36.9 20.1 22.9 11.9 2.1 18.2 53.5 68.3 44.3 33.2 0.0 49.8 69.6 49.2 78.8 9.8 97.6 23.3 49.4 74.8 25.8 19.9 14.9 50.3 18.9 3.2 54.1 14.1 3.8 159.5 19.0 5.3 21.9 2.8 42.2 17.0 36.8 31.3 18.7 64.3 11.3 12.9 11.7 106.6 71.8 10.2 31.2 7.2 46.6 15.9 WDR76 FLJ12973 ENSG00000092470 "WD repeat domain 76" Q9H967 15 43826963-43868419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 37.2" "Cell type enhanced" "Detected in many" 10 "Spermatogonia: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039804, HPA040626" Uncertain Approved "Nucleoli fibrillar center,Nuclear bodies" NA Yes "Nuclear bodies" "Nucleoli fibrillar center" "HPA039804: AB_10795297, HPA040626: AB_10795527" "unprognostic (2.26e-1)" "unprognostic (7.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.85e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (6.98e-4)" "prognostic unfavorable (8.02e-5)" "unprognostic (4.24e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.91e-2)" "prognostic unfavorable (1.35e-8)" "unprognostic (7.71e-2)" "unprognostic (9.42e-2)" "unprognostic (4.02e-2)" "unprognostic (3.28e-2)" 5.4 1.8 2.4 21.9 3.0 17.5 4.8 12.9 6.0 5.3 6.3 1.5 1.6 3.6 4.9 3.6 8.2 3.3 2.1 2.5 2.4 2.0 2.8 2.5 5.1 19.8 2.4 2.1 4.2 4.8 3.9 3.3 4.3 3.3 4.2 6.8 4.5 4.6 2.4 1.4 6.3 5.8 7.0 3.9 6.5 4.8 6.7 2.1 37.2 2.9 7.1 21.9 5.3 5.5 3.2 1.6 0.4 0.8 5.7 8.3 2.6 11.1 5.7 13.6 10.4 1.5 3.7 3.7 18.8 11.2 20.6 26.0 7.2 5.9 16.5 8.3 8.7 10.4 16.2 14.0 6.7 18.0 25.6 8.3 20.3 18.2 2.3 0.8 20.6 9.1 1.1 1.1 11.3 2.6 3.0 6.5 17.9 15.3 28.9 14.1 3.9 19.9 4.8 4.8 3.5 5.9 21.4 23.4 10.4 3.8 11.6 10.5 10.4 11.8 7.5 2.3 4.4 11.6 10.0 2.9 19.0 9.0 21.2 19.0 14.3 35.6 42.1 13.6 18.3 10.4 0.0 0.8 0.4 5.1 0.5 5.4 2.5 6.4 4.4 1.3 3.2 5.2 4.1 0.0 5.7 0.2 1.6 8.3 2.6 2.4 3.0 12.9 6.0 2.4 2.0 2.4 2.1 3.3 2.1 3.0 2.2 6.0 3.1 6.5 2.0 1.2 0.0 0.0 3.4 1.8 9.8 5.5 1.7 2.0 1.5 3.5 0.8 0.0 3.5 11.4 2.5 1.6 5.7 0.4 7.5 1.6 0.0 3.1 3.3 0.6 1.7 3.1 3.3 3.6 2.2 7.3 0.9 1.5 2.1 0.6 15.7 6.5 5.3 8.7 44.7 5.1 3.0 10.9 5.6 1.3 ZC3H15 LEREPO4 ENSG00000065548 "Zinc finger CCCH-type containing 15" Q8WU90 2 186486156-186509363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031099, HPA031100, HPA031101" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669" "unprognostic (1.51e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.24e-1)" "unprognostic (3.11e-3)" "unprognostic (5.92e-2)" "unprognostic (8.15e-2)" "prognostic unfavorable (1.48e-7)" "unprognostic (9.08e-3)" "unprognostic (4.95e-2)" "prognostic favorable (3.98e-4)" "prognostic unfavorable (9.75e-4)" "unprognostic (5.72e-3)" "unprognostic (5.69e-2)" "unprognostic (1.87e-1)" "unprognostic (1.82e-1)" "unprognostic (8.89e-2)" "unprognostic (3.45e-2)" 25.2 31.1 35.7 25.2 40.1 67.3 38.0 32.9 52.6 24.7 24.7 10.5 30.2 29.0 25.1 30.7 28.2 19.8 22.6 25.2 60.0 35.4 32.8 40.3 20.3 29.5 32.3 33.5 24.5 32.7 26.9 35.3 29.4 51.6 24.3 28.9 10.7 25.8 26.2 58.0 27.0 29.9 27.4 43.4 28.5 23.3 23.7 21.7 28.3 30.5 19.0 30.1 30.0 38.8 32.8 31.1 28.3 39.1 32.5 36.9 22.4 27.2 18.5 22.9 29.4 26.1 26.5 34.4 30.4 20.8 28.2 25.5 53.9 22.1 37.2 27.9 21.5 36.2 19.9 42.1 37.1 40.0 33.8 32.2 53.4 28.6 59.6 35.3 54.3 32.8 21.6 41.2 30.6 43.6 24.9 30.2 23.2 51.0 29.2 29.4 24.5 34.6 38.8 43.2 36.0 46.9 27.7 31.0 34.6 35.7 33.3 27.7 20.4 19.2 26.3 43.9 36.0 18.5 39.6 25.9 31.9 27.6 19.5 36.2 25.5 42.7 53.2 28.3 38.6 27.8 28.3 27.5 26.9 27.2 34.0 33.7 32.8 33.8 34.5 31.1 24.7 31.5 33.2 16.8 32.5 39.1 27.5 36.9 22.4 35.7 40.1 32.9 52.6 60.0 35.4 32.3 33.5 51.6 21.7 68.5 78.9 141.2 127.1 188.5 73.2 87.6 66.2 78.9 102.4 109.9 56.9 114.7 217.2 91.2 123.7 87.8 121.8 46.7 90.4 141.8 94.0 129.7 109.7 114.6 109.7 54.0 97.5 65.7 86.1 224.0 72.8 100.6 60.8 118.2 99.1 80.5 96.4 97.7 82.0 189.8 120.6 32.3 103.2 184.4 186.8 182.8 148.5 83.7 117.5 153.1 ZNF367 FLJ33970 ENSG00000165244 "Zinc finger protein 367" Q7RTV3 9 96385941-96418329 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.8;lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.9;Sertoli cells: 6.5;Spermatocytes: 7.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 7 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015319, HPA015785" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA015319: AB_2669185, HPA015785: AB_2217750" "unprognostic (5.91e-2)" "unprognostic (2.78e-3)" "unprognostic (2.17e-2)" "unprognostic (1.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.57e-3)" "unprognostic (7.76e-3)" "unprognostic (1.60e-3)" "unprognostic (4.35e-2)" "unprognostic (3.01e-1)" "unprognostic (3.78e-3)" "unprognostic (2.71e-2)" "unprognostic (4.88e-3)" "unprognostic (3.23e-3)" "unprognostic (1.72e-1)" "prognostic favorable (2.34e-4)" "unprognostic (2.28e-1)" 2.7 1.2 2.1 8.9 4.6 23.8 4.4 2.9 3.9 2.2 4.9 2.9 1.7 3.2 1.3 2.1 4.5 1.3 3.0 4.6 2.5 2.1 3.3 12.0 2.6 4.7 4.4 2.0 2.2 1.8 3.9 0.6 3.7 3.8 1.4 3.8 2.1 3.2 0.6 3.9 3.9 3.2 2.6 4.3 3.4 2.4 9.6 4.3 21.5 1.3 6.5 5.0 2.1 2.5 0.1 0.2 0.1 0.2 0.1 1.8 0.7 13.3 5.5 5.4 4.9 2.1 3.0 7.4 18.7 11.1 9.3 11.2 3.4 9.5 10.2 8.0 8.9 7.0 16.5 6.3 6.8 11.1 11.1 5.5 7.4 10.6 2.8 0.0 10.3 9.1 0.5 0.4 7.5 3.8 2.0 3.4 7.2 6.7 24.9 11.9 8.9 15.8 8.5 3.7 14.8 9.1 8.0 27.6 6.2 2.7 9.0 9.6 6.7 8.2 9.9 5.7 4.6 5.2 9.2 3.0 15.4 8.8 14.1 14.1 9.7 16.4 4.2 9.3 9.1 12.9 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.8 1.2 0.2 0.1 1.1 1.3 0.0 0.1 0.2 0.1 1.8 0.7 2.1 4.6 2.9 3.9 2.5 2.1 4.4 2.0 3.8 4.3 0.0 0.0 2.2 1.0 8.9 0.6 2.2 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.4 0.6 0.6 0.6 0.0 1.0 3.5 1.7 0.4 0.0 3.9 1.7 0.0 0.0 1.3 2.5 0.6 0.6 1.5 3.3 0.0 1.9 0.5 0.5 0.0 0.7 2.2 1.5 6.5 2.5 7.2 1.4 5.6 0.7 2.5 2.5 0.1 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872363-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 2: 5.6;granulocytes: 6.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.6;U-2 OS: 31.2" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Nucleoli rim,Intermediate filaments" NA Yes "Nucleoli, Nucleoli rim" "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: AB_2732705" "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 0.9 2.2 4.6 0.7 4.8 0.1 2.6 5.8 4.8 1.5 2.5 0.2 2.0 10.9 1.2 3.7 2.2 6.0 4.6 4.4 1.5 1.0 1.8 3.1 6.0 7.5 0.8 2.6 8.2 2.6 4.6 1.6 2.6 2.2 1.5 2.9 1.0 1.8 7.0 3.9 1.9 3.4 2.6 1.2 1.5 1.1 1.9 0.9 1.9 0.4 2.1 1.9 0.6 2.3 0.3 2.4 0.3 6.0 8.6 1.4 3.2 1.6 2.0 2.8 0.2 0.8 0.0 3.4 1.5 0.0 0.3 0.4 1.6 2.8 0.3 2.3 0.8 0.0 0.9 2.2 0.2 0.6 5.1 3.9 1.5 1.4 7.0 1.7 0.0 0.1 0.0 1.9 0.2 0.0 0.0 1.9 0.1 0.5 0.0 1.3 0.4 2.0 1.5 1.3 1.0 1.3 0.6 1.6 4.5 0.1 0.9 0.7 2.9 31.2 2.6 1.8 4.1 5.3 0.0 4.1 0.0 1.6 0.0 0.3 1.9 0.7 0.0 0.8 0.9 1.4 0.0 0.4 1.9 1.9 1.5 0.0 2.1 0.4 0.9 1.3 0.6 0.0 5.6 0.0 0.5 0.0 3.7 4.0 0.0 1.4 0.0 0.0 0.0 1.2 0.0 0.5 0.9 0.4 0.2 0.0 0.2 1.0 0.8 0.6 6.9 0.0 0.6 4.8 2.4 1.3 0.3 0.0 0.9 0.1 0.0 0.0 0.6 3.5 0.2 0.0 3.2 0.3 2.5 0.0 1.0 1.6 1.9 0.0 0.8 0.0 0.8 0.6 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 11.3 12.5 11.1 16.4 13.6 15.1 12.1 18.6 15.3 10.2 13.0 17.3 15.0 13.8 12.1 10.7 15.9 11.3 13.3 20.1 11.4 10.2 14.8 27.5 13.6 16.7 14.1 7.5 12.0 14.1 20.4 14.1 16.1 12.4 18.7 11.1 15.1 24.1 14.8 46.6 13.3 16.8 11.3 11.2 16.0 12.7 12.4 14.5 28.1 21.7 21.0 17.3 14.5 10.4 14.5 20.8 9.6 13.4 10.5 8.0 10.3 10.2 11.7 9.6 10.7 5.4 3.8 18.1 9.8 5.3 6.9 7.6 6.4 10.8 11.6 10.1 6.4 5.4 10.1 5.2 7.2 4.6 16.8 2.9 17.7 10.8 8.6 7.0 7.7 13.7 4.2 6.0 9.2 6.6 5.7 6.5 8.0 21.5 9.7 4.9 7.4 13.6 7.7 11.0 11.8 19.9 25.7 9.1 9.1 7.2 8.5 14.1 12.4 8.7 13.3 8.6 6.0 7.7 15.8 5.5 9.8 5.8 6.5 19.8 29.1 10.9 6.8 9.1 13.6 8.0 7.6 13.3 9.6 8.0 13.4 6.7 10.8 5.7 7.9 20.8 14.5 6.3 5.6 8.1 10.5 12.4 11.7 6.5 10.3 11.1 13.6 18.6 15.3 11.4 10.2 14.1 7.5 12.4 14.5 3.0 17.5 21.4 22.4 11.6 21.0 16.9 7.6 5.3 4.5 15.7 11.8 28.2 18.3 16.4 6.2 12.1 18.8 0.0 9.4 16.4 10.8 20.5 28.7 14.8 15.4 9.5 17.3 5.5 15.2 8.9 5.2 14.1 11.8 12.6 16.6 19.2 12.1 17.3 5.3 13.5 30.2 6.5 9.9 22.9 13.6 12.8 59.6 13.8 15.2 19.9 ZNF718 FLJ90036 ENSG00000250312 "Zinc finger protein 718" 4 124480-202303 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 17.0" NA Yes "unprognostic (1.96e-1)" "unprognostic (1.38e-1)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (3.62e-2)" "unprognostic (6.59e-3)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.60e-1)" "unprognostic (8.97e-2)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.67e-6)" "unprognostic (1.39e-1)" "unprognostic (6.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" 3.1 6.0 5.9 5.7 7.7 4.7 4.6 16.0 7.5 6.9 4.7 7.7 4.5 3.0 6.5 4.3 2.8 5.9 3.6 2.9 6.5 4.8 2.7 3.5 6.5 9.7 5.8 7.2 4.6 8.8 17.8 5.4 7.2 5.9 4.4 7.8 3.1 4.2 1.4 5.3 3.3 5.0 9.1 5.0 3.4 3.9 10.5 11.0 9.1 1.7 6.2 5.4 3.0 4.3 4.4 9.6 3.2 9.0 4.2 2.1 0.0 0.9 5.1 0.1 3.2 5.9 1.2 6.3 0.9 4.1 3.4 5.3 7.1 7.6 3.8 2.2 7.2 1.9 4.0 2.9 5.5 0.0 1.5 0.0 1.3 0.0 3.9 0.0 0.2 3.1 2.6 4.1 0.5 3.6 2.7 2.2 3.5 0.0 7.0 3.9 0.7 4.8 6.3 0.0 2.4 17.0 2.0 4.3 3.3 1.9 6.8 1.6 3.2 1.1 3.8 4.2 11.7 1.9 1.9 3.0 3.8 3.8 4.6 0.0 0.0 12.1 0.0 0.0 3.7 4.7 2.5 9.6 4.2 3.2 4.1 3.9 3.6 2.6 4.3 4.3 4.2 4.0 3.1 9.0 1.9 4.4 2.7 2.1 3.0 2.2 0.5 1.7 1.8 8.3 1.6 0.0 4.0 7.9 0.0 2.0 1.6 0.0 2.8 0.3 2.9 0.5 0.0 1.2 1.2 1.5 1.5 5.7 0.4 1.2 7.9 1.2 8.0 2.1 0.4 3.4 2.5 3.3 1.0 0.7 2.4 1.2 0.0 4.2 1.8 4.6 0.0 2.8 1.7 2.3 0.6 1.1 2.9 0.6 0.6 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081297 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 26.4 27.4 39.8 31.1 42.2 35.1 34.4 54.1 48.6 39.3 28.8 19.6 33.3 23.4 48.3 45.6 20.2 30.6 20.3 27.5 33.5 30.6 20.1 19.5 26.7 37.8 34.1 40.5 39.5 23.9 23.1 77.5 24.6 32.0 30.5 29.3 17.5 25.1 33.2 54.4 27.9 24.9 35.1 42.2 26.2 23.6 31.6 38.0 40.0 32.8 24.3 30.9 32.8 25.6 31.4 34.0 32.1 16.3 20.9 30.8 13.8 23.7 8.6 35.6 20.5 13.9 24.0 20.3 29.1 16.0 25.6 32.7 16.1 15.4 49.3 25.8 17.9 24.1 15.0 30.1 18.1 38.4 34.8 21.7 42.8 33.8 13.4 20.7 46.6 17.5 18.2 22.7 24.9 21.5 29.0 21.5 25.5 44.7 26.4 19.5 8.1 38.1 15.1 36.3 14.2 16.9 43.4 26.6 28.9 16.5 20.3 26.5 16.8 24.8 16.7 24.8 19.4 20.5 20.5 28.8 18.9 18.1 14.8 28.7 21.8 27.0 54.2 27.9 43.5 26.5 32.1 16.3 14.2 22.2 15.0 25.1 30.6 23.6 21.3 12.4 31.4 30.8 24.2 14.6 20.9 14.8 34.0 22.0 13.8 39.8 42.2 54.1 48.6 33.5 30.6 34.1 40.5 32.0 38.0 92.3 128.7 70.6 66.5 45.0 171.8 89.9 58.6 91.0 72.8 47.1 121.7 45.9 41.4 45.1 111.6 51.1 53.4 23.3 58.7 46.6 56.3 44.1 84.4 36.4 38.8 201.8 70.2 51.0 27.2 20.7 171.7 52.0 45.5 50.5 41.0 144.1 55.6 45.6 108.5 30.6 205.0 116.4 59.5 149.3 96.0 40.7 53.1 60.9 36.0 49.3 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 13.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favorable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.2 4.0 11.3 2.2 12.1 3.5 11.2 36.4 27.6 8.0 9.9 3.6 5.9 3.2 16.3 8.4 9.9 6.8 15.5 6.4 8.0 3.8 5.2 4.5 8.7 1.9 16.7 5.6 17.7 8.1 4.8 8.3 2.3 14.9 7.1 5.1 3.5 6.5 8.3 7.0 11.0 3.5 10.7 21.9 2.1 13.3 18.4 11.8 0.6 21.0 5.6 3.1 7.3 6.9 1.5 2.0 13.4 0.3 1.4 1.5 0.3 1.0 1.4 2.2 10.3 0.3 0.5 3.3 0.5 0.6 0.5 0.4 1.3 15.7 0.2 21.8 0.7 3.2 3.3 1.1 0.9 0.3 1.8 0.9 3.6 8.1 2.4 0.9 7.3 4.5 0.3 8.7 0.6 0.9 1.0 14.9 2.8 3.9 2.8 2.3 1.5 1.2 1.7 0.7 0.7 6.4 3.2 2.0 1.9 1.5 1.3 7.3 2.0 13.9 9.0 2.0 1.7 4.5 2.5 16.3 3.3 26.6 0.7 1.2 1.1 1.6 0.2 0.4 3.5 0.7 13.4 0.3 0.6 1.5 0.2 1.3 1.5 1.2 1.2 0.3 1.3 1.0 1.5 0.3 1.4 0.3 2.0 0.2 0.3 11.3 12.1 36.4 27.6 8.0 3.8 16.7 5.6 14.9 11.8 26.8 3.5 0.0 2.2 0.7 6.5 6.1 5.1 2.7 12.5 3.5 0.0 1.8 6.6 2.4 114.2 4.5 1.6 0.0 7.1 0.8 1.5 1.7 2.3 3.9 0.6 1.6 5.8 2.5 0.3 52.0 3.4 1.1 1.7 1.0 2.2 7.3 4.0 3.5 4.9 4.2 4.9 6.5 1.7 2.3 2.5 1.9 0.7 1.5 2.3 1.3 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.9 31.8 22.7 25.2 1.6 2.3 18.5 29.5 22.3 35.7 32.5 56.2 24.0 20.6 11.3 10.1 16.7 20.6 31.8 22.2 33.3 52.3 16.6 20.5 25.6 26.0 0.1 33.8 27.6 1.1 1.4 33.2 13.7 4.4 17.9 27.7 27.7 25.3 31.3 32.3 29.8 21.4 16.1 27.5 39.3 30.5 44.1 11.0 11.1 17.9 21.1 12.9 27.9 63.5 7.4 13.7 41.1 33.1 9.7 15.6 40.3 16.1 45.1 22.3 10.7 35.8 22.1 42.6 19.6 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 3.0 1.7 4.5 4.8 16.4 1.3 0.8 5.1 1.4 3.4 5.2 0.0 36.2 0.0 9.4 58.5 2.3 7.0 46.7 11.7 87.4 2.8 1.3 0.0 3.4 41.1 0.0 0.0 9.8 8.3 149.1 4.6 7.4 6.8 2.8 11.6 1.2 6.7 11.8 2.5 4.6 1.1 0.0 0.9 124.1 125.8 7.2 19.3 7.9 22.7 2.0